{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "37409f3f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'D:\\\\pgkb_graph'"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from googletrans import Translator\n",
    "import tqdm\n",
    "import os\n",
    "import pandas as pd\n",
    "os.getcwd()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "264a2099",
   "metadata": {},
   "outputs": [],
   "source": [
    "translator = Translator()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "ab3da64e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "如果正常的起始剂量为>或= 75mg / m 2 /天或>或= 1.5mg / kg /天（例如在25-60mg / m 2 /天开始时，从减少的起始剂量（30-80％的正常剂量）开始或0.45-1.2毫克/千克/天），基于骨髓抑制和疾病特定指南的程度调整巯基嘌呤剂量。每次剂量调节后，允许2-4周达到稳态。如果发生骨髓抑制，并且根据其他治疗，则重点应该在还原巯基嘌呤上的其他药物。如果正常的起始剂量已经是<75mg / m 2 /天或<1.5mg / kg /天，则可能不推荐使用剂量减少。\n"
     ]
    }
   ],
   "source": [
    "result = translator.translate('Start with reduced starting doses (30-80% of normal dose) if normal starting dosea is > or = 75 mg/m2/day or > or = 1.5 mg/kg/day (e.g. start at 25-60 mg/m2/day or 0.45-1.2 mg/kg/day) and adjust doses of mercaptopurine based on degree of myelosuppression and disease-specific guidelines. Allow 2-4 weeks to reach steady-state after each dose adjustment. If myelosuppression occurs, and depending on other therapy, emphasis should be on reducing mercaptopurine over other agents. If normal starting dose is already < 75 mg/m2/day or < 1.5 mg/kg/day, dose reduction may not be recommended.', src=\"en\", dest=\"zh-CN\")\n",
    "print(result.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "7e4a3c53",
   "metadata": {},
   "outputs": [],
   "source": [
    "translate_str_list = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "9a43c081",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['variant', 'evidence_level', 'phenotype_category', 'phenotype',\n",
      "       'update_date', 'drug', 'link', 'level_modifier', 'score',\n",
      "       'data_source'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_clinical = pd.read_csv(\"processed/clinical_drug_variant_annotation.csv\", dtype=str).fillna(\"\")\n",
    "print(df_clinical.columns)\n",
    "translate_str_list.extend(list(set(df_clinical[\"phenotype\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "3880c429",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['phenotype_category', 'phenotype', 'diplotype', 'genotype',\n",
      "       'implication', 'description', 'recommendation', 'gene', 'drug',\n",
      "       'organization', 'title', 'link', 'data_source', 'update_date'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_diplotype_drug = pd.read_csv(\"processed/diplotype_drug_relation.csv\", dtype=str).fillna(\"\")\n",
    "print(df_diplotype_drug.columns)\n",
    "translate_str_list.extend(list(set(df_diplotype_drug[\"genotype\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_drug[\"implication\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_drug[\"recommendation\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "d49911f0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['diplotype', 'phenotype_category', 'phenotype', 'genotype',\n",
      "       'implication', 'description', 'recommendation', 'dosing', 'drug',\n",
      "       'organization', 'title', 'link', 'data_source', 'update_date'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_diplotype_guideline = pd.read_csv(\"processed/diplotype_record_guideline.csv\", dtype=str).fillna(\"\")\n",
    "print(df_diplotype_guideline.columns)\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"genotype\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"implication\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"recommendation\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"dosing\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "eed00e86",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['phenotype', 'diplotype', 'genotype', 'implication', 'description',\n",
      "       'recommendation', 'dosing', 'gene', 'drug', 'organization', 'title'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_geno_drug = pd.read_csv(\"processed/geno_drug_relations.csv\", dtype=str).fillna(\"\")\n",
    "print(df_geno_drug.columns)\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"genotype\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"implication\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"recommendation\"].values)))\n",
    "translate_str_list.extend(list(set(df_diplotype_guideline[\"dosing\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "cee19de0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['guideline_institute', 'guideline_name', 'drug', 'gene', 'haplotype',\n",
      "       'term', 'guideline_link', 'cancer_genome', 'literature', 'source',\n",
      "       'data_source', 'update_date'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_variant_guideline = pd.read_csv(\"processed/guideline_drug_variant_annotation.csv\", dtype=str).fillna(\"\")\n",
    "print(df_variant_guideline.columns)\n",
    "translate_str_list.extend(list(set(df_variant_guideline[\"guideline_name\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "481e8288",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['haplotype', 'phenotype_category', 'phenotype', 'genotype',\n",
      "       'implication', 'description', 'recommendation', 'dosing', 'drug',\n",
      "       'organization', 'title', 'link', 'data_source', 'update_date'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_haplotype_guideline = pd.read_csv(\"processed/haplotype_record_guideline.csv\", dtype=str).fillna(\"\")\n",
    "print(df_haplotype_guideline.columns)\n",
    "translate_str_list.extend(list(set(df_haplotype_guideline[\"genotype\"].values)))\n",
    "translate_str_list.extend(list(set(df_haplotype_guideline[\"implication\"].values)))\n",
    "translate_str_list.extend(list(set(df_haplotype_guideline[\"recommendation\"].values)))\n",
    "translate_str_list.extend(list(set(df_haplotype_guideline[\"dosing\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "4577ab11",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['phenotype_category', 'phenotype', 'diplotype', 'genotype',\n",
      "       'implication', 'description', 'recommendation', 'dosing', 'gene',\n",
      "       'drug', 'organization', 'title', 'link', 'data_source', 'update_date',\n",
      "       'variant'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_pheno_drug = pd.read_csv(\"processed/phenotype_drug_relation.csv\", dtype=str).fillna(\"\")\n",
    "print(df_pheno_drug.columns)\n",
    "translate_str_list.extend(list(set(df_pheno_drug[\"implication\"].values)))\n",
    "translate_str_list.extend(list(set(df_pheno_drug[\"description\"].values)))\n",
    "translate_str_list.extend(list(set(df_pheno_drug[\"recommendation\"].values)))\n",
    "translate_str_list.extend(list(set(df_pheno_drug[\"dosing\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "45f2b7c4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['phenotype_category', 'phenotype', 'diplotype', 'genotype',\n",
      "       'implication', 'description', 'recommendation', 'dosing', 'gene',\n",
      "       'drug', 'organization', 'title', 'link', 'data_source', 'update_date',\n",
      "       'variant'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_pheno_drug_no_metabolizer = pd.read_csv(\"processed/phenotype_drug_relation_no_metabolizer.csv\", dtype=str).fillna(\"\")\n",
    "print(df_pheno_drug_no_metabolizer.columns)\n",
    "translate_str_list.extend(list(set(df_pheno_drug_no_metabolizer[\"implication\"].values)))\n",
    "translate_str_list.extend(list(set(df_pheno_drug_no_metabolizer[\"description\"].values)))\n",
    "translate_str_list.extend(list(set(df_pheno_drug_no_metabolizer[\"recommendation\"].values)))\n",
    "translate_str_list.extend(list(set(df_pheno_drug_no_metabolizer[\"dosing\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "1fe0aba2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['drug', 'phenotype_category', 'p_value', 'bio_geo_group', 'PMID',\n",
      "       'PMID_link', 'note', 'sentence', 'diplotype', 'link', 'data_source',\n",
      "       'update_date'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_research_diplotype = pd.read_csv(\"processed/research_drug_diplotype_annotation.csv\", dtype=str).fillna(\"\")\n",
    "print(df_research_diplotype.columns)\n",
    "translate_str_list.extend(list(set(df_research_diplotype[\"note\"].values)))\n",
    "translate_str_list.extend(list(set(df_research_diplotype[\"sentence\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "0b380fea",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['drug', 'phenotype_category', 'p_value', 'bio_geo_group', 'PMID',\n",
      "       'PMID_link', 'note', 'sentence', 'variant', 'link', 'data_source',\n",
      "       'update_date'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "df_research_variant = pd.read_csv(\"processed/research_drug_variant_annotation.csv\", dtype=str).fillna(\"\")\n",
    "print(df_research_variant.columns)\n",
    "translate_str_list.extend(list(set(df_research_variant[\"note\"].values)))\n",
    "translate_str_list.extend(list(set(df_research_variant[\"sentence\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "b6c5d9bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "translate_str_list = list(filter(lambda x: x!= \"\", set(translate_str_list)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "e9b95421",
   "metadata": {},
   "outputs": [],
   "source": [
    "len(translate_str_list)\n",
    "pd.DataFrame({\"en_str\": translate_str_list}).to_csv(\"translate/en_str.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "2535b4f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "translate_str_list = list(pd.read_csv(\"translate/en_str.csv\")[\"en_str\"].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "88da31e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "translate_en_list = []\n",
    "translate_cn_list = []\n",
    "count = 0\n",
    "for t_str in translate_str_list:\n",
    "    count += 1\n",
    "    if count != 0 and count % 1000 == 0:\n",
    "        pd.DataFrame({\n",
    "            \"en_str\": translate_en_list,\n",
    "            \"cn_str\": translate_cn_list\n",
    "        }).to_csv(\"translate/translate_{}.csv\".format(count), index=False)\n",
    "        translate_en_list = []\n",
    "        translate_cn_list = []\n",
    "    \n",
    "    try:\n",
    "        result = translator.translate(t_str, src=\"en\", dest=\"zh-CN\")\n",
    "        translate_en_list.append(t_str)\n",
    "        translate_cn_list.append(result.text)\n",
    "    except:\n",
    "        continue\n",
    "\n",
    "if len(translate_en_list) > 0:\n",
    "    pd.DataFrame({\n",
    "            \"en_str\": translate_en_list,\n",
    "            \"cn_str\": translate_cn_list\n",
    "        }).to_csv(\"translate/translate_{}.csv\".format(count), index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "38caf41d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5567fd10",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "c075a774",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_translate = pd.DataFrame(columns=[\"en_str\", \"cn_str\"])\n",
    "for path in os.listdir(\"translate\"):\n",
    "    if \"translate_\" in path:\n",
    "        df_translate = pd.concat(\n",
    "            [\n",
    "                df_translate,\n",
    "                pd.read_csv(os.path.join(\"translate\", path), dtype=str, encoding=\"utf-8\").fillna(\"\")\n",
    "            ],\n",
    "            ignore_index=True,\n",
    "            axis=0\n",
    "        )\n",
    "df_translate.to_csv(\"processed/translate.csv\", index=False, encoding=\"utf-8\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "d6f6a399",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{\"Patients with the GG genotype and kidney transplantation may have increased risk for anemia when treated with mycophenolate mofetil as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to mycophenolate mofetil.; Kidney Transplantation\": '与AA基因型的患者相比，患有霉菌Mofetil时，GG基因型和肾移植的患者可能会增加贫血风险。其他遗传和临床因素也可能影响患者对霉酚酸酯Mofetil的反应。肾移植',\n",
       " 'Patients with the TT genotype and decompensated heart failure may have greater weight loss when treated with furosemide as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to furosemide.; Heart Failure': '与GG基因型患者相比，患有TT基因型和失代偿的心力衰竭的患者可能具有更大的体重减轻。其他遗传和临床因素也可能影响对呋塞米的反应。心脏衰竭',\n",
       " 'Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.': '等位基因G与抑郁症中的抑郁毒素的响应降低有关，与等位基因C相比，主要的主要响应。',\n",
       " 'Patients with tuberculosis and two copies of the NAT2*7B allele or one copy of the *7B allele in combination with one copy of the *5B or *6A alleles may have an increased risk of developing toxic liver disease when treated with anti-tuberculosis drugs as compared to patients with two copies of the *4 allele. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect the risk of developing toxic liver disease.; drug-induced liver injury;Toxic liver disease;Tuberculosis': '结核病患者和NAT2 * 7B等位基因的两份拷贝或一份* 7B等位基因与* 5B或* 6A等位基因的一份副本组合可能在用抗结核药物治疗时发育有毒肝病的风险增加与患有两种等位基因的两份拷贝的患者相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响发育有毒肝病的风险。药物诱导的肝损伤;有毒肝病;结核病',\n",
       " 'Patients carrying the CYP2D6*4 allele in combination with another no function allele may have decreased methadone dose requirements as compared to patients carrying a normal function allele in combination with a no function allele. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect methadone dose requirements.; Heroin Dependence;Opioid-Related Disorders': '携带CYP2D6 * 4等位基因与另外的功能等位基因组合的患者可能降低了与携带正常函数等位基因的患者相比的甲基剂量要求，而没有任何功能等位基因。但是，已经报告了相互矛盾的证据。这种药物变异对被CPIC分配了“不建议”，因为它被确定在临床上可操作。其他遗传和临床因素也可能影响美沙酮剂量要求。海洛因依赖;阿片类药物相关的疾病',\n",
       " 'and decreased In concentration/dose ratio.': '浓度/剂量比下降。',\n",
       " 'The number of T alleles present in a patient was positively associated with CGI-S score.': '存在于患者中的T等位基因的数量与CGI-S得分正相关。',\n",
       " 'Genotype CC is associated with decreased metabolism of fluvastatin in healthy individuals as compared to genotype AA.': '与基因型AA相比，基因型CC与氟伐他汀在健康个体中的代谢降低有关。',\n",
       " \"Patients with the TCCTC/TCCTC genotype may have decreased but not non-existent risk of side effects (thrombocytopenia, anemia and neuropathy) with cisplatin and cyclophosphamide chemotherapy regimens as compared to patients with the TC/TC or TC/TCCTC genotype. Other genetic and clinical factors may also influence a patient's risk of adverse events.s; Drug Toxicity\": '与TC / TC / TCCTC基因型患者相比，TCCTC / TCCTC基因型的患者可能降低但不存在与顺铂和环磷酰胺化疗方案的副作用（血小板减少症，贫血和神经病变的风险。其他遗传和临床因素也可能影响患者不良事件的风险;药物毒性',\n",
       " \"Patients with the AA genotype and Heroin Dependence may require a decreased dose of methadone as compared to patients with the GG genotype. This was seen in Asian patients - the opposite association was seen in a different study with White patients. Other genetic and clinical factors may also influence a patient's dose requirements.; Heroin Dependence\": '与GG基因型的患者相比，AA基因型和海洛因依赖性的患者可能需要降低的美沙酮剂量。这是在亚洲患者中看到的 - 在与白人患者的不同研究中看到相反的关联。其他遗传和临床因素也可能影响患者的剂量要求。海洛因依赖',\n",
       " 'The CYP2C19*2 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2C19*2 allele in combination with a no, decreased, normal, or increased function allele and cardiovascular disease who are treated with clopidogrel may have an increased risk for adverse cardiovascular events as compared to patients with two normal function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence the risk for adverse cardiovascular events.; Acute coronary syndrome;Cardiovascular Diseases': 'CYP2C19 * 2等位基因被CPIC分配为无功能等位基因。患有CYP2C19 * 2等位基因的患者与用氯吡格雷治疗的NO，降低，正常或增加的函数等位基因和心血管疾病可能会产生不良心血管事件的风险增加，相比具有两个正常功能等位基因的患者。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响不良心血管事件的风险。急性冠状动脉综合征;心血管疾病',\n",
       " 'Patients with the AA genotype and hypertension may have a smaller decrease in diastolic blood pressure when treated with benazepril as compared to patients with the AG or GG genotype. No significant results have been seen for systolic blood pressure. Additionally, the same study reported no significant differences in systolic or diastolic blood pressure between genotypes in a different cohort. Other genetic and clinical factors may also influence change in diastolic or systolic blood pressure.; Essential hypertension': '与AG或GG基因型的患者相比，患有AA基因型和高血压的患者可能在苯息普利患者用苯大普尔治疗时较小。对于收缩压没有显着的结果。此外，同一研究报告说报告在不同队列中基因型之间的收缩性或舒张血压没有显着差异。其他遗传和临床因素也可能影响舒张或收缩压的变化。原发性高血压',\n",
       " \"Patients with the TT genotype may have a decreased, but not absent, risk for acute rejection after kidney transplantation as compared to patients with the CC genotype but the TT genotype influence is controversy discussed among different studies. Other genetic and clinical factors may also influence a patient's risk for acute rejection after transplantation.; \": '与CC基因型患者相比，TT基因型的患者可能有降低，但不是缺席，肾移植患者急性排斥，但TT基因型影响是不同研究中讨论的TT基因型影响。其他遗传和临床因素也可能影响患者在移植后急性排斥的风险。',\n",
       " 'Patients with the CT genotype may have a reduced likelihood of being overanticoagulated when treated with phenprocoumon, and may require an increased dose, as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to and dose of phenprocoumon.; ': '与诸如CC基因型患者相比，CT基因型的患者可能具有减少的含量覆盖的可能性，并且可能需要增加剂量。其他遗传和临床因素也可能影响诸如苯处理的响应和剂量。',\n",
       " 'The current evidence base suggests that there is no significant association between the rs1799971 AA genotype and likelihood of experiencing adverse events when treated with sufentanil. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect likelihood of experiencing adverse events when treated with sufentanil.; adverse events;Pain, Postoperative': '目前的证据基础表明，在用Sufentanil处理时，RS1799971 AA基因型与在经历不良事件时没有显着关联。但是，已经报告了相互矛盾的证据。这种药物变异对被CPIC分配了“不建议”，因为它被确定在临床上可操作。其他遗传和临床因素也可能影响用Sufentanil治疗时经历不良事件的可能性。不良事件;痛苦，术后',\n",
       " 'Patients with the GT genotype who are treated with mycophenolic acid following lung transplantation may be at an increased risk of transplant rejection as compared to patients with the GG genotype. Other genetic and clinical factors may also affect response to mycophenolic acid. in lung transplant patients.; lung transplantation;transplant rejection': '与肺移植后肌霉素酸治疗的GT基因型患者可能与GG基因型的患者相比，移植抑制的风险增加。其他遗传和临床因素也可能影响对霉酚酸的反应。在肺移植患者中;肺移植;移植抑制',\n",
       " 'Allele T is associated with increased concentrations of efavirenz in people with HIV Infections as compared to allele G.': '与等位基因G.',\n",
       " 'Patients with the GG genotype and ADHD may have a better response when treated with methylphenidate as compared to patients with the AA genotype. However, other studies have failed to find this association or have found contradictory evidence. Other genetic and clinical factors may also influence response to methylphenidate.; Attention Deficit Disorder with Hyperactivity': '与AA基因型患者相比，GG基因型和ADHD的患者可能具有更好的反应，与AA基因型患者相比，当用甲基透明剂处理时。然而，其他研究未能找到此协会或发现矛盾的证据。其他遗传和临床因素也可能影响对甲基酚的反应。注意力缺陷症与多动症',\n",
       " \"Schizophrenia patients with the GG genotype may have decreased severity of tardive dyskinesia when treated with antipsychotics in people who were smokers as compared to patients with the AA or AG genotype. Genotype GG is not associated with increased QT interval in Schizophrenia patients treated with antipsychotics as compared to genotype AA. Other genetic and clinical factors may also influence a patient's risk for adverse events to antipsychotics.; Schizophrenia\": '当用AA或AG基因型患者的患者用抗精神病药治疗时，患有GG基因型的精神分裂症患者可能会降低迟钝的止吐细胞的严重程度。与基因型AA相比，基因型Gg与抗精神病药治疗的精神分裂症患者的QT间隔增加无关。其他遗传和临床因素也可能影响患者对抗精神病药的不良事件的风险。精神分裂症',\n",
       " 'Patients with the rs111888148 GG genotype may have a decreased, but not absent, risk for malignant hyperthermia based on this variant when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with genotype AG or AA. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.; Malignant Hyperthermia': '当用挥发性麻醉剂（DESFLURANE，ENFLUNANE，氟烷，异氟烷，甲氧基氟醚，七氟丙烷）和/或琥珀酰胆碱相比，基因型患者的患者有降低，但不是缺席，但不存在恶性热疗的恶性热疗风险基因型AG或AA。其他遗传或临床因素也可能影响恶性热疗的风险。恶性热疗',\n",
       " \"Patients with schizophrenia and the GG genotype may have a decreased response to quetiapine as compared to patients with the AA or AG genotypes. Other genetic or clinical factors may also affect a patient's response to quetiapine.; Schizophrenia\": '与AA或AG基因型的患者相比，精神分裂症和GG基因型的患者可能对喹硫碱的反应降低。其他遗传或临床因素也可能影响患者对喹诗的反应;精神分裂症',\n",
       " 'Plasma concentrations of midazolam (adjusted for dose) were significantly lower in carriers of the CYP3A5*1 allele compared to those with *3/*3. Concentrations of the 1´-OH-MDZ metabolite were not significantly different.': \"与含有* 3 / * 3的那些相比，Cyp3a5 * 1等位基因载体的载体血管唑（调节剂量）的血浆浓度显着降低。1'-OH-MDZ代谢物的浓度没有显着差异。\",\n",
       " \"Patients with two X-chromosomes, the CC genotype and psychiatric disorders who are treated with risperidone may have an increased risk of weight gain as compared to patients with the TT genotype. However, some studies find no association with weight gain. Other genetic and clinical factors may also influence a patient's risk for weight gain with antipsychotic treatment. This gene is on the X chromosome therefore some individuals may have only one allele.; Mental Disorders;Schizophrenia\": '与TT基因型患者相比，患有两种X-染色体，CC基因型和精神疾病的CC基因型和精神病疾病可能具有增加的体重增加风险。然而，一些研究发现没有重量增益的关联。其他遗传和临床因素也可能影响患者对抗精神病的体重增加的风险。该基因位于X染色体上，因此一些人可能只有一个等位基因。精神障碍;精神分裂症',\n",
       " 'Patients with the TT genotype may have a greater increase in HDL cholesterol when treated with pravastatin as compared to patients with the CC genotype. However, a different study finds no association with HDL cholesterol levels. Other genetic and clinical factors may also influence HDL cholesterol response.; ': '与CC基因型的患者相比，当用普伐他汀处理时，TT基因型的患者可能在HDL胆固醇中具有更大的增加。然而，不同的研究发现没有与HDL胆固醇水平相关的关联。其他遗传和临床因素也可能影响HDL胆固醇反应。',\n",
       " 'Patients with the CYP2B6 *1/*6 diplotype and chronic pain, or cancer may have decreased clearance of ketamine as compared to patients with the CYP2B6 *1/*1 diplotype and increased clearance of ketamine as compared to patients with the *6/*6 diplotypes. Other clinical and genetic factors may also influence clearance of ketamine.; Neoplasms;Pain': 'CYP2B6 * 1 / * 6二氧化型和慢性疼痛的患者可能降低了氯胺酮的清除，与CYP2B6 * 1 / * 1 / * 1二曲型患者相比，与* 6 / *相比，氯胺酮的清除率增加6张二曲型。其他临床和遗传因素也可能影响氯胺酮的间隙。肿瘤;疼痛',\n",
       " 'Patients with the AG genotype and non-small-cell lung carcinoma may have increased risk of toxicities, including thrombocytopenia, toxic liver disease, and vomiting when treated with platinum compounds compared to patients with the GG genotype. Other genetic and clinical factors may affect risk of toxicities with platinum compound treatment.; Carcinoma, Non-Small-Cell Lung': '患有AG基因型和非小细胞肺癌的患者可能增加毒性的风险，包括血小板减少症，有毒肝脏疾病，与铂化合物与GG基因型患者相比用铂化合物处理时呕吐。其他遗传和临床因素可能影响铂复合处理的毒性风险。癌，非小细胞肺',\n",
       " 'Patients with the CC genotype and non-small cell lung cancer may have an increased risk of diarrhea when treated with irinotecan as compared to patients with the CT or TT genotype. No association has been seen for neutropenia. Other genetic and clinical factors may also influence risk of diarrhea.; Carcinoma, Non-Small-Cell Lung': '与CT或TT基因型的患者相比，患有CC基因型和非小细胞肺癌的患者可能产生腹泻的风险增加。没有关联的中性粒细胞减少症。其他遗传和临床因素也可能影响腹泻的风险。癌，非小细胞肺',\n",
       " 'Consider 25% reduction of recommended starting dose.g Utilize therapeutic drug monitoring to guide dose adjustments.e': '考虑25％的推荐开始剂量减少.g利用治疗药物监测来指导剂量调整。',\n",
       " 'Genotype CC is associated with increased trough concentration of imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与白血病，髓鞘，慢性，BCR-ABL阳性增加的伊替尼的槽浓度增加有关。',\n",
       " 'Genotype GG is associated with decreased response to bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes AA + AG.': '与基因分型AA + Ag相比，基因型Gg与对具有结肠直肠肿瘤的人的抗北伐单抗，氟尿嘧啶，伊替替康省和白草素的响应减少有关。',\n",
       " 'in both European Americans and African Americans. The dose reduction per variant allele was comparable among European Americans (34.6% vs 34.4%, interaction P value=0.98) vs. African Americans.': '在欧洲人和非洲裔美国人。欧洲美国人之间的每种变体等位基因的剂量降低（34.6％与34.4％，相互作用P值= 0.98）与非洲裔美国人。',\n",
       " 'Patients with the AA genotype may have increased likelihood of Toxic liver disease when treated with ethambutol, isoniazid, pyrazinamide and rifampin in people with Tuberculosis as compared to patients with genotype GG. Other genetic and clinical factors may also influence the risk of toxicity to antituberculosis drugs.; Toxic liver disease;Tuberculosis': '患有AA基因型的患者可能会增加有毒肝脏疾病的可能性，当用基因型GG患者与结核病的患者用乙胺醇，异烟醇，吡嗪酰胺和利福平有毒肝病。其他遗传和临床因素也可能影响毒性毒性的毒性。有毒肝病;结核病',\n",
       " 'Patients with the TT genotype may have an increased risk of Heroin Dependence when exposed to heroin as compared to patients with the AA genotype. Other genetic and clinical factors may also influence risk of Heroin Dependence.; Heroin Dependence': '与AA基因型患者相比，TT基因型的患者可能导致海洛因依赖性的风险增加。其他遗传和临床因素也可能影响海洛因依赖的风险。海洛因依赖',\n",
       " \"Patients with the TT genotype may have a decreased response to mexiletine as compared to patients with the GG genotype. Other genetic and clinical factors may also affect a patient's response to mexiletine.; Myotonic Disorders\": '与GG基因型的患者相比，TT基因型的患者可能对甘石的反应降低。其他遗传和临床因素也可能影响患者对梅西汀的反应。肌肌号疾病',\n",
       " 'Patients with the rs10929302 GG genotype may have decreased risk of neutropenia when treated with irinotecan as compared to patients with the AA genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence irinotecan-related toxicity.; Neutropenia': '与AA基因型患者相比，患有RS10929302 GG基因型的患者可能降低了中性粒细胞率的风险。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响伊耳丹相关的毒性。中性粒细胞减少症',\n",
       " 'The TPMT*4 allele is assigned as a no function allele by CPIC. Patients with the *4 allele, in combination with a normal function allele or a no function allele, may have an increased likelihood of toxicity when treated with mercaptopurine as compared to patients with two normal function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence mercaptopurine toxicity.; ': 'TPMT * 4等位基因被CPIC分配为无功能等位基因。患者患有* 4等位基因，与正常功能等位基因组合或无功能等位基因组合，当用巯基嘌呤处理时，毒性可能会增加毒性，而与具有两个正常功能等位基因的患者相比，含有巯基嘌呤的毒性。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响巯基嘌呤毒性。',\n",
       " 'Patients with the GT genotype may have decreased sulfation of acetaminophen as compared to patients with the TT genotype. Other genetic and clinical factors may also affect acetaminophen sulfation.; ': '与TT基因型的患者相比，GT基因型的患者可能降低了乙酰氨基酚的硫酸化。其他遗传和临床因素也可能影响乙酰氨基酚硫化。',\n",
       " 'The CYP2D6*5 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2D6*5 allele in combination with a no, decreased or normal function allele who are treated with nortriptyline may have an increased likelihood of treatment side effects as compared to patients with alleles that result in a normal metabolizer phenotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence treatment related side effects.; Depressive Disorder': 'CYP2D6 * 5等位基因由CPIC分配为NO功能等位基因。患有CYP2D6 * 5等位基因的患者与Nortriptyline治疗的NO，减少或正常功能等位基因组合可能具有增加的治疗副作用的可能性，与导致正常代谢物表型的等位基因患者相比，治疗副作用。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响治疗相关副作用。抑郁症',\n",
       " 'Patients with the CT genotype may have an increased chance of response to treatment with docetaxel and thalidomide as compared to patients with the TT genotypes. Other genetic and clinical factors may also influence treatment response.; Prostatic Neoplasms': '与TT基因型的患者相比，CT基因型的患者可能具有增加对多西紫杉醇和沙利度胺治疗的几率。其他遗传和临床因素也可能影响治疗反应。前列腺肿瘤',\n",
       " \"Patients with the GG genotype (do not have a copy of the CFTR G970R variant) and cystic fibrosis have an unknown response to ivacaftor treatment, as response may depend on the presence of other CFTR variants. Other genetic and clinical factors may also influence a patient's response to ivacaftor.; Cystic Fibrosis\": '患有GG基因型的患者（不具有CFTR G970R变体的副本）和囊性纤维化对IVACafetor治疗具有未知的反应，因为响应可能取决于其他CFTR变体的存在。其他遗传和临床因素也可能影响患者对IVACAFTOR的反应。囊性纤维化',\n",
       " 'Genotypes AG + GG are associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.': '与基因型AA相比，基因型Ag + Gg与心瓣置换的人们的含量增加的造成剂量增加。',\n",
       " \"Female patients with the AA genotype and Migraine who are treated with folic acid and a vitamin b-complex may have decreased severity of pain as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's severity of pain.; Migraine with Aura\": '与叶酸和维生素B-复合物治疗的AA基因型和偏头痛的女性患者可能降低了与GG基因型的患者疼痛的严重程度。其他遗传和临床因素也可能影响患者的疼痛严重程度。偏头痛与光环',\n",
       " \"Patients with hypertension and the AG genotype may have an increased response to hydrochlorothiazide, as measured by a decrease in systolic blood pressure, as compared to patients with the GG genotype. Other genetic and clinical factors may also affect a patient's response to hydrochlorothiazide.; Hypertension\": '高血压和Ag基因型的患者可能对氢氯噻嗪的反应增加，如通过收缩压的降低而测量，与GG基因型的患者相比。其他遗传和临床因素也可能影响患者对氢氯噻嗪的反应。高血压',\n",
       " 'The CYP2D6*4 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2D6*4 allele in combination with a no, decreased or normal function allele may have decreased metabolism of fluvoxamine as compared to patients with alleles that result in a normal metabolizer phenotype. This annotation only covers the pharmacokinetic relationship between CYP2D6 and fluvoxamine and does not include evidence about clinical outcomes. Be aware that the CPIC guideline for fluvoxamine and CYP2D6 has a ‘no recommendation’ for ultrarapid metabolizers. This drug-variant pair has been assigned a “no recommendation” by DPWG, as it was determined to be not clinically actionable. Other genetic and clinical factors may also influence metabolism of fluvoxamine.; Depressive Disorder': 'CYP2D6 * 4等位基因被CPIC分配为无功能等位基因。携带CYP2D6 * 4等位基因的患者与NO，降低或正常的功能等位基因组合可能会降低氟戊胺的代谢，相比具有正常代谢物表型的等位基因的患者。该注释仅涵盖CYP2D6和FLUVOXAMINE之间的药代动力学关系，并且不包括有关临床结果的证据。请注意，Fluvoxamine和Cyp2D6的CPIC指南为UltraRAPID代谢者提供了“无建议”。这种药物变异对被DPWG分配了“不建议”，因为它被确定在临床上不可缩小。其他遗传和临床因素也可能影响氟毒素的代谢。抑郁症',\n",
       " \"Children with the AA genotype and Precursor Cell Lymphoblastic Leukemia-Lymphoma who are treated with combination chemotherapy may have a worse treatment response as compared to patients with the AC or CC genotype. Other genetic and clinical factors may also influence a patient's response to treatment.; \": '与AC或CC基因型患者相比，用组合化疗治疗的AA基因型和前体细胞淋巴细胞白血病淋巴瘤的儿童可能具有较差的治疗响应。其他遗传和临床因素也可能影响患者对治疗的反应。',\n",
       " 'Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele A.': '与等位基因A相比，等位基因G与哮喘儿童皮质类固醇的响应降低有关。',\n",
       " 'Extremely high concentrations of TGN metabolites; fatal toxicity possible without dose decrease.  Greatly increased risk of thiopurine-related leukopenia, neutropenia, myelosuppression.': '极高浓度的TGN代谢物;没有剂量减少的致命毒性可能会降低。大大增加了硫嘌呤相关的白细胞减少症风险，中性粒细胞率，骨髓抑制。',\n",
       " 'Patients with the TT genotype and cancer may have a decreased risk for experiencing drug toxicity, particularly hand-foot syndrome, when treated with capecitabine as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk for experiencing drug toxicity when treated with capecitabine.; Neoplasms': '与CC基因型患者相比，TT基因型和癌症的患者可能对经历药物毒性的风险降低，特别是手提氏综合征，特别是用CCITABINE治疗。当用Capecitabine处理时，其他遗传和临床因素也可能影响体验药物毒性的风险。肿瘤',\n",
       " \"Patients with the AA genotype and Alzheimer's disease may have increased response to galantamine compared to patients with the AG or GG genotype. Other genetic and clinical factors may also impact the metabolism of galantamine .; Alzheimer Disease\": '与AG或GG基因型患者相比，患有AA基因型和阿尔茨海默病的患者可能对加兰酮的反应增加。其他遗传和临床因素也可能影响加兰汀的代谢。;阿尔茨海默病',\n",
       " 'The CYP2C19*1 allele is assigned as a normal function allele by CPIC. Patients carrying the CYP2C19*1 allele in combination with another normal function allele may have increased metabolism of dexlansoprazole as compared to patients with a no or decreased function allele in combination with a normal or increased function allele or with two no or decreased function alleles. This annotation only covers the pharmacokinetic relationship between CYP2C19 and dexlansoprazole and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of dexlansoprazole.; ': 'CYP2C19 * 1等位基因由CPIC分配为正常功能等位基因。携带CYP2C19 * 1等位基因与另一个正常功能等位基因组合的患者可能增加DexlansoLazole的代谢，而与NO或降低的功能等位基因与正常或增加的功能等位基因组合或有两种没有或减少的功能等位基因。该注释仅涵盖CYP2C19和DexlansoLazole之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响DexlansoLazole的代谢。',\n",
       " 'Patients with the AA genotype who are treated with allopurinol may have a decreased risk of DRESS Syndrome or Stevens-Johnson Syndrome as compared to patients with the AG or GG genotypes. Please note: the AG and GG genotypes were found to be in high linkage disequilibrium with an allele known to be associated with SCARs, HLA*58:01. Other clinical and genetic factors may also influence risk of DRESS Syndrome or Stevens-Johnson Syndrome in patients administered allopurinol.; drug reaction with eosinophilia and systemic symptoms;Stevens-Johnson Syndrome': '与AG或GG基因型的患者相比，患有Allopurinol治疗的AA基因型的AA基因型可能具有降低的综合征或史蒂文森 - 约翰逊综合征的风险。请注意：发现AG和GG基因型在高键入不平衡中，已知与瘢痕相关，HLA * 58：01相关。其他临床和遗传因素也可能影响服装综合征或史蒂文斯 - 约翰逊综合征的患者患者Allopurinol。药物反应与嗜酸性粒细胞和全身症状;史蒂文斯 - 约翰逊综合征',\n",
       " 'Genotype GG is associated with response to benazepril in women with Hypertension as compared to genotype AA.': '与基因型AA相比，基因型Gg与高血压患者的苯大普蛋白普利有关。',\n",
       " \"Patients with the AA genotype and Schizophrenia may have increased clearance of olanzapine as compared to patients with the AG or GG genotype. However, contradictory findings for no association are reported. Other genetic and clinical factors may also influence a patient's response to olanzapine.; Schizophrenia\": '与AG或GG基因型的患者相比，患有AA基因型和精神分裂症的患者可能会增加奥氮平的间隙。但是，报告了没有关联的矛盾调查结果。其他遗传和临床因素也可能影响患者对奥氮平的反应。精神分裂症',\n",
       " 'Patients with the CC genotype may require an increased dose of phenprocoumon as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence dosage of phenprocoumon.; ': '与CT或TT基因型的患者相比，CC基因型的患者可能需要增加的苯处理剂量增加。其他遗传和临床因素也可能影响诸如苯处理的剂量。',\n",
       " 'When considering the RECIPIENT genotype, CYP3A5 expressers required 0.012 (95% CI 0.005-0.018) mg/kg higher tacrolimus daily dose.': '在考虑受体基因型时，CYP3A5表达者需要0.012（95％CI5-0.018）Mg / kg较高的Tacrolimus每日剂量。',\n",
       " 'Patients with the AA genotype and nephrotic syndrome may have an increased response when treated with tacrolimus as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence response to tacrolimus treatment in patients with nephrotic syndrome.; Nephrotic Syndrome': '与AG或GG基因型的患者相比，患有AA基因型和肾病综合征的患者可能具有增加的响应率。其他遗传和临床因素也可能影响肾病综合征患者的曲粒治疗的反应。肾病综合征',\n",
       " 'Patients with the CT genotype and non-small-cell lung carcinoma may have increased risk of toxicities, including anemia, leukopenia, thrombocytopenia, toxic liver disease, and vomiting when treated with platinum compounds compared to patients with the CC genotype. Other genetic and clinical factors may affect risk of toxicities with platinum compound treatment.; Carcinoma, Non-Small-Cell Lung': '与铂化合物相比，患有CT基因型和非小细胞肺癌的患者可能会增加毒性的风险增加，包括贫血，白细胞减少，血小板，有毒肝病和呕吐。其他遗传和临床因素可能影响铂复合处理的毒性风险。癌，非小细胞肺',\n",
       " 'Patients with the rs7597593 TT genotype may have a decreased risk of developing opioid dependence when exposed to opioids as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk of developing opioid dependence.; Opioid-Related Disorders': '与CC基因型的患者相比，患者患有RS7597593 TT基因型可能会降低开发阿片类药物依赖性的风险。其他遗传和临床因素也可能影响开发阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " \"Patients with genotype AG may have increased plasma drug levels of phenytoin in people with no disease as compared to genotype GG. However, another study reported no association between this variant and increased dose of phenytoin in people with Epilepsy. Other genetic and clinical factors may influence a patient's dose of phenytoin.; \": '与基因型GG相比，基因型AG的患者可能对没有疾病的人的苯妥汀的血脂水平增加。然而，另一项研究报告了这种变体与癫痫患者的苯妥汀的苯妥汀之间的关联。其他遗传和临床因素可能影响患者的苯妥辛。',\n",
       " \"Patients with the ATTTGTTCATGCCT/ATTTGTTCATGCCT genotype and early stage Rheumatoid Arthritis who are treated with methotrexate may have a poorer response as compared to patients with the del/del genotype. This association was not seen in a separate study of long-term RA patients. Other genetic and clinical factors may also influence a patient's response to methotrexate treatment.; Arthritis, Rheumatoid\": '患有Atttgttcatgcct / Atttgttcatgcct基因型和早期用甲氨蝶呤治疗的类风湿性关节炎可能具有较差的反应，与Del / del基因型患者相比。在长期RA患者的单独研究中没有看到这种关联。其他遗传和临床因素也可能影响患者对甲氨蝶呤治疗的反应。关节炎，类风湿',\n",
       " \"Patients with the AG genotype and breast cancer who are treated with cyclophosphamide may have a decreased survival as compared to patients with the AA genotype or may have increased survival as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's survival when treated with cyclophosphamide.; Breast Neoplasms\": '与环磷酰胺处理的AG基因型和乳腺癌的患者可能会降低存活率，与AA基因型的患者相比，与GG基因型的患者相比，存活率增加。当用环磷酰胺处理时，其他遗传和临床因素也可能影响患者的存活。乳房肿瘤',\n",
       " 'No significant findings available.; Carcinoma, Non-Small-Cell Lung': '没有重要的发现。癌，非小细胞肺',\n",
       " \"Patients with rs9958628 AT genotype may have an increased risk of Pegaspargase Hypersensitivity as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk of Pegaspargase Hypersensitivity.; \": '与AA基因型的患者相比，基因型患者在基因型上的患者可能具有增加的PEGASPARGASE过敏的风险。其他遗传和临床因素也可能影响患者PEGASPARGASE超敏的风险;',\n",
       " \"Patients with the GG genotype and Epilepsy who are treated with carbamazepine, phenytoin or valproic acid may have increased risk for drug-resistance as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk for drug-resistance.; Epilepsy\": '与AA基因型的患者相比，患有卡巴马嗪或缬氨酸或丙戊酸的GG基因型和癫痫的患者可能会增加耐药风险。其他遗传和临床因素也可能影响患者的耐药风险;癫痫',\n",
       " 'Patients with breast cancer and the rs2449598 TT genotype may have a decreased response to anastrozole as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to anastrozole.; Breast Neoplasms': '与GG基因型的患者相比，乳腺癌和乳腺癌的患者和RS2449598 TT基因型可能对Anstrozole的反应降低。其他遗传和临床因素也可能影响对Anstrozole的反应。乳房肿瘤',\n",
       " \"Patients with the AA genotype and HIV who are treated with nevirapine may have decreased clearance of nevirapine as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence a patient's response to nevirapine.; HIV Infections\": '与AG或GG基因型的患者相比，患有Nevirapine治疗的AA基因型和艾滋病毒的患者可能降低了Nevirapine的清除。其他遗传和临床因素也可能影响患者对Nevirapine的反应。艾滋病毒感染',\n",
       " 'The study reported this variant as within the MDFI gene with alleles G/T. [stat_test: chi squared allele test]': '该研究报告了与MDFI基因内的这种变体，其等位基因G / T.[stat_test：chi squared等位基因测试]',\n",
       " 'Patients with the rs578776 AG genotype may have a decreased risk for nicotine dependence as compared to patients with the GG genotype, or an increased risk as compared to patients with the AA genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk for nicotine dependence and cotinine levels.; Tobacco Use Disorder': '患有RS578776 AG基因型的患者可能对尼古丁依赖性的风险降低，与患有GG基因型的患者相比，与AA基因型患者相比，风险增加。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响尼古丁依赖性和胞苷水平的风险。烟草使用障碍',\n",
       " 'Patients with the AG genotype and receiving methadone maintenance therapy may have increased plasma concentrations of cotinine, a metabolite of nicotine, as compared to patients with the GG genotype. Other genetic and clinical factors may also affect plasma concentrations of cotinine in patients receiving methadone maintenance therapy.; ': '与GG基因型的患者相比，患者AG基因型和接受美沙酮维持治疗的血浆浓度增加，尼古丁代谢物。其他遗传和临床因素还可能影响接受美沙酮维持治疗患者的血浆浓度。',\n",
       " \"Patients with the CC genotype may have increased response to risperidone as compared to patients with the CG and GG genotypes. Other genetic and clinical factors may also influence a patient's response to risperidone.; \": '与CG和GG基因型的患者相比，CC基因型的患者可能对Risperidone的反应增加。其他遗传和临床因素也可能影响患者对Risperidone的反应。',\n",
       " 'Healthy males with the CG genotype may have smaller increases in fractional shortening and systolic blood pressure when given dobutamine, as compared to healthy males with the CC genotype. No significant differences were seen for heart rate. Other genetic and clinical factors may also influence fractional shortening and systolic blood pressure.; ': '与CC基因型的健康雄性相比，含有CG基因型的健康雄性可能较小，分数缩短和收缩压，与健康雄性相比。对于心率没有显着差异。其他遗传和临床因素也可能影响分数缩短和收缩压。',\n",
       " \"Patients with the TT genotype and type II diabetes who are treated with sulfonylureas may be less likely to achieve a target HbA1c level of <7% as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response.; Diabetes Mellitus, Type 2\": '与磺酰脲处理的TT基因型和II型糖尿病患者可能不太可能达到与GG基因型患者相比的靶HBA1C水平<7％。其他遗传和临床因素也可能影响患者的反应。糖尿病，2型',\n",
       " 'CYP2D6 *10/*10 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1/*1.': '与CYP2D6 * 1 / * 1相比，CYP2D6 * 10 / * 10与健康个体中的右旋沙氏肾上腺素的代谢降低有关。',\n",
       " 'Patients with the CT genotype and heart valve replacement may require a larger stable dose of warfarin compared to patients with the CC genotypes, although this is contradicted in one study. Other clinical and genetic factors affect stable dose of warfarin.; heart valve replacement': '与CC基因型的患者相比，CT基因型和心脏瓣膜置换患者可能需要更大的稳定剂量的Warfarin，尽管这在一项研究中相矛盾。其他临床和遗传因素影响稳定的Warfarin剂量。心瓣换乘',\n",
       " 'Patients with the rs2298383 CT genotype and Rheumatoid Arthritis who are treated with methotrexate may have a decreased, but not absent, risk for adverse events as compared to patients with the TT genotype or may have an increased risk for adverse events as compared to patients with the CC genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk for adverse events when treated with methotrexate.; Arthritis, Rheumatoid': '与TT基因型的患者相比，甲氨蝶呤治疗的RS2298383 CT基因型和类风湿性关节炎的患者可能有降低，但不存在不良事件的风险，或者与患者相比，不良事件的风险增加CC基因型。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能在用甲氨蝶呤处理时影响不良事件的风险。关节炎，类风湿',\n",
       " 'Patients with the AG genotype and schizophrenia may have a greater increase in total cholesterol levels when treated with HMG-CoA reductase inhibitors as compared to patients with the GG genotype. Other genetic and clinical factors may also influence total cholesterol levels.; Schizophrenia': '与GG基因型患者相比，当用HMG-CoA还原酶抑制剂进行处理时，AG基因型和精神分裂症的患者可能具有更大的总胆固醇水平。其他遗传和临床因素也可能影响总胆固醇水平;精神分裂症',\n",
       " 'Patients with the AG genotype and non-small cell lung cancer who are treated with platinum compounds may have a increased severity of thrombocytopenia as compared to patients with the AA genotype. Other clinical and genetic factors may also influence risk of thrombocytopenia in patients with non-small lung cancer who are treated with platinum compounds.; Thrombocytopenia': '与铂化合物处理的AG基因型和非小细胞肺癌患者可能对血小板减少症的严重程度增加，与AA基因型患者相比。其他临床和遗传因素也可能影响用铂化合物处理的非小肺癌患者血小板减少症的风险。血小板减少症',\n",
       " 'Patients with the AA genotype and Rheumatoid Arthritis or Juvenile Rheumatoid Arthritis may have decreased response when treated with methotrexate as compared to patients with the GG genotype. Other genetic and clinical factors may also influence methotrexate response.; Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid': '患有AA基因型和类风湿性关节炎或青少年类风湿性关节炎的患者可能会减少与甲氨蝶呤相比用GG基因型的患者进行处理时的响应。其他遗传和临床因素也可能影响甲氨蝶呤反应。关节炎，青少年风湿;关节炎，类风湿性',\n",
       " \"Patients with the GG genotype may have poorer pain relief response to rofecoxib as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to rofecoxib.; \": '与CC基因型患者相比，GG基因型的患者可能对ROFecoxib的痛苦反应较差。其他遗传和临床因素也可能影响患者对Rofecoxib的反应。',\n",
       " 'Patients with the AA genotype and ulcerative colitis may have a poorer response to anti-TNF therapy as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to anti-TNF therapy.; Colitis, Ulcerative': '与GG基因型患者相比，患有AA基因型和溃疡性结肠炎的患者可能对抗TNF治疗的反应较差。其他遗传和临床因素也可能影响对抗TNF治疗的反应。结肠炎，溃疡性',\n",
       " 'Patients with the GT genotype and cancer who are treated with erlotinib may have decreased severity of Diarrhea compared to patients with the GG genotype. Other genetic and clinical factors may also influence severity of Diarrhea when treated with erlotinib.; Neoplasms': '与欧洛替尼治疗的GT基因型和癌症的患者可能与GG基因型的患者相比，腹泻的严重程度降低。其他遗传和临床因素也可能在用Erlotinib处理时影响腹泻的严重程度。肿瘤',\n",
       " 'Patients with the CT genotype and schizophrenia may have greater weight gain when treated with risperidone as compared to patients with the TT genotype. Other genetic and clinical factors may also influence weight gain in patients taking risperidone.; Schizophrenia': '与TT基因型患者相比，患有CT基因型和精神分裂症的患者可能具有更大的体重增加。其他遗传和临床因素也可能影响服用risperidone的患者的体重增加。精神分裂症',\n",
       " 'Patients with the GG genotype and decompensated heart failure may have less weight loss when treated with furosemide as compared to patients with the TT genotype. Other genetic and clinical factors may also influence response to furosemide.; Heart Failure': '与TT基因型患者相比，GG基因型和失代偿性心力衰竭的患者可能具有较小的体重减轻。其他遗传和临床因素也可能影响对呋塞米的反应。心脏衰竭',\n",
       " 'Patients with the *1/*3 genotype and bipolar disorder and other psychotic disorders may have decreased dose of valproic acid compared to patients with the *1/*1 genotype. However, dose-adjusted and absolute serum concentrations were not found to differ by genotype. Other clinical and genetic factors may affect required dose of valproic acid.; Bipolar Disorder;Psychotic Disorders': '与患有* 1 / * 1基因型的患者相比，患者* 1 / * 3基因型和双相障碍和其他精神障碍和其他精神病患者的剂量降低。然而，未发现剂量调节和绝对的血清浓度因基因型而异。其他临床和遗传因素可能会影响所需剂量的丙戊酸。双相障碍;精神病疾病',\n",
       " 'The current evidence base suggests that there is no significant association between the rs1801131 GT genotype and methotrexate dosage in patients with ALL. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence methotrexate dose requirements.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '目前的证据基础表明，全部患者的RS1801131 GT基因型和甲氨蝶呤剂量之间没有显着关联。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响甲氨蝶呤剂量要求。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " \"Patients with the CT genotype and Rheumatoid Arthritis who are treated with methotrexate may have an increased risk of adverse events as compared to patients with the CC genotype or may have a decreased, but not absent, risk of adverse events as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for adverse events when treated with methotrexate.; Arthritis, Rheumatoid\": '与甲氨蝶呤治疗的CT基因型和类风湿性关节炎的患者可能导致不良事件的风险增加，而与CC基因型或可能有降低，但不存在不良事件的风险相比，与TT的患者相比基因型。其他遗传和临床因素也可能影响患者在用甲氨蝶呤处理时对不良事件的风险。关节炎，类风湿',\n",
       " 'Patients with the rs4149056 TT genotype may have decreased serum concentrations of simvastatin acid as compared to patients with the CC or CT genotypes. This annotation only covers the pharmacokinetic relationship between rs4149056 and simvastatin acid and does not include evidence about clinical outcomes. Other genetic and clinical factors may also affect serum concentrations of simvastatin acid.; ': '与CC或CT基因型的患者相比，患有RS4149056 TT基因型的血清浓度可能降低了血清浓度。该注释仅涵盖RS4149056和辛伐他汀酸之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响血清浓度的辛伐他汀酸。',\n",
       " \"Patients with the GA genotype and Epilepsy who are treated with carbamazepine, phenytoin or valproic acid may have increased risk for drug-resistance as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk for drug-resistance.; Epilepsy\": '与AA基因型的患者相比，患有卡巴马嗪或缬氨酸或丙戊酸的GA基因型和癫痫患者可能会增加耐药风险。其他遗传和临床因素也可能影响患者的耐药风险;癫痫',\n",
       " \"Patients with the CT genotype may begin using heroin at a later age as compared to patients with the TT genotype. Other genetic and clinical factors may also affect a patient's age at first use of heroin.; Heroin Dependence\": '与TT基因型患者相比，CT基因型的患者可以在后期使用海洛因。其他遗传和临床因素也可能在首次使用海洛因时影响患者的年龄。海洛因依赖',\n",
       " 'Patients with the GG genotype and epilepsy may have decreased clearance of carbamazepine as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence carbamazepine clearance.; Epilepsy': '与AA或AG基因型的患者相比，GG基因型和癫痫患者可能降低了卡巴马嗪的间隙。其他遗传和临床因素也可能影响血小胺脂的间隙。癫痫',\n",
       " 'Genotypes CT + TT are associated with increased clearance of tacrolimus in people with Kidney Transplantation as compared to genotype CC.': '与基因型CC相比，基因型CT + TT与肾移植的人中的曲粒素的间隙增加有关。',\n",
       " 'Patients with the AT genotype and stable coronary artery disease who are treated with clopidogrel may have increased risk of hemorrhage as compared to patients with the AA genotype and decreased risk as compared to the TT genotype. Other clinical and genetic factors may also influence risk of hemorrhage in patients with stable coronary artery disease who are treated with clopidogrel.; Coronary Artery Disease': '与氯吡格雷治疗的基因型和稳定冠状动脉疾病的患者可能会增加出血风险，与AA基因型的患者相比，与TT基因型相比，风险降低。其他临床和遗传因素也可能影响用氯吡格雷治疗的稳定冠状动脉疾病患者出血风险。冠状动脉疾病',\n",
       " 'Patients with the null/null genotype may have a decreased risk for neutropenia when treated with clozapine as compared to patients with the null/non-null or non-null/non-null genotype. Other genetic and clinical factors may also influence neutropenia risk.; ': '与柠檬嘧啶处理相比，含有Null / Null基因型的患者可能对中性粒细胞率降低的风险降低，与零核或非零空穴/非零基因型的患者相比，中性粒细胞凋亡。其他遗传和临床因素也可能影响中性粒细胞减少风险。',\n",
       " 'Patients with the GG genotype and receiving chemotherapy treatment may have decreased severity of nausea as compared to patients with the AG genotype. Other genetic and clinical factors may also affect the severity of nausea following chemotherapy treatment.; Neoplasms': '与AG基因型患者相比，GG基因型和接受化疗治疗的患者可能会降低恶心的严重程度。其他遗传和临床因素也可能影响化疗治疗后恶心的严重程度。肿瘤',\n",
       " \"Patients with the CC genotype may be at a decreased risk of developing alcoholism as compared to patients with the AA or AC genotypes. Other genetic and clinical factors may also affect a patient's risk of developing alcoholism.; Alcoholism\": '与AA或AC基因型的患者相比，CC基因型的患者可能会降低发育酒精中毒的风险。其他遗传和临床因素也可能影响患者发育酗酒的风险。酗酒',\n",
       " 'MR of was higher for *17/*17 (n=10) mean value 3.94 as compared to *1/*17 (n=23) mean value 1.45 (p<0.001) or compared to mean MR values *1/*1(n=12) =0.56 or *1/*2 (n=13)=0.59 (both p<0.001).': '与* 1 / * 17（n = 23）平均值1.45（p <0.001）或与平均MR值相比，MR更高的* 17 /β17（n = 10）平均值3.94。或者与平均mR值* 1 / * 1相比（n = 12）= 0.56或* 1 / * 2（n = 13）= 0.59（P <0.001）。',\n",
       " 'Patients with the rs79910351 TT genotype may have a decreased response to fentanyl as compared to patients with the CC genotype. Other genetic and clinical factors may also affect response to fentanyl.; ': '与CC基因型患者相比，RS79910351 TT基因型的患者可能对芬太尼的响应降低。其他遗传和临床因素也可能影响对芬太尼的反应。',\n",
       " 'Patients with the TT genotype may have lower tamoxifen-induced increase in triglycerides in postmenopausal woman as compared to patients with the CC genotype. Other genetic and clinical factors may influence the response to tamoxifen.; ': '与CC基因型患者相比，患有TT基因型的蛋白质诱导的绝经后蛋白质蛋白蛋白质诱导的甘油三酯增加。其他遗传和临床因素可能影响对他莫昔芬的反应。',\n",
       " \"Patients with the SLC6A4 HTTLPR long form (L allele)/HTTLPR short form (S allele) genotype who are treated with citalopram may have decreased response as compared to patients with the SLC6A4 HTTLPR long form (L allele)/HTTLPR long form (L allele) genotype. However, contradictory findings exist reporting no association with the genotype and citalopram response. Other genetic and clinical factors may also influence a patient's response to citalopram.; Depressive Disorder, Major\": '用CitalOpram治疗的SLC6A4 HTTLPR长形式（L等位基因）/ HTTLPR短型（S等位基因）基因型可能会降低响应，与SLC6A4 HTTLPR长形（L等位基因）/ HTTLPR长形式（L等位基因）基因型。然而，存在与基因型和西酞普兰反应的关系报告的矛盾发现。其他遗传和临床因素也可能影响患者对西酞普兰的反应。抑郁症，主要',\n",
       " 'Patients with the *14/*1A may have decreased lipid-lowering efficacy to fluvastatin in elderly hypercholesterolemic patients as compared to patients with the *14/*14 genotype. Other genetic and clinical factors may also influence response to fluvastatin.; Hypercholesterolemia': '与* 14 / * 14基因型的患者相比，患有* 14 / * 1A的患者对老年高胆固醇血症患者的脂肪磷酸素降低。其他遗传和临床因素也可能影响对氟伐他汀的反应。高胆固醇血症',\n",
       " 'Allele C is associated with decreased response to allopurinol.': '等位基因型C与对Allopurinol的反应降低有关。',\n",
       " 'Select alternative drug not predominantly metabolized by CYP2D6.d': '选择不受CYP2D6.D代谢的替代药物',\n",
       " 'Patients with the AT genotype may have decreased likelihood of Diabetes Mellitus when treated with hydrochlorothiazide in people with Hypertension as compared to patients with genotype TT. Other genetic and clinical factors may also influence the risk of toxicity to hydrochlorothiazide.; Diabetes Mellitus;Hypertension': '当用高血压患者与基因型TT患者相比，患有糖尿病患者的基因型可能降低了糖尿病的可能性。其他遗传和临床因素也可能影响氢氯噻嗪的毒性风险。糖尿病;高血压',\n",
       " 'Patients with the AA genotype are unlikely to be resistant to warfarin and may require a decreased dose of warfarin as compared to patients with the AC or CC genotype. Other genetic and clinical factors may also influence warfarin dose.; ': '与AC或CC基因型患者相比，患有AA基因型的患者可能对华法林有可能需要降低的华法林剂量。其他遗传和临床因素也可能影响华法林剂量。',\n",
       " \"Patients with the TT genotype and precursor cell lymphoblastic leukemia-lymphoma who are treated with methotrexate may have an increased risk for GI toxicity as compared to patients with the CC genotype. However, contradictory findings have been reported. Other genetic and clinical factors may also influence a patient's risk for GI toxicity when treated with methotrexate.; Precursor Cell Lymphoblastic Leukemia-Lymphoma\": '与甲氨蝶呤治疗的TT基因型和前体细胞淋巴细胞白血病淋巴瘤患者可能对患有CC基因型的患者相比，GI毒性的风险增加。但是，已经报道了矛盾的结果。当用甲氨蝶呤处理时，其他遗传和临床因素也可能影响患者在患者的GI毒性的风险。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'CYP2C9 *1/*1 is associated with increased dose of warfarin.': 'CYP2C9 * 1 / * 1与Warfarin的增加剂量相关。',\n",
       " 'Significantly lower baseline plasma levels of IP-10 were associated with this SNP. Lower levels of IP-10 were found to be statistically significantly associated with better treatment outcome. This SNP was found to be in strong linkage disequilibrium with rs8099917.': '显着降低IP-10的基线血浆水平与该SNP相关。发现较低级别的IP-10与更好的治疗结果有统计显着相关。该SNP被发现与RS8099917具有强烈的连锁不平衡。',\n",
       " 'Low or reduced risk of abacavir hypersensitivity': '减少或降低了Abacavir超敏反应的风险',\n",
       " 'measured by concentration/(dose/body weight) ratio. (alleles complemented to plus strand). No TT homozygotes were observed.': '通过浓度/（剂量/体重）比率测量。（等位基因补充为加号）。没有观察到TT纯合子。',\n",
       " 'Patients with the AG genotype may have increased risk of sensory peripheral neuropathy when treated with paclitaxel in women with breast cancer as compared to patients with genotype GG. Other genetic or clinical factors may also influence the risk of toxicity to paclitaxel.; ': '当与乳腺癌患者的患者与基因型GG患者相比，患有AG基因型的患者可能会增加感觉周围神经病变的风险。其他遗传或临床因素也可能影响对紫杉醇的毒性风险。',\n",
       " 'Patients with the TT genotype and hypertriglyceridemia may have a decreased response when treated with fenofibrate as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to fenofibrate.; Hypertriglyceridemia': '与CC基因型患者相比，用TT基因型和高甘油钙化血症的患者可能具有减少的响应，与CC基因型患者相比。其他遗传和临床因素也可能影响对环境纤维的反应。过度甘油脂血症',\n",
       " 'Post-menopausal women with the AA genotype and breast cancer may have decreased disease free survival when treated with tamoxifen as compared to patients with the AC and CC genotypes. Other genetic and clinical factors may also influence response to tamoxifen.; Breast Neoplasms;Menopause': '与AC和CC基因型患者相比，患有AA基因型和乳腺癌的绝经后妇女可能会减少无病的自由存活。其他遗传和临床因素也可能影响对Tamoxifen的反应。乳腺肿瘤;更年期',\n",
       " 'Patients with the TT genotype and age-related macular degeneration may require a fewer number of bevacizumab injections as compared to those with the CT genotype. Other genetic and clinical factors may also influence number of injections of bevacizumab.; Macular Degeneration': '与CT基因型的那些相比，TT基因型和年龄相关性黄斑变性的患者可能需要较少数量的Bevacizumab注射液。其他遗传和临床因素也可能影响贝伐单抗的注射次数。黄斑变性',\n",
       " 'Patients with the AA genotype may have decreased risk of overall capecitabine-related toxicity in cancer patients as compared to patients with the GG genotype. Other genetic and clinical factors may also influence the toxicity to capecitabine.; Drug Toxicity': '与GG基因型的患者相比，患有AA基因型的患者可能降低了癌症患者在癌症患者中的整体Capecitabine相关毒性的风险。其他遗传和临床因素也可能影响到Capecitabine的毒性。药物毒性',\n",
       " 'Patients with the TT genotype and non-small-cell lung cancer may have a decreased risk for pneumonitis when treated with platinum-based chemotherapy as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk for pneumonitis.; Carcinoma, Non-Small-Cell Lung': '与GG基因型患者相比，TT基因型和非小细胞肺癌的患者可能对血糖炎的风险降低。其他遗传和临床因素也可能影响肺炎风险。癌，非小细胞肺',\n",
       " 'Patients with the TT genotype and colon cancer may have a shorter time to tumor recurrence when treated with fluorouracil-based chemotherapy as compared to patients with the CC or CT genotype. Other genetic and clinical factors may also influence response to fluorouracil.; Colonic Neoplasms': '与CC或CT基因型患者相比，当用基于氟尿嘧啶的化疗处理时，TT基因型和结肠癌的患者可能具有较短的肿瘤复发时间。其他遗传和临床因素也可能影响对氟尿嘧啶的反应。结肠瘤',\n",
       " 'In this meta-analysis of three studies, any non-*17 alleles were considered to be *1. *17 carriers had a lower prevalence of high platelet reactivity as compared to non-carriers (37.9% vs. 50.8 %)': '在三项研究的这种荟萃分析中，任何非 -  * 17等位基因被认为是* 1。*与非载体相比，17个载体具有较低的血小板反应性的普及率（37.9％与50.8％）',\n",
       " 'Patients with the AA genotype may have a smaller increase in HDL cholesterol when treated with fluvastatin as compared to patients with the AG genotype. Other genetic and clinical factors may also influence HDL cholesterol response.; ': '与AG基因型患者相比，患有AA基因型的AA基因型的患者可能较小，HDL胆固醇较小。其他遗传和临床因素也可能影响HDL胆固醇反应。',\n",
       " \"Patients with the CC genotype and major depressive disorder who are treated with paroxetine may have a faster response time as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to paroxetine.; Depressive Disorder, Major\": '与帕罗西汀治疗的CC基因型和主要抑郁症的患者可能具有更快的响应时间，与TT基因型患者相比。其他遗传和临床因素也可能影响患者对帕罗西汀的反应。抑郁症，主要',\n",
       " 'Patients with the AT genotype may have a decreased likelihood of experiencing respiratory depression as a result of fentanyl as compared to patients with the AA genotype. Other genetic and clinical factors may also affect the likelihood of a patient developing respiratory depression as a result of fentanyl.; Pain, Postoperative;Respiratory Insufficiency': '与AA基因型患者相比，患有基因型的患者可能具有减少经历呼吸道抑制的可能性。其他遗传和临床因素也可能影响芬太尼产生患者发育呼吸抑制的可能性。疼痛，术后;呼吸功能不全',\n",
       " \"Patients with a HCV genotype I infection and the CC genotype may have an increased response to treatment with interferons as compared to patients with the CT or TT genotypes. However, this association was not found in patients with HCV genotype II infections. Other genetic and clinical factors may also affect a patient's response to treatment with interferons.; Hepatitis C\": '患有HCV基因型I感染的患者和CC基因型可能具有增加对干扰素治疗的响应，与CT或TT基因型的患者相比。然而，在HCV基因型II感染患者中未发现这种关联。其他遗传和临床因素也可能影响患者对干扰素治疗的反应。丙型肝炎',\n",
       " \"Patients with the CC genotype and heart failure may have a poorer response to carvedilol treatment as compared to patients with the CG or GG genotype. Other genetic and clinical factors may also influence a patient's chance of response.; Heart Failure\": '与CG或GG基因型患者相比，CC基因型和心力衰竭的患者可能对卡维地洛治疗较差。其他遗传和临床因素也可能影响患者的反应机会。心脏衰竭',\n",
       " 'Allele C is associated with increased concentrations of efavirenz in people with HIV Infections as compared to allele T.': '与等位基因T.',\n",
       " 'Patients with the GG genotype and pancreatic cancer may have a decreased chance of survival when treated with fluorouracil as compared to patients with the AA genotype. Other genetic and clinical factors may also influence chance of survival in patients receiving fluorouracil.; Pancreatic Neoplasms': '与AA基因型患者相比，GG基因型和胰腺癌的患者可能有氟尿嘧啶处理时的存活率降低。其他遗传和临床因素也可能影响氟尿嘧啶患者的存活率。胰腺肿瘤',\n",
       " 'Patients with the CC genotype and autism spectrum disorders may have a better tolerance for methylphenidate treatment as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence tolerability for methylphenidate treatment.; Autism Spectrum Disorder': '与CT或TT基因型的患者相比，CC基因型和自闭症谱系疾病的患者可具有更好的耐受甲基酚治疗。其他遗传和临床因素也可能对甲基酚治疗的耐受性影响。自闭症谱系障碍',\n",
       " \"Patients with the CT genotype and Lewy Body disease or Alzheimer's disease may have an improved response to rivastigmine as compared to patients with the TT genotype, although some studies show contradictory results. Other clinical and genetic factors may also influence response to rivastigmine in patients with Lewy Body disease or Alzheimer's disease.; Alzheimer Disease;Lewy Body Disease\": '虽然有些研究表明存在矛盾的结果，但患有CT基因型和石油型疾病或阿尔茨海默病或阿尔茨海默病的患者可能对RIVASTIGMIN的反应有所改善。其他临床和遗传因素也可能影响患有石油体疾病或阿尔茨海默病的患者对菌敏的反应。阿尔茨海默病;石油体疾病',\n",
       " 'Carriers of the G allele reported significantly higher vigor scores and significantly lower negative mood scores after drinking as compared with AA subjects.': '与AA受试者相比，G等位基因的携带者报告了显着更高的活力分数，并且在饮用后显着降低了负面情绪分数。',\n",
       " 'Patients with the AA genotype and psoriasis may have a better response when treated with TNF-inhibitors or ustekinumab as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence TNF-inhibitor or ustekinumab response.; Psoriasis': '与AG或GG基因型的患者相比，当用TNF抑制剂或Ustekinumab处理时，AA基因型和牛皮癣的患者可能具有更好的反应。其他遗传和临床因素也可能影响TNF抑制剂或USTekumab反应。银屑病',\n",
       " \"Cancer patients with genotype GG may be more likely to respond to topoisomerase I inhibitors compared to patients with genotypes GT or TT (based solely on in vitro work). Other genetic and clinical factors may also influence a patient's response.; Neoplasms\": '与患有基因型GT或TT的患者相比，癌症患者的基因型GG可能更可能应对拓扑异构酶I抑制剂（仅基于体外工作）。其他遗传和临床因素也可能影响患者的反应。肿瘤',\n",
       " \"Patients with the AA genotype may have 1) a decreased, but not absent, risk for acute rejection after kidney transplantation as compared to patients with the GA or GG genotype and 2) an increased incidence of lymphopenia as compared to patients with the GA genotype. However, the AA genotype influence is controversy discussed among different studies. Other genetic and clinical factors may also influence a patient's response to mycophenolate mofetil.; Kidney Transplantation\": '与GA或GG基因型的患者相比，肾移植患者患者减少，肾移植患者的患者可能有1）％，但不存在肾移植患者。然而，AA基因型影响是不同研究中讨论的争议。其他遗传和临床因素也可能影响患者对霉酚酸酯Mofetil的反应。肾移植',\n",
       " 'Patients had a stable therapeutic international normalized ratio (INR) between 2 and 3.': '患者在2和3之间具有稳定的治疗性国际标准化比率（INR）。',\n",
       " 'Patients with the AA genotype undergoing kidney transplantation or liver transplantation (donor or recipient genotype) may have increased dose-adjusted trough concentrations of tacrolimus as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence tacrolimus concentrations.; Kidney Transplantation;liver transplantation': '患有肾移植或肝移植（供体或受体基因型）的AA基因型的患者可增加与AG或GG基因型的患者相比的Tacrolimus的剂量调节的槽浓度。其他遗传和临床因素也可能影响他克莫司浓度。肾移植;肝移植',\n",
       " 'Patients with the AG genotype may have decreased response to salbutamol in people with Asthma as compared to patients with the AA genotype. However, the association is significant only in one of the three cohorts tested. Other genetic and clinical factors may also influence the bronchodilator response.; Asthma': '与AA基因型患者相比，AG基因型的患者可能对哮喘的人们对哮喘的人们的反应降低。然而，该关联仅在三个测试的三个队列中的一个。其他遗传和临床因素也可能影响支气管扩张剂反应。哮喘',\n",
       " 'Genotypes AT + TT are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA.': '与基因型AA相比，+ TT的基因型与对儿童的甲基苯苯甲酰酯的响应增加有关。',\n",
       " 'Patients with the TT genotype and macular degeneration may have a greater improvement in visual acuity when treated with ranibizumab or bevacizumab as compared to patients with the CC genotype. However, some studies have found no association with response to ranibizumab or bevacizumab. Other genetic and clinical factors may also influence response to ranibizumab or bevacizumab.; Macular Degeneration': '与CC基因型患者相比，当用Ranibizumab或Bevacizumab处理时，患有TT基因型和黄斑变性的患者可能对视力有更大的改善。然而，一些研究发现没有与Ranibizumab或Bevacizumab的反应相关联。其他遗传和临床因素也可能影响对Ranibizumab或Bevacizumab的反应。黄斑变性',\n",
       " \"Patients with the CG genotype and depressive disorder may have an increased response to milnacipran as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's risk of side effects when treated with milnacipran; Depressive Disorder\": '与GG基因型的患者相比，CG基因型和抑郁症的患者可能对MilnaCipran的反应增加。其他遗传和临床因素也可能影响患有MilnaCipran治疗时患者的副作用的风险;抑郁症',\n",
       " \"Patients with the CT genotype and Bipolar Disorder may be more likely to respond to lithium or valproic acid as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to lithium.; Bipolar Disorder\": '与CC基因型患者相比，CT基因型和双相障碍的患者可能更容易响应锂或丙戊酸。其他遗传和临床因素也可能影响患者对锂的反应。躁郁症',\n",
       " \"Patients with the GG genotype and Hypertension who are treated with diuretics may have an increased likelihood of Myocardial Infarction as compared to patients with the GT or TT genotype. However, this association was not found in a large cohort of patients. Other genetic and clinical factors may also influence a patient's response to diuretics.; Hypertension;Myocardial Infarction\": '患有用于利尿剂的GG基因型和高血压的患者可能对心肌梗死的可能性增加，而与GT或TT基因型的患者相比，心肌梗死的可能性增加。然而，在大型患者队列中没有发现这种关联。其他遗传和临床因素也可能影响患者对利尿剂的反应。高血压;心肌梗死',\n",
       " 'These were patients undergoing percutaneous coronary intervention. Carriers of the A allele at rs4244285(determining *2) showed significantly increased residual platelet aggregation after a 600 mg loading dose of clopidogrel when compared to non-carriers. Patients were also typed for the main variants which determine *3 and *17. Patients also were dosed with 500 mg aspirin and 70 u/kg body weight unfractionated heparin prior to PCI. Patients were classified as having low or high residual platelet aggregation and the comparison was between those with low and high RPA.': '这些是经皮冠状动脉干预的患者。在与非载体相比，RS424285（测定* 2）的载体在600mg加载剂量的氯吡格雷后显着增加了残留的血小板聚集。患者还键入了确定* 3和* 17的主要变体。在PCI之前，患者也用500mgAspirin和70u / kg体重未分压肝素给药。患者被分类为具有低或高残留的血小板聚集，并且比较在具有低和高RPA之间的比较。',\n",
       " 'Allele G is associated with increased response to quetiapine in people with Schizophrenia as compared to allele A.': '与等位基因A相比，等位基因G与精神分裂症的人们对喹硫碱的反应增加有关。',\n",
       " 'Post-menopausal women with the CC genotype and breast cancer may have increased disease free survival when treated with tamoxifen as compared to patients with the AA genotypes. Other genetic and clinical factors may also influence response to tamoxifen.; Breast Neoplasms;Menopause': '与AA基因型的患者相比，患有CC基因型和乳腺癌的绝经后妇女可能会增加无疾病的自由存活。其他遗传和临床因素也可能影响对Tamoxifen的反应。乳腺肿瘤;更年期',\n",
       " \"Patients with the CC genotype were not studied. Patients with the CT genotype and ovarian cancer who are treated with chemotherapy involving cisplatin and cyclophosphamide may have reduced progression-free survival as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to chemotherapy.; Ovarian Neoplasms\": '没有研究患有CC基因型的患者。与涉及顺铂和环磷酰胺的化疗治疗的CT基因型和卵巢癌的患者可能会减少无流动性基因型的患者的无进展生存率。其他遗传和临床因素也可能影响患者对化疗的反应。卵巢肿瘤',\n",
       " '- avoid azathioprine and mercaptopurine.  If it is not possible to avoid azathioprine and mercaptopurine: use 10% of the standard dose and advise patients to seek medical attention when symptoms of myelosuppression (such as severe sore throat in combination with fever, regular nosebleeds and tendency to bruising) occur. Any adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and efficacy.Note: The percentage of 10% is based on the analogy with TPMT, for which the gene variants have a comparable effect on toxicity to those of NUDT15. A percentage of < 20% was calculated for NUDT15 PM, but there were insufficient data available to calculate the exact percentage.Note: Dose adjustment based on the total of 6-TGN metabolites is not possible for these patients, as they develop toxicity within the therapeutic range that applies for patients without gene variants.': ' - 避免Azathioprine和巯基嘌呤。如果不可能避免硫唑嘌呤和巯基嘌呤：使用10％的标准剂量并建议患者在肌球瓶抑制的症状（如发烧的严重疼痛，定期流鼻血和瘀伤倾向）的症状时寻求医疗注意。初始剂量的任何调整应以毒性（血统监测）和效力为指导。为NUDT15 PM计算了<20％的百分比，但没有足够的数据来计算确切的百分比。注意：这些患者不可能基于6-TGN代谢物的总量，因为它们在含有毒性适用于没有基因变异的患者适用的治疗范围。',\n",
       " \"Patients with the AG genotype who are treated with phenprocoumon may require a lower dose as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's dose of phenprocoumon.; \": '与诸如AA基因型患者相比，用苯处理的AG基因型患者可能需要较低剂量。其他遗传和临床因素也可能影响患者剂量的苯处理。',\n",
       " 'Patients with the AG genotype and psoriasis may have an increased risk for paradoxical psoriasiform reactions when treated with TNF-inhibitors as compared to patients with the AA genotype. Other genetic and clinical factors may also influence risk for paradoxical psoriasiform reactions.; Psoriasis': '与AA基因型患者相比，患有AG基因型和牛皮癣的患者可能对矛盾的牛皮癣反应的风险增加。其他遗传和临床因素也可能影响矛盾的牛皮癣的风险。银屑病',\n",
       " 'The AG genotype carriers had smaller tamoxifen-induced decrease in total cholesterol in postmenopausal woman and intermediate tamoxifen-induced increase in triglycerides and decrease in high density lipoprotein in premenopausal women compared to GG genotype carriers.; ': '与GG基因型载体相比，Ag基因型载体在绝经后患者中，在绝经后患者中，在绝经后的胆固醇中的总胆固醇中的总胆固醇降低，并与GG基因型携带者相比，前甘油三酯的甘油三酯的增加和高密度脂蛋白的降低。',\n",
       " 'Patients with the rs1801253 CC genotype and heart failure may have increased emergency department utilization when treated with cardiovascular drugs as compared to patients with the GG genotype. Other genetic and clinical factors may also influence efficacy of cardiovascular drugs.; Heart Failure': '与GG基因型患者相比，患有RS1801253 CC基因型和心力衰竭的患者可能会增加应急部门利用率。其他遗传和临床因素也可能影响心血管药物的疗效。心脏衰竭',\n",
       " 'Subjects with the CT genotype may have increased exposure to atorvastatin as compared to subjects with the CC or TT genotypes. Other clinical and genetic factors may also influence exposure to atorvastatin.; ': '与具有CC或TT基因型的受试者相比，具有CT基因型的受试者可能会导致暴露于阿托伐他汀。其他临床和遗传因素也可能影响暴露于阿托伐他汀。',\n",
       " \"Patients with the CT genotype may have increased subjective responses to alcohol as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's response to alcohol.; \": '与CC基因型的患者相比，CT基因型的患者可能会增加对酒精的主观反应。其他遗传和临床因素也可能影响患者对酒精的反应。',\n",
       " 'Patients with breast cancer as the rs1695 AG genotype may have an increased response to treatment with cyclophosphamide and epirubicin as compared to patients with the GG genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to cyclophosphamide and epirubicin.; Breast Neoplasms': '乳腺癌患者作为RS1695 AG基因型的患者可能对与GG基因型的患者相比，对环磷酰胺和同性蛋白治疗的反应增加。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对环磷酰胺和同性素的反应。乳房肿瘤',\n",
       " 'Patients with the CC genotype who are undergoing methadone maintenance treatment may have increased severity of opiate withdrawal symptoms as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence opiate withdrawal symptoms in patients receiving methadone.; Opioid-Related Disorders': '与CT或TT基因型患者相比，患有甲基维持治疗的CC基因型可能会增加印章戒断症状的严重程度。其他遗传和临床因素也可能影响接受美沙酮患者的印章戒断症状。与阿片类药物相关的疾病',\n",
       " 'Patients with the CC or CT genotypes had a greater reduction in anxiety scores compared to patients with the TT genotype.': '与TT基因型的患者相比，CC或CT基因型的患者对焦虑评分进行了更大的降低。',\n",
       " 'Genotypes GT + TT is associated with decreased clearance of nevirapine in people with HIV Infections as compared to genotype GG.': '与基因型GG相比，基因型GT + TT与HIV感染的人们中奈韦拉汀的清除降低有关。',\n",
       " \"Patients with the AT genotype who are treated with ACE inhibitors may have a decreased, but not absent, risk for cough as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for cough.; Cough\": '与TT基因型患者相比，患有ACE抑制剂治疗的患者可能有降低，但不存在咳嗽的风险。其他遗传和临床因素也可能影响患者对咳嗽的风险。咳嗽',\n",
       " 'Patients with nasopharyngeal cancer and the AA genotype who are treated with docetaxel may have more severe anemia as compared to patients with the AG and GG genotypes. Other clinical and genetic factors may also influence severity of anemia in patients with nasopharyngeal cancer.; Anemia;Nasopharyngeal Neoplasms': '患有鼻咽癌的患者和被多西紫杉醇治疗的AA基因型可能具有更严重的贫血，与AG和GG基因型患者相比。其他临床和遗传因素也可能影响鼻咽癌患者贫血的严重程度。贫血;鼻咽肿瘤',\n",
       " 'Patients with the CC genotype may have increased Stimulation and Euphoria scores after amphetamine exposure as compared to patients with the TT genotype.; ': '与TT基因型患者相比，患有CC基因型的患者可能会增加刺激和eUphoria分数。',\n",
       " \"Patients with the CC genotype may have increased risk of resistant hypertension when treated with antihypertensive drugs including diuretics as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence a patient's response to antihypertensives.; Hypertension\": '患有CC基因型的患者可能会增加抗高血压药物治疗时抗性药物的风险，包括利尿剂，与CT或TT基因型患者相比。其他遗传和临床因素也可能影响患者对抗高血压性的反应。高血压',\n",
       " \"Patients with the AA genotype may have a decreased but not absent risk for rash when treated with EGFR inhibitors, such as erlotinib, as compared to patients with the GG genotypes. No significant association is found between this variant and cetuximab or panitumumab response. Other genetic and clinical factors may also influence a patient's risk for toxicity.; Carcinoma, Non-Small-Cell Lung;Colorectal Neoplasms;Neoplasms;Pancreatic Neoplasms\": '与GG基因型的患者相比，患有AA基因型的AA基因型可能有降低但在欧洲毒素等EGFR抑制剂（例如ERLOTINIB）的患者中，患者的风险降低。这种变体和西妥昔单抗或Panitumumab反应之间没有明显的关联。其他遗传和临床因素也可能影响患者毒性的风险。癌，非小细胞肺;结肠直肠肿瘤;肿瘤;胰腺肿瘤',\n",
       " 'S1251 allele. KONNECTION study evaluated safety and efficacy of ivacaftor in CF patients with a non-G551D gating mutation. Efficacy was measured by changes in FEV, sweat chloride, BMI and CFQ-R score. P value is given for improvement of all genotypes across all efficacy measurements in 8 weeks of treatment.': 'S1251等位基因。Konnection研究评估了IVAcafeafer在CF患者中的IVAcafeaferor患者的安全性和有效性。通过FEV，汗水，BMI和CFQ-R分数的变化测量功效。给出P值以改善在治疗8周内所有疗效测量的所有基因型。',\n",
       " 'Patients with the AA genotype and non-small-cell lung cancer may have a poorer response to platinum-based chemotherapy as compared to patients with the GG genotype. This was only seen in those of Asian ethnicity. Other genetic and clinical factors may also influence response to platinum-based chemotherapy.; Carcinoma, Non-Small-Cell Lung': '与GG基因型的患者相比，患有AA基因型和非小细胞肺癌的患者可能对铂类化疗的反应较差。这只是在亚洲种族中看到的。其他遗传和临床因素也可能影响对基于铂的化疗的反应。癌，非小细胞肺',\n",
       " 'Patients with the *1A allele in combination with another *1A allele may have decreased bioavailability of pravastatin as compared to individuals with the *15/*15 or *1A/*15 genotype. Other genetic and clinical factors may also influence the pharmacokinetics of pravastatin. This annotation only covers the pharmacokinetic relationship between SLCO1B1 and pravastatin and does not include evidence about clinical outcomes.; ': '与具有* 15 / * 15或* 1A / * 15基因型的个体相比，患有* 1A等位基因与另一个* 1A等位基因组合的患者可能降低了普伐他汀的生物利用度。其他遗传和临床因素也可能影响普伐他汀的药代动力学。该注释仅涵盖SLCO1B1和普伐他汀之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " 'Cognitive response to treatment was assessed in patients with mild cognitive decline from Alzheimer’s Disease Assessment (ADAS) Score-Cognition by contrasting total ADAS-Cog score obtained at baseline with that obtained at 36 months after MCI diagnosis (diff. ADAS-Cog score). There was a significantly earlier age of onset for female T allele carriers, and APOE4/T co-carriers. Improved response was associated with reduced brain cholinergic activity in carriers.': '通过在MCI诊断后36个月获得的基线获得的总ADAS-COG评分对患有Alzheimer的疾病评估（ADAS）评分认知的患者对治疗的认知反应。女性T等位基因携带者和ApoE4 / T Co-携带者的发病率显着提前。改善的反应与载体中的脑胆碱能活性降低有关。',\n",
       " 'Volunteers with the *10/*10 genotype had a significantly higher AUC of tramadol compared to volunteers carrying only *1 or *2 alleles. Note that the paper does not give any details of which variants were used to identify star alleles.': '与仅携带* 1或* 2等位基因的志愿者相比，具有* 10 / * 10基因型的志愿者具有显着更高的曲马多的AUC。请注意，该论文没有提供哪些变体识别星等位基因的细节。',\n",
       " 'The CYP2D6*2 allele is assigned as a normal function allele by CPIC. Patients carrying the *2 allele in combination with alleles that result in a normal metabolizer phenotype may have decreased metabolism of propafenone as compared to patients carrying two increased function alleles or an increased function allele in combination with a normal function allele. Patients carrying the *2 allele in combination with alleles that result in a normal metabolizer phenotype may also have decreased metabolism of propafenone as compared to patients carrying an increased function allele with an activity value of 3 or greater in combination with a decreased or no function allele but increased metabolism of propafenone as compared to patients with a no function allele in combination with a decreased or normal function allele or two decreased or no function alleles. This annotation only covers the pharmacokinetic relationship between CYP2D6 and propafenone and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence propafenone metabolism.; Arrhythmias, Cardiac;Tachycardia': 'CYP2D6 * 2等位基因由CPIC分配为正常功能等位基因。与携带两种函数等位基因的患者相结合的患者与正常功能等位基因组合的患者相比，携带常规代谢物表型的等位基因的患者携带常规代谢物表型的等位基因可能降低了丙杂酮的代谢。与患有正常代谢物表型的等位基因携带* 2等位基因的患者也可能降低了丙酮酮的代谢，与患有增加的函数等位基因的患者，其活性值为3或更高的患者组合减少或无功能等位基因但与NO功能等位基因的患者相比，丙酮酮的代谢增加，与下降或正常的功能等位基因或两种降低或无功能等位基因相比。该注释仅涵盖CYP2D6和ProPafenone之间的药代动力学关系，并且不包括关于临床结果的证据。其他遗传和临床因素也可能影响丙酮酮代谢。心律失常，心脏;心动过速',\n",
       " \"Patients with the GG genotype who are undergoing surgery may have an increased response to propofol and remifentanil administered as anesthesia as compared to patients with the AA or AG genotypes. Other genetic and clinical factors may also affect a patient's response to propofol and remifentanil.; \": '正在进行手术的GG基因型的患者可能对异丙酚和Remifentanil的反应增加，与AA或AG基因型的患者相比施用为麻醉。其他遗传和临床因素也可能影响患者对异丙酚和Remifentanil的反应。',\n",
       " 'Patients with the CC genotype with substance withdrawal syndrome may have an increased likelihood of headache when discontinuing the use of analgesics (such as opioids, NSAIDs, triptans, ergot) as compared to patients with the TT genotype. Other clinical and genetic factors may also influence likelihood of headache in patients with withdrawal syndrome who discontinue the use of analgesics.; ': '患有物质戒断综合征的CC基因型可能会在与TT基因型患者相比，在停止使用镇痛药（如阿片类药物，NSAIDS，雷丝特）时，患者可能会增加头痛时的可能性。其他临床和遗传因素也可能影响停止使用镇痛药的戒断综合征患者头痛的可能性。',\n",
       " 'Patients with the CYP2D6*1 allele may have 1) an increased clearance of n-desmethyltamoxifen as compared to patients with the CYP2D6*9 or *25 or *26 or *28 or *32 or *39 or *43 or *45 or *48 or *70 allele, 2) similar clearance of n-desmethyltamoxifen as compared to patients with the CYP2D6*22 or *23 or *24 or *27 or *33 or *49 allele, and 3) increased activity of CYP2D6 when assayed with n-desmethyltamoxifen compared to CYP2D6*7 or *10 or *12 or *14A or *14B or *17 or *18 or *29 or *30 or *31 or *36 or *37 or *40 or *46 or *47 or *50 or *51 or *52 or *54 or *55 or *57 or *61 or *62 or *63 or *64 or *65 or *71 or *72 or *75 allele. Other genetic and clinical factors may also influence the metabolism of n-desmethyltamoxifen.; ': 'CYP2D6 * 1等位基因的患者可能具有1）与CYP2D6 * 9或* 25或* 26或* 28或* 32或* 32或* 32或* 32或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或* 43或*相比，N-Desmethylamoxifen的间隙增加48或* 70等位基因，2）与CYP2D6 * 22或* 23或* 24或* 24或* 27或* 33或* 43或* 33或* 33或* 49等位基因相比，N-DESMethylamoxifen的相似间隙，以及3）在测定时增加CYP2D6的活性相比CYP2D6* 7或*10或* 12或*14A或*14B正desmethyltamoxifen或* 17或* 18或* 29或* 30或* 31或* 36或* 37或* 40或* 46或* 47或* 50或* 51或* 52或* 54或* 55或* 57或* 61或* 62或* 63或* 64或* 65或* 71或* 72或* 75等位基因。其他遗传和临床因素也可能影响N-Desmethylamoxifen的代谢。',\n",
       " 'Genotype (CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3 is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 + (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3.': '基因型（CCGCGCCACTTGGCCTGCCTCCGTCCCG）3 /（CCGCGCCACTTGGCCTGCCTCCGTCCCG）3与在人与关节炎，类风湿响应减少到甲氨蝶呤相比于基因型（CCGCGCCACTTGGCCTGCCTCCGTCCCG）2 /（CCGCGCCACTTGGCCTGCCTCCGTCCCG）2 +（CCGCGCCACTTGGCCTGCCTCCGTCCCG）2 /（CCGCGCCACTTGGCCTGCCTCCGTCCCG）3相关联。',\n",
       " 'Genotype TT is associated with decreased response to sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to genotype GG.': '基因型TT与糖尿病糖尿病人群的尿素衍生物的尿素衍生物的响应降低有关，与基因型Gg相比。',\n",
       " 'Patients with two copies of the *4 allele or one copy of the *4 allele in combination with one copy of the *12 or *13 alleles may have increased metabolism of isoniazid as compared to patients with any of the following genotype combinations: one copy of the *4, *12 or *13 alleles in combination with one copy of the *5, *6, *7 or *14 alleles; any combination of the *5, *6, *7 or *14 alleles; two copies of the *5B allele; one copy of the *5B allele in combination with one copy of the *6A, *6J, *7B or *7G alleles; one copy of the *6A allele in combination with one copy of the *7B allele; two copies of the *7B allele, while patients with one copy of the *4 allele in combination with one copy of the *5B, *5C, *6A, *6O or *7G alleles may have increased metabolism of isoniazid as compared to patients with the follow genotype combinations: two copies of the *5B allele; one copy of the *5B allele in combination with one copy of the *6A, *6J, *7B or *7G alleles; one copy of the *6A allele in combination with one copy of the *7B allele. Other genetic and clinical factors may also affect isoniazid metabolism. This annotation only covers the pharmacokinetic relationship between NAT2 and isoniazid and does not include evidence about clinical outcomes.; Tuberculosis': '患有两种副本的* 4等位基因或一份* 4等位基因的一份副本与* 12或* 13等位基因组合的组合可能会增加异喹丽突的代谢增加，而患者则为以下任何基因型组合（一种副本） * 4，* 12或* 13等位基因与* 5，* 6，* 7或* 14等位基因的一个副本组合; * 5，* 6，* 7或* 14等位基因的任何组合;两个副本* 5B等位基因; * 5B等位基因的一份副本与* 6a，* 6j，* 7b或* 7g等位基因的一个副本组合; * 6A等位基因的一个副本与* 7B等位基因的一份副本组合; * 7B等位基因的两份，而患有一份副本* 4等位基因的患者与* 5b，* 5c，* 6a，* 6o或* 7g等位基因组合的一份副本可能会增加异硝基吡啶的代谢遵循基因型组合：两份* 5B等位基因; * 5B等位基因的一份副本与* 6a，* 6j，* 7b或* 7g等位基因的一个副本组合; * 6A等位基因的一个副本与* 7B等位基因的一份副本组合。其他遗传和临床因素也可能影响异烟肼代谢。该注释仅涵盖NAT2和Isoniazid之间的药代动力学关系，并不包括有关临床结果的证据。结核',\n",
       " 'The genotype association is in RECIPIENTS of kidneys and is the combination of the association between CYP3A4*1B and CYP3A5*1 vs. CYP3A4*1A/CYP3A5*3. Mapped *1B to rs2740574 C and *1A to rs2740574 T.': '基因型关联是肾脏的接受者，是CYP3A4 * 1B和CYP3A5 * 1与CYP3A4 * 1A / CYP3A5 * 3之间的关联的组合。映射* 1B至RS2740574 C和* 1A至RS2740574 T.',\n",
       " 'Patients were receiving tramadol and acetaminophen as combination to relieve pain, specifically neuropathic pain associated with oxaliplatin treatment (as part of a FOLFOX or XELOX regimen) for adenocarcinoma.': '患者接受曲马多和乙酰氨基酚作为组合以缓解疼痛，特别是与奥沙利铂治疗相关的神经性疼痛（作为Folfox或Xelox方案的一部分）用于腺癌。',\n",
       " 'Patients with the CT genotype and ADHD may have a faster response when treated with methylphenidate as compared to patients with the TT genotype. Other genetic and clinical factors may also influence the speed of efficacy of methylphenidate.; Attention Deficit Disorder with Hyperactivity': '与TT基因型患者相比，患有CT基因型和ADHD的患者可能具有更快的响应。其他遗传和临床因素也可能影响甲基酚的功效速度。注意力缺陷症与多动症',\n",
       " 'Cells with the CC genotype have normal ability to efflux fluorescently labelled paclitaxel.; ': '具有CC基因型的细胞具有荧光标记的紫杉醇的正常能力;',\n",
       " 'Patients with asthma and the TT genotype may have an increased response to montelukast as compared to patients with the GG and GT genotypes genotypes. Other clinical and genetic factors may also affect response to montelukast in patients with asthma.; Asthma': '与GG和GT基因型基因型的患者相比，哮喘患者和TT基因型可能对孟鲁司司斯特的反应增加。其他临床和遗传因素也可能影响对哮喘患者的蒙特利亚斯特的反应。哮喘',\n",
       " \"Patients with the GA genotype may be more likely to respond to venlafaxine as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to venlafaxine.; Anxiety Disorders\": '与AA基因型患者相比，患有GA基因型的患者可能更可能应对Venlafaxine。其他遗传和临床因素也可能影响患者对Venlafaxine的反应。焦虑症',\n",
       " 'Patients with the TT genotype may have increased conversion of tramadol to O-desmethyltramadol (M1) as compared to patients with the AA or AT genotypes. Other genetic and clinical factors may also affect tramadol metabolism in a patient.; ': '与患有AA或基因型的患者相比，TT基因型的患者可以增加曲马多转化为O-去甲基三醇（M1）。其他遗传和临床因素也可能影响患者的曲马多代谢。',\n",
       " \"Patients with the ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del genotype may be associated with improvement in left ventricular ejection fraction, end-systolic and end-diastolic volume in people with chronic heart failure treated with spironolactone as compared to patients with the del/del genotype. Other genetic and clinical factors may also influence a patient's response.; Heart Failure\": '与ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/德尔基因型患者可能与改善左心室射血分数，收缩末期和舒张末期容积在人与安体舒通治疗慢性心脏衰竭的病人相比，使用del/德尔基因型有关。其他遗传和临床因素也可能影响患者的反应。心脏衰竭',\n",
       " 'Patients with the CT genotype may have an increased risk of adverse events (bleeding, over-anticoagulation or increased time above therapeutic range) when treated with phenprocoumon as compared to patients with the CC genotype. Other clinical and genetic factors may also influence risk of adverse events to phenprocoumon.; Hemorrhage;over-anticoagulation;time above therapeutic range': '当用CC基因型患者用苯处理处理时，CT基因型的患者可能具有增加的不良事件的风险（出血，过度抗凝或高于治疗范围的时间）。其他临床和遗传因素也可能影响苯处理的不良事件的风险。出血;过度抗凝;时间高于治疗范围',\n",
       " 'Patients with Alzheimer Disease and the *1/*1xN diplotype (ultrarapid metabolizers) may have increased clearance of donepezil as compared to patients who are extensive metabolizers (diplotypes *1/*3, *1/*4, *1/*5, *1/*6, *1/*1, *4/*1xN, *6/*1xN) or poor metabolizers (*4/*4, *4/*5). Other genetic and clinical factors may also influence donepezil clearance.; Alzheimer Disease': '与广泛代谢剂的患者相比，阿尔茨海默病和* 1 / * 1xN二曲（Ultrapolat代谢物）的患者可能会增加多奈哌齐的间隙（二型型* 1 / * 3，* 1 / * 4，* 1 / * 5，* 1 / * 6，* 1 / * 1，* 4 / * 1xn，* 6 / * 1xn）或代谢差（* 4 / * 4，* 4 / * 5）。其他遗传和临床因素也可能影响Dentpezil清除。阿尔茨海默病',\n",
       " 'Patients with the AG genotype and colorectal cancer may have a poorer response to anti-EGFR plus irinotecan treatment, as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to anti-EGFR plus irinotecan treatment.; Colorectal Neoplasms': '与患有GG基因型患者相比，患有AG基因型和结肠直肠癌的患者可能对抗EGFR加上伊耳癌治疗的反应较差。其他遗传和临床因素也可能影响对抗EGFR加上伊耳癌处理的反应。结直肠肿瘤',\n",
       " 'Patients with the rs45445694 3R/3R genotype ((CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3) and colorectal cancer may have an increased risk of asthenia when treated with irinotecan and raltitrexed as compared to patients with the 2R/2R genotype. Other genetic and clinical factors may also influence risk of asthenia.; Colorectal Neoplasms': '患者患有RS45445694 3R / 3R基因型（（CCGCGCCACTTGGCCTGCCTCCGTCCGTCCGTCCCG）3）和结肠直肠癌可能在用伊立康康和罗尔特拉特妥塞治疗时具有增加的哮喘风险，与2R / 2R基因型患者相比。其他遗传和临床因素也可能影响哮喘的风险。结直肠肿瘤',\n",
       " 'Patients with the AA genotype and lung cancer may have an improved response to platinum compounds as compared to patients with the AG and GG genotypes. Other clinical and genetic factors may affect response to platinum compounds in patients with lung cancer.; Lung Neoplasms': '与AG和GG基因型患者相比，患有AA基因型和肺癌的患者可能对铂化合物的反应有所改善。其他临床和遗传因素可能影响肺癌患者对铂化合物的反应。肺肿瘤',\n",
       " 'Women who delivered via C-section and were prescribed codeine for postpartum pain. Prescribed \"Tylenol #3\" (300 mg acetaminophen and 30 mg codeine). Some women also prescribed naproxen. Those with the AA genotype consumed a lower mean dose of codeine as compared to those with the AG genotype. This SNP was found to significantly predict mean dose intake in multiple linear regression. The authors go on to note that this variant was not predictive of mean dose intake by Asians, though it was predictive of mean dose intake by Caucasians; this may be due to differences in allele frequencies between the two ethnicities.': '通过C-Section交付的妇女并被规定的产后疼痛。规定的“Tylenol＃3”（300mg乙酰氨基酚和30mg Comeine）。有些女性也规定了萘普生。与AG基因型的那些相比，具有AA基因型的那些与AA基因型消耗较低平均剂量。发现这种SNP显着预测多元线性回归中的平均剂量摄入量。作者继续注意，这种变体不是通过亚洲人预测的平均剂量摄入量，尽管它是通过高加索人的平均剂量摄入的预测;这可能是由于两种种族之间等位基因频率的差异。',\n",
       " 'The TT genotype may be associated with increased likelihood of nephrotoxicity when treated with cisplatin as compared to the CT or TT genotype. Other clinical and genetic factors may influence likelihood of nephrotoxicity in patients treated with cisplatin.; Neoplasms;nephrotoxicity': '与CT或TT基因型相比，当用顺铂处理时，TT基因型可能与肾毒性的可能性增加。其他临床和遗传因素可能影响用顺铂治疗的患者肾毒性的可能性。肿瘤;肾毒性',\n",
       " \"Patients with the TT genotype who are treated with iloperidone may have increased risk for adverse cardiovascular events as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response.; Acquired Long QT Syndrome (aLQTS)\": '与CC基因型患者相比，含有Iloperidone治疗的TT基因型的患者可能会增加不良心血管事件的风险。其他遗传和临床因素也可能影响患者的反应。获得长QT综合症（ALQTS）',\n",
       " \"Patients with the GG genotype may have decreased dexmedetomidine ED50 values for drug-induced dorsal hand vein constriction as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to dexmedetomidine.; \": '与TT基因型患者相比，患有GG基因型的患者可能降低了药物诱导的背部手静脉收缩的Dexmedetomidine ED50值。其他遗传和临床因素也可能影响患者对Dexmedetomidine的反应。',\n",
       " \"Patients with the TT genotype may have an increased chance of response to bisphosphonate treatment, or may have an increase in bone density when treated with atorvastatin, as compared to patients with the GG or GT genotype. Other genetic and clinical factors may also influence a patient's chance of response.; Osteoporosis;Osteoporosis, Postmenopausal\": '患有TT基因型的患者可能具有对双膦酸盐处理的反应的增加的可能性，或者与阿托伐他汀处理的骨密度增加，与GG或GT基因型的患者相比。其他遗传和临床因素也可能影响患者的反应机会。骨质疏松症;骨质疏松症，绝经后症',\n",
       " 'Patients who are undergoing liver transplantation and receive a donor liver with the CC genotype may have an increased risk for new-onset diabetes mellitus (NODM) when treated with tacrolimus as compared to patients who receive a donor liver with the TT genotype. Other genetic and clinical factors may also influence risk for NODM.; liver transplantation': '与接受TT基因型接受供体肝脏的患者相比，正在接受肝移植的肝脏移植和接受供体肝脏的患者可能对新出售糖尿病MELLITUS（NODM）的风险增加增加。其他遗传和临床因素也可能影响nodm的风险。肝移植术',\n",
       " 'Patients who are recipients of an organ transplant and carry two copies of the CYP3A4*3 allele or one copy of the *3 allele in combination with the *1 allele may require a decreased dose of tacrolimus as compared to patients with two copies of the CYP3A4*1 allele. Other genetic and clinical factors may also influence tacrolimus dose.; Kidney Transplantation;Organ Transplantation': '器官移植受体的患者并携带两种CYP3A4 * 3等位基因或一份* 3等位基因的一份副本，与* 1等位基因组合可能需要减少的躯干剂量，与CYP3A4的两份拷贝患者相比* 1等位基因。其他遗传和临床因素也可能影响Tacrolimus剂量。肾移植;器官移植',\n",
       " 'Insufficient data to allow calculation of dose adjustment. Be alert to low zuclopenthixol plasma concentrations or select alternative drug (flupenthixol, quetiapine, olanzapine, clozapine).': '数据不足以允许计算剂量调整。警惕低Zuclopenthixol等离子体浓度或选择替代药物（Flupenthixol，喹啉，奥拉扎，氯氮平）。',\n",
       " 'HIV positive patients who are treated with nevirapine and are also carriers of the HLA-B*78:01:01 allele may have an increased risk of DRESS Syndrome or SJS/TEN as compared to non-carriers.; drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome': 'HIV阳性患者用Nevirapine治疗，也是HLA-B * 78：01：01：01等位基因的载体也可能具有增加的综合征或与非载体相比的SJS / 10的风险。药物反应与嗜酸性粒细胞和全身症状;表皮坏死，有毒;史蒂文斯 - 约翰逊综合征',\n",
       " 'Patients with the rs9934438 AG genotype may require decreased dose of acenocoumarol as compared to patients with genotype GG. Other genetic and clinical factors may also influence the dose of acenocoumarol.; ': '与基因型GG的患者相比，患有RS9934438 AG基因型的患者可能需要降低的aceNocoumarol。其他遗传和临床因素也可能影响aceNocoumarol的剂量。',\n",
       " 'Patients with the rs121909011 CT genotype (one copy of the CFTR R334W variant) and cystic fibrosis may respond to treatment with ivacaftor/lumacaftor. Other genetic and clinical factors may also influence response to ivacaftor/lumacaftor.; Cystic Fibrosis': '患者121909011 CT基因型（CFTR R334W变体的一份拷贝）和囊性纤维化可响应IVACAFTOR / Lumacaforor治疗。其他遗传和临床因素也可能影响对IVACAFTOR / Lumacaftor的反应。囊性纤维化',\n",
       " 'The CYP2B6*6 allele is assigned as a decreased function allele by CPIC. Patients carrying CYP2B6*6 allele in combination with a no, decreased, normal, or increased function allele may require decreased dose of efavirenz as compared to patients with two normal function alleles. Other genetic and clinical factors may also influence the dose of efavirenz.; HIV Infections': 'CYP2B6 * 6等位基因被CPIC分配为函数等位基因。携带CYP2B6 * 6等位基因的患者与NO，降低，正常或增加的功能等位基因相比可能需要减少的efavirenz剂量，而具有两个正常功能等位基因的患者。其他遗传和临床因素也可能影响efaviraz的剂量。艾滋病毒感染',\n",
       " 'Patients with the CT genotype may have decreased metabolism of tolbutamide as compared to patients with the CC genotype. Other genetic and clinical factors may also influence tolbutamide metabolism.; ': '与CC基因型患者相比，CT基因型的患者可能降低了甲醛酰胺的代谢。其他遗传和临床因素也可能影响甲醛酰胺代谢。',\n",
       " \"Patients with the AG genotype may have decreased survival when treated with cisplatin-based chemotherapy as compared to patients with the AA genotype. However, some studies find no association with drug toxicity, and one study found the opposite association. Other genetic and clinical factors may also influence a patient's response to platinum-based chemotherapy.; overall survival;progression-free survival\": '与AA基因型的患者相比，患有基于顺铂的化疗时，AG基因型的患者可能会降低存活率。然而，一些研究发现没有药物毒性的关系，一项研究发现了相反的关联。其他遗传和临床因素也可能影响患者对基于铂的化疗的反应。整体生存;无进展生存',\n",
       " 'Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CT + TT.': '基因型CC与乙型肝炎，乙型肝炎，慢性与基因型CT + TT相比的慢性的响应增加了对Peginterferon Alfa-2a，Peginterferon Alfa-2b和利巴韦林的响应。',\n",
       " \"Patients with schizophrenia and the GG genotype may have an increased response to risperidone as compared to patients with the CC genotype. However, this association lost significance following correction for multiple testing. Other genetic or clinical factors may also affect a patient's response to risperidone.; Schizophrenia\": '与患有CC基因型的患者相比，精神分裂症和GG基因型的患者可能对Risperidone的反应增加。然而，这种关联在多次测试校正后丧失了重要性。其他遗传或临床因素也可能影响患者对Risperidone的反应。精神分裂症',\n",
       " 'Patients with the TT genotype and receiving methadone maintenance therapy may have increased plasma concentrations of cotinine, a metabolite of nicotine, as compared to patients with the GG genotype. Other genetic and clinical factors may also affect plasma concentrations of cotinine in patients receiving methadone maintenance therapy.; ': '与GG基因型患者相比，TT基因型和接受美沙酮维持治疗的患者可能增加了血浆浓度，尼古丁代谢物。其他遗传和临床因素还可能影响接受美沙酮维持治疗患者的血浆浓度。',\n",
       " 'Patients with the CC genotype and bladder cancer may have increased metabolism of temsirolimus as compared to patients with the TT genotype, and an increased likelihood of adverse events including bone marrow, gastro-intestinal and other toxicities as compared to patients with the CT or TT genotypes. Other clinical and genetic factors may also influence metabolism of temsirolimus as well as likelihood of adverse events in patients with bladder cancer.; adverse events;gastrointestinal toxicity;Myelosuppression;Urinary Bladder Neoplasms': '与TT基因型患者相比，患有CC基因型和膀胱癌的患者可能会增加Temsirolimus的代谢，而与CT或TT基因型患者相比，包括骨髓，胃肠和其他毒性的不良事件的可能性增加。其他临床和遗传因素还可能影响天花豆类的代谢以及膀胱癌患者的不良事件的可能性。不良事件;胃肠道毒性;骨髓抑制;膀胱肿瘤',\n",
       " 'Patients with the AA genotype may have decreased but not absent risk for cardiotoxicity when exposed to anthracyclines for pediatric cancer as compared to patients with the GG genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence risk for cardiotoxicity.; Neoplasms': '与GG基因型的患者相比，患有AA基因型的AA基因型的患者可能降低但不存在心脏毒性的风险，但与GG基因型的患者相比，虽然这在一项研究中相矛盾。其他遗传和临床因素也可能影响心脏毒性的风险。肿瘤',\n",
       " \"Patients with the TT genotype may be more likely to require a dose reduction of imatinib due to drug toxicity as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's imatinib dosage requirements.; Drug Toxicity;Gastrointestinal Stromal Tumors\": '与患有CC基因型患者相比，患有TT基因型的患者可能更可能需要由于药物毒性而降低伊马替尼。其他遗传和临床因素也可能影响患者的伊马替尼剂量。药物毒性;胃肠道间质瘤',\n",
       " 'In human liver microsomes, the UGT1A1*1/*1 genotype was found to result in the increased formation of the clozapine metabolite clozapine N+-glucuronide as compared to the UGT1A1*28/*28 genotype.; ': '在人肝微粒体中，发现UGT1A1 * 1 / * 1基因型导致与UGT1A1 * 28 / * 28基因型相比，氯氮平代谢物氯氮平N + -Glucuronide的形成增加。',\n",
       " 'Cells with the CT genotype would show no difference in P-glycoprotein expression or ability to transport forskolin compared to cells with other genotypes(inferred).; ': '与具有其他基因型（推断）的细胞相比，具有CT基因型的细胞没有对P-糖蛋白表达的表达或运输前克洛林的能力（推断）。',\n",
       " 'Patients with the GG genotype had significantly longer analepsia time, longer autonomous respiratory recovery time and longer orientation recovery time than patients with the AA genotype.': 'GG基因型的患者具有明显更长的ANANPSIA时间，较长的自主呼吸恢复时间和比AA基因型的患者更长的取向恢复时间。',\n",
       " 'The authors did not report p-value correction for multiple hypotheses (103 snps tested). Though they report multiple snps are significantly associated with alcohol metabolism (early or late) tested on blood or breath alcohol concentrations, this snp is NOT significant after Bonferroni correction (<0.00049). Also, the authors did not state which alleles are associated with increased or decreased metabolism. Instead, they simply report an association with the snp in general. Note that this gene is on the minus strand.': '作者没有报告多个假设的P值校正（103个SNPS测试）。虽然他们报告多个SNP与血液或呼吸醇浓度测试的酒精新陈代谢（早期或晚期）显着相关，但这种SNP在Bonferroni校正后没有显着（<0.00049）。此外，作者没有说明哪些等位基因与新陈代谢增加或降低相关。相反，他们只是报告了与SNP的关联一般。请注意，该基因在减去股线上。',\n",
       " 'An individual carrying two no function alleles': '个人携带两个功能等位基因',\n",
       " 'Patients with the GG genotype may have a decreased response to metformin as compared to patients with the CG and CC genotype. Other genetic and clinical factors may also influence response to metformin.; ': '与CG和CC基因型患者相比，GG基因型的患者可能对二甲双胍的响应减少。其他遗传和临床因素也可能影响对二甲双胍的反应。',\n",
       " 'The A allele of this variant, when measured on plus chromosomal strand, is assigned decreased function by CPIC. Patients with the TT genotype may have increased activity of DPYD as compared to patients with the AT or AA genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence catalytic activity of DPYD.; ': '当在加染色体股线上测量时，该变体的等位基因被CPIC指定了降低的功能。与AT或AA基因型的患者相比，TT基因型的患者可能增加了DPYD的活性。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响DPYD的催化活性;',\n",
       " 'Allele C is associated with increased concentrations of fluvastatin in healthy individuals as compared to allele T.': '与等位基因T.相比，等位基因C与健康个体中氟伐他汀的浓度增加有关。',\n",
       " 'Patients with the CC genotype and major depressive disorder may have increased sexual side-effects when treated with bupropion as compared to patients with the TT genotype. Other genetic and clinical factors may also influence sexual side-effects.; Depressive Disorder, Major': '与TT基因型的患者相比，患有CC基因型和主要抑郁症的患者可能会增加性副作用时效果增加。其他遗传和临床因素也可能影响性副作用。抑郁症，主要',\n",
       " 'Patients with the AC genotype may have decreased clearance of tolbutamide as compared to patients with the AA genotype. This may be at least partly due to decreased expression of CYP2C9 protein as compared to the AA genotype. Other genetic and clinical factors may also affect tolbutamide clearance.; ': '与AA基因型患者相比，患有AC基因型的患者可能降低了甲醛酰胺的清除。与AA基因型相比，这可能至少部分地部分地是由于CYP2C9蛋白的表达降低。其他遗传和临床因素也可能影响甲醛酰胺清除。',\n",
       " \"Patients with the TT genotype may have a decreased response to treatment with interferons and ribavirin as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's response to treatment with interferons and ribavirin.; Hepatitis C\": '与患有CC基因型患者相比，TT基因型的患者可能对干扰素和利巴韦林的治疗有降低的反应。其他遗传和临床因素也可能影响患者对干扰素和利巴韦林治疗的反应。丙型肝炎',\n",
       " \"Children with the CC genotype and cancer who are treated with cisplatin may have an lower, but not absent, risk for hearing loss as compared to children with the TT genotype. However, multiple studies have found no association between this SNP and risk of cisplatin-induced ototoxicity. Other genetic and clinical factors may also influence a patient's risk for hearing loss with cisplatin treatment.; Drug Toxicity;Neoplasms;Ototoxicity\": '与Cisplatin治疗的CC基因型和癌症的儿童可能具有较低但不缺，与TT基因型的儿童相比，听力损失的风险。然而，多项研究发现这种SNP与顺铂诱导的耳毒性的风险之间没有关联。其他遗传和临床因素也可能影响患者对患者对顺铂治疗的损失的风险。药物毒性;肿瘤;耳毒性',\n",
       " \"Patients with the CC genotype and Schizophrenia who are treated with clozapine or olanzapine may have greater weight gain as compared to patients with the CT or TT genotype. Weight gain may be higher in patients who also have a T allele at SNP rs2268639. Other genetic and clinical factors may also influence a patient's likelihood of weight gain and extent when treated with antipsychotics.; Schizophrenia\": '与CT或TT基因型患者相比，用氯氮平或奥氮藻治疗的CC基因型和精神分裂症的患者可能具有更大的体重增加。在SNP RS2268639的患者中，体重增加可能更高。其他遗传和临床因素也可能影响患者在用抗精神病学治疗时的体重增加和程度的可能性。精神分裂症',\n",
       " \"Patients with the AC genotype may have an increased risk of biopsy-proven acute rejection at 12 month post-transplant when treated with cyclosporine and mycophenolate mofetil as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to mycophenolate mofetil.; Kidney Transplantation\": '与CC基因型的患者相比，患有AC基因型的患者可能在12个月后12个月后的活组织检查证明急性排斥风险增加。其他遗传和临床因素也可能影响患者对霉酚酸酯Mofetil的反应。肾移植',\n",
       " 'Patients with the rs3842 CC genotype may have decreased clearance of olanzapine as compared to patients with the CT or TT genotypes. This annotation only covers the pharmacokinetic relationship between rs3842 and olanzapine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence clearance of olanzapine.; ': '与CT或TT基因型的患者相比，RS3842 CC基因型的患者可能降低了奥氮平的清除。该注释仅涵盖了RS3842和奥氮平之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响奥氮翼的清除;',\n",
       " 'Patients with AA genotype may have increased risk of diarrhea when treated with fluorouracil in people with Colorectal Neoplasms as compared to patients with genotype GG. Other genetic and clinical factors may also impact a patients response to fluorouracil.; Colorectal Neoplasms': '当与基因型GG患者相比，患有氟尿嘧啶的氟尿嘧啶处理时，患有AA基因型的患者可能会增加腹泻风险。其他遗传和临床因素也可能影响患者对氟尿嘧啶的反应。结直肠肿瘤',\n",
       " \"Patients with the CC genotype and Schizophrenia may have increased risk for body weight gain when treated with clozapine, olanzapine or risperidone as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence a patient's response to clozapine, olanzapine or risperidone.; Schizophrenia\": '与CT或TT基因型患者相比，患有CC基因型和精神分裂症的患者可能对体重增加的风险增加了体重增加的风险增加。其他遗传和临床因素也可能影响患者对氯氮平，奥氮萘或氯酮的反应。精神分裂症',\n",
       " 'There is currently no available evidence regarding the association between the rs4240803 AA genotype and risk of adverse events when treated with pregabalin. However, patients with the AG genotype may be at an increased risk of experiencing adverse events when treated with pregabalin as compared to patients with the GG genotype. Other genetic and clinical factors may also affect risk of experiencing adverse events when treated with pregabalin.; adverse events;neuropathic pain': '目前没有有关用普瑞巴林治疗的RS4240803 AA基因型与不良事件风险的可用证据。然而，与GG基因型的患者相比，患有AG基因型的患者可能是在用普瑞巴林进行处理时经历不良事件的风险。其他遗传和临床因素也可能影响用普瑞巴林治疗时经历不良事件的风险。不良事件;神经性疼痛',\n",
       " 'Patients with the AG genotype 1) may have decreased clearance of doxorubicin 2) increased exposure to doxorubicin compared to patients with the GG genotype. Other genetic and clinical factors may also influence clearance and exposure to doxorubicin.; Breast Neoplasms': '与GG基因型的患者相比，患有Ag基因型1）的患者可能会降低多柔比星2）增加对多柔比星的暴露。其他遗传和临床因素也可能影响到多柔比星的间隙和暴露。乳房肿瘤',\n",
       " 'CYP3A5 expressors (*1/*1+*1/*3 genotypes) showed lower TAC C/D than the nonexpressors (CYP3A5*3/*3) at all evaluated times': 'CYP3A5表达器（* 1 / * 1 + * 1 / * 3基因型）显示出在所有评估时间的低压缩机（CYP3A5 * 3 / * 3）下降',\n",
       " \"Patients with two no function CYP2C19 alleles (*3/*3) (rs4986893) may have decreased metabolism of mephenytoin compared to patients with *1/*1 genotype. Other genetic and clinical factors may influence a patient's metabolism of mephenytoin.; \": '与患有* 1 / * 1基因型的患者相比，患有两种功能CYP2C19等位基因（* 3 / * 3）（* 3 / * 3）的患者可能会降低Mephenytoin的代谢。其他遗传和临床因素可能影响患者的肉食酵母的代谢。',\n",
       " 'CYP3A5 expressers (*1/*1, *1/*3) had a relatively higher dose requirement in order to maintain target trough concentrations of tacrolimus, as compared to non-expressers (*3/*3). Note that the paper did not specify the number of individuals with the *1/*1 or *1/*3 genotype, only the number of *1 allele carriers.': 'CYP3A5表达者（* 1 / * 1，* 1 / * 3）具有相对较高的剂量要求，以维持与非表达者（* 3 / * 3）相比维持Tacolimus的靶槽浓度。请注意，本文未指定具有* 1 / * 1或* 1 / * 3基因型的个体的数量，只有* 1等位基因载体的数量。',\n",
       " \"Patients with the GG genotype and non-Hodgkin lymphoma who are treated with doxorubicin may have a decreased, but not absent, risk of cardiotoxicity as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk of cardiotoxicity.; Lymphoma, Non-Hodgkin\": '与患有AA基因型的患者相比，患有由多柔比星治疗的GG基因型和非霍奇金淋巴瘤的患者可能有降低，但不缺乏症状的风险。其他遗传和临床因素也可能影响患者心脏毒性的风险。淋巴瘤，非霍奇金',\n",
       " 'Post menopausal women with the CC genotype and schizophrenia may have increased response to raloxifene compared to patients with the CG genotype. Other genetic and clinical factors may affect response to raloxifene.; Menopause;Schizophrenia': '与CG基因型的患者相比，患有CC基因型和精神分裂症的绝经后妇女对雷洛昔甙的反应增加。其他遗传和临床因素可能影响对雷洛昔芬的反应;更年期;精神分裂症',\n",
       " 'Patients with acute myeloid leukemia and the GT genotype may have decreased survival time when treated with daunorubicin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to daunorubicin.; Leukemia, Myeloid, Acute': '与GG基因型的患者相比，急性髓性白血病和GT基因型的患者可能降低存活时间。其他遗传和临床因素也可能影响对大生布的反应。白血病，米洛克，急性',\n",
       " 'Patients with the AG genotype may have increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to patients with genotype GG. Other genetic and clinical factors may influence the response to peginterferon alpha and ribavirin.; Hepatitis C, Chronic': '当用乙型蛋白酶C，乙型肝炎患者与基因型GG患者相比，患有Peginterferon Alfa-2b和利巴韦林的患者时，AG基因型的患者可能增加了持续的病毒学反应（SVR）。其他遗传和临床因素可能影响对Peginterferonα和利巴韦林的反应。丙型肝炎，慢性',\n",
       " \"Patients with AT genotype may require an increased dose of paroxetine and may have an increased risk of fatigue when treated with paroxetine as compared to patients with the CC genotype. Other genetic and clinical factors may also influence patient's response to paroxetine.; Depressive Disorder, Major\": '患有基因型的患者可能需要增加的帕罗西汀剂量增加，与帕罗西汀处理的患者相比，与CC基因型患者相比，疲劳风险增加。其他遗传和临床因素也可能影响患者对帕罗西汀的反应。抑郁症，主要',\n",
       " 'Patients with mood disorders and the rs4713916 AG genotype may have an increased response to mirtazapine as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to mirtazapine.; Mood Disorders': '与GG基因型患者相比，情绪障碍和RS4713916 AG基因型的患者可能对Mirtazapine的反应增加。其他遗传和临床因素也可能影响对Mirtazapine的反应。情绪障碍',\n",
       " \"Patients with beta-thalassemia and the TT genotype may have a decreased response to deferasirox, as measured by higher liver stiffness values, as compared to patients with the GG genotype. Other genetic and clinical factors may also affect a patient's response to deferasirox.; beta-Thalassemia\": '与患有GG基因型的患者相比，β-地中海贫血症和TT基因型的患者可具有对脱硅酸的响应降低。其他遗传和临床因素也可能影响患者对Deferasirox的反应。Beta-thalassemia',\n",
       " 'Pediatric patients with the GG genotype who are undergoing hematopoietic stem cell transplantation may have decreased clearance of busulfan as compared to patients with the AA genotype. Other genetic and clinical factors may also influence busulfan clearance.; Transplantation': '与AA基因型患者相比，患有造血干细胞移植的GG基因型的小儿科患者可能降低了Busulfan的清除。其他遗传和临床因素也可能影响Busulfan间隙。移植',\n",
       " 'Initiate therapy with recommended starting dose. If patient does not respond to recommended maintenance dosing, consider alternative drug not predominantly metabolized by CYP2C19.c': '用推荐的开始剂量启动治疗。如果患者没有响应推荐的维护给药，则考虑不受CYP2C19.c的替代药物不受代谢的替代药物',\n",
       " 'Patients with the AC genotype and non-small cell lung cancer may have increased overall survival time when treated with platinum compounds in combination with either docetaxel, gemcitabine, paclitaxel or vinorelbine, as compared to patients with the CC genotype. No significant association between this SNP and overall survival time was seen when considering patients taking gemcitabine only. Other genetic and clinical factors may also influence overall survival time.; Carcinoma, Non-Small-Cell Lung': '与CC基因型患者相比，患有铂化合物处理时，患有AC基因型和非小细胞肺癌的患者可能会增加总存活时间。当考虑仅服用吉西他滨的患者时，可以看到这种SNP和整体生存时间之间没有显着关联。其他遗传和临床因素也可能影响整体存活时间。癌，非小细胞肺',\n",
       " 'Patients with the GG genotype and breast cancer may have increased concentrations of tamoxifen-n-glucuronide when taking tamoxifen compared to patients with the TT genotype. Other clinical and genetic factors may affect the metabolism of tamoxifen.; Breast Neoplasms': '与TT基因型的患者相比，患有GG基因型和乳腺癌的患者可能增加了Tamoxifen-N-葡糖尿病患者的浓度。其他临床和遗传因素可能会影响他莫昔芬的代谢。乳房肿瘤',\n",
       " 'Patients with the GG genotype and Cirrhosis may have an increased response when treated with propranolol as compared to patients with the AA and AG genotype. Other genetic and clinical factors may also influence response to propranolol.; Liver Cirrhosis': '与AA和AG基因型患者相比，患有GG基因型和肝硬化的患者可能具有增加的响应率。其他遗传和临床因素也可能影响对普萘洛尔的反应。肝硬化',\n",
       " 'Patients with the rs6928499 GG genotype may have a decreased risk of developing opioid dependence when exposed to opioids as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk of developing opioid dependence.; Opioid-Related Disorders': '与CC基因型患者相比，患有RS6928499 GG基因型的患者可能会导致阿片类药物依赖性的风险降低。其他遗传和临床因素也可能影响开发阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " \"Association described as 'nominally significant' in the paper and was only seen in European Caucasian patients. Please note that alleles have been complemented to the positive strand.\": '协会被描述为论文中的“名义目称重要”，仅在欧洲高加索患者中看到。请注意，等位基因已与正股线相辅相成。',\n",
       " \"Patients with the AA genotype may be at a decreased risk of developing heroin dependence as compared to patients with the AG or GG genotypes. Other genetic and clinical factors may also affect a patient's risk of developing heroin dependence.; Heroin Dependence\": '与AG或GG基因型的患者相比，AA基因型的患者可能处于发育海洛因依赖性的风险下降。其他遗传和临床因素也可能影响患者发展海洛因依赖的风险。海洛因依赖',\n",
       " 'Patients with the TT genotype may have decreased clearance of midazolam as compared to patients with the CC or CT genotype. This SNP is present in the VDR gene, and the VDR protein is known to transcriptionally regulate intestinal CYP3A4 expression. Other genetic and clinical factors may also influence clearance of midazolam.; ': '与CC或CT基因型的患者相比，TT基因型的患者可能降低了咪达唑仑。该SNP存在于VDR基因中，已知VDR蛋白转录调节肠CYP3A4表达。其他遗传和临床因素也可能影响咪达唑仑的间隙。',\n",
       " 'Patients with the CC genotype who are treated with fluvastatin may have a lesser reduction in LDL-C as compared to patients with the AC and AA genotype.; Hypercholesterolemia': '与氟伐他汀治疗的CC基因型的患者可以在与AC和AA基因型的患者相比的LDL-C中具有较小的降低。高胆固醇血症',\n",
       " 'Patients with the rs7597593 CC genotype may have an increased risk of developing opioid dependence when exposed to opioids as compared to patients with the CT or TT genotypes. Other genetic and clinical factors may also influence risk of developing opioid dependence.; Opioid-Related Disorders': '与CT或TT基因型患者相比，患有RS7597593 CC基因型的患者可能产生增加表明阿片类药物依赖性的风险。其他遗传和临床因素也可能影响开发阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'Allele G is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele T.': '与等位基因T.相比，等位基因G与高血压人的氢氯噻嗪的响应降低有关。',\n",
       " \"Patients with the TT genotype and Major Depressive Disorder may be less likely to respond to antidepressant treatment as compared to patients with the CC or CT genotype. Other genetic and clinical factors may also influence a patient's response to anti-depressant treatment.; Depressive Disorder, Major\": '与CC或CT基因型患者相比，TT基因型和主要抑郁症的患者可能不太可能响应抗抑郁药物治疗。其他遗传和临床因素也可能影响患者对抗抑郁药治疗的反应。抑郁症，主要',\n",
       " \"Patients with the AG genotype who are treated with statins (hmg coa reductase inhibitors) may have increased creatine kinase levels, and an increased risk of adverse events in response to treatment as compared to patients with the GG genotype, but a lower creatine kinase levels and lower risk of intolerance as compared to the AA genotype, although this is contradicted in some studies. Other genetic and clinical factors may also influence a patient's response to statin treatment.; Coronary Artery Disease;Diabetes Mellitus;Hypercholesterolemia\": '用他汀类药物治疗的AG基因型（HMG CoA还原酶抑制剂）可能增加肌酸激酶水平，与GG基因型的患者相比，患有患者的抗癫痫发生的不良事件的风险增加，但肌酸激酶水平降低与AA基因型相比，不耐受性的风险较低，尽管这在一些研究中相矛盾。其他遗传和临床因素也可能影响患者对他汀类药物治疗的反应。冠状动脉疾病;糖尿病;高胆固醇血症',\n",
       " 'Patients with the CC genotype (*3/*3) had a decrease in metabolism compared to carriers of the T allele (*1/*3 or *1/*1), indicated by: increased area under the blood concentration-time curve (AUC) from 0 to 24 hours (AUC0-24; units = ng*h/mL), AUC from 12 to 24 hours (AUC12-24; units = ng*h/mL), trough blood concentration (C0; units = ng/mL), dose adjusted AUC0-24 (AUC0-24/D; units = ng*h/mL/mg) and dose-adjusted C0 (C0/D; units = ng/mL/mg). These patients received tacrolimus as a once-daily formulation (Advagraf, Prograf XL or Graceptor).': '与T等位基因（* 1 / * 3或* 1 / * 1）的载体相比，CC基因型（* 3 / * 3）的患者的代谢减少，如下：血液浓度 - 时间曲线下的面积增加（AUC）从0到24小时（AUC0-24;单位= Ng * H / ml），1来自12-24小时（AUC12-24;单位= Ng * H / mL），槽血液浓度（C0;单位=Ng / ml），剂量调节AUC0-24（AUC0-24 / D;单位= Ng * h / ml / mg）和剂量调节的C0（CO / D;单位= Ng / ml / mg）。这些患者接受了一次每日制剂（Advagraf，Prograf XL或Graceptor）的躯干肢体。',\n",
       " 'CYP2D6 *10/*10 is associated with decreased clearance of atomoxetine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*10.': '与CYP2D6 * 1 / * 1 + * 1 / * 10相比，CYP2D6 * 10 / * 10与健康个体中的杂草胺的间隙降低有关。',\n",
       " 'Patients with the GT genotype may have a decreased rate of sulfation of morphine as compared to patients with the TT genotype. Other genetic and clinical factors may also affect morphine sulfation in patients.; ': '与TT基因型的患者相比，GT基因型的患者可能对吗啡的硫化率降低。其他遗传和临床因素也可能影响患者的吗啡硫化。',\n",
       " 'Patients with the *3B allele, in combination with a normal function allele or a no function allele, may have an increased likelihood of dose reduction when treated with azathioprine as compared to patients with two normal function alleles. Other genetic and clinical factors may also influence azathioprine dosage.; dose reduction': '与正常功能等位基因组合的患者患者与正常功能等位基因组合，当用两种正常功能等位基因的患者相比，当用氮杂唑处理时，减少剂量降低的可能性增加。其他遗传和临床因素也可能影响Azathioprine剂量。减少剂量',\n",
       " 'The current evidence base suggests that there is no significant association between the CYP2D6*17 allele and risk of side effects or intolerance to citalopram. This drug-variant pair has been assigned a “no recommendation” by DPWG, as it was determined to be not clinically actionable. Other genetic and clinical factors may also influence risk of side effects or intolerance to citalopram.; Depressive Disorder, Major': '目前的证据基础表明，CYP2D6 * 17等位基因之间没有显着关联以及对西酞普兰的副作用或不容忍的风险。这种药物变异对被DPWG分配了“不建议”，因为它被确定在临床上不可缩小。其他遗传和临床因素也可能影响副作用或不耐受性的风险。抑郁症，主要',\n",
       " 'Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.': '与等位基因A相比，等位基因G与双相障碍的人对锂的响应增加有关。',\n",
       " 'as measured by decreases in triglycerides seen in patients with the GT or TT genotype, but decreases were not seen in those with the GG genotype.': '通过GT或TT基因型中患者中看到的甘油三酯的降低来测量，但在GG基因型中没有看到降低。',\n",
       " \"Patients with the C/del genotype and hypertension may have decreased response to hydrochlorothiazide compared to patients with genotype del/del. Other genetic and clinical factors may influence the patient's response to hydrochlorothiazide.; Hypertension\": '与基因型Del / Del的患者相比，C / DEL基因型和高血压患者可能对氢氯噻嗪的反应降低。其他遗传和临床因素可能影响患者对氢氯噻嗪的反应。高血压',\n",
       " 'CYP2B6 516T allele was significantly associ- ated with higher efavirenz plasma level. Subjects received ART containing 600mg efavirenz and were prescribed fixed- dose artemether and lumefantrine for uncomplicated malaria by their primary physician.': 'CYP2B6 516T等位基因与较高的EFAVIRENZ等离子体水平有显着关联。受试者接受含有600mg efaviraenz的艺术，并以主要医生为不复杂的疟疾进行规定的固定剂蒿甲醚和Lumefantrine。',\n",
       " \"Patients with the AG who are treated with bortezomib, melphalan and prednisone may have a later onset of bortezomib-induced peripheral neuropathy as compared to patients with the GG genotype. However, no association was found for bortezomib and dexamethasone treatment. Other genetic and clinical factors may also influence a patient's risk for treatment-induced peripheral neuropathy.; \": '用硼替佐米（Melphalan和Prednisone）治疗的AG患者可能在患有GG基因型的患者的患者相比，嗜氨酚和泼尼松治疗的AG可能具有后来的硼螨诱导的周围神经病变。然而，没有发现Bortezomib和地塞米松治疗的任何关联。其他遗传和临床因素也可能影响患者治疗诱导的周围神经病变的风险。',\n",
       " 'Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele T.': '与等位基因T.相比，等位基因G与海洛因依赖性的人们浓度增加。',\n",
       " 'Patients with the CT genotype may have increased glucuronidation metabolic ratios of ABT-751 as compared to patients with TT genotype. Other genetic and clinical factors may also influence clearance of ABT-751.; Neoplasms': '与TT基因型的患者相比，CT基因型的患者可以增加ABT-751的葡糖醛代谢比。其他遗传和临床因素也可能影响ABT-751的间隙。肿瘤',\n",
       " 'Patients with the rs6313 GG genotype and major depressive disorder may be less likely to develop sexual dysfunction when treated with citalopram as compared to patients with the AA genotype. Other genetic and clinical factors may also influence likelihood of developing sexual dysfunction when treated with citalopram.; Depressive Disorder, Major;Sexual Dysfunctions, Psychological': '与AA基因型患者相比，患有RS6313 GG基因型和重大抑郁症的患者可能不太可能在用基因素治疗时发生性功能障碍。其他遗传和临床因素也可能影响用西普拉姆治疗时发育性功能障碍的可能性。抑郁症，主要;性功能困扰，心理',\n",
       " \"Patients with the GG genotype may have an increased response to treatment with duloxetine for major depressive disorder as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's response to duloxetine.; Depressive Disorder, Major\": '与AA基因型的患者相比，GG基因型的患者可能对用杜洛汀治疗的响应增加，而抑郁症相比。其他遗传和临床因素也可能影响患者对Duloxetine的反应;抑郁症，主要',\n",
       " 'Patients with the rs17782313 CT genotype may be at a decreased risk of experiencing weight gain when treated with quetiapine as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk of experiencing weight gain when treated with quetiapine.; Weight gain': '与CC基因型患者相比，RS17782313 CT基因型CT基因型的患者可能处于使用喹硫曲尼处理的患者中进行体重增加的风险。其他遗传和临床因素也可能影响用喹诗处理时体重增加的风险。体重增加',\n",
       " \"Patients with the TT genotype may be at an increased risk of developing alcoholism as compared to patients with the CC genotype. Other genetic or clinical factors may also affect a patient's risk of developing alcoholism.; Alcoholism\": '与患有CC基因型患者相比，TT基因型的患者可能是发育酗酒的风险增加。其他遗传或临床因素也可能影响患者发育酗酒的风险。酗酒',\n",
       " 'Patients with the 961delT+C(n) allele (represented here by the rs1556422499 CCCCCCC allele) may have an increased risk of experiencing hearing loss when treated with streptomycin as compared to patients with the T allele. However, conflicting evidence has been reported. MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of hearing loss when treated with streptomycin.; Ototoxicity': '患有961平方米+ C（N）等位基因（CCCCCCC等位基因的CCCCCC等位基因在此代表）可能具有增加的体验听力损失的风险，与患有T等位基因患者相比治疗链霉素。但是，已经报告了相互矛盾的证据。MT-RNR1是线粒体基因，其作为单倍体（即只有一个等位基因存在）。其他遗传和临床因素也可能影响用链霉素处理时的听力损失风险。ototoxicity.',\n",
       " 'Patients with the AG genotype and schizophrenia may have greater weight gain when treated with antipsychotics as compared to patients with the AA genotype. Other genetic and clinical factors may also influence weight gain in patients taking antipsychotics.; Schizophrenia': '与AA基因型患者相比，患有AG基因型和精神分裂症的患者可能具有更大的体重增加。其他遗传和临床因素也可能影响服用抗精神病药患者的体重增加。精神分裂症',\n",
       " 'The CC genotype is associated with decreased catalytic activity of DPYD as compared to the CT or TT genotypes. Other clinical and genetic factors may also influence catalytic activity of DPYD.; ': '与CT或TT基因型相比，CC基因型与DPYD的催化活性降低有关。其他临床和遗传因素也可能影响DPYD的催化活性;',\n",
       " 'Patients with the AG genotype may require decreased doses of warfarin as compared to patients with the GG genotype, and increased doses as compared to the AA genotype. Other genetic and clinical factors may also influence warfarin dose, such as variations in the CYP2C9 and VKORC1 genes.; ': '与患有GG基因型的患者相比，AG基因型的患者可能需要减少的Warfarin剂量，与AA基因型相比增加剂量。其他遗传和临床因素也可能影响华法林剂量，例如CYP2C9和VKORC1基因的变化;',\n",
       " 'CYP3A5 genotype was associated with dose-adjusted blood concentration at 12 hours after tacrolimus administration in stable state: patients with the *3/*3 genotype had the highest concentration, followed by *1/*3 then *1/*1. Significant in stepwise selection multiple linear regression analysis. Allele frequencies listed below are for entire cohort (n=109).': 'CYP3A5基因型在稳定状态下在Tacromus施用后12小时内与剂量调节的血液浓度相关联：* 3 / * 3基因型的患者具有最高的浓度，其次是* 1 / * 3然后* 1 / * 1。在逐步选择多元线性回归分析中显着。下面列出的等位基因频率适用于整个队列（n = 109）。',\n",
       " 'Genotypes AA + AT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.': '基因型AA + AT与冠状动脉疾病与基因型TT相比的人们对Perindopril的反应减少有关。',\n",
       " 'UGT1A9 *3a is associated with increased exposure to raltegravir in people with HIV.': 'UGT1A9 * 3A与艾滋病毒的人们的raltegravir接触增加有关。',\n",
       " 'Patients with the AA genotype may have a better response to the pertussis vaccine as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence efficacy of the pertussis vaccine.; ': '与AG或GG基因型的患者相比，AA基因型的患者可能对百日咳疫苗具有更好的反应。其他遗传和临床因素也可能影响百日咳疫苗的疗效。',\n",
       " 'Genotype AC is associated with decreased clearance of irbesartan in healthy individuals as compared to genotype AA.': '与基因型AA相比，基因型AC与健康个体中的厄贝沙坦的间隙降低有关。',\n",
       " 'Patients with the TT genotype may have increased steady-state levels of vitamin E when taking vitamin E supplements as compared to patients with the CT and CC genotypes. Other clinical and genetic factors may also influence steady-state levels of vitamin E in patients taking vitamin E supplements.; ': '与患有CT和CC基因型的患者相比，TT基因型的患者可增加维生素E稳态水平的维生素E水平。其他临床和遗传因素也可能影响维生素E补充剂的患者维生素E的稳态水平。',\n",
       " 'Genotypes AA + AG are associated with decreased response to clopidogrel in people with Cardiovascular Diseases as compared to genotype GG.': '与基因型GG相比，基因型AA + AG与心血管疾病的人们对氯吡格雷的响应降低有关。',\n",
       " 'CYP2C9 *3 is associated with decreased dose of phenprocoumon as compared to CYP2C9 *1.': '与CYP2C9 * 1相比，CYP2C9 * 3与诸如苯处理剂量的减少相关。',\n",
       " 'Patients with the GG genotype may experience an increased severity of nausea and vomiting when treated with opioids as compared to people with the GT or TT genotypes. Other genetic and clinical factors may also affect the severity of nausea and vomiting in patients treated with opioids.; Nausea;Vomiting': '与GT或TT基因型的人相比，患有GG基因型的患者可能会经历恶心和呕吐的严重程度和呕吐。其他遗传和临床因素也可能影响用阿片类药物治疗的患者的恶心和呕吐的严重程度。恶心，呕吐',\n",
       " \"Male patients with the A-202A_376G haplotype (hemizygous for the A- variant, associated with G6PD deficiency) who are treated with a high dose of chloroquine may have an increased risk of hemolytic anemia as compared to patients with the wildtype B haplotype (not associated with G6PD deficiency). Most studies show no association with increased risk with normal chloroquine dosage. Please note: all studies reported an association with G6PD deficiency but only one reported genotyping, here we are representing this association under the Mediterranean or A- haplotype which is associated with G6PD deficiency, with the B (wildtype) haplotype representing G6PD non-deficient. Other genetic and clinical factors may also influence a patient's risk of drug-induced hemolysis.; Anemia, Hemolytic\": '患有高剂量氯喹处理的A-202A_376G单倍型（与G6PD缺乏相关的α-变体的嗜血症）可能具有含有野生型B单倍型的患者的溶血性贫血的风险增加（无关缺乏G6PD）。大多数研究表明，没有正常氯喹剂量的风险增加。请注意：所有研究均报告与G6PD缺乏的关联，但只有一个报告的基因分型，我们在这里代表了与G6PD缺乏相关的地中海或A-单倍型，其中B（野生型）单倍型表示G6PD非缺乏。其他遗传和临床因素也可能影响患者的药物诱导溶血的风险。贫血，溶血',\n",
       " 'Genotype CC is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CT + TT.': '基因型CC与乙型肝炎的响应减少，与丙型肝炎，慢性相比，与基因型CT + TT相比的乙型肝炎。',\n",
       " \"Patients with the AG genotype may be at a decreased risk of developing neurotoxicity after receiving cyclosporine following hematopoietic stem cell transplant as compared to patients with the GG genotype. However, this association was not statistically significant. Other genetic and clinical factors may also affect a patient's rick of developing neurotoxicity following cyclosporine treatment.; hematopoietic stem cell transplantation;Neurotoxicity Syndromes\": '与GG基因型的患者相比，患有AG基因型在接受造血干细胞移植后接受造血干细胞移植后发育神经毒性的风险降低。然而，这种关联没有统计学意义。其他遗传和临床因素也可能影响患者在环孢菌素处理后发育神经毒性的瑞典。造血干细胞移植;神经毒性综合征',\n",
       " 'Annotation of DPWG Guideline for omeprazole and CYP2C19': 'Omeprazole和CYP2C19的DPWG指南注释',\n",
       " 'Patients with the AA genotype and gastrointestinal stromal tumors may have an increased risk for toxicity when treated with imatinib as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence risk for toxicity in patients receiving imatinib.; Gastrointestinal Stromal Tumors': '患有AA基因型和胃肠间质量肿瘤的患者可能在用AG或GG基因型患者与伊马替尼处理的毒性时具有增加的毒性风险。其他遗传和临床因素也可能对接受伊马替尼的患者影响毒性风险。胃肠道间质瘤',\n",
       " 'The study partitioned the poor metabolizer group (PM) into adults <40, adults 40-65 and elderly adults (>65). Several PK parameters of venlafaxine metabolism were assessed (dose adjusted serum concentration of venlafaxine, O-desmethylvenlafaxine, N-desmethylvenlafaxine, active moiety, and the metabolic ratio of venlafaxine and its metabolites). Adults 40-65 showed greater decreases in venlafaxine metabolism when compared with the control group of adults <40.': '该研究将贫瘠的代谢物组（PM）分为成人<40，成人40-65岁及老年人（> 65）。评估几种pk参数的venlafaxine代谢（剂量调节血清浓度Venlafaxine，O- desmethylylvenlafaxine，N- desmethylvenlafaxine，活性部分和venlafaxine的代谢比及其代谢物）。与成人对照组相比，成年人40-65表现出venlafaxine代谢的更大减少<40。',\n",
       " 'Patients with the GG genotype may have decreased severity of nicotine dependence, as measured by FTND score, as compared to patients with the CC genotype. Other genetic and clinical factors may also affect severity of nicotine dependence.; Tobacco Use Disorder': '与CC基因型患者相比，患有GG基因型的患者可能会降低尼古丁依赖性的严重程度。其他遗传和临床因素也可能影响尼古丁依赖的严重程度。烟草使用障碍',\n",
       " 'Patients carrying the CYP2C9 *3 allele were found to have an increased risk of severe overanticoagulation, and required a lower maintenance dose of phenprocoumon as compared to patients homozygous for the *1 allele.': '发现携带CYP2C9 * 3等位基因的患者产生严重溢出的风险增加，与* 1等位基因纯合的患者相比，需要较低的维持剂量的苯处理剂量。',\n",
       " 'Patients with the rs1799971 AA genotype who are receiving hydrocodone may have a decreased risk for experiencing side effects as compared to patients with the AG or GG genotype. This drug-variant pair has been assigned a “no recommendation” by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also influence risk of side effects when receiving hydrocodone.; Constipation;dry mouth;Respiratory Insufficiency': '接受氢陶器的RS1799971 AA基因型的患者可能对经历副作用的风险降低，与AG或GG基因型的患者相比。这种药物变异对被CPIC分配了“不建议”，因为它被确定在临床上可操作。其他遗传和临床因素也可能影响接受氢酮时副作用的风险。便秘;口干;呼吸功能不全',\n",
       " 'Patients with the CYP3A5 *3/*3 genotype who are administered midazolam may have slower clearance rates, and decreased metabolism of midazolam as compared to patients with the CYP3A5 *1/*3 or *1/*1 genotypes, although this is contradicted in one study. Other clinical and genetic factors may also influence clearance and metabolism of midazolam.; ': '与CYP3A5 * 1 / * 3或* 1 / * 1基因型相比，患有Midazolam的CYP3A5 * 3 / * 3基因型的患者可能具有较慢的间隙率，并降低咪达唑仑的代谢，尽管这相比之下一项研究。其他临床和遗传因素也可能影响咪达唑仑的许可和代谢。',\n",
       " \"Patients with schizophrenia and the TT genotype may have an increased response to risperidone as compared to patients with the CC or CT genotypes. However, this association lost significance following correction for multiple testing. Other genetic or clinical factors may also affect a patient's response to risperidone.; Schizophrenia\": '与CC或CT基因型患者相比，精神分裂症和TT基因型的患者可能对Risperidone的反应增加。然而，这种关联在多次测试校正后丧失了重要性。其他遗传或临床因素也可能影响患者对Risperidone的反应。精神分裂症',\n",
       " \"Patients with the AA genotype may have an increased risk of acetylsalicylic acid-intolerant chronic urticaria as compared to the AG or GG genotype. Other genetic and clinical factors may also influence a patient's risk for aspirin sensitivity.; \": '与AG或GG基因型相比，患有AA基因型的患者可能具有增加的乙酰胱氨酸酸性慢性荨麻疹的风险。其他遗传和临床因素也可能影响患者的阿司匹林敏感性的风险。',\n",
       " 'Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Alzheimer Disease as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与Alzheimer疾病的人们对HMG CoA还原酶抑制剂的响应增加相关。',\n",
       " \"Patients with the GG genotype may have an increased metabolism of clozapine as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's clozapine metabolism.; \": '与AA基因型患者相比，GG基因型的患者可能增加氯氮平的代谢。其他遗传和临床因素也可能影响患者的氯氮平新陈代谢;',\n",
       " 'Patients with cystic fibrosis and the rs113993960 CTT/del genotype (one copy of the CFTR F508del variant) may experience a limited benefit from treatment with the combination drug of ivacaftor/lumacaftor, as shown by improvement in sweat chloride concentrations CFQ-R questionnaire scores when compared to treatment with placebo. However, ppFEV1, BMI or body weight did not show a significant improvement following ivacaftor/lumacaftor treatment. This genotype is not an indication for use of the combination drug of ivacaftor/lumacaftor according to the FDA-approved drug label for this drug combination. Other genetic and clinical factors may also influence response to ivacaftor/lumacaftor.; Cystic Fibrosis': '囊性纤维化患者和RS113993960 CTT / DEL基因型（CFTR F508DEL变体的一份拷贝）可能会对IVACAFTOR / Lumacaforor的组合药物进行有限的益处，如汗液氯化物浓度的改善所示，当时与安慰剂治疗相比。然而，PPFEV1，BMI或体重没有显示IVACAFTOR / Lumacaforor治疗后的显着改善。该基因型不是根据该药物组合的FDA批准的药物标签使用Ivacafacter / Lumacafacer的组合药物的指示。其他遗传和临床因素也可能影响对IVACAFTOR / Lumacaftor的反应。囊性纤维化',\n",
       " 'Patients with genotype GG and epilepsy may have an increased risk of drug toxicity when taking valproic acid as compared to patients with the AA and AG genotypes. Other clinical and genetic factors may also affect risk of drug toxicity when taking valproic acid.; Epilepsy': '与AA和AG基因型患者相比，基因型GG和癫痫的患者可能产生增加的药物毒性风险。其他临床和遗传因素也可能在服用丙戊酸时影响药物毒性的风险;癫痫',\n",
       " \"Patients with the GG genotype may have decreased risk for progression with platinum-based treatments as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response.; Neoplasms\": '与AA基因型的患者相比，GG基因型的患者可能降低了铂族治疗的进展风险。其他遗传和临床因素也可能影响患者的反应。肿瘤',\n",
       " 'Patients with the rs397508328 AG genotype (one copy of the CFTR M1V variant) and cystic fibrosis may respond to ivacaftor treatment. Other genetic and clinical factors may also influence response to ivacaftor.; Cystic Fibrosis': '患者RS397508328 AG基因型（CFTR M1V变体的一份拷贝）和囊性纤维化可能会响应IVAcafetor治疗。其他遗传和临床因素也可能影响对IVACAFTOR的反应。囊性纤维化',\n",
       " \"Patients with the CT genotype and Bipolar Disorder may be more likely to respond to lithium as compared to patients with the CC genotype. However, contradictory findings have been reported. Other genetic and clinical factors may also influence a patient's response to lithium.; Bipolar Disorder\": '与CC基因型患者相比，CT基因型和双相障碍的患者可能更有可能对锂响应。但是，已经报道了矛盾的结果。其他遗传和临床因素也可能影响患者对锂的反应。躁郁症',\n",
       " \"Patients with the GG genotype may have increased likelihood of cardiotoxicity when exposed to anthracyclines and related substances in children with Neoplasms as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to anthracyclines and related substance.; Neoplasms\": '与AA基因型患者相比，患有GG基因型的患者可能会增加心脏毒性的可能性毒性，并且在肿瘤儿童中的相关物质。其他遗传和临床因素也可能影响患者对蒽环类和相关物质的反应。肿瘤',\n",
       " \"Patients with the AA genotype may have a decreased response to treatment with duloxetine for major depressive disorder as compared to patients with the AC or CC genotypes. Other genetic and clinical factors may also affect a patient's response to duloxetine.; Depressive Disorder, Major\": '患有AA基因型的患者可能对患有AC或CC基因型的患者的患者对杜洛汀治疗的响应降低。其他遗传和临床因素也可能影响患者对Duloxetine的反应;抑郁症，主要',\n",
       " 'When combined with rs1468412 AA and AT genotypes. rs165854 AG+GG/rs1468412 AA+AT was associated with a significantly increased likelihood of patients having an incomplete antipsychotic response within a cohort of 1) all patients, 2) patients receiving atypical monotherapy and 3) patients receiving risperidone. Response assessed using CGI scale, patients were either complete responders (CR) or incomplete responders (IR) based on this scale.': '与RS1468412 AA和基因型相结合时。RS165854 AG + GG / RS1468412 AA + AT与1）群体队列，2）患者在接受risperidone的患者中具有不完全抗精神病药症的患者的患者显着增加的患者。使用CGI规模评估的响应，患者是基于此规模的完整响应者（CR）或不完整的响应者（IR）。',\n",
       " 'The presence of CYP3A5*1 allele was associated with lower dose-adjusted tacrolimus C0 and higher tacrolimus dose requirement at 1, 3, 6 and 12 months post-transplantation.': 'CYP3A5 * 1等位基因的存在与移植后1,3,6和12个月的较低剂量调节的Tacrolimus C0和较高的Tacolimus剂量要求相关。',\n",
       " 'Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as normal metabolizer phenotype) .': '与等位基因T（分配为正常代谢物表型）相比，等位基因C（分配为差的代谢物表型）与HIV感染的人们的代谢降低有关。',\n",
       " 'Patients with the TT genotype and non-small cell lung cancer may have decreased overall survival time when treated with platinum compounds in combination with either docetaxel, gemcitabine, paclitaxel or vinorelbine, as compared to patients with the CC or CT genotype. No significant association between this SNP and overall survival time was seen when considering patients taking gemcitabine only. Other genetic and clinical factors may also influence overall survival time.; Carcinoma, Non-Small-Cell Lung': '与CC或CT基因型的患者相比，用铂化合物处理时，TT基因型和非小细胞肺癌的患者可能降低了用铂化合物处理的总存活时间。当考虑仅服用吉西他滨的患者时，可以看到这种SNP和整体生存时间之间没有显着关联。其他遗传和临床因素也可能影响整体存活时间。癌，非小细胞肺',\n",
       " 'Patients with the AG genotype and vascular diseases may have a poorer response to pravastatin treatment as compared to patients with the GG genotype, or a better response as compared to patients with the AA genotype. Other genetic and clinical factors may also influence pravastatin response.; Vascular Diseases': '与GG基因型患者相比，AG基因型和血管疾病的患者可能对普伐他汀治疗的反应较差，或与AA基因型的患者相比具有更好的反应。其他遗传和临床因素也可能影响普伐他汀反应。血管疾病',\n",
       " \"Patients with the CC genotype and solid tumors, may have decreased response to gemcitabine compared to the AA and AC genotypes. Other genetic and clinical factors may also influence a patient's response to gemcitabine.; Neoplasms\": '与AA和AC基因型相比，患有CC基因型和实体瘤的患者可能对吉西他滨的反应降低。其他遗传和临床因素也可能影响患者对吉西他滨的反应。肿瘤',\n",
       " 'The CYP2D6*1 allele is assigned as a normal function allele by CPIC. Patients carrying the *1 allele in combination with alleles that result in a normal metabolizer phenotype may have a similar analgesic response to codeine as compared to patients carrying two increased function alleles or an increased function allele in combination with a normal function allele or a decreased function allele with an activity value of 0.5. Patients carrying the *1 allele in combination with alleles that result in a normal metabolizer phenotype may also have a similar analgesic response to codeine as compared to patients carrying an increased function allele with an activity value of 3 or greater in combination with a no function allele or a decreased function allele with an activity value of 0.25 but an increased analgesic response to codeine as compared to patients with a no function allele in combination with a decreased or normal function allele or two decreased or no function alleles. Other genetic and clinical factors may also influence analgesic response when treated with codeine.; Pain': 'CYP2D6 * 1等位基因由CPIC分配为正常功能等位基因。携带* 1等位基因的患者与导致正常代谢物表型的等位基因可以具有与携带两种功能等位基因的患者相比具有类似的镇痛反应，或者与正常功能等位基因或减少功能相结合等位基因活动值0.5。携带* 1等位基因与导致正常代谢物表型的等位基因组合的患者也可以具有与携带活性值增加3或更高的函数等位基因的患者相比类似的镇痛反应，与无功能等位基因组合或减少的功能等位基因，活性值为0.25，但与无功能等位基因的患者相比，镇痛反应增加了与无函数等位基因的患者相比，或者常规功能等位基因或两种降低或无功能等位基因相比。当用可待因处理时，其他遗传和临床因素也可能影响镇痛反应。疼痛',\n",
       " \"Patients with the AG genotype may have increased overall survival when treated with thalidomide in people with Multiple Myeloma as compared to patients with the AA genotype. Other clinical or genetic factors may also influence a patient's response to thalidomide.; Multiple Myeloma\": '与AA基因型患者相比，当用多发性骨髓瘤的人们用亚马亚度胺处理时，AG基因型的患者可能会增加整体存活。其他临床或遗传因素也可能影响患者对沙利度胺的反应。多发性骨髓瘤',\n",
       " 'Patients with the GG genotype may have increased conversion of tramadol to O-desmethyltramadol (M1) as compared to patients with the CC or CG genotypes. Other genetic and clinical factors may also affect tramadol metabolism in a patient.; ': '与患有CC或CG基因型的患者相比，GG基因型的患者可能会增加曲马多转化为O-去甲基三醇（M1）。其他遗传和临床因素也可能影响患者的曲马多代谢。',\n",
       " 'The CYP2D6*29 allele has been assigned as a decreased function allele with an activity score of 0.5 by CPIC. Patients carrying the *29 allele in combination with another decreased function allele or a no function allele may have decreased metabolism of codeine as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *29 allele in combination with an increased function allele may have increased metabolism of codeine as compared to patients with alleles that result in a normal metabolizer phenotype. This annotation only covers the pharmacokinetic relationship between CYP2D6 and codeine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence codeine metabolism.; ': 'CYP2D6 * 29等位基因已被分配为减少的函数等位基因，CPIC的活动分数为0.5。患者与另一种减少的功能等位基因或NO功能等位基因组合的患者可能降低了可待因的代谢，相比具有正常代谢物表型的等位基因，而携带* 29等位基因的患者组合增加与患有正常代谢物表型的等位基因的患者相比，功能等位基因可能增加可待因的代谢。该注释仅涵盖CYP2D6和Comeine之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响可待征的新陈代谢。',\n",
       " 'Patients with the AG genotype with substance withdrawal syndrome may have a decreased likelihood of headache when discontinuing the use of analgesics (such as opioids, NSAIDs, triptans, ergot) as compared to patients with the GG genotype. Other clinical and genetic factors may also influence likelihood of headache in patients with withdrawal syndrome who discontinue the use of analgesics.; Substance Withdrawal Syndrome': '患有药物戒断综合征的AG基因型可能会减少头痛时的可能性降低（例如与GG基因型的患者相比使用镇痛药（如阿片类药物，NSAIDS，restans，ergot）。其他临床和遗传因素也可能影响停止使用镇痛药的戒断综合征患者头痛的可能性。药物戒断综合征',\n",
       " 'The CYP2C19*3 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2C19*3 allele in combination with a no, decreased, normal, or increased function allele may have decreased metabolism of voriconazole as compared to patients with two normal function alleles. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between CYP2C19 and voriconazole and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of voriconazole.; ': 'CYP2C19 * 3等位基因由CPIC分配为NO功能等位基因。携带CYP2C19 * 3等位基因的患者与NO，降低，正常或增加的功能等位基因可能降低了伏立康唑的代谢，相比具有两个正常功能等位基因的患者。但是，已经报告了相互矛盾的证据。该注释仅涵盖CYP2C19和Voriconazole之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响伏立康唑的代谢。',\n",
       " 'Patients with the CYP3A5 *3/*3 may have a decreased metabolism of cilostazol as compared to patients with the CYP3A5 *1/*1 diplotype. Other clinical and genetic factors may also influence metabolism of cilostazol.; ': '与CYP3A5 * 1 / * 1二曲面型患者相比，CYP3A5 * 3 / * 3患者可能对西洛司唑的代谢降低。其他临床和遗传因素也可能影响西洛司唑的代谢。',\n",
       " 'Patients with the TT genotype and hypertension may reach target blood pressure faster when treated with ramipril as compared to patients with the CT genotype. Other genetic and clinical factors may also influence blood pressure in patients receiving ramipril.; Hypertension': '与CT基因型患者相比，TT基因型和高血压的患者可更快地达到ramipril的靶血压。其他遗传和临床因素也可能影响接受Ramipril的患者的血压。高血压',\n",
       " 'Alcohol-dependent patients with the AT genotype may have decreased stress-induced alcohol cravings as compared to patients with the TT genotype. Other genetic and clinical factors may also affect stress-induced alcohol craving in alcohol-dependent patients.; Alcoholism': '与TT基因型患者相比，含有AT基因型的醇依赖性患者可能降低了应激诱导的酒精诱导。其他遗传和临床因素也可能影响压力诱导的酒精依赖患者渴望。酗酒',\n",
       " 'Individuals with the GG genotype and bipolar disorder may have a worse response to lithium as compared to individuals with the GT or TT genotype. Other clinical and genetic factors may also influence response to lithium in individuals with bipolar disorder.; Bipolar Disorder': '与具有GT或TT基因型的个体相比，具有GG基因型和双极性障碍的个体可能对锂的响应较差。其他临床和遗传因素还可能影响对具有双相障碍的个体中锂的响应。躁郁症',\n",
       " 'Patients with the GG genotype may experience an increased severity of nicotine withdrawal as compared to patients with the AA or AG genotypes. Other genetic and clinical factors may also affect the severity of nicotine withdrawal.; Tobacco Use Disorder': '与AA或AG基因型患者相比，GG基因型的患者可能会经历增加尼古丁戒断的严重程度。其他遗传和临床因素也可能影响尼古丁戒断的严重程度。烟草使用障碍',\n",
       " \"Patients with the CT genotype and schizophrenia who are treated with olanzapine may have an increased risk of weight gain as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's risk of weight gain with olanzapine.; Schizophrenia;Weight gain\": '与奥拉扎齐齐型治疗的CT基因型和精神分裂症患者可能导致体重增加的风险增加，与患有CC基因型的患者相比。其他遗传和临床因素也可能影响患者的体重增加风险与奥氮平。精神分裂症;体重增加',\n",
       " 'Associated with longer overall survival and time to progression. Stats corrected with the false-discovery rate for candidate SNPs and Bonferroni method (p<0.05 was considered significant).': '与较长的整体生存和时间相关联。用候选SNP和Bonferroni方法的假发现率纠正的统计数据（P <0.05被认为是显着的）。',\n",
       " \"Patients with the CT genotype may require an increased dose of warfarin as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's dose of warfarin.; \": '与TT基因型的患者相比，CT基因型的患者可能需要增加的Warfarin剂量。其他遗传和临床因素也可能影响患者的患者的Warfarin。',\n",
       " 'Initiate therapy with recommended starting dose.g': '用推荐的开始剂量启动治疗',\n",
       " \"Infants who have been exposed to methadone in utero and are born to women with the CC genotype may be less likely to require treatment with at least two medications for neonatal abstinence syndrome as compared to infants born to women with the AA or AC genotypes. Be aware that this annotation is on the mother's genotype, even though the phenotype is observed in the infant and that this was not a statistically significant association. Other genetic and clinical factors may also affect severity of neonatal abstinence syndrome.; Neonatal Abstinence Syndrome\": '暴露于子宫内美沙酮并出生于患有CC基因型的婴儿可能不太可能需要治疗至少两种用于新生儿禁欲综合征的药物，而与AA或AC基因型出生的患者相比。请注意，即使在婴儿在婴儿观察到表型并且这不是统计学上的关联，即使表型也是在母亲的基因型上。其他遗传和临床因素也可能影响新生儿禁忌综合征的严重程度。新生儿禁欲综合征',\n",
       " 'Patients with the CC genotype who are taking buprenorphine for pain may have an increased analgesic response as compared to patients with the CT or TT genotypes. Other genetic and clinical factors may also influence analgesic response to buprenorphine.; Pain': '与患有CT或TT基因型的患者相比，服用尿嘧啶的CC基因型的患者可能具有增加的镇痛反应。其他遗传和临床因素也可能影响对丁丙诺啡的镇痛反应。疼痛',\n",
       " 'The outcome of this study was the variable rate of fall in the INR in patients withdrawing from warfarin treatment prior to elective surgery. Patients were assessed along with rs1057910. Patients with two variant alleles *2*2 or *2*3 had increased odds of having an INR over 1.5 on the planned surgery.': '本研究的结果是在选修外科之前从华法林治疗中退出的患者中的INR中秋季的变量率。患者与RS1057910一起评估。患有两种变体等位基因* 2 * 2或* 2 * 3的患者在计划的手术上具有超过1.5的INR的几率增加。',\n",
       " 'Patients with the rs2231142 GT genotype and who are treated with rosuvastatin may have higher concentration of rosuvastatin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to rosuvastatin treatment and rosuvastatin pharmacokinetics.This annotation only covers the pharmacokinetic relationship between rs2231142 and rosuvastatin and does not include evidence about clinical outcomes.; ': '与罗斯汀治疗的RS2231142 GT基因型患者可能具有较高浓度的罗苏伐他汀，与患有GG基因型的患者相比。其他遗传和临床因素也可能影响对罗苏伐他汀治疗和罗苏伐他汀药代动力学的反应。本发明仅涵盖RS2231142和罗苏伐他汀之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " \"Patients with the GG genotype may have an increased severity of nicotine dependence, as indicated by a higher Fagerstrom Test for Nicotine Dependence score, as compared to patients with the AA genotype. Other genetic and clinical factors may also affect the severity of a patient's nicotine dependence.; Tobacco Use Disorder\": '与AA基因型的患者相比，患有GG基因型的尼古丁依赖性的严重程度增加，如尼古丁依赖性得分的更高的Fagerstrom试验。其他遗传和临床因素也可能影响患者尼古丁依赖的严重程度。烟草使用障碍',\n",
       " \"Patients with the CC genotype may have an increased response to treatment with duloxetine for major depressive disorder as compared to patients with the CG or GG genotypes. Other genetic and clinical factors may also affect a patient's response to duloxetine.; Depressive Disorder, Major\": '与CG或GG基因型患者相比，患有CC基因型的患者可能对用杜洛汀治疗的响应增加，抑郁症患者。其他遗传和临床因素也可能影响患者对Duloxetine的反应;抑郁症，主要',\n",
       " 'Patients with the rs1801133 GG genotype may have an increased response to methotrexate as compared to patients with the AA or AG genotypes. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to methotrexate.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与AA或AG基因型患者相比，RS1801133 GG基因型的患者可能对甲氨蝶呤的反应增加。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对甲氨蝶呤的反应。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Significance for genotype shown for african americans, significance not shown for the genotype for european american but was significant for diplotype with rs909706.': '非洲裔美国人的基因型的重要性，欧洲美国的基因型未显示出意义，但对于RS909706的二曲型而言是显着的。',\n",
       " \"Patients with the TT genotype may have a decreased analgesic response to morphine as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's response to morphine.; Pain\": '与CC基因型的患者相比，TT基因型的患者可能对吗啡的镇痛反应降低。其他遗传和临床因素也可能影响患者对吗啡的反应;疼痛',\n",
       " 'Genotypes AG + GG is associated with decreased dose of warfarin as compared to genotype AA.': '与基因型AA相比，基因型Ag + Gg与Warfarin的减少有关。',\n",
       " 'Patients with the rs118192172 TT genotype may have increased risk to statin-related myopathy as compared patients with the CC genotype. Other genetic and clinical factors may also influence risk of toxicity to statins.; Muscular Diseases': '患者患有RS118192172 TT基因型可能对患有CC基因型的患者相比，患者与他汀类药物相关的肌病的风险增加。其他遗传和临床因素也可能影响毒性对他汀类药物的风险。肌肉疾病',\n",
       " 'Patients with genotype CC may have decreased likelihood of Drug Hypersensitivity when treated with efavirenz in people with HIV Infections as compared to patients with genotype TT. Other genetic and clinical factors may also influence the toxicity to efavirenz.; HIV Infections': '与基因型TT患者相比，基因型CC的患者可能降低药物过敏的可能性超敏反应。其他遗传和临床因素也可能影响对EFAVIRENZ的毒性。艾滋病毒感染',\n",
       " 'Patients with the AG genotype may require an increased dose of warfarin as compared to patients with the GG genotype and a decreased dose of warfarin as compared to patients with the AA genotype. Other clinical and genetic factors may also influence the dose of warfarin.; ': '与AA基因型患者相比，患有AG基因型的AG基因型的患者可能需要增加的Warfarin剂量和患者的患者的患者。其他临床和遗传因素也可能影响华法林的剂量。',\n",
       " 'Patients with the CT genotype who are undergoing methadone maintenance treatment may have decreased severity of opiate withdrawal symptoms as compared to patients with the TT genotype. Other genetic and clinical factors may also influence opiate withdrawal symptoms in patients receiving methadone.; Opioid-Related Disorders': '与TT基因型患者相比，患有甲基维持治疗的CT基因型的患者可能会降低印度戒断症状的严重程度。其他遗传和临床因素也可能影响接受美沙酮患者的印章戒断症状。与阿片类药物相关的疾病',\n",
       " 'Patients with colorectal cancer and the AC genotype may have a reduced response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin, or oxaliplatin as compared to patients with the CC genotype. Other clinical and genetic factors may also affect response to chemotherapy in people with colorectal cancer.; Colorectal Neoplasms': '与CC基因型患者相比，结直肠癌和交流基因型的患者可能对Bevacizumab，Capecitabine，氟尿嘧啶，伊替康，白杨素或奥沙利铂的反应减少。其他临床和遗传因素也可能影响与结直肠癌人的化疗的反应。结直肠肿瘤',\n",
       " \"Patients with the AA genotype may have worse response when treated with platinum compounds in people with Non-Small-Cell Lung Carcinoma or Ovarian Neoplasms as compared to patients with CC genotype. However, contradictory findings (better and poorer responses or no association) have been reported. Other genetic and clinical factors may also influence a patient's response to Platinum compounds.; Carcinoma, Non-Small-Cell Lung;Ovarian Neoplasms\": '当与患有非小细胞肺癌或卵巢肿瘤的铂化合物处理时，患有AA基因型的患者可能更差，与CC基因型患者相比，用非小细胞肺癌或卵巢肿瘤的人处理。但是，据报道，矛盾的结果（更好，差或没有关联）。其他遗传和临床因素也可能影响患者对铂化合物的反应。癌，非小细胞肺;卵巢肿瘤',\n",
       " \"Patients with the AC genotype may be at an increased risk of developing alcoholism as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's risk of developing alcoholism.; Alcoholism\": '与CC基因型患者相比，患有AC基因型的患者可能是发育酗酒的风险。其他遗传和临床因素也可能影响患者发育酗酒的风险。酗酒',\n",
       " 'Genotypes CC + CT is associated with decreased concentrations of 4-hydroxycyclophosphamide in people with Lupus Nephritis as compared to genotype TT.': '与基因型TT相比，基因型CC + CT与狼疮性肾炎的人们的4-羟基环磷酰胺的浓度降低有关。',\n",
       " 'Patients with the AA genotype may have decreased response when treated with oxaliplatin regimens as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to oxaliplatin.; ': '与GG基因型的患者相比，患有AA基因型的AA基因型的患者可能会降低响应。其他遗传和临床因素也可能影响对Oxaliplatin的反应。',\n",
       " 'Genotypes CC + CT are associated with increased concentrations of lamotrigine in people with Epilepsy as compared to genotype TT.': '与基因型TT相比，基因型CC + CT与癫痫的患者中的乳草嗪的浓度增加有关。',\n",
       " \"Patients with schizophrenia and the AG genotype may have a decreased response to risperidone as compared to patients with the GG genotype. However, the association lost significance following correction for multiple testing while another study failed to find an association. Other genetic or clinical factors may also affect a patient's response to risperidone.; Schizophrenia\": '与患有GG基因型的患者相比，精神分裂症和AG基因型的患者可能对Risperidone的反应降低。然而，在另一个研究未能找到关联未能找到一个关联时，该关联在多次测试校正后丧失了重要性。其他遗传或临床因素也可能影响患者对Risperidone的反应。精神分裂症',\n",
       " 'Allele T is associated with decreased dose of warfarin in people with Cardiovascular Diseases as compared to allele C.': '与等位基因C相比，等位基因T与心血管疾病的人们的季草素病毒减少有关。',\n",
       " 'Patients with the rs9923231 CC genotype may require an increased dose of acenocoumarol as compared to patients with the TT and CT genotypes. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence acenocoumarol dose requirements.; ': '与TT和CT基因型患者相比，RS9923231 CC基因型可能需要增加的aceNocoumarol剂量。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响aceNocoumarol剂量要求。',\n",
       " 'Patients with the AC genotype may have increased risk for nephrotoxicity with cisplatin regimens as compared to patients with the AA genotypes. Other genetic and clinical factors may also influence response to platinum-based regimens.; Neoplasms': '与AA基因型的患者相比，患有AC基因型的患者可能对顺铂方案的风险增加了肾毒性方案。其他遗传和临床因素也可能影响对基于铂的方案的反应。肿瘤',\n",
       " 'Patients with the rs139945292 CT genotype may have increased adverse cardiovascular risk after treatment with the beta blocking agents as compared to patients with the CC genotype. Other genetic and clinical factors may also influence the toxicity to beta-blocking agents.; ': '患者139945292 CT基因型可能会随着β受阻剂的治疗而导致β受阻剂的患者增加，与患有CC基因型的患者进行治疗后。其他遗传和临床因素也可能影响β-封闭剂的毒性。',\n",
       " \"Patients with AA genotype may have an increased risk of drug toxicity when treated with platinum drugs as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence a patient's risk for toxicity when receiving platinum-based chemotherapy.; Neoplasms\": '与AG或GG基因型的患者相比，患有AA基因型的患者可能产生增加的药物毒性风险。其他遗传和临床因素也可能影响患者在接受基于铂的化疗时患者的毒性风险。肿瘤',\n",
       " 'CYP2D6 *10/*10 + *1/*10 are associated with increased concentrations of atomoxetine in healthy individuals as compared to CYP2D6 *1/*1.': '与CYP2D6 * 1 / * 1相比，CYP2D6 * 10 / * 10 + 1 * 1 / * 10与健康个体中的氧杂体浓度增加有关。',\n",
       " 'Patients with the CYP2D6*92 allele may have a decreased enzyme activity of CYP2D6 as compared to patients with the CYP2D6*1 allele. The CYP2D6*92 allele construct was found to exhibited >90% decreases in catalytic activity than CYP2D6*1 during in-vitro characterization with bufuralol or dextromethorphan. Other genetic and clinical factors may also influence the metabolism of bufuralol or dextromethorphan.; ': '与CYP2D6 * 1等位基因的患者相比，CYP2D6 * 92等位基因患者可具有CYP2D6的酶活性降低。发现CYP2D6 * 92等位基因构建体在体外表征与Bufuratol或右旋甘露出剂中表现出催化活性的90％降低。其他遗传和临床因素也可能影响Bufuralol或Dextromethorphan的代谢。',\n",
       " \"Patients with the CC genotype and rheumatoid arthritis may have a poorer response when treated with infliximab as compared to patients with the AA genotype. However, contradictory evidence exists for this association. Other genetic and clinical factors may also influence a patient's response to infliximab.; Arthritis, Rheumatoid\": '与AA基因型的患者相比，CC基因型和类风湿性关节炎的患者可能具有较差的响应率。但是，这种协会存在矛盾的证据。其他遗传和临床因素也可能影响患者对英夫利昔单抗的反应;关节炎，类风湿',\n",
       " 'No significant results have been seen for patients with the CT genotype.; Carcinoma, Non-Small-Cell Lung': '对于CT基因型的患者没有看到显着的结果。癌，非小细胞肺',\n",
       " 'Patients with the CYP2D6*2/*101 genotype may have a decreased metabolism of dextromethorphan (probe drug) as compared to patients with the CYP2D6*1/*1 genotype. Other genetic and clinical factors may also influence the metabolism of dextromethorphan.; ': '与CYP2D6 * 1 / * 1个基因型的患者相比，CYP2D6 * 2 / * 101基因型可能具有降低的葡聚糖（探针药物）的代谢。其他遗传和临床因素也可能影响右三甲醚的代谢。',\n",
       " 'Healthy individuals with the CYP3A5 *1/*1 or *1/*6 (rs10264272) genotype had 1.6-fold higher oral tacrolimus clearance and 2.0 - 2.7-fold higher metabolite/parent area under the curve (AUC) ratios for 31-desmethyl tacrolimus (31-DMT), 12-hydroxytacrolimus, and 13-desmethyl tacrolimus (13-DMT), as compared to individuals with the *6/*6 genotype. Subjects who carry two copies of loss-of-function CYP3A5 alleles (CYP3A5*3/rs776746, CYP3A5*6 or CYP3A5*7/rs41303343) were pooled together as CYP3A5 non-expressors for this analysis. CYP3A5 *1 allele carriers were pooled togethers as CYP3A5 expressors.': '具有CYP3A5 * 1 / * 1或* 1 / * 6（RS10264272）基因型的健康个体具有1.6倍高的口服巨杆菌间隙和31-去甲基的曲线（AUC）比下的2.0-2.7倍的代谢物/父区域。与具有* 6 / * 6基因型的个体相比，Tacrolimus（31-DMT），12-羟基葡萄球菌和13-Demethylylimus（13-DMT）。作为CYP3A5非表现因子，将汇集有两种功能性CYP3A5等位基因（CYP3A5 * 3 / RS776746，CYP3A5 * 6或CYP3A5 * 7 / RS41303343）作为该分析的CYP3A5非表达器。CYP3A5 * 1等位基因载流子被汇集为CYP3A5表达者。',\n",
       " 'Patients with the CT genotype may have decreased metabolism of cyclophosphamide, resulting in decreased concentrations of active cyclophosphamide metabolites, and decreased risk of gastrointestinal toxicity, or leukopenia, as compared to patients with the TT genotypes and increased metabolism and increased risk of toxicity as compared to patients with the CC genotype. Other clinical and genetic factors may also influence metabolism of cyclophosphamide, as well as risk of toxicity in patients with lupus.; Lupus erythematosus': 'CT基因型的患者可能降低环磷酰胺的代谢，导致活性环磷酰胺代谢物的浓度降低，与TT基因型的患者相比，胃肠道毒性的浓度降低，或胃肠道毒性的风险降低，并且与患者CC基因型。其他临床和遗传因素还可能影响环磷酰胺的代谢，以及狼疮患者的毒性风险。红斑狼疮',\n",
       " 'Patients carrying the CYP2C9*5 allele in combination with a normal function allele (e.g. *1/*5) or another decreased function allele (e.g.*5/*8) or a no function allele (e.g. *5/*6) may have decreased metabolism of losartan as compared to patients with two normal function alleles. This annotation only covers the pharmacokinetic relationship between CYP2C9 and losartan and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of losartan.; ': '携带CYP2C9 * 5等位基因的患者与正常功能等位基因组合（例如* 1 / * 5）或另一种降低的函数等位基因（例如* 5 / * 8）或无功能等位基因可能具有与具有两个正常功能等位基因的患者相比，氯沙坦的代谢降低。该注释仅涵盖CYP2C9和氯沙坦之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响洛萨沙的代谢。',\n",
       " 'Genotype CC is associated with decreased response to bevacizumab and ranibizumab in people with Macular Degeneration as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与黄斑变性的人们对贝伐单抗和Ranibizumab的响应降低有关。',\n",
       " 'Four CYP2D6 intermediate metabolizer (*3/*9, *4/*17, *4/*41, *4/*10) had maintenance dose not greater than 75 mg/day vs most of the EM (79%) had a dose of 150 mg or more/ day (p<0.002).': '四种CYP2D6中间代谢物（* 3 / * 9，* 4 / * 17，* 4 / * 41，* 4 / * 10）的维持剂量不大于75毫克/天，VS大多数EM（79％）有一个剂量为150毫克或更多/天（p <0.002）。',\n",
       " 'as measured by ratio of amitriptyline to hydroxyamitriptyline. Also ratio of nortriptyline to hydroxynortriptyline was significantly lower for *10/*10 compared to *1/*1 or *1/*10.': '按照氨基丙酸与羟基亚硝基的比率测量。与* 1 / * 1或* 1 / * 10相比，* 10 / * 10的NortRiptyline对羟炔素的比率显着降低。',\n",
       " 'Patients with the AA genotype and essential hypertension may have a decreased response when treated with hydrochlorothiazide as compared to patients with the AT and TT genotypes. Other genetic and clinical factors may also influence response to hydrochlorothiazide in patients with essential hypertension.; Essential hypertension': '与AT和TT基因型的患者相比，患有AA基因型和必需高血压的患者可能具有降低的响应响应。其他遗传和临床因素也可能影响对原发性高血压患者对氢氯噻嗪的反应。原发性高血压',\n",
       " \"Patients with the TTAAAGTTA/TTAAAGTTA genotype and Colorectal Cancer who are treated with fluorouracil-based adjuvant therapy may have a better response as compared to patients with the TTAAAGTTA/del or del/del genotype who also have rs45445694 genotype 2R/2R. Other genetic and clinical factors may also influence a patient's response to treatment.; Colorectal Neoplasms\": '与氟尿基佐剂治疗治疗的TTAAAGTTA / TTAAAGTTA基因型和结直肠癌的患者可能具有更好的响应，与TTAAAGTTA / DEL或DEL / DEL基因型的患者相比，他们还具有RS45445694基因型2R / 2R。其他遗传和临床因素也可能影响患者对治疗的反应。结直肠肿瘤',\n",
       " \"Patients with the CC genotype may be at a decreased risk of developing heroin dependence as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's risk of developing heroin dependence.; Heroin Dependence\": '与AA基因型患者相比，CC基因型的患者可能是在发育海洛因依赖的风险下降。其他遗传和临床因素也可能影响患者发展海洛因依赖的风险。海洛因依赖',\n",
       " \"Patients with at least one copy of the HLA-A*31:01:02 allele may have an increased risk of developing DRESS as a result of taking oxcarbazepine as compared to patients who do not carry the HLA-A*31:01:02 allele. Other genetic and clinical factors may also affect a patient's risk of developing DRESS.; drug reaction with eosinophilia and systemic symptoms\": '患有至少一种HLA-A * 31：01：02等位基因的患者可能导致稻瘟病患者的发育衣的风险增加，而不能携带HLA-A * 31：01：02等位基因。其他遗传和临床因素也可能影响患者的养育裙的风险。药物反应与嗜酸性粒细胞和全身症状',\n",
       " \"Patients with the TT genotype may have a decreased response to oxycodone as compared to patients with the CC or CT genotypes. Other genetic and clinical factors may also affect a patient's response to oxycodone.; Pain\": '与患有CC或CT基因型的患者相比，TT基因型的患者可能对羟考酮的反应降低。其他遗传和临床因素也可能影响患者对羟考酮的反应。疼痛',\n",
       " 'Individuals with one *3 allele in combination with one functional (*1) allele may metabolize atazanavir more rapidly as compared to individuals with any combination of two non-functional alleles (*3, *6, or *7) alleles, but may metabolize atazanavir more slowly as compared to individuals with the *1/*1 genotype. Please note: this association was only significant in White subjects and is for atazanavir boosted with ritonavir, which inhibits CYP3A5. Other clinical and genetic factors may also influence the rate of atazanavir metabolism.; HIV Infections': '与一种功能性（* 1）相结合的个体与一种功能性（* 1）等位基因相比，与具有两种非功能型等位基因（* 3，* 6或* 7）等位基因的任何组合的个体相比，与个体相比可以更快地将Atazanavir代谢更快，但可以代谢与具有* 1 / * 1基因型的个体相比，Atazanavir更慢。请注意：此协会在白色科目中仅为重要，是Atazanavir促进了ritonavir，抑制Cyp3a5。其他临床和遗传因素也可能影响Atazanavir代谢的速率。艾滋病毒感染',\n",
       " 'The CYP2D6*5 allele has been assigned as a no function allele by CPIC. Patients carrying the *5 allele in combination with a decreased, normal or no function allele may have decreased metabolism of propafenone as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying the *5 allele in combination with an increased function allele with an activity value of 2 may have similar metabolism of propafenone as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *5 allele in combination with an increased function allele with an activity value of 3 or greater may have increased metabolism of propafenone as compared to patients with alleles that result in a normal metabolizer phenotype. This annotation only covers the pharmacokinetic relationship between CYP2D6 and propafenone and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence propafenone metabolism.; Arrhythmias, Cardiac;Tachycardia': 'CYP2D6 * 5等位基因已由CPIC分配为无功能等位基因。患者与患者相结合的患者结合减少，正常或无功能等位基因可能降低了丙酮酮的代谢，与导致正常代谢物表型的等位基因的患者相比。患有* 5等位基因的患者与活性值2的功能值相结合，与具有成果的患者的患者相比，患者具有类似的丙酮酮的代谢，同时患有正常代谢物表型，而携带* 5等位基因的患者组合与患有正常代谢物表型的等位基因的患者相比，具有3或更大的活性值3或更大的功能等位基因可能增加了丙酮酮的代谢。该注释仅涵盖CYP2D6和ProPafenone之间的药代动力学关系，并且不包括关于临床结果的证据。其他遗传和临床因素也可能影响丙酮酮代谢。心律失常，心脏;心动过速',\n",
       " 'Genotype TT is associated with decreased dose of warfarin in children as compared to genotypes CC + CT.': '与基因型CC + CT相比，基因型TT与儿童中的Warfarin剂量降低有关。',\n",
       " 'Both variants of rs1801159 are assigned normal function by CPIC. Patients with the CT genotype and cancer who are treated with capecitabine, a fluoropyrimidine-based chemotherapy, may not have altered risk of drug toxicity as compared to patients with the CC or TT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of drug toxicity.; Neoplasms': 'RS1801159的两个变体由CPIC分配正常功能。与CC或TT基因型的患者相比，患有Capecitabine的CT基因型和癌症的患者，可能没有改变药物毒性的风险。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响药物毒性的风险。肿瘤',\n",
       " 'Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G.': '与等位基因G相比，等位基因T与痛风中的患有痛风中的患者的响应减少有关。',\n",
       " 'Genotypes CT + TT are associated with increased dose of warfarin in people with mechanical heart valve replacement as compared to genotype CC.': '与基因型CC相比，基因型CT + TT与机械心瓣膜置换的人们增加的Warfarin剂量增加。',\n",
       " 'Genotype TT is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes GG + GT.': '与基因型Gg + GT相比，基因型TT与高胆固醇血症的人们对阿托伐他汀的反应增加有关。',\n",
       " 'Genotype AA is associated with increased response to montelukast in people with Asthma as compared to genotype GG.': '与基因型GG相比，基因型AA与哮喘患者的孟鲁斯特的反应增加有关。',\n",
       " \"Patients with the GG genotype may be at an increased risk of developing heroin dependence as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's risk of developing heroin dependence.; Heroin Dependence\": '与CC基因型的患者相比，GG基因型的患者可能是在发育海洛因依赖性的风险上升。其他遗传和临床因素也可能影响患者发展海洛因依赖的风险。海洛因依赖',\n",
       " 'Patients with the AA genotype may have decreased sulfation of tapentadol as compared to patients with the AG or GG genotypes. Other genetic and clinical factors may also affect tapentadol sulfation.; ': '与AG或GG基因型的患者相比，患有AA基因型的患者可能降低了Tabentadol的硫酸盐。其他遗传和临床因素也可能影响TabentAdol硫化。',\n",
       " 'Patients with the GG genotype may have an increased chance of response to treatment with docetaxel and thalidomide as compared to patients with the CC genotype. Other genetic and clinical factors may also influence treatment response.; Prostatic Neoplasms': '与CC基因型患者相比，GG基因型的患者可能具有增加对多西紫杉醇和沙利度胺治疗的几率。其他遗传和临床因素也可能影响治疗反应。前列腺肿瘤',\n",
       " 'Patients with the GG genotype and schizophrenia or schizoaffective disorder may have greater weight gain when treated with clozapine or olanzapine as compared to patients with the GT genotype. Other genetic and clinical factors may also influence weight gain when receiving clozapine or olanzapine.; schizoaffective disorder;Schizophrenia': '与具有GT基因型患者相比，用GG基因型和精神分裂症或精神分裂症或SchizoOpheria或Schizopheria或SchizoOpheria疾病的患者可能具有更大的体重增加。其他遗传和临床因素也可能在接受氯氮平或奥氮藻时影响体重增加。精神分裂症;精神分裂症',\n",
       " 'Patients with the *1/*1 genotype and bipolar disorder and other psychotic disorders may have increased dose of valproic acid compared to patients with the *1/*2 and *1/*3 genotypes. However, dose-adjusted and absolute serum concentrations were not found to differ by genotype. Other clinical and genetic factors may affect required dose of valproic acid.; Bipolar Disorder;Psychotic Disorders': '与* 1 / * 2和* 1 / * 3基因型相比，患有* 1 / * 1基因型和双相障碍和其他精神病障碍的患者可能会增加丙戊酸剂量增加。然而，未发现剂量调节和绝对的血清浓度因基因型而异。其他临床和遗传因素可能会影响所需剂量的丙戊酸。双相障碍;精神病疾病',\n",
       " 'Patients with HIV and the TT genotype may have decreased plasma levels of lopinavir as compared to patients with the CC genotype. However, one study failed to find this association. Other genetic and clinical factors may also influence lopinavir concentrations in a patients. This annotation only covers the pharmacokinetic relationship between rs4149056 and lopinavir and does not include evidence about clinical outcomes.; HIV Infections': '与CC基因型患者相比，患有HIV和TT基因型的患者可能降低了血浆水平的血浆水平。但是，一项研究未能找到此协会。其他遗传和临床因素也可能影响患者的洛诺比亚浓度。该注释仅涵盖了RS4149056和Lopinavir之间的药代动力学关系，并不包括有关临床结果的证据。艾滋病毒感染',\n",
       " 'Patients with the GG genotype may have an increased risk of toxicity with docetaxel and thalidomide as compared to patients with the CC genotype. Other genetic and clinical factors may also influence treatment response.; Prostatic Neoplasms': '与CC基因型的患者相比，GG基因型的患者可能对多西紫杉醇和沙利度胺产生毒性的风险。其他遗传和临床因素也可能影响治疗反应。前列腺肿瘤',\n",
       " 'Patients with thromboembolism and the TT genotype may have a decreased risk of hemorrhage when treated with acenocoumarol or warfarin as compared to patients with the CT or CC genotypes. Other clinical and genetic factors may also influence risk of hemorrhage in patients with venous thromboembolism.; Hemorrhage;venous thromboembolism': '与CT或CC基因型患者相比，血栓栓塞和TT基因型的患者可能具有减少的出血风险降低。其他临床和遗传因素也可能影响静脉血栓栓塞患者出血风险。出血;静脉血栓栓塞',\n",
       " 'Patients from a psychiatric hospital were retrospective studied. Steady state serum concentration were used for calculation. Patients that were co-treated with medication that influences CYP2C19 were excluded. Only *2 was genotype. CYP2C19*2/*2 had highest log(AT/NT ratio), *1*2 had intermediate and *1*1 lowest. It seems CYP2D6 was also analyzed in association with log(AT/NT ratio) but no detailed data are presented except that conclusion that CYP2D6 did not affect the log(AT/NT ratio).': '来自精神病院的患者是研究的回顾性。使用稳态血清浓度来计算。用影响CYP2C19的药物共同处理的患者被排除在外。只有* 2是基因型。CYP2C19 * 2 / * 2具有最高的LOG（AT / NT比率），* 1 * 2具有中间和* 1 * 1最低。似乎CYP2D6也与日志（AT / NT比率）相关联，但除了CYP2D6不影响日志（AT / NT比率）之外，没有提出详细数据。',\n",
       " \"Patients with the AG genotype may be at a decreased risk of developing cannabis dependence as compared to patients with the AA genotype. However, this association was not significant. Other genetic or clinical factors may also affect a patient's risk of developing cannabis dependence.; Marijuana Abuse\": '与AA基因型的患者相比，患有AG基因型的患者可能是开发大麻依赖性的风险。但是，这种关联并不重要。其他遗传或临床因素也可能影响患者开发大麻依赖的风险。大麻虐待',\n",
       " 'Patients with kidney transplantation and the del/T genotype may have decreased metabolism of mycophenolic acid as compared to patients with the TT genotypes but increased metabolism of mycophenolic acid as compared to patients with the del/del genotype. Other clinical and genetic factors may also influence metabolism of mycophenolic acid in patients with kidney transplantation.; Kidney Transplantation': '与TT基因型的患者相比，肾移植患者和DEL / T基因型的代谢可能降低了霉菌酸的代谢，但与Del / Del基因型患者相比，霉菌酸的代谢增加。其他临床和遗传因素还可能影响肾移植患者霉菌酸的代谢。肾移植',\n",
       " 'Response was determined by survival rates.': '响应是通过存活率确定的。',\n",
       " 'Patients with the GG genotype and asthma may have a decreased response when treated with inhaled corticosteroids as compared to patients with the CC and CG genotypes. Other genetic and clinical factors may also influence response to corticosteroids in asthmatics.; Asthma': '与CC和CG基因型患者相比，用吸入的皮质类固醇处理时，GG基因型和哮喘患者可能具有降低的响应。其他遗传和临床因素也可能影响哮喘中皮质类固醇的反应。哮喘',\n",
       " 'Genotype TT is associated with decreased metabolism of efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.': '与基因型GG + GT相比，基因型TT与艾滋病病毒感染和结核病的人们的代谢降低有关。',\n",
       " 'Patients with the *14/*14 may have enhanced lipid-lowering efficacy to fluvastatin in elderly hypercholesterolemic patients as compared to patients with the *1A/*14 or *1A/*1A genotype. Other genetic and clinical factors may also influence response to fluvastatin.; Hypercholesterolemia': '* 14 / * 14的患者可提高老年人高胆固醇患者氟伐他汀的脂质降低疗效，与患者为* 1A / * 14或* 1A / * 1A基因型相比。其他遗传和临床因素也可能影响对氟伐他汀的反应。高胆固醇血症',\n",
       " 'Allele A is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to allele G.': '等位基因A与等位基因G.相比，等位基因A与肾移植的人的浓度增加。',\n",
       " 'HIV positive patients who are treated with nevirapine and are also carriers of the HLA-DRB1*01:03 allele may have an increased risk of DRESS Syndrome or SJS/TEN as compared to non-carriers.; drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome': 'HIV阳性患者被Nevirapine治疗，也是HLA-DRB1 * 01：03等位基因的载体，而与非载体相比，等位基因可能会增加服饰综合征或SJS / Ten的风险。药物反应与嗜酸性粒细胞和全身症状;表皮坏死，有毒;史蒂文斯 - 约翰逊综合征',\n",
       " \"Patients with the CT genotype who are receiving concomitant phenytoin and isoniazid may be at an increased risk of phenytoin toxicity resulting from isoniazid-phenytoin interaction as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's risk of developing phenytoin toxicity when treated with both isoniazid and phenytoin.; Drug interaction with drug;Drug Toxicity\": '接受伴随苯妥林和异烟肼的CT基因型的患者可能是由异烟肼 - 苯妥林蛋白相互作用的苯妥英毒性的风险增加，与CC基因型患者相比。其他遗传和临床因素也可能影响患者在用异烟肼和苯妥林治疗时发育苯毒素毒性的风险。药物与药物相互作用;药物毒性',\n",
       " 'Patients with the CC genotype and HIV may have an increased risk for virological failure when treated with highly active antiretroviral therapy (HAART) as compared to patients with the TT genotype. Other genetic and clinical factors may also influence risk for virological failure.; HIV Infections': '与TT基因型患者相比，CC基因型和艾滋病毒患者可能对病毒学破坏的风险增加增加，而有效的抗逆转录病毒治疗（HAART）。其他遗传和临床因素也可能影响病毒学失败的风险。艾滋病毒感染',\n",
       " 'Patients with the AT genotype may have a decreased likelihood of smoking addiction as compared to patients with the TT genotype, or an increased likelihood as compared to patients with the AA genotype. Other genetic and clinical factors may also influence smoking addiction.; Tobacco Use Disorder': '与TT基因型的患者相比，患有AT基因型的患者可能具有减少的吸烟成瘾的可能性，或与AA基因型患者相比的患者增加。其他遗传和临床因素也可能影响吸烟成瘾。烟草使用障碍',\n",
       " 'Patients with the CC genotype may have reduced response to daunorubicin compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to treatment.; Drug Toxicity': '与GG基因型的患者相比，CC基因型的患者可能对大生霉素的反应减少。其他遗传和临床因素也可能影响对治疗的反应。药物毒性',\n",
       " 'Women with the GG genotype and hypertension may have greater decreases in systolic or diastolic blood pressure when treated with atenolol as compared to women with the AA or AG genotype. No significant results were seen in men. When considering systolic blood pressure only, significant results were seen for men and women combined. Other genetic and clinical factors may also influence systolic and diastolic blood pressure response to atenolol.; Essential hypertension': '与AA或AG基因型的女性相比，当用ATONOL处理时，患有GG基因型和高血压的妇女可能在收缩期或舒张压时的减少。在男性中没有看到显着的结果。仅考虑收缩压仅，对于男女合并，可以看到显着的结果。其他遗传和临床因素也可能影响收缩系和舒张血压反应对阿替洛尔。原发性高血压',\n",
       " \"Patients with the GG genotype may have decreased subjective responses to alcohol as compared to patients with the GT or TT genotypes. Other genetic and clinical factors may also affect a patient's response to alcohol.; \": '与GT或TT基因型的患者相比，GG基因型的患者可能降低对酒精的主观反应。其他遗传和临床因素也可能影响患者对酒精的反应。',\n",
       " \"Patients with the AG genotype who are treated with simvastatin may have a better response to treatment (measured by a higher reduction in total cholesterol) compared to patients with the GG genotype or may have a reduced response (measured by a lower reduction in total cholesterol) as compared to patients with the AA genotype. In another study no association was seen. Other genetic and clinical factors may also influence a patient's response to simvastatin treatment.; \": '与辛伐他汀治疗的AG基因型的患者可能与GG基因型的患者相比，对治疗（通过总胆固醇的较高减少测量），或者可以具有减少的反应（通过总胆固醇的较低减少测量）与AA基因型患者相比。在另一项研究中，没有看到关联。其他遗传和临床因素也可能影响患者对辛伐他汀治疗的反应。',\n",
       " 'Patients with the GG genotype and psoriasis may have a decreased risk for paradoxical psoriasiform reactions when treated with TNF-inhibitors as compared to patients with the AG genotype. Other genetic and clinical factors may also influence risk for paradoxical psoriasiform reactions.; Psoriasis': '与AG基因型患者相比，患有GG基因型和牛皮癣的患者可能对矛盾的副血管型反应的风险降低。其他遗传和临床因素也可能影响矛盾的牛皮癣的风险。银屑病',\n",
       " 'Avoid tramadol use because of possibility of diminished analgesia. If opioid use is warranted, consider a non-codeine opioid.': '由于镇痛减少的可能性，避免曲马多。如果有保证阿片类药物，请考虑非疑称表阿片类药物。',\n",
       " 'The CYP2D6*6 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2D6*6 allele in combination with a no, decreased or normal function allele who are treated with nortriptyline may have an increased likelihood of treatment side effects as compared to patients with alleles that result in a normal metabolizer phenotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence treatment related side effects.; Depressive Disorder': 'CYP2D6 * 6等位基因由CPIC分配为无功能等位基因。患有CYP2D6 * 6等位基因的患者与NORTriptyline治疗的NO，减少或正常的功能等位基因组合可能会增加治疗副作用的可能性增加，与导致正常代谢物表型的等位基因的患者相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响治疗相关副作用。抑郁症',\n",
       " '4% to 12% increase in the warfarin dose per T allele. This is in Whites presumably of European descent.': '每次T等位基因的华法林剂量增加4％至12％。这是欧洲血统的怀疑。',\n",
       " 'Patients with the CT genotype may be less likely to develop an addiction to crack cocaine as compared to patients with the TT genotype. Other clinical and genetic factors may also be associated with addiction to crack cocaine.; Cocaine-Related Disorders': '与TT基因型的患者相比，CT基因型的患者可能不太可能对破解可卡因进行成瘾。其他临床和遗传因素也可能与橡裂的成瘾有关。可卡因相关疾病',\n",
       " 'Patients with the AA genotype may have decreased risk of Death when treated with etoposide and Platinum compounds in people with Carcinoma, Small Cell as compared to patients with genotype GG or AG. Other genetic and clinical factors may also influence the response to etoposide and Platinum compounds.; ': '当用癌细胞和基因型GG或Ag的患者相比，使用肠苷和铂化合物治疗时，患有AA基因型的患者可能会降低死亡风险。其他遗传和临床因素也可能影响对依托泊苷和铂化合物的反应。',\n",
       " \"Rheumatoid Arthritis patients with the GG genotype may be more likely to respond to TNF inhibitors compared to patients with genotypes AA or AG. Other genetic and clinical factors may also influence a patient's response.; Arthritis, Rheumatoid\": '与基因型AA或AG的患者相比，具有GG基因型的类风湿性关节炎患者可能更可能应对TNF抑制剂。其他遗传和临床因素也可能影响患者的反应。关节炎，类风湿',\n",
       " 'Genotype TT is associated with increased dose of warfarin as compared to genotypes CC + CT.': '与基因型CC + CT相比，基因型TT与varfarin的增加剂量有关。',\n",
       " 'Genotype AA is associated with decreased dose of methadone in people with Opioid-Related Disorders as compared to genotypes AG + GG.': '基因型AA与阿片类药物相关疾病的人的甲基剂量减少有关，与基因型+ Gg相比。',\n",
       " 'in han chinese.': '在汉族。',\n",
       " 'Patients with the AT genotype and hypertension who are administered hydrochlorothiazide or chlorothiazide may have a greater increase in blood glucose than patients with the TT genotype. Other clinical and genetic factors may also influence elevations in blood glucose in patients administered chlorothiazide or hydrochlorothiazide.; Hyperglycemia;Hypertension': '患有氢氯噻嗪或氯噻嗪的基因型和高血压的患者可能比TT基因型的患者血糖较大。其他临床和遗传因素也可能影响含氯甲酰胺或氢氯噻嗪的患者血糖中的升高。高血糖;高血压',\n",
       " 'Infants who have been exposed to buprenorphine in utero and who have the AC genotype may be more likely to require medication to treat neonatal abstinence syndrome as compared to infants with the CC genotype. However, this was not a statistically significant association. Other genetic and clinical factors may also affect severity of neonatal abstinence syndrome.; Neonatal Abstinence Syndrome': '已暴露于Uttero的Buprenorphine的婴儿，并且具有AC基因型的婴儿可能更有可能需要药物治疗与CC基因型的婴儿相比治疗新生儿禁欲综合征。但是，这不是一个统计上重要的关联。其他遗传和临床因素也可能影响新生儿禁忌综合征的严重程度。新生儿禁欲综合征',\n",
       " 'On days 3 and 7 post-transplant. Trough concentration was also significantly decreased in those with the *1/*1 or *1/*3 genotype on both days. Additionally, the proportion of patients in whom tacrolimus concentrations were within the subtherapeutic range was higher in those with the *1/*1 or *1/*3 genotype as compared to those with the *3/*3 genotype.': '在移植后3和7天。在两天内具有* 1 / * 1或* 1 / * 3基因型的槽浓度也显着降低。另外，与* 3 / * 3基因型的那些相比，统治素浓度在子管浓度在子治浓度内的患者的比例较高。',\n",
       " 'The current evidence base suggests that there is no significant association between the rs4124874 TT genotype and risk of adverse effects when treated with irinotecan. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of adverse effects when treated with irinotecan.; Lymphoma;Neoplasms': '目前的证据基础表明，在用Irinotecan治疗时，RS4124874 TT基因型与不良反应风险之间没有显着关联。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能在用伊替康治疗时影响不良反应的风险。淋巴瘤;肿瘤',\n",
       " 'Patients with the CT genotype may require increased dose of acenocoumarol as compared to patients with the CC genotype. Other clinical or genetic factors may also influence acenocoumarol dose.; ': '与CC基因型的患者相比，CT基因型的患者可能需要增加的aceNocoumarol剂量。其他临床或遗传因素也可能影响Acenocoumarol剂量。',\n",
       " 'People with the CC genotype may have decreased exposure to dabigatran compared to patients with a variant at this position, including genotypes AA, AC, CT, and TT, when assessed in conjunction with a variant at position rs1045642. Other clinical and genetic factors may affect exposure to dabigatran.; ': '与在该位置的变体的患者相比，CC基因型的人可能会降低到Dabigatran，包括在与在位置Rs1045642的变体结合时进行基因型AA，AC，CT和TT。其他临床和遗传因素可能会影响Dabigatran的暴露。',\n",
       " 'Patients with the GG genotype and non-small-cell lung cancer may have an increased risk for pneumonitis when treated with platinum-based chemotherapy as compared to patients with the GT or TT genotype. Other genetic and clinical factors may also influence risk for pneumonitis.; Carcinoma, Non-Small-Cell Lung': '与GT或TT基因型患者相比，患有GG基因型和非小细胞肺癌的患者可能对肺炎化疗时肺炎的风险增加。其他遗传和临床因素也可能影响肺炎风险。癌，非小细胞肺',\n",
       " \"Patients with the AG genotype and hypertension who are treated with chlorthalidone may have an increased risk for stroke as compared to patients with A allele who are treated with amlodipine or lisinopril. Other genetic and clinical factors may also influence a patient's response to treatment and risk of stroke.; Hypertension\": '与氯化酰卫生酮治疗的AG基因型和高血压患者可能对中风的风险增加，而患有由氨氯地平或丽思诺普利治疗的等位基因的患者相比。其他遗传和临床因素也可能影响患者对治疗和中风风险的反应。高血压',\n",
       " 'Patients with the GG genotype (do not have a copy of the CFTR S1251N variant) and cystic fibrosis have an unknown response to ivacaftor treatment, as response may depend on the presence of other CFTR variants. FDA-approved drug labeling information and CPIC guidelines indicate use of ivacaftor in cystic fibrosis patients with at least one copy of a list of 33 CFTR genetic variants, including S1251N. Other genetic and clinical factors may also influence response to ivacaftor.; Cystic Fibrosis': '患有GG基因型的患者（不具有CFTR S1251N变体的副本）和囊性纤维化对IVACafetor治疗具有未知的反应，因为响应可能取决于其他CFTR变体的存在。FDA批准的药物标签信息和CPIC指南表明IVACafeaferor在囊性纤维化患者中使用至少一份33个CFTR遗传变异列表的副本，包括S1251N。其他遗传和临床因素也可能影响对IVACAFTOR的反应。囊性纤维化',\n",
       " 'Patients with genotype GG may have decreased response to metformin in people with diabetes mellitus or polycystic ovarian syndrome as compared to patients with genotype AA, though other evidence contradicts this association depending on the measure of response. Other genetic and clinical factors may also influence the response to metformin.; Diabetes Mellitus, Type 2;Polycystic Ovary Syndrome': '与基因型AA的患者相比，基因型GG的患者可能对糖尿病或多囊卵巢综合征的糖尿病或多囊卵巢综合征的响应减少，尽管其他证据根据反应的衡量标准相比，这种关联与这种关联相矛盾。其他遗传和临床因素也可能影响对二甲双胍的反应;糖尿病，2型;多囊卵巢综合征',\n",
       " \"Patients with the SLC6A4 HTTLPR short form (S allele)/HTTLPR short form (S allele) genotype who are treated with fluoxetine may have decreased response as compared to patients with the SLC6A4 HTTLPR long form (L allele)/HTTLPR long form (L allele) genotype. However, contradictory findings exist reporting the opposite effect with an association of the SLC6A4 HTTLPR long form (L allele)/HTTLPR long form (L allele) genotype and increased fluoxetine response. Other genetic and clinical factors may also influence a patient's response to fluoxetine.; Depressive Disorder, Major\": '用氟西汀治疗的SLC6A4 HTTLPR短型（S等位基因）/ HTTLPR短型（S等位基因）基因型可能会降低响应，与SLC6A4 HTTLPR长形式（L等位基因）/ HTTLPR长形式（L等位基因）基因型。然而，存在对SLC6A4 HTTLPR长形式（L等位基因）/ HTTLPR长形式（L等位基因）基因型和氟西汀反应的关联的相反效果。其他遗传和临床因素也可能影响患者对氟西汀的反应。抑郁症，主要',\n",
       " 'Association is for the plasma concentraction ratio of endoxifen/N-desmethyltamoxifen. Pre- and postmenopausal woman completed all primary surgery, radiation, and adjuvant chemotherapy and excluded from the registry if they had started tamoxifen therapy concurrently with either adjuvant chemotherapy or adjuvant radiation therapy (or both). DNA was extracted from blood and screened with AmpliChip CYP450 Test. Null alleles (CYP2D6*3, *4, *5, and *6), dysfunctional alleles (CYP2D6*9, *10, *17, *29, and *41), and functional alleles (CYP2D6*1, *2, and *35) were designated as poor metabolizer (PM), intermediate metabolizer (IM), and extensive metabolizer (EM) alleles. 29% of patients were receiving CYP2D6 inhibitors concomitantly. mean endoxifen plasma concentration was significantly lower in patients taking CYP2D6 inhibitors than in those not taking any concomitant CYP2D6 inhibitors. [pre-menopausal][post-menopausal] [adjuvant] [DNA source: blood]': '关联是肠毒素/ N-去除甲基氧基氧基血浆的血浆浓度比。预后和绝经后妇女完成了所有初级手术，辐射和佐剂化疗，如果它们与佐剂化疗或佐剂放射治疗（或两者）同时开始他莫昔芬疗法，则从注册表中排除。从血液中提取DNA并用Anglichip Cyp450测试筛选。NULL等位基因（CYP2D6 * 3，* 4，* 5和* 6），功能障碍等位基因（CYP2D6 * 9，* 10，* 17，* 29和* 41）和功能等位基因（CYP2D6 * 1，* 2，* 35）被指定为代谢物（PM），中间代谢物（IM）和广泛的代谢物（EM）等位基因。29％的患者伴随着CYP2D6抑制剂。在服用CYP2D6抑制剂的患者中，平均肠蛋白血浆浓度显着降低，而不是在不服用任何伴随的CYP2D6抑制剂的患者。[预生前] [美女后] [佐剂] [DNA来源：血液]',\n",
       " 'Response assessed after 24 weeks of treatment using the Bath Ankylosing Spondylitis Activity Index (BASDAI). Good response was a BASDAI improvement of >50% from baseline, moderate response an improvement of >=20% and <=50%, and non-response an improvement of <20%. No patients with the AA genotype were present in the population. Patients with the GG genotype had a larger improvement in BASDAI score (3.30 +/- 1.52) as compared to those with the AG genotype (1.21 +/- 0.39).': '使用浴巾脊柱膜活动指数（Basdai）治疗24周后评估的反应。良好的反应是从基线的基础改善> 50％，适度反应的改善> = 20％和<= 50％，而不应答提高<20％。没有AA基因型的患者存在于人口中。与AG基因型（1.21 +/- 0.39）相比，GG基因型的患者在Basdai评分（3.30 +/- 1.52）上具有更大的改善（3.30 +/- 1.52）。',\n",
       " \"Patients with the AC genotype may have decreased on-treatment platelet reactivity when treated with clopidogrel as compared to patients with the CC genotype. However, another study found no association with risk of major adverse cardiac events. Other genetic and clinical factors may influence a patient's response to clopidogrel.; \": '与CC基因型的患者相比，患有AC基因型的患者可能降低了治疗血小板反应性。然而，另一项研究发现没有与主要不良心脏事件的风险有关。其他遗传和临床因素可能影响患者对氯吡格雷的反应。',\n",
       " 'Allele G is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele A.': '与等位基因A相比，等位基因G与精神分裂症的抗精神病药的反应增加有关。',\n",
       " 'Genotype GG is associated with increased dose of tacrolimus in children with liver transplantation as compared to genotypes AA + AG.': '与基因型AA + Ag相比，基因型GG与肝移植儿童的患儿剂量增加有关。',\n",
       " \"Patients with the GT genotype may have a decreased metabolism of nicotine as compared to patients with the TT genotype. Other genetic and clinical factors may also effect patients' response to nicotine. This annotation only covers the pharmacokinetic relationship between rs61750900 and nicotine and does not include evidence about clinical outcomes.; \": '与TT基因型患者相比，GT基因型的患者可能具有降低的尼古丁代谢。其他遗传和临床因素也可能影响患者对尼古丁的反应。该注释仅涵盖RS61750900和尼古丁之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " \"Patients with the AA genotype and acute myeloid leukemia who are treated with cytarabine and cladribine may be more likely to have a complete response to first remission induction therapy as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence a patient's response to cytarabine and cladribine treatment.; Leukemia, Myeloid, Acute\": '患有由糖醇和克兰汀治疗的AA基因型和急性髓性白血病，与AG或GG基因型的患者相比，对第一缓解诱导治疗的患者可能更有可能对第一缓解感应治疗具有完全反应。其他遗传和临床因素也可能影响患者对糖素和克拉酮治疗的反应。白血病，米洛克，急性',\n",
       " 'Patients with the GG genotype may have decreased clozapine plasma concentrations, as well as a decreased risk for clozapine-induced agranulocytosis or neutropenia, as compared to patients with the AA genotype. Other genetic and clinical factors may also influence concentrations and risk of clozapine-induced toxicity.; ': '与AA基因型的患者相比，GG基因型的氯氮平血浆浓度可能降低，以及氯氮平诱导的抗植物细胞瘤病或中性粒细胞病的风险降低。其他遗传和临床因素也可能影响浓度和氯氮平诱导的毒性的风险。',\n",
       " 'Patients with the rs1051266 CT genotype and rheumatoid arthritis may have decreased response when treated with methotrexate as compared to patients with the TT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence methotrexate response.; Arthritis, Rheumatoid': '与TT基因型患者相比，患有RS1051266 CT基因型和类风湿性关节炎的响应可能会降低。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响甲氨蝶呤反应。关节炎，类风湿',\n",
       " \"Patients with the CC genotype who are treated with gemcitabine and platinum compounds may have a decreased risk for nausea as compared to patients with the TT genotype. Other genetic and clinical factors may also effect patients' risk for nausea.; Mesothelioma\": '与TT基因型的患者相比，用吉西滨和铂化合物治疗的CC基因型的患者可能对恶心的风险降低。其他遗传和临床因素也可能影响患者对恶心的风险。间皮瘤',\n",
       " 'in Lebanese participants on long-term warfarin therapy.': '在黎巴嫩参与者长期华法林治疗。',\n",
       " 'in a Mexican population undergoing percutaneous coronary intervention.': '在经皮冠状动脉干预的墨西哥人群中。',\n",
       " 'Patients with the rs121908755 GG genotype (do not have a copy of the CFTR S549N variant) and cystic fibrosis have an unknown response to ivacaftor treatment, as response may depend on the presence of other CFTR variants. FDA-approved drug labeling information and CPIC guidelines indicate use of ivacaftor in cystic fibrosis patients with at least one copy of a list of 33 CFTR genetic variants, including S549N. Other genetic and clinical factors may also influence response to ivacaftor.; Cystic Fibrosis': '患者121908755 GG基因型（没有CFTR S549N变体的拷贝）和囊性纤维化对Ivacafeafer治疗具有未知的反应，因为响应可能取决于其他CFTR变体的存在。FDA批准的药物标签信息和CPIC指南表示IVACafetor在囊性纤维化患者中使用至少一份33个CFTR遗传变体列表的副本，包括S549N。其他遗传和临床因素也可能影响对IVACAFTOR的反应。囊性纤维化',\n",
       " 'Genotypes AA + AC is associated with increased metabolism of caffeine as compared to genotype CC.': '与基因型CC相比，基因型AA + AC与咖啡因的代谢增加有关。',\n",
       " \"Patients with the CG genotype and Attention Deficit Disorder with Hyperactivity may have an increased response to treatment with methylphenidate as compared to patients with the GG genotype. Other genetic and clinical factors may also affect a patient's response to methylphenidate.; Attention Deficit Disorder with Hyperactivity\": '患有CG基因型和注意力缺陷障碍的患者可能对与GG基因型的患者相比，对甲基壁治疗的反应增加。其他遗传和临床因素也可能影响患者对甲基酚的反应。注意力缺陷症与多动症',\n",
       " 'Postmenopausal women with HR+ breast cancer and the CC genotype may have increased likelihood of breast cancer recurrence (increased recurrence free survival) when treated with anastrozole as compared to women with the AA genotype. Other clinical and genetic factors may also influence the likelihood of breast cancer recurrence in postmenopausal women with HR+ breast cancer who are treated with anastrozole.; Breast Neoplasms': '与AA基因型的女性相比，当用AA基因型的女性进行治疗时，HR +乳腺癌和CC基因型的绝经乳腺癌和CC基因型可能会增加乳腺癌复发（增加的复发存活率）。其他临床和遗传因素也可能影响乳腺癌患者在患有Anastrozole治疗的人力资源癌患者中乳腺癌复发的可能性。乳房肿瘤',\n",
       " \"Patients with the A/del genotype and Coronary Artery Disease may be more likely to benefit from pravastatin treatment as compared to patients with the del/del genotype. Other genetic and clinical factors may also influence a patient's response to pravastatin treatment.; Coronary Artery Disease\": '与Del / Del基因型的患者相比，A / DEL基因型和冠状动脉疾病的患者可能更容易受益于普伐他汀治疗。其他遗传和临床因素也可能影响患者对普伐他汀治疗的反应。冠状动脉疾病',\n",
       " \"Patients with the GG genotype and Rheumatoid Arthritis may have increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to tumor necrosis factor alpha (TNF-alpha) inhibitors.; Arthritis, Rheumatoid\": '与AA基因型患者相比，GG基因型和类风湿性关节炎的患者可能对肿瘤坏死因子α（TNF-α）抑制剂的反应增加。其他遗传和临床因素也可能影响患者对肿瘤坏死因子α（TNF-α）抑制剂的反应。关节炎，类风湿',\n",
       " 'Patients with the GT genotype may have increased metabolism of carbamazepine in people with Epilepsy as compared to patients with genotype GG. Other genetic and clinical factors may also influence metabolism of carbamazepine.; Epilepsy': '与基因型GG患者相比，GT基因型的患者可能增加癫痫患者的癫痫患者的代谢。其他遗传和临床因素也可能影响卡巴马嗪的代谢。癫痫',\n",
       " 'Patients with the GG genotype who are taking oral contraceptives may have an increased risk of venous thrombosis as compared to patients with the G/del or del/del genotypes. Other genetic and clinical factors may also influence risk for venous thrombosis in patients taking oral contraceptives.; ': '与患有G / DEL或DEL / DEL基因型患者相比，服用口服避孕药的GG基因型的患者可能具有增加的静脉血栓形成风险。其他遗传和临床因素也可能影响口服避孕药患者静脉血栓形成的风险。',\n",
       " 'Patients with the rs6928499 CC genotype may have an increased risk of developing opioid dependence when exposed to opioids as compared to patients with the CG or GG genotypes. Other genetic and clinical factors may also influence risk of developing opioid dependence.; Opioid-Related Disorders': '与CG或GG基因型患者相比，患有RS6928499 CC基因型CC基因型的患者可能具有增加的依赖性依赖性的风险。其他遗传和临床因素也可能影响开发阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'The authors report that rs21086622 genotype accounted for 1.9% of the variability in warfarin dose.': '作者报告称，RS21086622基因型占华法林剂量变异性的1.9％。',\n",
       " \"Patients with the AA genotype may have a significantly higher odds of Musculoskeletal adverse events (MSAEs) and vasomotor symptoms (VMSs) in postmenopausal hormone receptor (HR)-positive breast cancer patients when treated with exemestane as compared to patients with genotype AG or GG. Other genetic and clinical factors may also influence a patient's risk of toxicity to exemestane.; Breast Neoplasms\": '与患有基因型Ag或GG的患者相比，患有AA基因型的AA基因型的肌肉骨骼不良事件（MSAES）和血管传道症状（VMS）的患者具有显着较高的肌肉骨骼不良事件（MSAES）和血管瘤症状（VMS）。其他遗传和临床因素也可能影响患者对巨大的毒性的风险。乳房肿瘤',\n",
       " 'Allele C is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele A.': '与等位基因A相比，等位基因C与癫痫患者中的卡马西肽的代谢增加有关。',\n",
       " \"Patients with the GG genotype and Leukemia who are treated with cytarabine and idarubicin may have increased risk for induction failure as compared to patients with the AG or AA genotype. Other genetic and clinical factors may also influence a patient's response to cytarabine and idarubicin.; Leukemia, Myeloid, Acute\": '与患有Cytarabine和Idarubicin治疗的GG基因型和白血病的患者可能导致诱导损失的风险增加，与AG或AA基因型患者相比。其他遗传和临床因素也可能影响患者对糖素和紫芽蛋白的反应。白血病，米洛克，急性',\n",
       " 'Patients with the AA genotype may have a decreased risk for nicotine dependence as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk for nicotine dependence.; Tobacco Use Disorder': '与GG基因型患者相比，AA基因型的患者可能对尼古丁依赖性的风险降低。其他遗传和临床因素也可能影响尼古丁依赖的风险。烟草使用障碍',\n",
       " \"Patients with the AA genotype and rheumatoid arthritis who are with infliximab may have an increased response based on European League Against Rheumatism (EULAR) criteria and show more improvement using the Disease Activity Score 28 as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to infliximab.; Arthritis, Rheumatoid\": '患有AA基因型和类风湿性关节炎的患者，患有英夫利昔单抗，基于欧洲联盟对风湿病（欧洲）标准的响应增加，与GG基因型患者相比，使用疾病活性得分28更具改善。其他遗传和临床因素也可能影响患者对英夫利昔单抗的反应;关节炎，类风湿',\n",
       " 'Genotypes CT + TT are associated with increased response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to genotype CC.': '与基因型CC相比，基因型CT + TT与黄斑变性的人们对贝伐单抗或Ranibizumab的响应增加相关。',\n",
       " \"Patients with the CC genotype may be less likely to experience insomnia as a result of consuming caffeine as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's likelihood of experiencing insomnia due to caffeine.; insomnia\": '与AA基因型患者相比，CC基因型的患者可能不太可能在消耗咖啡因的结果中经历失眠。其他遗传和临床因素也可能影响患者因咖啡因而经历失眠的可能性。失眠',\n",
       " \"Patients with the GA genotype and Bipolar Disorder may be more likely to respond to lithium as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to lithium.; Bipolar Disorder\": '与AA基因型患者相比，患有GA基因型和双相障碍的患者可能更有可能对锂响应。其他遗传和临床因素也可能影响患者对锂的反应。躁郁症',\n",
       " 'The current evidence base suggests that there is no significant association between the CYP2D6*5 allele and risk of side effects or intolerance to citalopram. This drug-variant pair has been assigned a “no recommendation” by DPWG, as it was determined to be not clinically actionable. Other genetic and clinical factors may also influence risk of side effects or intolerance to citalopram.; Depressive Disorder, Major': '目前的证据基础表明，CYP2D6 * 5等位基因之间没有显着关联，并且对西普拉克的副作用或不容忍的风险。这种药物变异对被DPWG分配了“不建议”，因为它被确定在临床上不可缩小。其他遗传和临床因素也可能影响副作用或不耐受性的风险。抑郁症，主要',\n",
       " 'Patients with the rs324029 AG genotype may have an increased risk of developing opioid dependence when exposed to opioids as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk of developing opioid dependence.; Opioid-Related Disorders': '与GG基因型的患者相比，RS324029 AG基因型的患者可能产生增加，所述风险依赖于暴露于阿片类药物。其他遗传和临床因素也可能影响开发阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'Patients with the CC genotype and non-small cell lung cancer show no significant differences in progression-free survival time when treated with platinum compounds in combination with either docetaxel, gemcitabine, paclitaxel or vinorelbine, as compared to patients with the TT genotype. However, patients with the CT genotype and non-small cell lung cancer may have reduced progression-free survival time when treated with platinum compounds in combination with either docetaxel, gemcitabine, paclitaxel or vinorelbine, as compared to patients with the TT genotype. Other genetic and clinical factors may also influence progression-free survival time.; Carcinoma, Non-Small-Cell Lung': '患有CC基因型和非小细胞肺癌的患者在用TT基因型的患者相比，用铂化合物与多西紫杉醇，吉西他滨，紫杉醇或血管内的无铂化合物处理没有显着差异。然而，当用TT基因型的患者组合使用铂化合物处理时，患有CT基因型和非小细胞肺癌的患者可能具有减少的无进展的存活时间。其他遗传和临床因素也可能影响无进展的存活时间。癌，非小细胞肺',\n",
       " 'Response = complete cytogenetic response (CCyR) as defined by each individual study, 4 studies were analyzed.': '响应=每项研究中定义的完全细胞遗传学反应（CCYR），分析了4项研究。',\n",
       " 'The A allele of rs59086055 is assigned as no function by CPIC. The GG genotype may have increased catalytic activity of DPYD as compared to the AG or AA genotypes. Other clinical and genetic factors may also influence catalytic activity of DPYD.; ': 'RS59086055的等位基因由CPIC分配为无功能。与AG或AA基因型相比，GG基因型可增加DPYD的催化活性。其他临床和遗传因素也可能影响DPYD的催化活性;',\n",
       " 'Patients carrying the CYP2D6*1 allele may have increased metabolism of risperidone as compared to patients carrying at least one uncertain function allele. This annotation only covers the pharmacokinetic relationship between CYP2D6 and risperidone and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence the metabolism of risperidone.; ': '携带CYP2D6 * 1等位基因的患者可能增加利培酮的代谢，而患有至少一个不确定功能等位基因的患者。该注释仅涵盖CYP2D6和Risperidone之间的药代动力学关系，并且不包括关于临床结果的证据。其他遗传和临床因素也可能影响利培酮的代谢。',\n",
       " \"Patients with the CC genotype may have an increased analgesic response to morphine as compared to patients with the CT or TT genotypes. Other genetic or clinical factors may also affect a patient's response to morphine.; Pain\": '与患有CT或TT基因型的患者相比，CC基因型的患者对吗啡的镇痛反应增加。其他遗传或临床因素也可能影响患者对吗啡的反应。疼痛',\n",
       " \"Patients with the CG genotype may have a decreased response to metoprolol as compared to patients with the CC genotype. However, some studies have failed to find an association. Other genetic and clinical factors may also influence a patient's response to metoprolol.; \": '与CC基因型的患者相比，CG基因型的患者可能对富含托洛尔的反应降低。但是，一些研究未能找到一个关联。其他遗传和临床因素也可能影响患者对美托洛尔的反应。',\n",
       " \"Patients with the AT genotype and Hypercholesterolemia may have a reduced response to fluvastatin (a lower change in LDL-cholesterol levels) as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to fluvastatin treatment.; Hypercholesterolemia\": '与AA基因型的患者相比，患有基因型和高胆固醇血症的患者可能对氟伐他汀（LDL-胆固醇水平的较低变化）减少。其他遗传和临床因素也可能影响患者对氟伐他汀治疗的反应。高胆固醇血症',\n",
       " \"Patients with the CT genotype and Colorectal Neoplasms who are treated with fluorouracil, irinotecan and leucovorin may have a decreased, but not absent, risk for grade 3–4 severe diarrhea as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's risk for grade 3–4 severe diarrhea.; Colorectal Neoplasms\": '患有氟尿嘧啶，伊立替康和白草素治疗的CT基因型和结肠直肠肿瘤的患者可能降低，但不存在，与CC基因型患者相比，3-4级严重腹泻的风险。其他遗传和临床因素也可能影响患者3-4级严重腹泻的风险。结直肠肿瘤',\n",
       " \"Women with the AG genotype and rheumatoid arthritis may have a worse response when treated with dalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate as compared to women with the AA genotype. Other genetic and clinical factors may also influence a patient's response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate.; Arthritis, Rheumatoid\": '与AA基因型的女性相比，当用Dalimalab，Certolizumab Pegol，entanercept，葡节片剂，葡萄糖皮质激素，英屈肌或甲氨蝶呤进行处理时，患有Ag基因型和类风湿性关节炎的妇女可能具有更差的反应。其他遗传和临床因素还可能影响患者对患者对患者的反应，克切尔替洛替洛，依那天葡萄球菌，糖皮质激素，英美昔单抗或甲氨蝶呤。关节炎，类风湿',\n",
       " \"Patients with the CG genotype and Acute coronary syndrome who are treated with statins may have a decreased response to treatment as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to statin treatment.; Acute coronary syndrome\": '与CC基因型患者相比，患有他汀类药物治疗的CG基因型和急性冠状动脉综合征的患者可能对治疗的反应降低。其他遗传和临床因素也可能影响患者对他汀类药物治疗的反应。急性冠状动脉综合征',\n",
       " 'Genotype CC is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与关节炎人民中对甲氨蝶呤的反应增加有关。',\n",
       " 'The current evidence base suggests that there is no association between the rs4149056 CT genotype and the LDL-lowering response to rosuvastatin. Some studies report an association, however the majority of the studies documented no association. Other genetic and clinical factors may also influence response to rosuvastatin.; ': '目前的证据基础表明，RS4149056 CT基因型与降低对Rosuvastatin的LDL降低响应之间没有关联。有些研究报告了一个协会，然而大多数研究没有任何协会。其他遗传和临床因素也可能影响对罗苏伐他汀的反应。',\n",
       " 'Patients with the CT genotype may have increased risk for nausea, but a decreased likelihood of dose delay, when treated with cyclophosphamide, doxorubicin and fluorouracil, as compared to patients with TT genotype. Other genetic and clinical factors may also influence risk for dose delay and toxicity in patients taking cyclophosphamide, doxorubicin and fluorouracil.; Breast Neoplasms': '患有CT基因型的患者可能会增加恶心的风险，但与具有TT基因型患者相比，用环磷酰胺，多柔比蛋白和氟尿嘧啶处理时，剂量延迟的可能性降低。其他遗传和临床因素也可能影响服用环磷酰胺，多柔比星和氟尿嘧啶的患者剂量延迟和毒性的风险。乳房肿瘤',\n",
       " \"Patients with the GT genotype who are treated with aspirin may have decreased, but not absent, risk for Peptic Ulcer Hemorrhage as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to aspirin.; \": '用阿司匹林治疗的GT基因型患者可能降低，但不存在，与GG基因型患者相比消化性溃疡出血的风险。其他遗传和临床因素也可能影响患者对阿司匹林的反应。',\n",
       " 'Patients with the CC genotype may have a decreased risk of adverse events (bleeding, over-anticoagulation or increased time above therapeutic range) when treated with phenprocoumon as compared to patients with the TT or CT genotype. Other clinical and genetic factors may also influence risk of adverse events to phenprocoumon.; Hemorrhage;over-anticoagulation;time above therapeutic range': '当用TT或CT基因型的患者用苯处理处理时，患有CC基因型的患者可能会降低不良事件（出血，过度抗凝或增加时间）的风险。其他临床和遗传因素也可能影响苯处理的不良事件的风险。出血;过度抗凝;时间高于治疗范围',\n",
       " 'Patients with cancer and the rs25487 CT genotype may have decreased response when treated with platinum-based therapies as compared to patients with the CC genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to platinum-based regimens.; Neoplasms': '癌症和RS25487 CT基因型的患者可能会减少铂类疗法，与CC基因型患者相比用铂族疗法进行处理。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对基于铂的方案的反应。肿瘤',\n",
       " 'The number of T alleles present in a patient was negatively associated with CGI-S score.': '患者中存在的T等位基因的数量与CGI-S分数负相关。',\n",
       " 'Patients with the rs4728709 AG genotype may have a decreased likelihood of developing asthenia when treated with olanzapine as compared to patients with the GG genotype. Other genetic and clinical factors may also influence likelihood of developing olanzapine-induced asthenia.; Asthenia': '与奥氮滨处理的患者相比，患有RS4728709 AG基因型的患者可能降低了乳腺癌处理时的哮喘。其他遗传和临床因素也可能影响露出奥氮平诱导的哮喘的可能性。哮喘',\n",
       " \"Patients with the CYP2A6*1B/*1B genotype and who smoke may have increased daily nicotine consumption compared to patients carrying at least one copy of the *2 or *4 alleles or patients who are homozygous for the *1, *9 or *12 alleles. Other genetic and clinical factors may also affect a patient's daily nicotine consumption.; Tobacco Use Disorder\": '与携带至少一份* 1，* 9或* 12纯合的副本的患者相比，CYP2A6 * 1B / * 1B基因型和烟雾可能会增加每日尼古丁消费量增加尼古丁消费等位基因。其他遗传和临床因素也可能影响患者的日常尼古丁消费。烟草使用障碍',\n",
       " 'Patients with the CC genotype and colorectal neoplasms may have increased severity of neutropenia when taking irinotecan compared to patients with the CT and TT genotypes. Other clinical and genetic factors may affect severity of neutropenia when taking irinotecan.; Colorectal Neoplasms': '与CT和TT基因型患者相比，CC基因型和结肠直肠肿瘤的患者可能会增加中性粒细胞率的严重程度。其他临床和遗传因素可能会在服用Irinotecan时影响中性粒细胞病的严重程度。结直肠肿瘤',\n",
       " 'Somewhat decreased UGT1A1 activity; low likelihood of bilirubin-related discontinuation of atazanavir.': '有点减少UGT1A1活动;与胆红素相关的Atazanavir中断的低可能性。',\n",
       " \"Patients with the GG genotype and Hypercholesterolemia may have a better response to fluvastatin treatment (determined by higher change in HDL-C levels) as compared to patients with the AG or AA genotype. Other genetic and clinical factors may also influence a patient's response to fluvastatin treatment.; Hypercholesterolemia\": '与AG或AA基因型的患者相比，GG基因型和高胆固醇血症患者可能对氟伐他汀治疗（通过HDL-C水平的变化确定）具有更好的反应。其他遗传和临床因素也可能影响患者对氟伐他汀治疗的反应。高胆固醇血症',\n",
       " \"Female patients with the CT genotype and depression who are treated with antidepressants, benzodiazepine derivatives, mirtazapine or selective serotonin reuptake inhibitors may be less likely to respond to antidepressant treatment as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to antidepressants.; Depressive Disorder, Major\": '女性患者用抗抑郁药，苯二氮卓衍生物，Mirtazopine或选择性血清素再摄取抑制剂的CT基因型和抑郁症可能不太可能响应与TT基因型患者相比的抗抑郁药治疗。其他遗传和临床因素也可能影响患者对抗抑郁药的反应。抑郁症，主要',\n",
       " \"The CYP2D6*2 allele is assigned as a normal function allele by CPIC. Patients carrying the *2 allele in combination with alleles that result in a normal metabolizer phenotype may have decreased metabolism of haloperidol as compared to patients carrying two increased function alleles or an increased function allele in combination with a normal function allele. Patients carrying the *2 allele in combination with alleles that result in a normal metabolizer phenotype may also have decreased metabolism of haloperidol as compared to patients carrying an increased function allele with an activity value of 3 or greater in combination with a decreased or no function allele but increased metabolism of haloperidol as compared to patients with a no function allele in combination with a decreased or normal function allele or two decreased or no function alleles. Be aware that the DPWG guideline for haloperidol and CYP2D6 has a 'no recommendation' for intermediate metabolizers. This annotation only covers the pharmacokinetic relationship between CYP2D6 and haloperidol and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence haloperidol metabolism.; Schizophrenia\": 'CYP2D6 * 2等位基因由CPIC分配为正常功能等位基因。患者与导致正常代谢物表型导致的等位基因组合的等位基因可能降低了氟哌啶醇的代谢，与携带两种增加的函数等位基因或增加的功能等位基因与正常功能等位基因组合的患者相比。与患有正常代谢物表型的等位基因携带* 2等位基因的患者也可能降低氟哌啶醇的代谢，相比，与携带增加的活性值3或更高的函数等位基因的患者组合减少或无功能等位基因但与含有NO功能等位基因的患者相结合的患者增加了氟哌啶醇的新陈代谢增加，或者常规功能等位基因或两种降低或无功能等位基因。请注意，Haloperidol和Cyp2D6的DPWG指南为中间代谢者提供了“不建议”。该注释仅涵盖CYP2D6和Haloperidol之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响氟哌啶醇代谢。精神分裂症',\n",
       " 'Tacrolimus doses were significantly higher in patients with the *1/*1 or *1/*3 genotype (\"expressers\") as compared to those with the *3/*3 genotype (\"non-expressers\"). Dose-adjusted trough levels were significantly lower in the expressers as compared to the non-expressers. However, no significant association with trough levels was seen.': '与* 3 / * 3基因型（“非表达者”）相比，患有* 1 / * 1或* 1 / * 3种基因型（“患者”）的患者患者的喉司剂量显着较高。与非表达者相比，患者的剂量调节的槽水平显着较低。然而，没有看到与槽水平的显着关联。',\n",
       " 'Patients with the AA genotype who are administered atazanavir may have an increased risk of hyperbilirubinemia as compared to patients with the CC genotype. Other clinical and genetic factors may also influence risk of hyperbilirubinemia in patients who are taking atazanavir.; HIV Infections': '患有AAA基因型的患者ATAZANAVIR的患者可能对患有CC基因型的患者相比具有较高的高胆管血症的风险。其他临床和遗传因素也可能影响采用Atazanavir的患者的高胆管血症血症的风险。艾滋病毒感染',\n",
       " \"Patients with the AA genotype and solid tumors may have an increased clearance of XK469 as compared to patients with the GG genotype. Other genetic and clinical factors may also effect patients' clearance of XK469.; \": '与患有GG基因型的患者相比，AA基因型和实体瘤的患者可能对XK469的间隙增加。其他遗传和临床因素也可能影响患者的XK469的清仓。',\n",
       " 'Patients with the AA genotype and rectal cancer may have a better response to capecitabine-based chemoradiotherapy as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence response to capecitabine-based chemoradiotherapy.; Rectal Neoplasms': '与AG或GG基因型的患者相比，AA基因型和直肠癌基因癌的患者可能对基于Capecitabine的化学疗法具有更好的反应。其他遗传和临床因素也可能影响对Capecitabine的化学疗法的反应。直肠肿瘤',\n",
       " 'Patients who are recipients of a liver transplant and have the CYP3A5*1 allele in combination with another normal function allele may require an increased dose of tacrolimus as compared to patients with a normal function allele in combination with a no function allele or two no function alleles, while patients who have the CYP3A5*1 allele in combination with a no function allele may require an increased dose of tacrolimus as compared to patients with two no function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect tacrolimus dose requirements.; liver transplantation': '肝脏移植受者的患者并使CYP3A5 * 1等位基因与另一个正常功能等位基因组合可能需要增加的Tacolimus剂量，与常规功能等位基因组合的患者相结合，无功能等位基因或两个无功能等位基因相比，而具有CYP3A5 * 1等位基因与NO功能等位基因组合的患者可能需要增加的Tacolimus剂量，而另外两种功能等位基因相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响Tacrolimus剂量要求。肝移植术',\n",
       " 'Patients with genotype AA may have increased sustained virological response (svr) when treated with peginterferon/ribavirin therapy in people with Hepatitis C as compared to patients with genotype GG. Other genetic and clinical factors may also influence the response to peginterferon/ribavirin therapy.; Hepatitis C, Chronic': '当与丙基霉素治疗与丙基肝炎的人群相比，与基因型GG患者进行治疗时，基因型AA的患者可能会增加持续的病毒学反应（SVR）。其他遗传和临床因素也可能影响对Peg选项ron /利巴韦林治疗的反应;丙型肝炎，慢性',\n",
       " \"Female patients with the AG genotype may be more likely to respond to nicotine replacement therapy (NRT) for smoking cessation as compared to female patients with the GG genotype. Note that this association was not seen in male subjects in the same study. Other genetic and clinical factors may also affect a patient's response to NRT.; Tobacco Use Disorder\": '与女性患者的GG基因型患者相比，患有Ag基因型的女性患者可能更容易应对尼古丁替代治疗（NRT），用于吸烟。请注意，在同一研究中的男性受试者中没有看到该协会。其他遗传和临床因素也可能影响患者对NRT的反应;烟草使用障碍',\n",
       " 'Patients with retinal disease and the TT genotype may have increased intraocular pressure when treated with triamcinolone as compared to patients with the CT or CC genotypes. Other clinical and genetic factors may also influence changes in intraocular pressure in patients with retinal disease.; Retinal Diseases': '视网膜疾病和TT基因型的患者可能会在用CT或CC基因型的患者用曲安奈尔治疗时具有增加的眼内压力。其他临床和遗传因素还可能影响视网膜疾病患者的眼内压力的变化。视网膜疾病',\n",
       " \"Patients with schizophrenia and the GG genotype may have a decreased response to risperidone as compared to patients with the AA or AG genotypes. However, this association lost significance following correction for multiple testing. Other genetic or clinical factors may also affect a patient's response to risperidone.; Schizophrenia\": '与AA或AG基因型的患者相比，精神分裂症和GG基因型的患者可能对Risperidone的反应降低。然而，这种关联在多次测试校正后丧失了重要性。其他遗传或临床因素也可能影响患者对Risperidone的反应。精神分裂症',\n",
       " 'Both variants of rs17376848 are assigned normal function by CPIC. Patients with the GG genotype and cancer who are treated with capecitabine, a fluoropyrimidine-based chemotherapy, may not have altered risk of drug toxicity as compared to patients with the AG or AA genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of drug toxicity.; Neoplasms': 'RS17376848的两种变体由CPIC分配正常功能。与氟嘧啶基化疗治疗的GG基因型和癌症的患者可能不会改变药物毒性的风险，而与AG或AA基因型相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响药物毒性的风险。肿瘤',\n",
       " 'Patients with the AG genotype and schizophrenia may have an increased response when treated with clozapine as compared to patients with the GG genotype or a decreased response when treated with clozapine as compared to patients with the AA genotype. Other genetic and clinical factors may also influence response to clozapine.; Schizophrenia': '与用AA基因型的患者相比，患有氯氮平的患者（氯氮平的患者相比，患有AG基因型和精神分裂症的患者可能具有增加的反应。其他遗传和临床因素也可能影响对氯氮平的反应。精神分裂症',\n",
       " 'Patients with the rs193922762 TT genotype may develop malignant hyperthermia when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with the CC genotype. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.; Malignant Hyperthermia': '与CC基因型患者相比，患有RS193922762 TT基因型的TT基因型可能会发生恶性热疗，当用挥发性麻醉剂（DESFLURANE，ENFLUNANE，氟烷，异氟烷，甲氧基氟醚，七氟醚）和/或琥珀酰胆碱相比。其他遗传或临床因素也可能影响恶性热疗的风险。恶性热疗',\n",
       " 'Healthy males with the TT genotype have have a decreased response when given bumetanide, furosemide and torasemide as compared to healthy males with the CC genotype. Other genetic and clinical factors may also influence response to bumetanide, furosemide and torasemide.; ': '与具有CC基因型的健康雄性相比，当给予摩尔酐，呋塞米和托塞米德时，具有TT基因型的健康雄性具有降低的响应。其他遗传和临床因素也可能影响对硼铀，呋塞米和托塞米德的反应。',\n",
       " \"Patients with bladder cancer and the GG genotype may be at an increased risk of experiencing drug toxicity when treated with cisplatin as compared to patients with the TT genotype. Other genetic and clinical factors may also affect a patient's risk of drug toxicity when treated with cisplatin.; Drug Toxicity;Urinary Bladder Neoplasms\": '膀胱癌和GG基因型的患者可能是在用TT基因型的患者的用顺铂处理时经历药物毒性的风险增加。其他遗传和临床因素也可能影响用顺铂治疗时患者药物毒性的风险。药物毒性;膀胱肿瘤',\n",
       " \"Patients with the CC genotype may have an increased response to fentanyl as compared to patients with the TT genotype. However, another study failed to find this association. Other genetic and clinical factors may also affect a patient's response to fentanyl.; Pain, Postoperative\": '与TT基因型患者相比，CC基因型的患者可能对芬太尼的反应增加。但是，另一项研究未能找到此协会。其他遗传和临床因素也可能影响患者对芬太尼的反应。痛苦，术后',\n",
       " 'Patients with the AT genotype and epilepsy may have increased dose-adjusted trough concentrations of phenytoin as compared to patients with the AA genotype. Other genetic and clinical factors may also influence dose-adjusted trough concentrations of phenytoin.; Epilepsy': '与AA基因型的患者相比，患有基因型和癫痫的患者可能具有增加的剂量调节槽浓度的苯妥汀。其他遗传和临床因素也可能影响苯妥的剂量调节的槽浓度。癫痫',\n",
       " 'The CYP2C19*17 allele is assigned as an increased function allele by CPIC. Patients carrying the CYP2C19*17 allele in combination with a normal or increased function allele may have increased metabolism of omeprazole as compared to patients with two normal function alleles. Patients carrying the CYP2C19*17 allele in combination with a no or decreased function allele may have decreased metabolism of omeprazole as compared to patients with two normal function alleles. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between CYP2C19 and omeprazole and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of omeprazole.; Gastroesophageal Reflux': 'CYP2C19 * 17等位基因被CPIC分配为增加的函数等位基因。与具有两个正常功能等位基因的患者相比，携带CYP2C19 * 17等位基因与正常或增加的功能等位基因组合的患者可能增加奥美拉唑的代谢。携带CYP2C19 * 17等位基因与NO或降低的功能等位基因组合的患者可能降低奥美拉唑的代谢，相比具有两个正常功能等位基因的患者。但是，已经报告了相互矛盾的证据。该注释仅涵盖CYP2C19和OMEPRAZOLE之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响奥美拉唑的代谢。胃食管反流',\n",
       " 'The current evidence base suggests that there is no significant association between the rs717620 CC genotype and clearance of methotrexate. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between rs717620 and methotrexate and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence methotrexate clearance.; Leukemia, Lymphoid;Precursor Cell Lymphoblastic Leukemia-Lymphoma': '目前的证据基础表明RS717620 CC基因型与甲氨蝶呤的清除无显着关联。但是，已经报告了相互矛盾的证据。该注释仅涵盖RS717620和甲氨蝶呤之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响甲氨蝶呤清除。白血病，淋巴管;前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Measuring paraxanthine (17X) 8-hydroxylase activity.': '测量帕拉丝（17x）8-羟化酶活性。',\n",
       " 'TPMT *1/*3A is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to TPMT *1/*1.': '与TPMT * 1 / * 1相比，TPMT * 1 / * 3A与前体细胞淋巴细胞白血病淋巴瘤的儿童减少的巯基嘌呤有关。',\n",
       " 'depressive symptoms measured on Hamilton Rating Scale for Depression and outcome as change in symptoms, as measured 6 weeks after drug, following 10 days washout.': '抑郁症状在汉密尔顿评级规模上测量抑郁和结果作为症状的变化，如药物6周后测量，后10天洗净时间。',\n",
       " 'Patients with the AG genotype and gastrointestinal stromal tumors may have a decreased risk for toxicity when treated with imatinib as compared to patients with the AA genotype. Other genetic and clinical factors may also influence risk for toxicity in patients receiving imatinib.; Gastrointestinal Stromal Tumors': '与AA基因型患者相比，患有AG基因型和胃肠道基质肿瘤的毒性风险降低。其他遗传和临床因素也可能对接受伊马替尼的患者影响毒性风险。胃肠道间质瘤',\n",
       " 'Patients with the TT genotype may have increased risk of Hemorrhage in patients with mechanical cardiac valves treated with warfarin as compared to patients with genotype CC or CT. Other genetic or clinical factors may also influence the risk of toxicity to warfarin.; ': '与基因型CC或CT的患者相比，TT基因型的患者可能对用华法林治疗的机械心瓣患者的出血风险增加。其他遗传或临床因素也可能影响毒性对华法林的风险。',\n",
       " 'Patients with the AG genotype who are undergoing kidney transplantation may have higher dose-adjusted trough concentrations of cyclosporine, and have a lower likelihood of experiencing biopsy-proven acute rejection, as compared to patients with the AA genotype. Other genetic and clinical factors may also influence concentrations of and response to cyclosporine.; Kidney Transplantation': '与AA基因型患者相比，正在进行肾移植的AG基因型可能具有更高的剂量调节槽浓度的环孢菌素，并且具有较低的急性排斥反应。其他遗传和临床因素也可能影响对环孢菌素的浓度和反应。肾移植',\n",
       " 'AA homozygotes allele had greater decreases in systolic blood pressure (SBP) after 4 weeks and 8 weeks of treatment with atenolol, as compared to CC homozygotes. No significant results were seen for diastolic blood pressure.': '与CC纯合子相比，AA Homozygotes等位基因在4周和8周后8周和8周的治疗后的8周，与CC纯合子相比，在8周的时间内降低。对舒张压没有显着的结果。',\n",
       " \"The CYP2D6*3 allele is assigned as a no function alleles by CPIC. Patients carrying the *3 allele in combination with a normal, decreased or no function allele may have decreased metabolism of paroxetine as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying the *3 allele in combination with an increased function allele with an activity value of 3 or greater may have increased metabolism of paroxetine as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *3 allele in combination with an increased function allele with an activity value of 2 may have similar metabolism of paroxetine as compared to patients with other alleles that result in a normal metabolizer phenotype. Be aware that the DPWG guideline for paroxetine and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. This annotation only covers the pharmacokinetic relationship between CYP2D6 and paroxetine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence paroxetine metabolism.; \": 'CYP2D6 * 3等位基因被CPIC分配为无功能等位基因。与具有正常代谢物表型的等位基因的患者相比，携带* 3等位基因与正常，降低或无功能等位基因组合的患者可能降低了帕罗西汀的代谢。患者与活性值为3或更大的函数等位基因组合的患者可能会增加帕罗西汀的代谢增加，相比具有正常代谢物表型的等位基因，而患者组合携带* 3等位基因的患者对于具有导致正常代谢物表型的其他等位基因的患者，随着活性值2的函数等位基因的活性值可能具有相似的帕罗西汀代谢。请注意，Paroxetine和Cyp2D6的DPWG指南为CYP2D6中级和代购机差具有“不建议”。该注释仅涵盖CYP2D6和帕罗西汀之间的药代动力学关系，并不包括关于临床结果的证据。其他遗传和临床因素也可能影响帕罗西汀代谢。',\n",
       " 'The CYP2D6*10 allele has been assigned as a decreased function allele with an activity value of 0.25 by CPIC. Patients carrying the *10 allele in combination with a decreased or no function allele may have decreased metabolism of metoprolol as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *10 allele in combination with an increased function allele with an activity value of 2 may have similar metabolism of metoprolol as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying the *10 allele in combination with an increased function allele with an activity value of 3 or greater may have increased metabolism of metoprolol as compared to patients with alleles that result in a normal metabolizer phenotype. This annotation only covers the pharmacokinetic relationship between CYP2D6 and metoprolol and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metoprolol metabolism.; Hypertension': 'CYP2D6 * 10等位基因已被分配为下降的功能等位基因，CPIC的活动值为0.25。患者与降低或无功能等位基因组合的患者可能降低了甲状腺栓塞酚的代谢，相比具有正常代谢物表型的等位基因的患者，而携带* 10等位基因的患者与增加的功能等位基因组合与患有正常代谢物表型导致的等位基因的患者相比，2的活性值2的活性值可能具有相似的氟洛尔洛尔代谢。患者与活性值3或更大的函数等位基因组合的患者可能增加了与导致正常代谢物表型的等位基因的患者相比富含托洛尔的代谢。该注释仅涵盖CYP2D6和美容之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响氟托洛尔代谢。高血压',\n",
       " 'Patients with the AC genotype who are smokers may have increased physical responses to smoking as compared to patients with the CC genotype, or decreased physical responses as compared to patients with the AA genotype. No association with nicotine addiction has been seen. Other genetic and clinical factors may also influence physical responses to smoking.; Tobacco Use Disorder': '与患有CC基因型的患者相比，患有吸烟者的AC基因型的患者可能会增加对吸烟的物理反应，或与AA基因型患者相比减少物理反应。已经看到与尼古丁成瘾无关。其他遗传和临床因素也可能影响对吸烟的物理反应。烟草使用障碍',\n",
       " \"Patients with the TT genotype were not studied. But patients with the CT genotype and Asthma may have an increased response to montelukast treatment, based on an increased Forced expiratory volume in one second (FEV1) response to montelukast at 6 month of treatment, compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to montelukast.; Asthma\": '没有研究具有TT基因型的患者。但是，与患有CC基因型的6个月治疗的患者，CT基因型和哮喘患者对孟鲁斯司司司司对孢子治疗的响应增加，基因型和哮喘患者可能对Montelukast治疗的反应增加。其他遗传和临床因素也可能影响患者对蒙特洛特的反应;哮喘',\n",
       " 'Genotype AA is associated with increased clearance of atazanavir in healthy individuals as compared to genotypes AC + CC.': '与基因型AC + CC相比，基因型AA与健康个体中的Atazanavir的清除增加有关。',\n",
       " \"Patients with the GG genotype and with Precursor Cell Lymphoblastic Leukemia-Lymphoma who are treated with methotrexate may have an increased likelihood of Drug Toxicity as compared to patients with the AG and AA genotype. This finding is contradicted in other studies. Other genetic and clinical factors may also influence a patient's level of methotrexate induced toxicity.; Precursor Cell Lymphoblastic Leukemia-Lymphoma\": '与AG和AA基因型的患者相比，患有GG基因型和含有甲氨蝶呤的前体细胞淋巴细胞白血病淋巴瘤的患者可能具有增加的药物毒性可能性。这一发现在其他研究中矛盾。其他遗传和临床因素也可能影响患者的甲氨蝶呤诱导毒性水平。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " \"Patients with the CT genotype and HIV who are treated with ritonavir may have decreased severity of triglyceride elevation as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's triglyceride levels.; HIV Infections;Hyperlipidemias\": '与TT基因型的患者相比，患有Ritonavir治疗的CT基因型和艾滋病毒的患者可能降低了甘油三酯升高的严重程度。其他遗传和临床因素也可能影响患者的甘油三酯水平;HIV感染;高脂血症',\n",
       " \"Patients with the CC genotype and Macular Degeneration who are treated with ranibizumab may have an increased response as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence a patient's response to treatment.; Macular Degeneration\": '与Ranibizumab治疗的CC基因型和黄斑变性的患者可能具有增加的反应，与CT或TT基因型的患者相比。其他遗传和临床因素也可能影响患者对治疗的反应。黄斑变性',\n",
       " 'Patients with cancer and the CT genotype who are treated with capecitabine may have a decreased (but not absent) risk of nausea and vomiting as compared to patients with the TT genotype. Other clinical and genetic factors may also influence risk of nausea and vomiting in patients with cancer who are treated with capecitabine.; Nausea;Vomiting': '患有癌症和Capecitabine治疗的CT基因型的患者可能具有恶心和呕吐的降低（但不存在）风险，与TT基因型患者相比。其他临床和遗传因素也可能影响用Capecitabine治疗的癌症患者的恶心和呕吐的风险。恶心，呕吐',\n",
       " 'Patients with the CC genotype may have decreased levels of O-desmethylnaproxen sulfation as compared to patients with the CT or TT genotypes. Other genetic and clinical factors may also affect O-desmethylnaproxen sulfation.; ': '与CT或TT基因型的患者相比，CC基因型的患者可能降低了O-去甲基己酮硫化水平。其他遗传和临床因素也可能影响O-去甲基己酮硫酸盐。',\n",
       " \"Patients with the *31 allele 1) may have decreased inactivation of thiopurines due to decreased TPMT activity and 2) may have an increased risk for toxicity when receiving thiopurine drugs and purine analogues as compared to patients with the *1/*1 genotype. These effects may be more pronounced in those who are homozygous for two non-functional variants (e.g. *3A/*31) than in those who are heterozygous for the non-functional variant (*1/*31). Other genetic and clinical factors may also influence a patient's risk for toxicity.; \": '患有* 31等位基因1）的患者可能导致由于TPMT活性降低，2）可能在接受硫嘌呤药物和嘌呤类似物相比，与* 1 / * 1基因型的患者相比，毒性的风险增加。这些效果在纯合的两个非功能变体（例如* 3A / * 31）中的那些效果比对于非功能变体的杂合（* 1 / * 31）。其他遗传和临床因素也可能影响患者毒性的风险。',\n",
       " 'Patients with the AA genotype may have decreased likelihood of emerging viral drug resistance when exposed to efavirenz in people with HIV Infections as compared to patients with the CC genotype.This varaint is not associated with plasma exposure of efavirenz. Other genetic and clinical factors may also influence the response to efavirenz.; HIV Infections': '与CC基因型患者相比，AA基因型的AA基因型患者可能降低了新出现的病毒毒性耐药性的可能性。此处图与EFAVIRENZ的血浆暴露无关。其他遗传和临床因素也可能影响对Efaviraenz的反应。艾滋病毒感染',\n",
       " 'The GT genotype in patients with precursor cell lymphoblastic leukemia-lymphoma may be associated with an increased risk of leukopenia when treated with methotrexate as compared to the TT genotype. Other clinical and genetic factors may also influence risk of leukopenia in patients with precursor cell lymphoblastic leukemia-lymphoma.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与TT基因型相比，前体细胞淋巴细胞白血病淋巴瘤患者的GT基因型可能与白细胞缺乏症的风险增加有关。其他临床和遗传因素还可能影响前体细胞淋巴细胞白血病淋巴瘤患者白细胞减少症的风险。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Colon cancer patients with CC genotype may have shorter time to tumor recurrence when treated 5-fluorouracil compared to patients with CA + AA genotypes. Other genetic and clinical factors may also influence the tumor recurrence time.; Colonic Neoplasms': '与CA + AA基因型患者相比，患有CC基因型的CC基因型患者可能具有较短的肿瘤复发时间。其他遗传和临床因素也可能影响肿瘤复发时间。结肠瘤',\n",
       " \"Patients with the *1/*1G genotype may have a decreased analgesic response to sufentanil as compared to patients with the *1G/*1G genotype. Other genetic and clinical factors may also affect a patient's response to sufentanil.; \": '与患有* 1G / * 1G基因型的患者相比，患有* 1 / * 1G基因型的患者可能对Sufentanil的镇痛反应降低。其他遗传和临床因素也可能影响患者对Sufentanil的反应。',\n",
       " 'Patients with the CT genotype and gastrointestinal stromal tumors may have a decreased risk for toxicity when treated with imatinib as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk for toxicity in patients receiving imatinib.; Gastrointestinal Stromal Tumors': '与CC基因型患者相比，当用伊马替尼处理时，CT基因型和胃肠道间质瘤的患者可能对毒性的风险降低。其他遗传和临床因素也可能对接受伊马替尼的患者影响毒性风险。胃肠道间质瘤',\n",
       " 'Purified DCK proteins with the AG genotype may have increased clearance of gemcitabine as compared to those proteins with the AA genotype. Other genetic and clinical factors may also affect clearance of gemcitabine.; ': '与AA基因型的那些蛋白质相比，纯化的DCK蛋白可能具有增加的吉西他滨的间隙。其他遗传和临床因素也可能影响吉西他滨的清除。',\n",
       " 'Observed dose (mg/kg): GG (n=157) 8 (5.0–8.6), GA (n=97) 5.7 (4.3–7.5), AA (n=20) 5.2 (4.3–7.3) p=0.0047': '观察剂量（mg / kg）：gg（n = 157）8（5.0-8.6），ga（n = 97）5.7（4.3-7.5），aa（n = 20）5.2（4.3-7.3）p = 0.0047',\n",
       " 'Analgesia: select alternative drug (e.g., acetaminophen, NSAID, morphine-not tramadol or oxycodone) or be alert to symptoms of insufficient pain relief. Cough: no.': '镇痛：选择替代药物（例如，乙酰氨基酚，NSAID，吗啡 - 非曲马多或羟考酮）或警惕疼痛缓解不足的症状。咳嗽：没有。',\n",
       " 'Genotypes CG + GG is associated with decreased dose of warfarin as compared to genotype CC.': '与基因型CC相比，基因型CG + Gg与甘氨酸剂量降低有关。',\n",
       " 'Patients with the CG genotype may have decreased conversion of tramadol to O-desmethyltramadol (M1) as compared to patients with the GG genotype. Other genetic and clinical factors may also affect tramadol metabolism in a patient.; ': '与GG基因型患者相比，CG基因型的患者可能降低曲马多转化曲马多至O-去甲基三醛醇（M1）。其他遗传和临床因素也可能影响患者的曲马多代谢。',\n",
       " 'Patients carrying the CYP2D6*1 allele in combination with another normal function allele may be at a decreased risk of experiencing adverse events when treated with gefitinib as compared to patients carrying a normal function allele in combination with a no function allele or a decreased function allele with an activity value of 0.25. Patients carrying the CYP2D6*1 allele in combination with a no function allele or a decreased function allele with an activity value of 0.25 may be at an increased risk of experiencing adverse events when treated with gefitinib as compared to patients carrying two normal function alleles. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by DPWG, as it was determined to be not clinically actionable. Other genetic and clinical factors may also influence risk of adverse events when treated with gefitinib.; Adenocarcinoma;Carcinoma, Non-Small-Cell Lung;Drug Toxicity;Exanthema;Toxic liver disease': '携带CYP2D6 * 1等位基因与另一个正常功能等位基因组合的患者可能是在用吉非替尼处理的情况下，与携带正常功能等位基因的患者与NO功能等位基因组合或降低的功能等位基因进行治疗活动值为0.25。携带CYP2D6 * 1等位基因的患者与无功能等位基因组合或具有0.25的活性值的降低的函数等位基因可能是在用携带两种正常功能等位基因的患者进行吉非替尼处理时经历不良事件的风险增加。但是，已经报告了相互矛盾的证据。这种药物变异对被DPWG分配了“不建议”，因为它被确定在临床上不可缩小。其他遗传和临床因素也可能在用吉替尼处理时影响不良事件的风险。腺癌;癌，非小细胞肺;药物毒性; exanthema;有毒肝病',\n",
       " 'Patients with the CYP2D6*90 allele may have similar enzyme activity as compared to patients with the CYP2D6*1 allele. The CYP2D6*90 allele was found to have similar enzyme activity compared to CYP2D6*1 during in-vitro characterization with tolterodine. Other genetic and clinical factors may also influence the metabolism of tolterodine.; ': '与CYP2D6 * 1等位基因相比，CYP2D6 * 90等位基因的患者可能具有类似的酶活性。发现CYP2D6 * 90等位基因与在体外表征中与托特索汀的体外表征相比具有类似的酶活性。其他遗传和临床因素也可能影响托特索汀的代谢。',\n",
       " 'Patients with the AA genotype and type 2 diabetes may have a better response when treated with rosiglitazone as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to rosiglitazone.; Diabetes Mellitus, Type 2': '与GG基因型患者相比，患有AA基因型和2型糖尿病的患者可能具有更好的反应。其他遗传和临床因素也可能影响对Rosiglitazone的反应。糖尿病，2型',\n",
       " 'Genotypes AA + AG are associated with decreased metabolism of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.': '与基因型GG相比，基因型AA + AG与前体细胞淋巴细胞白血病淋巴瘤的儿童中巯基嘌呤的代谢降低有关。',\n",
       " 'Patients with the rs12979860 TT genotype and hepatitis C infection may have lower response rates (SVR) to triple therapy (telaprevir, peginterferon alfa-2a/b and ribavirin) as compared to patients with the CC genotype. However, conflicting evidence has been reported. The impact of IL28B genotype may be dampened in patients with prior PegIFN/RBV treatment failure. Other genetic and clinical factors may also influence response to HCV triple therapy.; Hepatitis C, Chronic': '与患有CC基因型的患者相比，患者TT12979860 TT基因型和丙型肝炎感染可能具有较低的反应率（SVR）至三重治疗（Telaprevir，Peginterferon Alfa-2a / B和利巴韦林）。但是，已经报告了相互矛盾的证据。IL28B基因型的影响可能抑制了先前PEGIFN / RBV处理衰竭的患者。其他遗传和临床因素也可能影响对HCV三重治疗的反应。丙型肝炎，慢性',\n",
       " 'Patients with the AA genotype and myasthenia gravis or organ transplantation may have reduced clearance of cyclosporine and therefore may require a decreased dose of cyclosporine, compared to patients with the GG genotype. Patients with the AA genotype may also have an increased risk of infection as compared to those with the GG genotype. Other genetic and clinical factors may also influence clearance and dose of cyclosporine.; Kidney Transplantation;Myasthenia Gravis': '患者AA基因型和肌肌瘤或器官移植可能降低环孢菌素的间隙，因此与GG基因型的患者相比可能需要降低的环孢菌素。与GG基因型相比，患有AA基因型的患者也可能具有增加的感染风险。其他遗传和临床因素也可能影响环孢菌素的间隙和剂量。肾移植;肌无力',\n",
       " 'The CYP2C9*3 allele is assigned as a no function allele by CPIC. Patients with CYP2C9*3 in combination with a normal, decreased, or no function allele may have increased risk of bleeding when treated with acenocoumarol as compared to patients with two normal function alleles. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by DPWG, as it was determined to be not clinically actionable.Other genetic and clinical factors may also influence the risk of bleeding when treated with acenocoumarol.; Hemorrhage': 'CYP2C9 * 3等位基因由CPIC分配为NO功能等位基因。CYP2C9 * 3患者与正常，下降或功能等位基因组合可能会增加患有aceNocoumarol的出血风险，与患有两个正常功能等位基因的患者相比。但是，已经报告了相互矛盾的证据。该药物变异对被DPWG分配了“不建议”，因为它被确定在临床上可操作的不可行。其他遗传和临床因素也可能影响用aceNocoumarol治疗时出血的风险。出血',\n",
       " 'Patients with the TT genotype who are smokers may have a better chance of smoking cessation when treated with bupropion as compared to patients with the CC genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence likelihood of smoking cessation.; Tobacco Use Disorder': '患者的TT基因型患者在通过CC基因型的患者相比，患有Bupropion的患者可能有更好的吸烟停止，尽管这在一项研究中相矛盾。其他遗传和临床因素也可能影响吸烟的可能性。烟草使用障碍',\n",
       " \"Patients with the GG genotype and Hypercholesterolemia who are treated with simvastatin may have a higher risk of developing myalgia as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk of simvastatin-induced myalgia.; Hypercholesterolemia;Myalgia unspecified\": '与辛伐他汀治疗的GG基因型和高胆固醇血症的患者可能具有更高的患有AA基因型患者的肌痛的风险较高。其他遗传和临床因素也可能影响患者患者的辛伐他汀诱导的肌痛的风险。高胆固醇血症; Myalgia未指明',\n",
       " \"Patients with the CC genotype may be at an increased risk of developing alcoholism as compared to patients with the TT genotype. This association was found in patients of African ancestry in the discovery cohort and was not replicated in either the replication cohort or in patients or European ancestry. Other genetic and clinical factors may also affect a patient's risk of developing alcoholism.; Alcoholism\": '与TT基因型患者相比，CC基因型的患者可能是发育酗酒的风险增加。该协会在探索队列中的非洲祖先患者中发现，并未在复制队列或患者或欧洲祖先中复制。其他遗传和临床因素也可能影响患者发育酗酒的风险。酗酒',\n",
       " 'Patients with the ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del genotype may have an increased response when treated with lisinopril as compared to patients with the del/del genotype, or a decreased response when treated with lisinopril as compared to patients with the ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC genotype. However, contradictory evidence exists. Other genetic and clinical factors may also influence response to lisinopril.; Diabetes Mellitus, Type 1;Heart Failure': '患者与ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/当用赖诺普利处理相比，患者用del/德尔基因型，或当与赖诺普利处理相比，患者与ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC基因型降低的响应德尔基因型可以具有增加的响应。但是，存在矛盾的证据。其他遗传和临床因素也可能影响对LisinoProil的反应。糖尿病，1型;心力衰竭',\n",
       " 'In human liver microsomes, the UGT1A1*28/*28 genotype was found to result in the decreased formation of the clozapine metabolite clozapine N+-glucuronide as compared to the UGT1A1*1/*1 orUGT1A1*1/*28 genotype.; ': '在人肝微粒体中，发现UGT1A1 * 28 / * 28基因型导致与UGT1A1 * 1 / * 1 orgt1a1 * 1 / * 28基因型相比，氯氮平代谢物氯氮平N + -Glucuronide的形成降低。',\n",
       " 'NAT2 *6A is associated with decreased metabolism of sulfapyridine in healthy individuals as compared to NAT2 *4.': '与NAT2 * 4相比，NAT2 * 6A与磺吡啶的代谢降低有关。',\n",
       " 'Genotype TT is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CC + CT.': '与基因型CC + CT相比，基因型TT与胰腺肿瘤中的人们对吉西他滨的反应增加相关。',\n",
       " 'Patients with the CT genotype and tuberculosis may be at increased risk of drug-induced liver toxicity when taking rifampicin compared to patients with the TT genotype. This SNP was identified in a GWAS study and maintained significance in combination with a replication study. Other genetic and clinical factors may affect response to rifampicin.; Tuberculosis': '与TT基因型患者相比，CT基因型和结核病的患者可能是在服用利福平时患者诱导的肝脏毒性的风险增加。该SNP在GWAS研究中鉴定并与复制研究结合保持重要性。其他遗传和临床因素可能影响对利福平的反应。结核',\n",
       " 'Patients with the CC and CT genotypes had increased overall survival time compared to those with the TT genotype. p-value remained significant after Bonferroni correction for multiple testing. Please note alleles have been complemented to the plus chromosomal strand.': '与具有TT基因型的人相比，CC和CT基因型的患者增加了总存活时间。在多次测试的Bonferroni校正后，P值仍然显着。请注意，等位基因已与加染色体股线相得益彰。',\n",
       " \"Patients with the TT genotype may have increased risk for statin-related myalgia as compared to patients with the CT or CC genotypes. Other genetic and clinical factors may also influence a patient's risk for adverse responses to statins.; Myalgia unspecified\": '与CT或CC基因型患者相比，TT基因型的患者可能对他汀类药物相关的肌痛的风险增加。其他遗传和临床因素也可能影响患者对他汀类药物的不良反应的风险。Myalgia未指明',\n",
       " \"Patients with co-infection of HIV and tuberculosis and with two copies of the *6 allele or one copy of the *6 allele in combination with the *5 or *7 alleles may have an increased risk of drug-induced liver injury when treated with a combination of HIV antivirals and anti-TB drugs as compared to patients with at least one copy of the *4, *12 or *13 alleles. Other genetic and clinical factors may also affect a patient's risk of drug-induced liver injury.; drug-induced liver injury;HIV Infections;Tuberculosis\": '患有艾滋病毒和结核病的患者，患有两种等位基因或一份副本的副本或与* 5或* 7等位基因组合的一份副本可能会产生增加的药物诱导的肝损伤风险与患有* 4，* 12或* 13等位基因的至少一种拷贝的患者相比，HIV抗病毒和抗TB药物的组合。其他遗传和临床因素也可能影响患者的药物诱导肝损伤的风险;药物诱导的肝损伤;艾滋病毒感染;结核病',\n",
       " 'in both European Americans and African Americans. However, the dose reduction per variant allele was higher among European Americans (28.3% vs 18.6%, interaction P value=0.002) compared with African Americans.': '在欧洲人和非洲裔美国人。然而，与非洲裔美国人相比，欧洲美国人的每种变异等位基因的剂量降低较高（28.3％，相互作用P值= 0.002）。',\n",
       " \"Patients with the CC genotype may have an increased risk for Coronary Disease when treated with chlorthalidone or lisinopril as compared to patients with the CC genotype who are treated with amlodipine. Other genetic and clinical factors may also influence a patient's response to treatment and risk for Coronary Disease.; \": '与用氨氯地平处理的CC基因型的患者相比，患有CC基因型的患者可能对冠状动脉疾病的风险增加增加。其他遗传和临床因素也可能影响患者对治疗和冠状病风险的反应。',\n",
       " 'Patients with genotype CT and atrial fibrillation may have decreased trough plasma concentrations of dabigatran compared to patients with the CC genotype. Other factors may affect dabigatran plasma concentrations.; Atrial Fibrillation': '与CC基因型的患者相比，患有基因型CT和心房颤动的患者可能降低了Dabigatran的槽血浆浓度。其他因素可能会影响Dabigatran等离子体浓度。心房颤动',\n",
       " 'Both variants of rs1801159 are assigned normal function by CPIC. Patients with the CC genotype and cancer who are treated with capecitabine, a fluoropyrimidine-based chemotherapy, may not have altered risk of drug toxicity as compared to patients with the CT or TT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of drug toxicity.; Neoplasms': 'RS1801159的两个变体由CPIC分配正常功能。与CT或TT基因型的患者相比，患有CCECITABINE治疗的CC基因型和癌症的患者，可能不会改变药物毒性的风险。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响药物毒性的风险。肿瘤',\n",
       " 'Patients carrying the CYP2D6*2xN allele in combination with a normal function allele may have increased metabolism of oxycodone as compared to patients carrying two normal function alleles or two no function alleles. This annotation only covers the pharmacokinetic relationship between CYP2D6 and oxycodone and does not include evidence about clinical outcomes. This drug-variant pair has been assigned a “no recommendation” by CPIC and DPWG, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect oxycodone metabolism.; Pain': '与携带两个正常功能等位基因或两种功能等位基因的患者相比，携带CYP2D6 * 2XN等位基因的患者组合含有正常功能等位基因的代谢可能增加了羟考酮的代谢。该注释仅涵盖CYP2D6和羟考酮之间的药代动力学关系，并不包括有关临床结果的证据。该药物变异对被CPIC和DPWG分配了“不建议”，因为它被确定在临床上不可互动。其他遗传和临床因素也可能影响羟考酮代谢。疼痛',\n",
       " \"Patients with the CT genotype may be at an increased risk of developing heroin dependence as compared to patients with the TT genotype. Other genetic or clinical factors may also affect a patient's risk of developing heroin dependence.; Heroin Dependence\": '与TT基因型的患者相比，CT基因型的患者可能是在发育海洛因依赖的患者的增加。其他遗传或临床因素也可能影响患者发展海洛因依赖的风险。海洛因依赖',\n",
       " 'CYP2D6 *1/*1 + *10/*10 + *1/*4 + *1/*10 (assigned as normal metabolizer phenotype) is associated with decreased concentrations of fluoxetine in people with Anxiety Disorders, Depression or Depressive Disorder, Major as compared to CYP2D6 *10/*4 (assigned as intermediate metabolizer phenotype) .': 'CYP2D6 * 1 / * 1 + * 10 / * 10 + * 1 / * 4 + * 1 / * 10（分配为正常代谢物表型）与焦虑症，抑郁或抑郁症，抑郁症或抑郁症，抑郁症的浓度降低有关与CYP2D6 * 10 / * 4相比（分配为中间代谢物表型）。',\n",
       " \"Patients with the GG genotype and cervical cancer who are treated with carboplatin, cisplatin and fluorouracil may have a better response to treatment as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to platinum-based neoadjuvant treatment.; Uterine Cervical Neoplasms\": '与AA基因型的患者相比，用卡铂和氟尿嘧啶治疗的GG基因型和宫颈癌的患者可能对治疗具有更好的反应。其他遗传和临床因素也可能影响患者对基于铂的新辅助治疗的反应。子宫子宫颈肿瘤',\n",
       " \"Patients with the CC genotype and HIV may have an increased creatinine clearance when treated with tenofovir as compared to patients with the CT genotype. Other genetic and clinical factors may also effect patients' creatinine clearance.; HIV Infections\": '与CT基因型患者相比，患有CC基因型和HIV的患者可能具有增加的肌酐清除率。其他遗传和临床因素也可能影响患者的肌酸酐清除。艾滋病毒感染',\n",
       " 'The CYP2D6*5 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2D6*5 allele in combination with a no, decreased or normal function allele may have decreased metabolism of imipramine as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying the CYP2D6*5 allele in combination with an increased function allele with an activity value of 3 or greater may have increased metabolism of imipramine as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the CYP2D6*5 allele in combination with an increased function allele with an activity value of 2 may have similar metabolism of imipramine as compared to patients with other alleles that result in a normal metabolizer phenotype. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between CYP2D6 and imipramine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of imipramine.; Depressive Disorder, Major;Mental Disorders': 'CYP2D6 * 5等位基因由CPIC分配为NO功能等位基因。携带CYP2D6 * 5等位基因的患者与NO，降低或正常的功能等位基因组合可能降低含咪唑的代谢，相比具有常规代谢物表型的等位基因的患者。患有CYP2D6 * 5等位基因的患者与活性值为3或更大的函数等位基因组合可能会增加含咪唑的代谢，相比具有正常代谢物表型的等位基因，而携带CYP2D6 * 5等位基因的患者与具有2个等位基因的患者相比，与活性值2的功能值相结合，其活性值2的活性值可能具有类似的脂氧碱的代谢。但是，已经报告了相互矛盾的证据。该注释仅涵盖CYP2D6和IMIPRAMINE之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响脂染氨酸的代谢。抑郁症，主要;精神障碍',\n",
       " \"Male patients with the B (wildtype) haplotype (not associated with G6PD deficiency) who are treated with a high dose of chloroquine may have a reduced risk of hemolytic anemia as compared to patients with the Mediterranean or A-202A_376G haplotype (hemizygous for variants associated with G6PD deficiency). Most studies show no association with increased risk with normal chloroquine dosage. Please note: all studies reported an association with G6PD deficiency but only one reported genotyping, here we are representing this association under the Mediterranean or A- haplotype which is associated with G6PD deficiency, with the B (wildtype) haplotype representing G6PD non-deficient. Other genetic and clinical factors may also influence a patient's risk of drug-induced hemolysis.; Anemia, Hemolytic\": '用高剂量氯喹处理的B（野生型）单倍型（与G6PD缺乏有关）可能具有降低的溶血性贫血的风险，与地中海或A-202A_376G单倍型（相关的变异性嗜血症）相比缺乏G6PD）。大多数研究表明，没有正常氯喹剂量的风险增加。请注意：所有研究均报告与G6PD缺乏的关联，但只有一个报告的基因分型，我们在这里代表了与G6PD缺乏相关的地中海或A-单倍型，其中B（野生型）单倍型表示G6PD非缺乏。其他遗传和临床因素也可能影响患者的药物诱导溶血的风险。贫血，溶血',\n",
       " \"Patients with the AA genotype and Anxiety Disorders who are treated with duloxetine may have increased response to duloxetine as compared to patients with the AG genotype. Other genetic and clinical factors may also influence a patient's response to duloxetine.; Anxiety Disorders\": '与Ag基因型患者相比，患有Duloxetine治疗的AA基因型和焦虑症的患者可能对Duloxetine的反应增加。其他遗传和临床因素也可能影响患者对Duloxetine的反应。焦虑症',\n",
       " 'Genotype AA is associated with increased metabolism of acetaminophen in healthy individuals as compared to genotypes AC + CC.': '与基因型AC + CC相比，基因型AA与乙酰氨基酚的代谢增加相关。',\n",
       " 'The CYP2C19*1 allele is assigned as a normal function allele by CPIC. Patients carrying the CYP2C19*1 allele in combination with a normal function allele who are treated with clopidogrel may have increased platelet inhibition and decreased residual platelet aggregation as compared to patients with a no or decreased function allele in combination with a normal or increased function allele or with two no or decreased function alleles. Patients carrying the CYP2C19*1 allele in combination with a normal function allele who are treated with clopidogrel may have decreased platelet inhibition and increased residual platelet aggregation compared to patients with two increased function alleles or a combination of a normal function allele with an increased function allele. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence platelet inhibition.; Cardiovascular Diseases': 'CYP2C19 * 1等位基因由CPIC分配为正常功能等位基因。患有CYP2C19 * 1等位基因与用氯吡格雷处理的正常功能等位基因组合的患者可能具有增加的血小板抑制和残留血小板聚集，与NO或降低的功能等位基因与正常或增加的功能等位基因组合或有两个没有或减少的功能等位基因。患有CYP2C19 * 1等位基因与用氯吡格雷处理的正常功能等位基因组合的患者可能降低了血小板抑制和血小板聚集增加的血小板抑制和增加的血小板聚集增加了两种增加的函数等位基因或具有增加的功能等位基因的正常功能等位基因的组合。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响血小板抑制。心血管疾病',\n",
       " 'Patients with the CYP2D6*93 allele may have decreased clearance of dapoxetine as compared to patients with the CYP2D6*1 allele. The CYP2D6*93 allele was found to have decreased intrinsic clearance during in-vitro characterization with dapoxetine. Other genetic and clinical factors may also influence the metabolism of dapoxetine.; ': '与CYP2D6 * 1等位基因的患者相比，CYP2D6 * 93等位基因患者可能降低了脂氧定的间隙。发现CYP2D6 * 93等位基因在体外表征与二夸甲酰胺中的内在间隙降低。其他遗传和临床因素也可能影响成兆汀的代谢。',\n",
       " \"Patients with the GG genotype may be at an increased risk of developing cocaine dependence as compared to patients with the AA genotype. Other genetic or clinical factors may also affect a patient's risk of developing cocaine dependence.; Cocaine-Related Disorders\": '与AA基因型的患者相比，GG基因型的患者可能存在越来越多的患有可卡因依赖性的风险。其他遗传或临床因素也可能影响患者开发可卡因依赖的风险。可卡因相关疾病',\n",
       " 'Patients with the GG genotype and non-small-cell lung cancer may have a better response to treatment with platinum-based chemotherapy as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence response to platinum-based chemotherapy.; Carcinoma, Non-Small-Cell Lung': '与AA或AG基因型的患者相比，患有GG基因型和非小细胞肺癌的患者可能对用铂类化疗进行更好的反应。其他遗传和临床因素也可能影响对基于铂的化疗的反应。癌，非小细胞肺',\n",
       " 'Individuals with the AA genotype who are addicted to methamphetamine may be less likely to experience psychosis when taking methamphetamine, as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk for psychosis when taking methamphetamine.; Psychotic Disorders': '与患有GG基因型患者相比，患有对甲基苯丙胺的AA基因型的人可能不太可能在服用甲基苯丙胺时体验精神病。其他遗传和临床因素也可能在服用甲基苯丙胺时影响精神病风险。精神病疾病',\n",
       " 'Patients carrying at least one copy of CYP3A5 *1 allele (CYP3A5 expressers) showed significantly lower concentration/dose ratios as compared to patients with the *3/*3 genotype (CYP3A5 non-expressers).': '患有至少一种CYP3A5 * 1等位基因（CYP3A5表达者）患者的患者显示出与* 3 / * 3基因型（CYP3A5非表达者）的患者相比显着降低浓度/剂量比。',\n",
       " \"Patients with the CC genotype are less likely to respond to repaglinide than patients with the CT or TT genotype in T2DM patients. Other genetic and clinical factors may also influence a patient's response.; Diabetes Mellitus, Type 2\": '患有CC基因型的患者不太可能响应于T2DM患者的CT或TT基因型的患者。其他遗传和临床因素也可能影响患者的反应。糖尿病，2型',\n",
       " 'Patients with the rs63749869 AA genotype may develop malignant hyperthermia when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with the GG genotype. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.; Malignant Hyperthermia': '与GG基因型患者相比，患有挥发性麻醉剂（DELFOLUNANE，卤甲烷，异氟烷，甲氧基氟醚，甲氧基氟醚）和/或甲氧基氟醚，甲氧基氟醚，七氟醚）和/或甲氧基氟醚时，可能会发生恶性热疗。其他遗传或临床因素也可能影响恶性热疗的风险。恶性热疗',\n",
       " 'Genotype GG is associated with decreased clearance of efavirenz in people with HIV Infections as compared to genotype AG.': '与基因型Ag相比，基因型GG与艾滋病毒感染的人们的eFaviraenz的间隙降低有关。',\n",
       " 'Both variants of rs56005131 are assigned normal function by CPIC. Patients with the GG genotype and cancer who are treated with capecitabine, a fluoropyrimidine-based chemotherapy, may not have altered risk of drug toxicity as compared to patients with the GT or TT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of drug toxicity.; ': 'RS56005131的两种变体由CPIC分配正常功能。与Capecitabine的GG基因型和癌症患者，氟嘧啶基化学疗法可能没有改变药物毒性的风险，与GT或TT基因型的患者相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响药物毒性的风险。',\n",
       " 'Patients with the AA genotype may have increased chance of achieving 6 month abstinence from smoking when treated with NRT (nicotine replacement therapy) as compared to patients with the GG genotype. However, another study failed to find an association between this variant and response to NRT. Other clinical and genetic factors may also influence response to smoking cessation therapies.; Tobacco Use Disorder': '患有AA基因型的患者可能增加了在用GG基因型患者的患者用NRT（尼古丁替代疗法）治疗时从吸烟中获得6个月禁止的可能性。然而，另一个研究未能在这种变体之间找到一个关联和对NRT的响应。其他临床和遗传因素也可能影响对吸烟的戒烟治疗的反应。烟草使用障碍',\n",
       " 'Patients with the GG genotype who are treated with mycophenolic acid following lung transplantation may be at a decreased risk of transplant rejection as compared to patients with the GT or TT genotypes. Other genetic and clinical factors may also affect response to mycophenolic acid. in lung transplant patients.; lung transplantation;transplant rejection': '与肺移植后肌霉素酸治疗的GG基因型患者可能是GT或TT基因型患者的移植抑制的风险下降。其他遗传和临床因素也可能影响对霉酚酸的反应。在肺移植患者中;肺移植;移植抑制',\n",
       " \"Patients with the CG genotype may have decreased risk of Coronary Disease when treated with aspirin as compared to patients with the CC genotype. However, Allele G may be associated with increased risk of Coronary Disease in people not taking aspirin as compared to allele C. Other genetic and clinical factors may influence patient's response to aspirin.; Coronary Artery Disease\": '与CC基因型患者相比，CG基因型的患者可能降低冠状动脉疾病的风险降低。然而，与等位基因C.相比，等位基因G可能与不服用阿司匹林的人们的风险增加。其他遗传和临床因素可能会影响患者对阿司匹林的反应。冠状动脉疾病',\n",
       " 'Patients with the TT genotype and rheumatoid arthritis may have decreased response to tocilizumab compared to patients with the CC genotype. Other genetic and clinical factors may affect response to tocilizumab.; Arthritis, Rheumatoid': '与患有CC基因型的患者相比，TT基因型和类风湿性关节炎的患者可能降低对对硅酸钙的反应。其他遗传和临床因素可能会影响对ToColizumab的反应;关节炎，类风湿',\n",
       " \"Patients carrying the *3 allele in addition to another no function allele may be at a decreased risk of developing opioid dependence as a result of taking hydrocodone as compared to patients carrying at least one normal function allele. Other genetic and clinical factors may also affect a patient's risk of developing opioid dependence.; Opioid-Related Disorders\": '携带* 3等位基因的患者除了另外的功能等位基因外，还可以在患有含有至少一个正常功能等位基因的患者的患者相比，由于服用氢碳酮而导致阿片类药物的风险降低。其他遗传和临床因素也可能影响患者发展阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'in Turkish patients taking warfarin for >2 months.': '在土耳其患者服用华法林> 2个月。',\n",
       " \"Patients with chronic pain and the AA genotype may be less likely to develop hyperalgesia when treated with long-term opioids as compared to patients with the AG genotype. Other genetic and clinical factors may also affect a patient's likelihood of developing hyperalgesia.; Hyperalgesia\": '与AG基因型患者相比，慢性疼痛和AA基因型的患者可能不太可能在用长期阿片类药物治疗时显影。其他遗传和临床因素也可能影响患者患有痛觉过敏的可能性。痛觉痛觉',\n",
       " \"Patients with the GG genotype may have increased expression of TCL1A, IL17RA and decreased expression of IL17A, IL12RB2, and IL1R2 when treated with estradiol as compared to patients with the CC genotype or may have decreased expression of TCL1A, IL17RA and increased expression of IL17A, IL12RB2, and IL1R2 when treated with estradiol as compared to patients with the GG genotype based on in-vitro results. Other genetic and clinical factors may also influence a patient's response to estradiol.; \": '与CC基因型的患者相比，GG基因型的GG基因型的表达增加了TCL1A，IL17A，IL17RA和IL1R2的表达，或者当用CC基因型的患者进行了患者，或者可能降低TCL1A，IL17RA，IL17A的表达和IL17a的表达增加，与雌二醇处理的基于体外结果的患者相比，IL12RB2和IL1R2。其他遗传和临床因素也可能影响患者对雌二醇的反应。',\n",
       " 'CYP2D6 *17/*17 is associated with decreased metabolism of debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.': '与CYP2D6 * 1 / * 1 + * 1 / * 2相比，CYP2D6 * 17 / * 17与健康个体中的碎片喹氏菌，葡萄球菌或氟洛尔的代谢降低有关。',\n",
       " 'Patients with the rs71647871 CT genotype who are treated with clopidogrel may have decreased platelet aggregation as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to clopidogrel.; ': '与CC基因型患者相比，用氯吡格雷治疗的RS71647871 CT基因型的患者可能降低了血小板聚集。其他遗传和临床因素也可能影响对氯吡格雷的反应。',\n",
       " 'People with the AA genotype may have increased inhibition of platelet aggregation in response to ticagrelor compared to people with the AG and GG genotypes. Other clinical and genetic factors may affect response to ticagrelor.; ': '与具有AG和GG基因型的人相比，具有AA基因型的人可能会增加血小板聚集的抑制作用。其他临床和遗传因素可能会影响对Ticagrel的反应。',\n",
       " 'Patients with the rs4149056 CT genotype may have an increased risk of developing myopathy when treated with statins as compared to patients with the TT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect risk of statin-induced myopathy.; statin-related myopathy': '与TT基因型的患者相比，患有RS4149056 CT基因型的CT基因型可能产生增加肌病的风险增加。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响他汀类药物诱导的肌病的风险。汀类药相关的肌病',\n",
       " \"Patients with the AC genotype and Mental Disorders who are treated with paroxetine may have a decreased risk of nausea as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to paroxetine.; Mental Disorders\": '与AA基因型患者相比，患有帕罗西汀治疗的AC基因型和精神障碍的患者可能会降低恶心的风险。其他遗传和临床因素也可能影响患者对帕罗西汀的反应。精神错乱',\n",
       " 'Patients with the GG genotype may have better response and longer progression-free survival when treated with abiraterone/prednisolone in metastatic castration-resistant prostate cancer patients as compared to patients with AA genotype. Other genetic and clinical factors may also influence the response to abiraterone/prednisolone.; Prostatic Neoplasms': '与AA基因型患者相比，患有GG基因型的GG基因型的患者可以具有更好的反应和无进展的前列腺癌患者。其他遗传和临床因素也可能影响对AbiraTerone / prednisolone的反应。前列腺肿瘤',\n",
       " \"Patients with the GG genotype may have an increased response to treatment with duloxetine for major depressive disorder as compared to patients with the TT genotype. Other genetic and clinical factors may also affect a patient's response to duloxetine.; Depressive Disorder, Major\": '与TT基因型的患者相比，GG基因型的患者可能对用Duloxetine治疗的响应增加。其他遗传和临床因素也可能影响患者对Duloxetine的反应;抑郁症，主要',\n",
       " 'Patients with the rs1695 GG genotype and various cancer may have an increased risk of ototoxicity when treated with cisplatin-based regimens as compared to patients with the AA genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of ototoxicity in patients receiving cisplatin-based regimens.; Medulloblastoma;Neoplasms;Ototoxicity;Testicular Neoplasms': '与AA基因型患者相比，患有1695克基因型和各种癌症的患者可能产生增加的基于顺铂的方案时耳毒性的风险。但是，已经报告了相互矛盾的证据。其他遗传和临床因素还可能影响接受基于顺铂的方案的患者耳毒性的风险。medulloblastoma;肿瘤;耳毒性;睾丸瘤',\n",
       " \"Patients with the *1/*3 genotype may have increased dose requirements of sufentanil as compared to patients with the *1/*1 genotype. Other genetic and clinical factors may also affect a patient's sufentanil dose requirements.; \": '与* 1 / * 1基因型的患者相比，患有* 1 / * 3基因型的患者可能会增加Sufentanil的剂量要求。其他遗传和临床因素也可能影响患者的Sufentanil剂量要求。',\n",
       " 'Egyptian patients with TT genotype showed significantly higher SVR rate than minor allele (TG/GG) carriers (74% vs. 26%, P=0.004). Logistic regression analysis revealed that TT carriers had 2.8 higher chance for SVR achievement than G allele carriers TG/GG (OR=2.8, 95% CI=1.4-5.6, P=0.004).': '埃及TT基因型的患者显示比次次等位基因（TG / GG）载体（74％对26％，P = 0.004）显着较高的SVR速率。Logistic回归分析显示，TT载体比G等位基因载体TG / GG（OR = 2.8,95％CI = 1.4-5.6，P = 0.004）对SVR成果的机会高2.8个载体。',\n",
       " \"Patients with HIV and the TT genotype may be less likely to develop hyperbilirubinemia when administered atazanavir and ritonavir as compared to patients with the GG genotypes. Please note: the GG genotype was only significantly associated with likelihood of hyperbilirubinemia when it was combined with the rs7586110 GG and rs17863778 AA (UGT1A7), rs3806596 CC (UGT1A3) and UGT1A1 *28/*28.Other clinical and genetic factors may also influence a patient's likelihood of developing hyperbilirubinemia in patients with HIV who were administered atazanavir and ritonavir.; HIV Infections;Hyperbilirubinemia\": '与GG基因型患者相比，艾滋病毒患者和TT基因型可能不太可能在施用Atazanavir和Ritonavir时发育高胆血清血症。请注意：当与RS7586110 GG和RS17863778 AA（UGT1A7），RS3806596CC（UGT1A3）和UGT1A1 * 28 / * 28相结合时，GG基因型仅与高胆血清血症的可能性显着相关。其他临床和遗传因素也可能会影响患者在艾滋病病毒患者中培养患者的患者的可能性，谁在atazanavir和ritonavir。艾滋病毒感染;高胆管血症',\n",
       " 'CYP3A5 *1 is associated with decreased trough concentration of tacrolimus in people with Kidney Transplantation.': 'CYP3A5 * 1与肾移植人的人的巨石蛋白的槽浓度降低有关。',\n",
       " 'Patients with retinal disease and the CC genotype may have decreased intraocular pressure when treated with triamcinolone as compared to patients with the CT or TT genotypes. Other clinical and genetic factors may also influence changes in intraocular pressure in patients with retinal disease.; Retinal Diseases': '与CT或TT基因型患者相比，患有视网膜疾病和CC基因型的患者可能会降低眼内压力。其他临床和遗传因素还可能影响视网膜疾病患者的眼内压力的变化。视网膜疾病',\n",
       " 'Patients with the AC genotype and bladder cancer may have decreased response to cisplatin-based therapy compared to patients with the CC genotype. Replication studies did not confirm these findings. Other clinical and genetic factors may affect response to cisplatin-based therapies.; Urinary Bladder Neoplasms': '与CC基因型患者相比，患有AC基因型和膀胱癌的患者可能降低对基于顺铂的疗法的反应。复制研究没有确认这些发现。其他临床和遗传因素可能影响对基于顺铂的疗法的反应。膀胱肿瘤',\n",
       " 'Patients with the CYP2D6*89 allele may have similar clearance of atomoxetine as compared to patients with the CYP2D6*1 allele. The CYP2D6*89 allele was found to have similar intrinsic clearance during in-vitro characterization with atomoxetine. This annotation only covers the pharmacokinetic relationship between CYP2D6 and atomoxetine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence the metabolism of atomoxetine.; ': '与CYP2D6 * 1等位基因患者相比，CYP2D6 * 89等位基因的患者可能具有类似的氧杂志的间隙。发现CYP2D6 * 89等位基因在体外表征中具有类似的内在间隙。该注释仅涵盖CYP2D6和Atomoxetine之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响甲氧嘧啶的代谢。',\n",
       " 'Annotation of DPWG Guideline for atomoxetine and CYP2D6': '奥昔象和CYP2D6的DPWG指南注释',\n",
       " 'Patients with the rs1799971 AG genotype may have decreased fentanyl dose requirements as compared to patients with the GG genotype. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by CPIC, as it was determined to be not clinically actionable. Other genetic or clinical factors may also affect fentanyl dose requirements.; Pain;Pain, Postoperative': '与GG基因型患者相比，患有RS1799971 AG基因型的患者可能降低了芬太尼剂量要求。但是，已经报告了相互矛盾的证据。这种药物变异对被CPIC分配了“不建议”，因为它被确定在临床上可操作。其他遗传或临床因素也可能影响芬太尼剂量要求。疼痛;疼痛，术后',\n",
       " 'Patients with the rs2071559 AG genotype may have decreased overall survival and progression-free survival when treated with sorafenib in people with Carcinoma, Renal Cell or hepatocellular carcinoma as compared to patients with the GG genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to sorafenib.; Carcinoma, Hepatocellular;Carcinoma, Renal Cell': '患有RS2071559AG基因型的患者可能在用GG基因型的患者与癌症，肾细胞或肝细胞癌的人们用索拉非尼治疗时减少整体存活和无进展生存。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响索拉非尼的反应。癌细胞，肝细胞癌;癌，肾细胞',\n",
       " \"Patients with the GG genotype may have increased likelihood of Drug Toxicity when treated with cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to patients with the AA and AG genotypes. Another study found no association with drug toxicity and doxorubicin. Other genetic and clinical factors may also influence a patient's risk for toxicity.; Breast Neoplasms\": '与AA和AG基因型患者相比，当用乳腺肿瘤的妇女用环磷酰胺和多柔比蛋白治疗时，GG基因型的患者可能会增加药物毒性的可能性。另一项研究发现没有药物毒性和多柔比星的关联。其他遗传和临床因素也可能影响患者毒性的风险。乳房肿瘤',\n",
       " 'Patients with the rs1045642 GG genotype who are receiving methadone maintenance therapy may have decreased clearance of methadone, leading to increased plasma concentration of methadone as compared to patients with the AA genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect methadone clearance and plasma concentrations. This annotation only covers the pharmacokinetic relationship between rs1045642 and methadone and does not include evidence about clinical outcomes.; Opioid-Related Disorders': '接受美沙酮维持治疗的RS1045642 GG基因型的患者可能降低了美沙酮的间隙，导致含有AA基因型患者的美沙酮的血浆浓度增加。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响美沙酮间隙和血浆浓度。该注释仅涵盖RS1045642和美沙酮之间的药代动力学关系，并不包括有关临床结果的证据。与阿片类药物相关的疾病',\n",
       " 'Patients carrying two copies of the CYP2A6*28A allele or one copy of the *28A allele in combination with one copy of the *1A allele may have decreased metabolism of nicotine as compared to patients with two copies of the *1A allele. This annotation only covers the pharmacokinetic relationship between CYP2A6 and nicotine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also affect nicotine metabolism.; Tobacco Use Disorder': '携带两份CYP2A6 * 28A等位基因或一份* 28A等位基因的一份拷贝的患者与* 1A等位基因的一份拷贝组合可能降低了尼古丁的代谢，相比之下是* 1A等位基因的两份拷贝的患者。该注释仅涵盖CYP2A6和尼古丁之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响尼古丁代谢。烟草使用障碍',\n",
       " \"No conclusive results were found for patients with the CT genotype. But patients with the TT genotype and Diabetes Mellitus who are treated with muraglitazar may have a decreased, but not absent, risk of edema as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's risk for edema when treated with muraglitazar.; Diabetes Mellitus;Edema;Hyperlipidemias\": '没有针对CT基因型的患者发现的确定结果。但是，与Muraglitazar治疗的TT基因型和糖尿病患者可能有降低，但不存在水肿的风险，与CC基因型患者相比。其他遗传和临床因素也可能在用Muraglitazar治疗时影响患者对水肿的风险。糖尿病;水肿;高脂血症',\n",
       " 'Patients with breast cancer as the rs1695 GG genotype may have a decreased response to treatment with cyclophosphamide and epirubicin as compared to patients with the AA or AG genotypes. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to cyclophosphamide and epirubicin.; Breast Neoplasms': '与AA或AG基因型患者相比，乳腺癌患者患有乳腺癌的RS1695 GG基因型可能具有降低的响应环磷酰胺和同性蛋白。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对环磷酰胺和同性素的反应。乳房肿瘤',\n",
       " 'Patients with the rs1556422499 T allele (also known as the 961T allele) may have a decreased, but not absent, risk of experiencing aminoglycoside-induced hearing loss as compared to patients with a delT+C(n) allele (e.g. CCCCCCC). MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of aminoglycoside-induced hearing loss.; Ototoxicity': '患者15564224999岁患者（也称为961T等位基因）可能有降低但不存在，与患有Delt + C（N）等位基因（例如CCCCCC）的患者相比，体验氨基糖苷诱导的听力损失的风险。MT-RNR1是线粒体基因，其作为单倍体（即只有一个等位基因存在）。其他遗传和临床因素也可能影响氨基糖苷诱导的听力损失的风险。ototoxicity.',\n",
       " 'Increased risk of developing cytogenetic resistance to imatinib.': '增加对伊马替尼产生细胞遗传学抗性的风险。',\n",
       " \"Asian patients with the AG genotype and Hypertension who are treated with hydrochlorothiazide may have a better response to treatment as compared to patients with the GG genotype. The opposite has been found in White patients. Other genetic and clinical factors may also influence a patient's response to hydrochlorothiazide treatment.; Hypertension\": '与氢氯噻嗪治疗的AG基因型和高血压患者可能对治疗有更好的反应，与患有GG基因型的患者相比。在白色患者中发现了相反。其他遗传和临床因素也可能影响患者对氢氯噻嗪处理的反应。高血压',\n",
       " 'CYP2C19 *1/*2 + *1/*3 is associated with increased metabolism of omeprazole in people with Gastroesophageal Reflux as compared to CYP2C19 *2/*2 + *2/*3 + *3/*3.': 'CYP2C19 * 1 / * 2 + * 1 / * 3与胃食管反流的人们增加的奥美拉唑的代谢增加相关，与CYP2C19 * 2 / * 2 + * 2 / * 3 + * 3 / * 3相比。',\n",
       " 'Patients with the rs2011425 TT genotype may have increased serum concentrations of lamotrigine when treated with lamotrigine as compared to patients with the GG genotype. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between rs2011425 and lamotrigine and does not include evidence about clinical outcomes. Other clinical and genetic factors may also influence metabolism of lamotrigine.; Epilepsy': '与患有GG基因型患者的患者用乳草嗪处理时，RS2011425 TT基因型的患者可能增加了血清浓度的乳草嗪。但是，已经报告了相互矛盾的证据。该注释仅涵盖了RS2011425和拉莫里林之间的药代动力学关系，并不包括有关临床结果的证据。其他临床和遗传因素也可能影响薄片的代谢。癫痫',\n",
       " 'Outcomes were response rate, progression free survival, and overall survival. Alleles given as Pro/Arg, which Pro (G on + strand) associated with worse response.': '结果是响应率，进展自由生存和整体生存。作为pro / arg的等位基因，哪个与更严重的反应相关的Pro（G上+股）。',\n",
       " \"Patients with the GG genotype and major depression may have increased response to citalopram and escitalopram as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to citalopram and escitalopram.; Depressive Disorder, Major\": '与CC基因型患者相比，GG基因型和主要抑郁症的患者可能会增加对西酞普兰和亚太经产申请的反应。其他遗传和临床因素也可能影响患者对西酞普兰和顾查普拉克的反应。抑郁症，主要',\n",
       " 'There is currently no available evidence regarding the association between the rs4240803 AA genotype and gabapentin dosage requirements. However, patients with the AG genotype may require an increased dose of gabapentin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence gabapentin dosage requirements.; neuropathic pain': '目前没有有关RS4240803 AA基因型和加巴亨坦剂量要求之间的关联的可用证据。然而，与GG基因型患者相比，患有Ag基因型的患者可能需要增加的加巴彭剂量。其他遗传和临床因素也可能影响加巴亨坦剂量要求。神经性疼痛',\n",
       " 'Patients with precursor cell lymphoblastic leukemia-lymphoma and the TT genotype may have decreased concentrations of methotrexate as compared to patients with the CC genotypes. There is no association with risk of mucositis or response to methotrexate. Other clinical and genetic factors may also influence concentrations of methotrexate in patients with precursor cell lymphoblastic leukemia-lymphoma.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与CC基因型患者相比，前体细胞淋巴细胞白血病白血病淋巴瘤和TT基因型的患者可能降低了甲氨蝶呤的浓度。没有与粘膜炎或对甲氨蝶呤的响应的风险相关联。其他临床和遗传因素还可能影响前体细胞淋巴细胞白血病淋巴瘤患者甲氨蝶呤的浓度。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'The CYP2D6*1xN alleles (*1x2 and *1x≥3) are assigned as increased function alleles by CPIC. Patients carrying a *1xN allele in combination with a normal or increased function allele or a decreased function allele with an activity value of 0.5 may have increased metabolism of tramadol as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying a *1xN allele with an activity value of 3 in combination with a decreased function allele with an activity value of 0.25 or a no function allele may also have increased metabolism of tramadol as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying a *1xN allele with an activity value of 2 in combination with a decreased function allele with an activity value of 0.25 or a no function allele may have similar metabolism of tramadol as compared to patients with alleles that result in a normal metabolizer phenotype. This annotation only covers the pharmacokinetic relationship between CYP2D6 and tramadol and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence tramadol metabolism.; ': 'CYP2D6 * 1XN等位基因（* 1x2和*1x≥3）被分配为CPIC增加的函数等位基因。携带* 1xN等位基因与正常或增加的功能等位基因组合的患者或具有0.5的活性值的降低的函数等位基因可能会增加曲马多的代谢，而导致正常代谢物表型的等位基因的患者相比。患者与活性值为3的活性值3的患者与活性值为0.25或NO功能等位基因组合，与导致正常代谢物表型的等位基因患者相比，曲马多的代谢也可能增加曲马多的代谢。患者与活性值为2的活性值2的患者与活性值为0.25或NO功能等位基因的相结合，与导致正常代谢物表型的等位基因的患者相比，曲马多的曲折醇可能具有相似的代谢。该注释仅涵盖CYP2D6和曲马多的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响曲马多代谢。',\n",
       " \"Patients with the AG genotype may have decreased likelihood of remission on anti-depressants as compared to patients with the GG genotype. Male patients with the AG genotype and depression who are treated with citalopram may have a decreased, but not absent, risk of suicidal ideation as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to antidepressants.; Depression\": '与GG基因型患者相比，患有AG基因型的患者可能降低了抗抑制剂的缓解阶段。与CitalOlartam治疗的AG基因型和抑郁症的男性患者可能有降低但不存在，与GG基因型的患者相比，自杀性诱因的风险。其他遗传和临床因素也可能影响患者对抗抑郁药的反应。沮丧',\n",
       " \"Patients with the TT genotype may be at a decreased risk of developing alcoholism as compared to patients with the CC or CT genotypes. This association was found in patients of African ancestry in the discovery cohort and was not replicated in either the replication cohort or in patients or European ancestry. Other genetic and clinical factors may also affect a patient's risk of developing alcoholism.; Alcoholism\": '与CC或CT基因型的患者相比，TT基因型的患者可能处于发育酗酒的风险下降。该协会在探索队列中的非洲祖先患者中发现，并未在复制队列或患者或欧洲祖先中复制。其他遗传和临床因素也可能影响患者发育酗酒的风险。酗酒',\n",
       " 'Patients with non-small cell lung cancer and the TT genotype may experience an increased severity of thrombocytopenia when treated with carboplatin and gemcitabine as compared to patients with the CC or CT genotypes. Other genetic and clinical factors may also affect severity of thrombocytopenia.; Carcinoma, Non-Small-Cell Lung;Thrombocytopenia': '与CC或CT基因型患者相比，非小细胞肺癌和TT基因型的患者可能会在用卡铂和吉西他滨治疗时经历血小板减少的严重程度。其他遗传和临床因素也可能影响血小板减少的严重程度。癌，非小细胞肺;血小板减少症',\n",
       " \"Patients with the CC genotype and any allele of rs3212198 who are treated with warfarin may require a lower dose as compared to patients with the TT genotype and rs3212198 T allele. The variant combination of rs2501873 and rs3212198 explained 1.7% of the overall interindividual variability in warfarin dose requirements among one study in a multivariate regression analysis. Other genetic and clinical factors may also influence a patient's dose of warfarin.; \": '与TT基因型和RS3212198 T等位基因相比，患有CC基因型和RS3212198的任何等位基因的患者可能需要较低剂量的剂量。RS2501873和RS3212198的变体组合在多元回归分析中的一项研究中解释了华法林剂量要求的总体细分变异的1.7％。其他遗传和临床因素也可能影响患者的患者的Warfarin。',\n",
       " \"Patients with the GG genotype who are treated with docetaxel may have a decreased clearance and increased risk of leukopenia as compared to patients with the CC genotype. However the association for clearance of docetaxel was not significant and no association was found with risk for neutropenia. Other genetic and clinical factors may also influence a patient's response to docetaxel.; \": '与CC类别治疗的GG基因型的患者可降低，与CC基因型的患者相比，白细胞减少的清除性降低和白细胞减少风险。然而，多西紫杉醇的许可关联并不显着，没有发现中性粒细胞减少风险的关联。其他遗传和临床因素也可能影响患者对多西紫杉醇的反应。',\n",
       " 'In patients with the rs4948496 CT+TT genotype, those with the TT genotype had lower serum methotrexate levels, as compared to those with the CT or CC genotype.': '在RS4948496 CT + TT基因型的患者中，与具有CT或CC基因型的那些相比，具有TT基因型的TT基因型的那些具有较低的甲氨蝶呤水平。',\n",
       " 'Patients carrying the *1 allele in combination with another normal function allele may have decreased concentrations of methadone as compared to patients with a normal function allele in combination with a decreased function allele or patients with a normal function allele in combination with a no function allele. However, multiple studies have failed to find this association. Other genetic and clinical factors may also affect methadone concentrations. This annotation only covers the pharmacokinetic relationship between CYP2C9 and methadone and does not include evidence about clinical outcomes.; ': '与另一个正常功能等位基因组合的患者与另一个正常功能等位基因组合的浓度降低，与常规功能等位基因的患者相结合的函数等位基因或正常功能等位基因的患者与NO功能等位基因组合的患者相比。但是，多项研究未能找到此协会。其他遗传和临床因素也可能影响美沙酮浓度。该注释仅涵盖CYP2C9和美沙酮之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " 'Patients carrying two copies of the CYP3A4*18 allele or one copy of the *18 allele in combination with one copy of the *1 allele may have increased metabolism of tacrolimus as compared to patients carrying two copies of the *1 allele. This annotation only covers the pharmacokinetic relationship between CYP3A4 and tacrolimus and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence tacrolimus metabolism.; heart transplantation;Kidney Transplantation;laparoscopic sleeve gastrectomy;liver transplantation;lung transplantation': '患有CYP3A4 * 18等位基因的两份拷贝的患者或一份* 18等位基因的一份副本与携带两种副本的患者的患者可能会增加特征司的代谢。该注释仅涵盖CYP3A4和Tacrolimus之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响Tacrolimus代谢。心脏移植;肾移植;腹腔镜套管胃切除术;肝移植;肺移植',\n",
       " \"Patients with the TT genotype and Alzheimer's Disease may have increasing creatinine levels when taking captopril compared to patients with the AT genotype. Other clinical and genetic factors may affect creatinine levels in patients with Alzheimer's Disease.; Alzheimer Disease\": '与在基因型患者相比，患有TT基因型和阿尔茨海默病的患者可能会增加Capopril时的肌酐水平。其他临床和遗传因素可能会影响阿尔茨海默病患者的肌酐水平。阿尔茨海默病',\n",
       " \"Patients with the AT genotype and Alzheimer's Disease may have increasing creatinine levels when taking captopril compared to patients with the AT genotype. Other clinical and genetic factors may affect creatinine levels in patients with Alzheimer's Disease.; Alzheimer Disease\": '与基因型患者相比，患有基因型和阿尔茨海默病的患者可能会增加Capopril时的肌酐水平。其他临床和遗传因素可能会影响阿尔茨海默病患者的肌酐水平。阿尔茨海默病',\n",
       " \"Patients with the CT genotype may have a lower odds of vasomotor symptoms (VMSs) in postmenopausal hormone receptor (HR)-positive breast cancer patients when treated with exemestane as compared to patients with genotype TT. Other genetic and clinical factors may also influence a patient's risk of toxicity to exemestane.; Breast Neoplasms\": '当与基因型TT患者相比，患有CT基因型的患者在绝经后激素受体（HR）阳性乳腺癌患者中的血管传道症状（VMSS）的几率较低。其他遗传和临床因素也可能影响患者对巨大的毒性的风险。乳房肿瘤',\n",
       " \"Patients with the AA genotype and Asthma may have a lower aspirin-induced decline in forced expiratory volume in 1 s (FEV1) after aspirin provocation as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence a patient's response to aspirin.; Asthma\": '与AG或GG基因型患者相比，AA基因型和哮喘患者在阿司匹林挑衅后，在阿司匹林挑衅后，患者可能具有较低的阿司匹林诱导的强制呼气量下降。其他遗传和临床因素也可能影响患者对阿司匹林的反应。哮喘',\n",
       " \"Patients with the GG genotype may have 1) increased risk for drug toxicity 2) increased event free survival when treated with methotrexate as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to methotrexate, particularly rs34743033.; Precursor Cell Lymphoblastic Leukemia-Lymphoma\": '患有GG基因型的患者可能有1）药物毒性的风险增加2）与AA基因型患者相比，用甲氨蝶呤治疗时，在用甲氨蝶呤治疗时增加的事件自由存活。其他遗传和临床因素也可能影响患者对甲氨蝶呤，特别是RS34743033的反应。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Genotype AA is associated with increased clearance of atazanavir in healthy individuals as compared to genotypes AG + GG.': '与基因型Ag + Gg相比，基因型AA与Atazanavir的间隙增加有关。',\n",
       " 'As determined by higher tacrolimus AUC and trough blood concentrations in patients with genotype *1/*1. Lowest levels were found in patients with the CYP3A4*1G allele who were also CYP3A5 expressors (allele *1).': '通过基因型* 1 / * 1的患者患者的较高的Tacrolimus Auc和槽血液浓度决定。在CYP3A4 * 1G等位基因患者中发现了最低水平，患者也是CYP3A5表达者（等位基因* 1）。',\n",
       " 'Patients with the AC genotype and colorectal neoplasms may have increased severity of neutropenia compared to patients with the AA genotype when taking irinotecan. Other clinical and genetic factors may affect severity of neutropenia with irinotecan treatment.; Colorectal Neoplasms;Neutropenia': '与AA基因型在服用Irinotecan时，患有AC基因型和结肠直肠肿瘤的患者可能会增加中性粒细胞率的严重程度。其他临床和遗传因素可能会影响中性粒细胞率的严重程度与伊立替康治疗;结直肠肿瘤;中性粒细胞病',\n",
       " \"Patients with the TTA/del genotype and hypertension may have increased response to atenolol, hydrochlorothiazide, or metoprolol as compared to patients with the TTA/TTA genotype. Other genetic and clinical factors may also influence a patient's response.; Hypertension\": '与TTA / TTA基因型的患者相比，TTA / DEL基因型和高血压和高血压的患者可能对Atenolol，氢氯噻嗪或氟洛尔罗尔的反应增加。其他遗传和临床因素也可能影响患者的反应。高血压',\n",
       " 'Patients carrying the CYP2D6*10 allele in combination with a no function allele may have increased carvedilol dose requirements as compared to patients carrying two normal function alleles or a normal function allele in combination with a increased or decreased function allele. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by DPWG, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect carvedilol dose requirements.; Heart Failure': '与NO功能等位基因组合的患者与NO功能等位基因组合可能会增加Carvedilol剂量要求，与携带两种正常功能等位基因或正常功能等位基因的患者相结合，与增加或降低的功能等位基因相结合。但是，已经报告了相互矛盾的证据。这种药物变异对被DPWG分配了“不建议”，因为它被确定在临床上不可缩小。其他遗传和临床因素也可能影响Carvedilol剂量要求。心脏衰竭',\n",
       " \"Patients with the GG genotype and Asthma may have a higher aspirin-induced decline in forced expiratory volume in 1 s (FEV1) after aspirin provocation as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to aspirin.; Asthma\": '与AA基因型患者相比，患有GG基因型和哮喘的患者可能在阿司匹林挑衅后在1S（FEV1）中具有更高的阿司匹林诱导的强制呼气量下降。其他遗传和临床因素也可能影响患者对阿司匹林的反应。哮喘',\n",
       " 'Patients with genotype AG may have decreased risk of hand-foot syndrome when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to patients wth genotype GG. Other genetic and clinical factors may also influence the response to sorafenib.; Carcinoma, Hepatocellular;hand-foot syndrome': '当与肝癌的人群，与患者的第五型基因型GG相比，基因型AG的患者可能会降低手足综合征的风险降低。其他遗传和临床因素也可能影响对索拉非尼的反应;癌细胞，肝细胞;手足综合征',\n",
       " \"Patients with the TT genotype who receive thiopurine treatment for autoimmune disease may be at an increased risk of developing thiopurine-related cytopenia as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's risk of developing thiopurine-related cytopenia.; Pancytopenia;Thrombocytopenia\": '与CC基因型患者相比，接受自身免疫疾病治疗的TT基因型的TT基因型可能是患有相关细胞凋亡的风险增加。其他遗传和临床因素也可能影响患者开发硫嘌呤相关细胞贫腺的风险。pancytopenia;血小板减少症',\n",
       " \"Patients with AG genotype may have an increased likelihood of smoking cessation when treated with nicotine replacement therapy as compared to patients with the GG genotype. However, contradictory findings have been reported. Other genetic and clinical factors may influence a patient's likelihood of smoking cessation.; Tobacco Use Disorder\": '与尼古丁替代疗法治疗相比，患有Ag基因型的患者可能会增加吸烟停止时的可能性，而与GG基因型患者相比，含有尼古丁替代治疗。但是，已经报道了矛盾的结果。其他遗传和临床因素可能影响患者的吸烟可能性。烟草使用障碍',\n",
       " 'Patients with the GG genotype who are heroin dependent may have less severe side effects when treated with methadone as compared to patients with the AA genotype. Other genetic and clinical factors may also influence side effects in patients receiving methadone.; Heroin Dependence': '与AA基因型患者相比，患有海洛因的GG基因型依赖于海洛因的GG基因型可能具有较小的副作用。其他遗传和临床因素也可能影响接受美沙酮的患者的副作用。海洛因依赖',\n",
       " 'Patients with the CC genotype and schizophrenia may have a poorer response when treated with risperidone as compared to patients with the TT genotype. However, another study found no association between this variant and response to riperidone in patients with schizophrenia. Other genetic and clinical factors may also influence response to risperidone.; Schizophrenia': '与TT基因型的患者相比，患有CC基因型和精神分裂症的患者可能具有较差的反应。然而，另一项研究发现这种变体与精神分裂症患者患者的Riperidone之间的关联。其他遗传和临床因素也可能影响对Risperidone的反应。精神分裂症',\n",
       " \"Patients with the CC genotype may have decreased likelihood of Osteonecrosis when treated with Bisphosphonates as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk of toxicity to bisphosphonates.; Osteonecrosis\": '与TT基因型的患者相比，CC基因型的患者可能降低了骨囊肌坏死的可能性。其他遗传和临床因素也可能影响患者对双膦酸盐的毒性的风险。骨折坏死',\n",
       " 'Patients with the GG genotype and schizophrenia who responded to treatment with antipsychotics may require an increased dose of antipsychotics as compared to patients with the AA genotype. Other genetic and clinical factors may also influence dose of antipsychotics.; Schizophrenia': '与抗精神病药物治疗的GG基因型和精神分裂症患者可能需要增加抗精神病药剂量增加，与AA基因型患者相比。其他遗传和临床因素也可能影响抗精神病药的剂量。精神分裂症',\n",
       " 'Patients with the TT genotype may have increased plasma concentrations of dolutegravir as compared to patients with the GT or GG genotype. Other genetic and clinical factors may also influence response to dolutegravir.; HIV Infections': '与GT或GG基因型的患者相比，TT基因型的患者可能增加了血浆浓度的DoluteGravir。其他遗传和临床因素也可能影响对DoluteGravir的反应。艾滋病毒感染',\n",
       " \"Patients with the GG genotype who are treated with metformin may have a increased response and decreased risk for gastrointestinal side effects as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to metformin.; Diabetes Mellitus, Type 2\": '与患有金属素蛋白处理的GG基因型的患者可能具有增加的反应和胃肠道副作用的风险降低，与AA基因型患者相比。其他遗传和临床因素也可能影响患者对二甲双胍的反应。糖尿病，2型',\n",
       " 'Patients had undergone percutaneous coronary intervention. Cases had definite stent thrombosis during the first 5 days after stent implantation. Controls had no stent thrombosis during the first 30 days following stent implantation. The CYP2C19 *2/*2 genotype was associated with increased risk for early stent thrombosis as compared to the *1/*1 and *1/*2 genotypes. This allele was significant in multivariate analysis as well as univariate.': '患者经过经皮冠状动脉干预。病例在支架植入后的前5天内具有明确的支架血栓形成。在支架植入后的前30天内，对照没有支架血栓形成。与* 1 / * 1和* 1 / * 2基因型相比，CYP2C19 * 2 / * 2基因型与早期支架血栓形成的风险增加有关。这种等位基因在多变量分析以及单变量中具有重要意义。',\n",
       " 'Genotype del/del is associated with decreased response to captopril in people with Diabetes Mellitus, Type 2 as compared to genotypes ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC + ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del.': '基因型德尔/德尔与在人与糖尿病响应下降到相关联的卡托普利，2型相比基因型ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC+ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/德尔如。',\n",
       " 'Please note that alleles have been complemented to the positive strand. Patients with the GG genotype consumed significantly more fentanyl to control postoperative pain than patients with the AA or AG genotypes.': '请注意，等位基因已与正股线相辅相成。患有GG基因型的患者消耗更多的芬太尼，以控制术后疼痛而不是AA或AG基因型。',\n",
       " 'The CYP2D6*5 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2D6*5 allele in combination with a no, decreased or normal function allele who are treated with desipramine may have an increased likelihood of treatment side effects as compared to patients with alleles that result in a normal metabolizer phenotype. Other genetic and clinical factors may also influence treatment related side effects.; Depressive Disorder;Depressive Disorder, Major': 'CYP2D6 * 5等位基因由CPIC分配为NO功能等位基因。患有CYP2D6 * 5等位基因的患者与甲状腺素治疗的NO，减少或正常的功能等位基因组合可能具有增加的治疗副作用的可能性，与导致正常代谢物表型的等位基因的患者相比。其他遗传和临床因素也可能影响治疗相关副作用。抑郁症;抑郁症，主要',\n",
       " 'Patients with the rs1054642 GG genotype may have increased fentanyl dose requirements as compared to patients with the AA or AG genotypes. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect fentanyl dose requirements.; Pain;Pain, Postoperative': '与AA或AG基因型的患者相比，RS1054642 GG基因型的患者可能会增加芬太尼剂量要求。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响芬太尼剂量要求。疼痛;疼痛，术后',\n",
       " 'C (*3) was associated with 38.1 %(95% CI 29.3 -45.7%) reduction in therapeutic dose (defined as the dose that gave an INR in the target therapeutic range after 7 consecutive days) per copy.': 'C（* 3）与治疗剂量减少38.1％（95％CI 29.3 -45.7％（定义为在每副拷贝后7例在靶治疗范围内提供INR的剂量）。',\n",
       " \"Patients with the CC genotype may be at a decreased risk of developing alcohol dependence as compared to patients with the CT or TT genotypes. Other genetic and clinical factors may also affect a patient's risk of developing alcohol dependence.; Alcoholism\": '与CT或TT基因型的患者相比，CC基因型的患者可能处于发育酒精依赖性的风险下降。其他遗传和临床因素也可能影响患者发展酒精依赖的风险。酗酒',\n",
       " 'Patients with the GG genotype and pancreatic cancer may have a shorter time to progression when treated with gemcitabine as compared to patients with the GT or TT genotype. Other genetic and clinical factors may also influence time to progression in pancreatic cancer patients.; Pancreatic Neoplasms': '与GT或TT基因型的患者相比，患有GG基因型和胰腺癌的患者可能在用吉西他滨治疗时具有更短的进展。其他遗传和临床因素也可能影响胰腺癌患者的进展时间。胰腺肿瘤',\n",
       " 'CYP2C19 *1/*2 + *1/*3 is associated with increased exposure to praziquantel in children with Schistosomiasis as compared to CYP2C19 *1/*1 + *1/*17.': 'CYP2C19 * 1 / * 2 + * 1 / * 3与CYP2C19 * 1 / * 1 + * 1 / * 17相比，与Schistosomiaisis的血吸虫病儿童接触增加有关。',\n",
       " 'when taking letrozole and lipid lowering agents (LLA), such as statins. Data are from a sub-analysis of the Exemestane and Letrozole Pharmacogenomics (ELPh) study, where post-menopausal women with early stage breast cancer were randomized to receive exemestane or letrozole. Of the 303 eligible women, 160 were randomized to the letrozole group, 52 of whom were also taking LLA. This SNP was associated with decreases in triglycerides of 33.2 mg/dL (SE 8.9).': '当服用letrozole和脂质降低剂（LLA），例如他汀类药物。数据来自Exemestane和Letrozole药物体系（ELPH）研究的分析，其中患有早期乳腺癌的绝经后妇女随机接受Exemestane或Letrozole。在303个符合条件的妇女中，160名被随机分配给Letrozole Group，其中52名也在占据LLA。该SNP与33.2mg / dL的甘油三酯的降低有关（SE 8.9）。',\n",
       " 'GWAS study.': 'GWAS学习。',\n",
       " 'Patients with the CC genotype may have increased progression-free survival and increased overall survival when treated with sorafenib in people with Hepatocellular Carcinoma as compared to patients with genotype TT. Other genetic and clinical factors may also influence the response to sorafenib.; Carcinoma, Hepatocellular': '患有CC基因型的患者可能增加进展的生存率和随着肝细胞癌的患者用基因型TT的患者用肝癌治疗时，随着Sorafenib治疗而增加的整体存活。其他遗传和临床因素也可能影响对索拉非尼的反应;癌细胞，肝细胞',\n",
       " \"Patients with the AA genotype may be at an increased risk of developing heroin dependence as compared to patients with the AC or CC genotypes. Other genetic and clinical factors may also affect a patient's risk of developing heroin dependence.; Heroin Dependence\": '与AC或CC基因型的患者相比，AA基因型的患者可能是发展海洛因依赖的风险。其他遗传和临床因素也可能影响患者发展海洛因依赖的风险。海洛因依赖',\n",
       " 'Patients with the CG genotype and breast cancer may have a better response when treated with cyclophosphamide, epirubicin and fluorouracil as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to treatment with cyclophosphamide, epirubicin and fluorouracil. (Note: with a C/G variant, particularly in a gene on the minus chromosomal strand, and frequencies close to 50% there can be a difficulty in interpreting the evidence for association.); Breast Neoplasms': '与CC基因型患者相比，CG基因型和乳腺癌的患者可能具有更好的反应，当用CC基因型患者处理环磷酰胺，同性素和氟尿嘧啶时。其他遗传和临床因素也可能影响与环磷酰胺，同质素和氟尿嘧啶治疗的反应。（注意：用C / G变体，特别是在减去染色体链的基因中，并且接近50％的频率可能难以解释关联的证据。）;乳房肿瘤',\n",
       " 'Patients with the CT genotype and who are being treated with buprenorphine with optional fentanyl and tramadol for prescription opioid dependence may less likely to experience sexual dysfunction or reproductive system disorders as compared to patients with the CC or TT genotypes. Other genetic and clinical factors may also affect the incidence of adverse events during treatment for opioid dependence.; Opioid-Related Disorders;Sexual Dysfunctions, Psychological': '患有CT基因型的患者和用任选的芬太尼和曲马多对方的苯丙胺治疗，用于处方阿片类药物依赖性可能不太可能与CC或TT基因型患者相比体验性功能障碍或生殖系统障碍。其他遗传和临床因素也可能影响对阿片类药物依赖的治疗过程中不良事件的发生率。阿片类药物相关疾病;性功能障碍，心理',\n",
       " 'The CYP2D6*10 allele is assigned as a decreased function allele with an activity value of 0.25 by CPIC. Patients carrying the CYP2D6*10 allele in combination with a no or decreased function allele may have decreased metabolism of clomipramine as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying the CYP2D6*10 allele in combination with an increased function allele with an activity value of 3 or greater may have increased metabolism of clomipramine as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the CYP2D6*10 allele in combination with an increased function allele with an activity value of 2 may have similar metabolism of clomipramine as compared to patients with other alleles that result in a normal metabolizer phenotype. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between CYP2D6 and clomipramine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of clomipramine.; Depressive Disorder, Major;Mental Disorders': 'CYP2D6 * 10等位基因被分配为减少的函数等位基因，CPIC的活动值为0.25。与NO或减少的功能等位基因组合携带CYP2D6 * 10等位基因的患者可能降低了划分的氯胺的代谢，与导致正常代谢物表型的等位基因的患者相比，划分的氯甲嘧啶。与具有3或更大的活性值3或更大的函数等位基因相结合的患者与活性值3或更大的函数增加可能会增加氯甲胺的代谢，相比具有正常代谢物表型的等位基因，而携带CYP2D6 * 10等位基因的患者与具有患有正常代谢物表型的其他等位基因的患者相比，与活性值2的函数等位基因的相结合可能具有相似的划分氯胺的代谢。但是，已经报告了相互矛盾的证据。该注释仅涵盖CYP2D6和CLOMIPRAMINE之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响划分氯胺的代谢。抑郁症，主要;精神障碍',\n",
       " 'Choose an alternative agent that is not dependent on CYP2C19 metabolism as primary therapy in lieu of voriconazole. Such agents include isavuconazole, liposomal amphotericin B, and posaconazole.f,g': '选择不依赖于CYP2C19代谢作为主要疗法代替伏立康唑的替代剂。这些试剂包括异戊酰唑，脂质体两性霉素B和posaconazole.f，g',\n",
       " \"Patients with the AG genotype who are treated with clopidogrel may have an increased risk of neurological events as compared to patients with the GG genotype. However, no association with differences in risk of cardiovascular events was reported. Other genetic and clinical factors may also influence a patient's response to clopidogrel.; \": '与氯吡格雷治疗的AG基因型的患者可能导致神经事件的风险增加，与GG基因型患者相比。然而，报告了与心血管事件风险差异的关联。其他遗传和临床因素也可能影响患者对氯吡格雷的反应。',\n",
       " \"Female patients with the TT genotype and depression who are treated with antidepressants, benzodiazepine derivatives, mirtazapine or selective serotonin reuptake inhibitors may be more likely to respond to antidepressant treatment as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to antidepressants.; Depressive Disorder, Major\": '女性患有由抗抑郁药，苯二氮卓衍生物，Mirtazopine或选择性血清素再摄取抑制剂进行治疗的TT基因型和抑郁症的患者可能更可能响应与CC基因型的患者相比的抗抑郁药治疗。其他遗传和临床因素也可能影响患者对抗抑郁药的反应。抑郁症，主要',\n",
       " 'CYP3A5 *1/*3 is associated with decreased concentrations of sirolimus as compared to CYP3A5 *3/*3.': '与CYP3A5 * 3 / * 3相比，CYP3A5 * 1 / * 3与SiroLimus的浓度降低有关。',\n",
       " 'Patients with metastatic stomach cancer and the rs1695 AG genotype may have a decreased response to treatment with epirubicin, fluorouracil and oxaliplatin as compare to patients with the GG genotype. Other genetic and clinical factors may also influence response to treatment with epirubicin, fluorouracil and oxaliplatin.; Neoplasm Metastasis;Stomach Neoplasms': '转移性胃癌和RS1695 AG基因型的患者可能对与Epirubicin，Fluyouracil和Oxaliplatin治疗的反应降低，与GG基因型的患者相比。其他遗传和临床因素也可能影响对Epirubicin，氟尿嘧啶和奥沙利铂治疗的反应。肿瘤转移;胃肿瘤',\n",
       " 'Patients with the TT genotype and inflammatory bowel disease may have increased response to adalimumab compared to patients with the CC and CT genotypes. Other factors may affect response to adalimumab.; Inflammatory Bowel Diseases': '与CC和CT基因型的患者相比，TT基因型和炎性肠病患者可能对Adalimalab的反应增加。其他因素可能会影响对Adalimumab的反应;炎症性肠病疾病',\n",
       " 'Women with the CT genotype and hypertensive nephrosclerosis may have a poorer response to treatment with metoprolol as compared to patients with the CC genotype. No significant results were seen for men. Other genetic and clinical factors may also influence response to metoprolol.; hypertensive nephrosclerosis': '与患有CC基因型患者相比，具有CT基因型和高血压肾粥样硬化的妇女可能对用富含托洛尔治疗的较差。对于男性没有看到明显的结果。其他遗传和临床因素也可能影响对美托洛尔的反应。高血压肾粥样硬化',\n",
       " 'This genetic variation (IM) is more common in Western populations than the wild-type (*1/*1). This means that treatment is largely geared to patients with this genetic variation. Adjustment of the treatment is therefore not useful.': '这种遗传变异（IM）比西方种群比野生型（* 1 / * 1）更常见。这意味着治疗在很大程度上涉及具有这种遗传变异的患者。因此，调整治疗是无用的。',\n",
       " 'CYP2C9 *3 is associated with decreased dose of acenocoumarol as compared to CYP2C9 *1/*1.': '与CYP2C9 * 1 / * 1相比，CYP2C9 * 3与AceNocoumarol的减少有关。',\n",
       " 'Genotypes GT + TT are associated with increased concentrations of rosuvastatin as compared to genotype GG.': '与基因型GG相比，基因型GT + TT与罗斯汀的浓度增加相关。',\n",
       " 'Patients with the TT genotype who are also CYP2A6 normal metabolizers may have increased metabolism of nicotine as compared to patients with the CC genotype. Other genetic and clinical factors may also influence metabolism of nicotine.; ': '与CC基因型患者相比，患有CYP2A6的TT基因型的患者也可能增加尼古丁的代谢。其他遗传和临床因素也可能影响尼古丁的代谢。',\n",
       " 'Patients with the GG genotype and prostate cancer may have longer progression-free survival time when treated with docetaxel plus oral metronomic cyclophosphamide as compared to patients with the AA genotype. Other genetic and clinical factors may also influence progression-free survival time.; Prostatic Neoplasms': '与AA基因型的患者相比，患有GG基因型和前列腺癌的患者可能具有更长的无进展的存活时间。其他遗传和临床因素也可能影响无进展的存活时间。前列腺肿瘤',\n",
       " 'Patients with glioma and the CC genotype may have increased survival rates when treated with temozolomide as part of radiochemotherapy as compared to patients with the CT genotype. However, this association was not replicated in other cohorts. Other genetic and clinical factors may also affect response to temozolomide.; Glioma': '与CT基因型患者相比，胶质瘤和CC基因型的患者和CC基因型可能会增加存活率。但是，这种关联未在其他队列中复制。其他遗传和临床因素也可能影响对替替莫唑胺的反应。胶质瘤',\n",
       " 'Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.': '等位基因A与前列腺肿瘤的人与等位基因G.',\n",
       " \"Patients with the GG genotype who are treated with iloperidone may have increased risk for adverse cardiovascular events as compared to patients with the TT or GT genotype. Other genetic and clinical factors may also influence a patient's response.; Acquired Long QT Syndrome (aLQTS)\": '与Iloperidone治疗的GG基因型患者可能会增加不良心血管事件的风险，与TT或GT基因型患者相比。其他遗传和临床因素也可能影响患者的反应。获得长QT综合症（ALQTS）',\n",
       " 'Patients with genotype TT and hypertension may have a greater reduction in HDL-C when administered atenolol as compared to patients with genotype CC and CT. Other clinical and genetic factors may also influence changes in HDL-C upon administration of atenolol in patients with hypertension.; Hypertension': '与基因型CC和CT的患者相比，基因型TT和高血压患者的HDL-C可能更少降低HDL-C.其他临床和遗传因素也可能影响高血压患者阿替洛尔后的HDL-C的变化。高血压',\n",
       " 'Genotype CC is associated with higher mean baseline HCV RNA level and also steeper 1st phase HCV RNA decline in genotype 2 and 3 HCV (RVR).': '基因型CC与较高的平均基线HCV RNA水平相关，并且还在基因型2和3 HCV（RVR）中令人衰减的第1相HCV RNA下降。',\n",
       " 'Patients with the rs4917639 AA genotype may require increased dose of warfarin as compared to patients with the CC or CA genotype. Other clinical or genetic factors may also influence warfarin dose.; ': '与CC或CA基因型患者相比，RS4917639 AA基因型的患者可能需要增加的华法林剂量。其他临床或遗传因素也可能影响华法林剂量。',\n",
       " 'Patients with the CT genotype and asthma may have a poorer response when treated with flunisolide as compared to patients with the TT genotype. Other genetic and clinical factors may also influence response to flunisolide.; Asthma': '与TT基因型患者相比，患有CT基因型和哮喘的患者可能具有较差的反应。其他遗传和临床因素也可能影响对氟硼化硼的反应。哮喘',\n",
       " 'Patients with the AG genotype may have decreased metabolism of nicotine as compared to patients with the AA genotype. They also may have a longer time between waking in the morning and the first cigarette as compared to the AA genotype. Other genetic and clinical factors may also influence nicotine metabolism and smoking habits.; Tobacco Use Disorder': '与AA基因型的患者相比，患有AG基因型的患者可能降低了尼古丁的代谢。与AA基因型相比，他们也可能在早晨醒来和第一个香烟之间具有更长的时间。其他遗传和临床因素也可能影响尼古丁代谢和吸烟习惯。烟草使用障碍',\n",
       " 'Patients with the GG genotype may have decreased risk of emergency department visits when treated with Ace Inhibitors, Plain, Angiotensin II Antagonists, Beta Blocking Agents, digoxin, diuretics or spironolactone in people with Heart Failureas compared to patients with genotype TT or GT. Other genetic or clinical factors may also influence the outcome of heart failure patients.; Heart Failure': '与患有Genotyteas的患者的患者治疗，患有ACE抑制剂，平原，血管紧张素II拮抗剂，β受阻剂，Digoxin，利尿剂，利尿剂，利尿剂，Diurectics，与基因型TT或GT的患者相比，患者的患者可能降低了急诊部门的风险。其他遗传或临床因素也可能影响心力衰竭患者的结果。心脏衰竭',\n",
       " \"There is currently no available evidence regarding the association between the AG genotype and a patient's rick of developing psychosis following phenytoin and phenobarbital treatment.; Epilepsy;Psychotic Disorders\": '目前没有有关苯甲酸和苯巴比妥治疗后AG基因型与患者瑞士发育精神病患者之间的关联的可用证据。癫痫;精神病疾病',\n",
       " 'Described as CYP3A5*3 (6986G>A minus chromosomal strand), but 6986A>G on the CYP nomenclature website, therefore here C represents the *3 allele. Association found between increasing number of CYP3A5 *3, *6 and *7 alleles and tacrolimus trough concentrations adjusted for dose. Lower CYP3A5 activity reduces tacrolimus clearance, resulting in decreased dose requirement.': '描述为CYP3A5 * 3（6986g>减去染色体链），但CYP命名网站上的6986A> G，因此C代表* 3等位基因。在越来越多的CYP3A5 * 3，* 6和* 7等位基因和调节剂量的型号之间的关联。降低CYP3A5活性降低了巨石血清间隙，导致剂量需求降低。',\n",
       " 'Patients with the rs28358572 T allele (also known as the 1520T allele) may have a decreased, but not absent, risk of experiencing aminoglycoside-induced hearing loss as compared to patients with the C allele. MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of aminoglycoside-induced hearing loss.; Ototoxicity': '患有RS28358572 T等位基因（也称为1520t等位基因）可能有降低但不存在，与C等位基因患者相比，经历氨基糖苷诱导的听力损失的风险。MT-RNR1是线粒体基因，其作为单倍体（即只有一个等位基因存在）。其他遗传和临床因素也可能影响氨基糖苷诱导的听力损失的风险。ototoxicity.',\n",
       " 'as measured by dose adjusted plasma VPA. Note: the mean age differed between CC and CT patient groups but was not significant (0.066) No TT homozygotes were observed.': '通过剂量调节的等离子体VPA测量。注意：CC和CT患者组之间的平均年龄差异，但不显着（0.066），未观察到TT纯合子。',\n",
       " 'when co-treated with azacitadine.': '与氮酰硝基共同处理。',\n",
       " \"Patients with the AA genotype and prostate cancer who are treated with radiotherapy may have a reduced risk of late stage toxicity as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's risk of radiotherapy-induced toxicity.; Prostatic Neoplasms\": '与CC基因型患者相比，患有放射疗法治疗的AA基因型和前列腺癌的患者可能具有降低的晚期毒性风险。其他遗传和临床因素也可能影响患者放射疗法诱导毒性的风险。前列腺肿瘤',\n",
       " 'Patients with the CC genotype and HIV may have a reduced risk of developing noncirrhotic portal hypertension when treated with didanosine as compared to patients with the AA genotype. Other genetic and clinical factors may also influence risk of noncirrhotic portal hypertension.; HIV Infections': '与AA基因型患者相比，CC基因型和艾滋病毒患者可能导致非芽孢菌蛋白处理时发育非抑菌门静脉高血压的风险。其他遗传和临床因素也可能影响非抑菌门静脉高压的风险;艾滋病毒感染',\n",
       " \"Patients with the TC genotype may have decreased likelihood of Toxic liver disease when treated with isoniazid and rifampin in people with Tuberculosis as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's risk of toxicity to isoniazid and rifampin.; Toxic liver disease;Tuberculosis\": '与CC基因型患者相比，患有TC基因型的TC基因型可能降低了有毒肝脏疾病的可能性，当用CC基因型的患者相比，在患有结核病的人群中。其他遗传和临床因素也可能影响患者对异烟肼和利福平的毒性风险。有毒肝病;结核病',\n",
       " \"Human liver microsomes with the GG genotype may have increased activity of UGT1A proteins when exposed to acetaminophen as compared to human liver microsomes with the CC genotype. SNP was specified as being in the UGT1A-3'UTR. Other genetic and clinical factors may also influence activity of UGT1A proteins.; \": \"与具有CC基因型的人类肝微粒体相比，与GG基因型的人肝微粒体有uGT1a蛋白的活性增加。SNP被指定为在UGT1A-3'UTR中。其他遗传和临床因素也可能影响UGT1A蛋白的活性。\",\n",
       " \"Patients with the GG genotype may have decreased resistance to etoposide as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to etoposide.; \": '与AA基因型的患者相比，GG基因型的患者可能对依托泊苷的抗性降低。其他遗传和临床因素也可能影响患者对依托泊苷的反应。',\n",
       " 'Genotype AA is associated with increased concentrations of daptomycin as compared to genotypes AG + GG.': '与基因型Ag + Gg相比，基因型AA与达达霉素的浓度增加有关。',\n",
       " \"Patients with the CC genotype and asthma who are treated with montelukast may have a decreased, but not absent, risk of asthma exacerbations as compared to patients with the AA genotype. However, this difference was not statistically significant. This may be related to the relatively low frequency of CC homozygotes (11%) in the study. Other genetic and clinical factors may also influence a patient's risk of asthma exacerbations with montelukast treatment.; Asthma\": '与蒙特洛斯特治疗的CC基因型和哮喘患者可能有降低但不存在，与AA基因型患者相比，哮喘恶化的风险。然而，这种差异没有统计学意义。这可能与该研究中的CC纯合蛋白（11％）的相对低频率有关。其他遗传和临床因素也可能影响患者与蒙特洛斯特治疗的哮喘恶化的风险。哮喘',\n",
       " \"Patients with the GG genotype may have a decreased but not absent risk of ADR when treated with CAF (cyclophosphamide, doxorubicin and fluorouracil) as compared to patients with the GT or TT genotype. Other genetic and clinical factors may also influence a patient's risk for ADRs.; Breast Neoplasms;Neoplasms\": '与患有GT或TT基因型的患者相比，GG基因型的患者可能具有减少但在用CAF（环膦酰胺，多柔比蛋白和氟尿嘧啶）的患者用CAF（环磷酰胺，多柔霉素和氟尿嘧啶）的风险。其他遗传和临床因素也可能影响患者对ADR的风险。乳房肿瘤;肿瘤',\n",
       " 'Patients with the TT genotype carriers may have increased tenofovir renal clearance, and lower AUC as compared to patients with CC or CT genotype. Contradictory evidence has been reported for this association. This annotation only covers the pharmacokinetic relationship between rs1751034 and tenofovir and does not include evidence about clinical outcomes.; HIV Infections': '与患有CC或CT基因型的患者相比，TT基因型载体的患者可能增加了胞多夫罗疹肾间隙，以及较低的AUC。本协会报告了矛盾的证据。该注释仅涵盖RS1751034和替诺福韦之间的药代动力学关系，不包括有关临床结果的证据。艾滋病毒感染',\n",
       " 'Patients with the GG genotype (Gly49/Gly49) were not reported in the studies of metoprolol efficacy.; Hypertension': '患有GG基因型（GLY49 / GLY49）的患者未报告美容抑制效果的研究。高血压',\n",
       " 'Patients with lupus and the CC genotype may have decreased metabolism of cyclophosphamide resulting in decreased concentrations of active cyclophosphamide metabolite as compared to patients with the CT or TT genotypes. Other clinical and genetic factors may also influence metabolism of cyclophosphamide in patients with lupus.; Lupus erythematosus': '狼疮和CC基因型的患者可能降低环磷酰胺的代谢，导致与CT或TT基因型的患者相比，活性环磷酰胺代谢物的浓度降低。其他临床和遗传因素也可能影响狼疮患者的环磷酰胺的代谢。红斑狼疮',\n",
       " 'This gene variation can result in lower pimozide concentrations. However, there is no evidence of reduced effectiveness.': '该基因变异可导致较低的偏充浓度。但是，没有证据证明有效性降低。',\n",
       " 'Genotype GG is associated with increased response to atenolol in people with Hypertrophy, Left Ventricular as compared to genotypes AA + AG.': '基因型GG与患有肥大，左心室的患者的响应增加，与基因型AA + AG相比。',\n",
       " 'Genotype TT is associated with decreased dose of phenprocoumon as compared to genotypes CC + CT.': '与基因型CC + CT相比，基因型TT与苯处理剂量降低有关。',\n",
       " 'Genotype CC is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CT + TT.': '基因型CC与对儿童的乳酸响应增加，与基因型CT + TT相比具有多动的儿童。',\n",
       " \"Patients with the del/del genotype and Parkinson Disease who are treated with levodopa may have decreased response to levodopa as compared to patients with the CACATACCATGCAACATACACACTCAGACA/CACATACCATGCAACATACACACTCAGACA genotype. Other genetic and clinical factors may also influence a patient's response to levodopa.; Parkinson Disease\": '与左旋多泮治疗的Del / Del基因型和帕金森病的患者可能会降低对左旋多巴的响应，而与Cacatackatgcaacatacacacactcagaca / Cacatackatgcaacatacacactcaca基因型患者相比。其他遗传和临床因素也可能影响患者对左旋多巴的反应。帕金森综合症',\n",
       " \"Patients with the AG genotype may have increased reduction in total cholesterol or LDL cholesterol levels when treated with simvastatin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to simvastatin.; Chronic Disease\": '与GG基因型的患者相比，患有Ag基因型的患者可以增加总胆固醇或LDL胆固醇水平的总胆固醇或LDL胆固醇水平。其他遗传和临床因素也可能影响患者对辛伐他汀的反应。慢性病',\n",
       " 'Genotype AG is associated with increased response to antidepressants in people with Mental Disorders.': '基因型AG与精神障碍人士对抗抑郁药的反应增加有关。',\n",
       " 'Patients with the TT genotype may have an increased rate of sulfation of O-desmethyl-tramadol, a metabolite of tramadol, as compared to patients with the CC or CT genotypes. Other genetic and clinical factors may also affect O-desmethyl-tramadol sulfation in patients.; ': '与CC或CT基因型的患者相比，TT基因型的患者可具有较高的O-去甲基 - 曲马多的硫化酸型酸型 - 曲马多，曲马多的代谢素。其他遗传和临床因素也可能影响患者的O-去甲基 - 曲马多硫酸盐。',\n",
       " \"Patients with the AA genotype and major depressive disorder who are treated with escitalopram may 1) have increased metabolism of escitalopram at week 2 of treatment 2) experience more severe side effects as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's metabolism of escitalopram and severity of drug-induced side effects.; Depressive Disorder, Major\": '患有AA基因型和主要抑郁症的患者，培养综合素治疗5月1日）在治疗中的第2周的第2周具有培养的亚太科申申申请的代谢增加，与患有GG基因型的患者相比，体验更严重的副作用。其他遗传和临床因素也可能影响患者的患者的亚太经产申请和药物诱导的副作用的严重性。抑郁症，主要',\n",
       " 'Alleles given as A and G. Based on inflammatory bowel disease questionnaire at week 20. Also looked at 4, 12, and 30 weeks after initiation of treatment. Response defined as increased in IBDQ of more than 22 points, or as IBDQ higher than 170 points.': '作为A和G的等位基因在第20周的基础上基于炎性肠病调查问卷。在开始治疗后，也看了4,12和30周。IBDQ的响应在22分以上超过22分，或IBDQ高于170点。',\n",
       " \"Patients with the CC genotype may have increased risk of side effects to amodiaquine as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for side effects.; \": '与TT基因型的患者相比，CC基因型的患者可能对副作用的风险增加。其他遗传和临床因素也可能影响患者对副作用的风险。',\n",
       " \"Patients with the GA genotype and schizophrenia who are treated with olanzapine may have an increased risk of weight gain as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's risk for weight gain with olanzapine treatment.; Schizophrenia;Weight gain\": '与奥拉扎齐齐普治疗的GA基因型和精神分裂症的患者可能具有增加的体重增加风险，与GG基因型患者相比。其他遗传和临床因素也可能影响患者的体重增加风险与奥氮平治疗;精神分裂症;体重增加',\n",
       " \"The CYP2D6*1xN alleles (*1x2 and *1x≥3) are assigned as increased function alleles by CPIC> Patients carrying a *1xN allele in combination with a normal or increased function allele or a decreased function allele with an activity value of 0.5 may have increased metabolism of paroxetine as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying a *1xN allele with an activity value of 3 or greater in combination with a decreased function allele with an activity value of 0.25 or a no function allele may also have increased metabolism of paroxetine as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying a *1xN allele with an activity value of 2 in combination with a decreased function allele with an activity value of 0.25 or a no function allele may have similar metabolism of paroxetine as compared to patients with other alleles that result in a normal metabolizer phenotype. Be aware that the DPWG guideline for paroxetine and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. This annotation only covers the pharmacokinetic relationship between CYP2D6 and paroxetine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence paroxetine metabolism.; \": 'CYP2D6 * 1xN等位基因（* 1x2和*1x≥3）被指定为CPIC>携带* 1xN等位基因的患者的函数等位基因，与正常或增加的功能等位基因或减少的函数等位基因组合，活动值为0.5与具有正常代谢物表型的等位基因患者相比，帕罗西汀的代谢增加了。患者与活性值为3或更大的活性值的患者与活性值为0.25或NO功能等位基因的相结合，也可能增加帕罗西汀的代谢，与导致正常的等位基因相比代谢物表型，而携带* 1xN等位基因的患者与活性值2的活性等位基因与活性值为0.25或NO功能等位基因的相结合，而与导致其他等位基因的患者相比，帕罗西汀的相似性代谢可能是相似的正常的代谢物表型。请注意，Paroxetine和Cyp2D6的DPWG指南为CYP2D6中级和代购机差具有“不建议”。该注释仅涵盖CYP2D6和帕罗西汀之间的药代动力学关系，并不包括关于临床结果的证据。其他遗传和临床因素也可能影响帕罗西汀代谢。',\n",
       " \"Patients with the AG genotype may have an increased risk of developing cocaine dependence as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's risk of developing cocaine dependence.; Cocaine-Related Disorders\": '与AA基因型患者相比，患有AG基因型的患者可能产生增加的可卡因依赖性的风险。其他遗传和临床因素也可能影响患者开发可卡因依赖的风险。可卡因相关疾病',\n",
       " \"Male patients with the Mediterranean haplotype (hemizygous for the Mediterranean variant, associated with G6PD deficiency) who are treated with phenazopyridine may have an increased risk of hemolytic anemia as compared to patients with the wildtype B haplotype (not associated with G6PD deficiency). Please note: all studies reported an association with G6PD deficiency but did not genotype or characterize the G6PD variant, here we are representing this association under the Mediterranean variant which is associated with G6PD deficiency, with the B (wildtype) haplotype representing G6PD non-deficient. Other genetic and clinical factors may also influence a patient's risk of drug-induced hemolysis.; Anemia, Hemolytic;Hemolysis\": '与野生型B单倍型（与G6PD缺乏无关的患者相比，用苯吡啶治疗的地中海单倍型（与G6PD缺乏有关的地中海变异有关的地中海变异的血栓缺乏）可能具有增加的溶血性贫血风险。请注意：所有研究均报告与G6PD缺乏的关联，但没有基因型或表征G6PD变体，在这里我们代表了与G6PD缺乏相关的地中海变体，其中B（野生型）单倍型表示G6PD非缺陷。其他遗传和临床因素也可能影响患者的药物诱导溶血的风险。贫血，溶血;溶血',\n",
       " 'Genotype del/del is associated with increased response to ivacaftor / lumacaftor in people with Cystic Fibrosis as compared to genotypes CTT/CTT + CTT/del.': '与基因型CTT / CTT + CTT / DEL相比，基因型Del / Del与囊性纤维化的人们对患有囊性纤维化的人的响应增加相关。',\n",
       " 'Patients with the rs6295 CG genotype may have decreased response when treated with paroxetine as compared to patients with the GG genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to paroxetine.; Panic Disorder': '与GG基因型患者相比，患有RS6295 CG基因型的患者可能会降低伴有帕罗西汀。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对帕罗西汀的反应。恐慌症',\n",
       " 'Patients with the AG genotype may have decreased metabolism of phenylalanine as compared to patients with the GG genotype. Other genetic and clinical factors may also affect metabolism of phenylalanine.; ': '与GG基因型患者相比，患有Ag基因型的患者可能降低了苯丙氨酸的代谢。其他遗传和临床因素也可能影响苯丙氨酸的代谢。',\n",
       " 'No patients with the AA genotype were available for analysis. However, patients with the AG genotype and beta-thalassemia may have increased concentrations of deferasirox as compared to patients with the GG genotype. Other genetic and clinical factors may also influence concentrations of deferasirox.; beta-Thalassemia': '没有AA基因型的患者可用于分析。然而，与GG基因型的患者相比，患有Ag基因型和β-地中海贫血症的患者可能增加了脱硫血管毒剂的浓度。其他遗传和临床因素也可能影响脱硫血管的浓度。Beta-thalassemia',\n",
       " 'Patients with the rs193922832 GG genotype may have a decreased, but not absent, risk for malignant hyperthermia based on this variant when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with AA or AG genotype. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.; Malignant Hyperthermia': '患有193922832GGG基因型的患者可能有所下降，但不是缺席，在用挥发性麻醉剂（DESFOLURANE，ENFLURANE，氟烷，异氟烷，与患者相比用挥发性麻醉剂（DESFLURANE，ENFLUNANE，氟烷，异氟醚）和/或甲氧基氟醚，甲氧基氟醚，七氟醚）和/或琥珀酰胆碱相比AA或AG基因型。其他遗传或临床因素也可能影响恶性热疗的风险。恶性热疗',\n",
       " \"Patients with the GG genotype may be at an increased risk of developing alcoholism as compared to patients with the AA genotype. Other genetic or clinical factors may also affect a patient's risk of developing alcoholism.; Alcoholism\": '与AA基因型的患者相比，GG基因型的患者可能是发育酗酒的风险增加。其他遗传或临床因素也可能影响患者发育酗酒的风险。酗酒',\n",
       " 'Significant only when also combined with the HLA-DRB1*15 allele, rs1800469 allele A and rs333 del allele. Risk of not responding to the drug was significantly increased in individuals carrying this allele combination.': '只有当也与HLA-DRB1 * 15等位基因相结合时，才能获得1800469等位基因A和RS333 Del等位基因。在携带这种等位基因组合的个体中，不响应药物的风险显着增加。',\n",
       " \"Patients carrying one copy of the 10-repeat allele and one copy of the 9-repeat allele may report more severe negative effects of alcohol as compared to patients carrying two copies of the 10-repeat allele. However, this association was only observed using certain scoring systems. Other genetic or clinical factors may also affect a patient's response to alcohol.; \": '携带10份重复等位基因的一份拷贝的患者和9重复等位基因的一份拷贝可能会报告患有10-重复等位基因的两份拷贝的患者的患者更严重的醇负影响。然而，仅使用某些评分系统观察到这种关联。其他遗传或临床因素也可能影响患者对酒精的反应。',\n",
       " \"Cancer patients with the AG genotype who are treated with doxorubicin or idarubicin may have a decreased, but not absent, risk for cardiotoxicity as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk for cardiotoxicity.; Neoplasms\": '与AA基因型的患者相比，癌症患者患有多柔比蛋白或含紫芽蛋白治疗的AG基因型可能具有减少，但不存在的风险，毒性不足。其他遗传和临床因素也可能影响患者心脏毒性的风险。肿瘤',\n",
       " 'Patients with the CC genotype and hypertension may have a lesser reduction in pulse wave velocity when treated with nitrendipine as compared to patients with the AA genotype. Other genetic and clinical factors may also influence pulse wave velocity.; Hypertension': '与AA基因型的患者相比，患有CC基因型和高血压的患者可能具有较小的脉搏波速度的降低。其他遗传和临床因素也可能影响脉搏波速度。高血压',\n",
       " 'Patients with the CT or TT genotype (CYP3A5 *1/*3 or *1/*1, or \"expressers\") had increased dose requirements of tacrolimus at 6, 9 and 12 months after transplantation, as compared to those with the CC genotype (*3/*3, or \"nonexpressers\").': '与CC基因型的那些相比，CT或TT基因型（CYP3A5 * 1 / * 3或* 1/1 / * 1或“患者”）的剂量要求增加了他克莫血清的躯干血症剂量的剂量要求（* 3 / * 3，或“非简单投票”）。',\n",
       " 'Genotypes AG + GG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype AA.': '与基因型AA相比，Genotypes Ag + Gg与牛皮癣的人们对Ustekinumab的反应增加有关。',\n",
       " 'Patients with the AA genotype may require increased dose of warfarin as compared to patients with the GG or AG genotype. Other clinical or genetic factors may also influence warfarin dose; ': '与GG或AG基因型的患者相比，患有AA基因型的患者可能需要增加的Warfarin剂量。其他临床或遗传因素也可能影响华法林剂量;',\n",
       " \"Patients with the AG genotype may have an increased risk of developing opioid dependence as compared to patients with the AA genotype. However, another study failed to find an association. Other genetic and clinical factors may also affect a patient's risk of developing opioid dependence.; Opioid-Related Disorders\": '与AA基因型患者相比，患有AG基因型的患者可能具有增加的患者依赖性的风险。但是，另一项研究未能找到一个关联。其他遗传和临床因素也可能影响患者发展阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'Genotypes CC + TT are associated with increased response to ramipril in people with Hypertension as compared to genotype CT.': '与基因型CT相比，基因型CC + TT与高血压的人们对ramipRil的反应增加相关。',\n",
       " \"Patients with the GG genotype who are treated with simvastatin may have a reduced response to treatment (measured by a lower reduction in total cholesterol) compared to patients with the AA genotype. In another study no association was seen. Other genetic and clinical factors may also influence a patient's response to simvastatin treatment.; \": '与AA基因型的患者相比，用辛伐他汀治疗的GG基因型的患者可减少对治疗的治疗（通过总胆固醇的降低测量）。在另一项研究中，没有看到关联。其他遗传和临床因素也可能影响患者对辛伐他汀治疗的反应。',\n",
       " \"Patients with the GA genotype who undergo elective surgery with nitrous oxide anesthesia may have higher plasma total homocysteine concentrations as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's homocysteine levels after nitrous oxide anesthesia.; \": '与氧化亚氮麻醉接受选修手术的GA基因型患者可能具有更高的血浆总同型浓度，与GG基因型患者相比。其他遗传和临床因素也可能在氧化亚氮麻醉后影响患者的同型半胱氨酸水平。',\n",
       " \"The CYP2D6*6 allele has been assigned as a no function allele by CPIC. Patients carrying the *6 allele in combination with another no function allele, a decreased function allele or a normal function allele may have decreased metabolism of tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *6 allele in combination with an increased function allele with an activity value of 2 may have similar metabolism of tropisetron as compared to patients with other alleles that result in a normal metabolizer phenotype. Patients carrying the *6 allele in combination with an increased function allele with an activity score of 3 or greater may have increased metabolism of tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype. Be aware that the CPIC guideline for tropisetron and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. This annotation only covers the pharmacokinetic relationship between CYP2D6 and tropisetron and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence tropisetron metabolism.; \": 'CYP2D6 * 6等位基因已被CPIC分配为无功能等位基因。患者与另外的功能等位基因组合携带* 6等位基因，函数等位基因减少或正常功能等位基因可能降低了对象菌素的代谢，与患有正常代谢物表型的等位基因的患者相比，患者携带* 6等位基因的患者与患者相比，与活性值为2的函数等位基因的增加的功能等位基因相比，与具有正常代谢物表型的其他等位基因的患者相比，Tropisetron的类似代谢。患者携带* 6等位基因与活性评分的增加的函数等位基因组合，与具有导致正常代谢物表型的等位基因的患者相比，对象棘轮的代谢可能增加了对象菌素的代谢。请注意，Cyp2D6中级和代购不良的CPIC指南为Tropisetron和Cyp2D6为“没有建议”。该注释仅涵盖CYP2D6和Tropisetron之间的药代动力学关系，并且不包括关于临床结果的证据。其他遗传和临床因素也可能影响对象区代谢。',\n",
       " 'Patients with the TT genotype may have a decreased rate of sulfation of acetaminophen as compared to patients with the GG genotype. Other genetic and clinical factors may also affect acetaminophen sulfation in patients.; ': '与GG基因型的患者相比，TT基因型的患者可能具有降低的乙酰氨基酚硫化率。其他遗传和临床因素也可能影响患者的乙酰氨基酚硫化。',\n",
       " 'Patients with the CT genotype may have decreased sulfation of acetaminophen as compared to patients with the CC genotype. Other genetic and clinical factors may also affect acetaminphen sulfation.; ': '与CC基因型患者相比，CT基因型的患者可能降低乙酰氨基酚硫酸盐。其他遗传和临床因素也可能影响乙酰胍硫化。',\n",
       " 'CYP3A5*3/*3 genotype was a significant risk factor for a progressively smaller tacrolimus dosing requirement when compared with the *1/*3 genotype after adjusting for ABCB1 polymorphsms C3435T and C1236T. Other risk factors for requiring small tacrolimus doses are: male sex; age>60 years; BMI>25; hepatitis C virus positive and lose steroid dose.': 'CYP3A5 * 3 / * 3基因型是在调整ABCB1多肽C3435T和C1236T和C1236T的ABCB1多晶晶晶晶型后，与* 1 / * 3基因型相比是一种显着的危险因素。需要小巨饰剂剂量的其他风险因素是：男性;年龄> 60岁;BMI> 25;丙型肝炎病毒阳性和丢失类固醇剂量。',\n",
       " 'in patients after aortic valve replacement within the 3 months of follow up.': '在主动脉瓣在3个月内更换后的患者。',\n",
       " 'as measured by monomethylarsonous acid in urine.': '通过尿液中单甲基胂酸来测量。',\n",
       " 'Patients with the CT genotype and colon cancer may have a longer time to tumor recurrence when treated with fluorouracil-based chemotherapy as compared to patients with the TT genotype. Other genetic and clinical factors may also influence response to fluorouracil.; Colonic Neoplasms': '与TT基因型患者相比，患有CT基因型和结肠癌的CT基因型和结肠癌的患者可能具有较长的肿瘤复发时间。其他遗传和临床因素也可能影响对氟尿嘧啶的反应。结肠瘤',\n",
       " \"Patients with the GG genotype may have decreased response to clopidogrel ( increased platelet activation to ADP) as compared to patients with the AA genotype. However, the majority of the literature suggests this variant is not significantly associated with response to clopidogrel. Other genetic and clinical factors may influence a patient's response to clopidogrel.; Acute coronary syndrome;Angina Pectoris\": '与AA基因型的患者相比，GG基因型的患者可能降低对氯吡格雷（增加血小板活化至ADP）的响应。然而，大多数文献表明这种变体与对氯吡格雷的反应没有显着相关。其他遗传和临床因素可能影响患者对氯吡格雷的反应。急性冠状动脉综合征;心绞痛',\n",
       " \"Patients with the CC genotype and epilepsy who are treated with valproic acid may have increased bone density as compared to patients with the AA + AC genotype. Other genetic and clinical factors may also influence a patient's response to treatment and bone density.; Epilepsy\": '与AA + AC基因型患者相比，患有丙戊酸治疗的CC基因型和癫痫的患者可能会增加骨密度。其他遗传和临床因素也可能影响患者对治疗和骨密度的反应。癫痫',\n",
       " 'Patients with one or two copies of the HLA-B*59:01:01:01 allele may have an increased risk of severe cutaneous adverse reactions, such as Stevens-Johnson Syndrome and toxic epidermal necrolysis, when treated with methazolamide as compared to patients with no HLA-B*59:01:01:01 alleles or negative for the HLA-B*59:01:01:01 test. Other genetic and clinical factors may also influence risk of methazolamide-induced adverse reactions.; Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome': 'HLA-B * 59：01：01：01等位基因患者的一个或两个拷贝可能具有增加的严重皮肤不良反应的风险，例如史蒂文斯-Johnson综合征和有毒表皮坏死，当与患者相比治疗没有HLA-B * 59：01：01：01：01 HLA-B * 59：01：01：01试验的等位基因或负片。其他遗传和临床因素也可能影响体育酰胺诱导的不良反应的风险。表皮坏死，有毒;史蒂文斯 - 约翰逊综合征',\n",
       " 'Patients with the rs2032582 CC genotype may have decreased dose requirements of sufentanil as compared to patients with the AA or AC genotypes. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect dose requirements of sufentanil.; Pain, Postoperative': '与AA或AC基因型患者相比，患有RS2032582 CC基因型的患者可能降低了Sufentanil的剂量要求。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响Sufentanil的剂量要求。痛苦，术后',\n",
       " 'Patients with the rs3745274 GT genotype and HIV infection may have increased plasma concentrations and decreased clearance of efavirenz as compared to patients with the GG genotype. Other genetic and clinical factors may also influence the metabolism of efavirenz. This annotation only covers the pharmacokinetic relationship between rs3745274 and efavirenz and does not include evidence about clinical outcomes.; HIV Infections': '与GG基因型的患者相比，RS3745274 GT基因型和HIV感染的患者可能具有增加的血浆浓度和efavirenz的清除程度。其他遗传和临床因素也可能影响efaviraenz的代谢。该注释仅涵盖RS3745274和EFAVIRENZ之间的药代动力学关系，并不包括有关临床结果的证据。艾滋病毒感染',\n",
       " \"Nicotine metabolism was assessed by measuring participants' nicotine metabolite ratio.\": '通过测量参与者的尼古丁代谢物比来评估尼古丁代谢。',\n",
       " \"Female patients homozygous for the Mediterranean variant (associated with G6PD deficiency) who are treated with ciprofloxacin may have an increased risk of hemolytic anemia as compared to patients with the wildtype B/B diplotype (not associated with G6PD deficiency). Please note: this study did not report genotyping, but reported the patient to have Mediterranean G6PD deficiency, therefore here we are representing this association under the Mediterranean variant. Other genetic and clinical factors may also influence a patient's risk of drug-induced hemolysis.; Anemia, Hemolytic\": '与用环丙沙星治疗的地中海变体（与G6PD缺乏有关）纯合的女性患者可能导致溶血性贫血的风险增加，与野生型B / B二曲面（与G6PD缺乏无关）相比。请注意：本研究没有报告基因分型，但报告患者有地中海G6PD缺乏，因此我们在这里代表了地中海变体下的这种关联。其他遗传和临床因素也可能影响患者的药物诱导溶血的风险。贫血，溶血',\n",
       " 'Patients with the AA genotype may have increased severity of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to patients with genotype GG. Other genetic and clinical factors may also influence the risk of toxicity to irinotecan.; ': '当与基因型GG患者相比，当用结肠直肠肿瘤的人们用伊立替康治疗时，患有AA基因型的严重程度增加。其他遗传和临床因素也可能影响毒素的毒性风险。',\n",
       " 'While the GG genotype is associated with reduced plasma concentrations of repaglinide, no results are shown for the GA genotype.; ': '虽然GG基因型与降低血浆浓度的批量间相关，但是没有显示GA基因型的结果。',\n",
       " 'The CYP2B6*1 allele is assigned as a normal function allele by CPIC. Patients carrying CYP2B6*1 allele in combination with another normal function allele may require increased dose of efavirenz as compared to patients with a no or decreased function allele in combination with a normal or increased function allele or with two no or decreased function alleles. Other genetic and clinical factors may also influence the dose of efavirenz.; HIV Infections': 'CYP2B6 * 1等位基因由CPIC分配为正常功能等位基因。携带CYP2B6 * 1等位基因与另一个正常功能等位基因组合的患者可能需要增加的efavirenz剂量，而与NO或降低的函数等位基因与正常或增加的功能等位基因组合或具有两个没有或减少的功能等位基因。其他遗传和临床因素也可能影响efaviraz的剂量。艾滋病毒感染',\n",
       " 'Patients with the AG genotype may have decreased sulfation of O-desmethylnaproxen as compared to patients with the GG genotype. Other genetic and clinical factors may also affect O-desmethylnaproxen sulfation.; ': '与GG基因型的患者相比，患有AG基因型的患者可能降低O-去甲基己酮的硫酸盐。其他遗传和临床因素也可能影响O-去甲基己酮硫酸盐。',\n",
       " 'Genotype CT is associated with increased response to atorvastatin as compared to genotype CC.': '与基因型CC相比，基因型CT与对阿托伐他汀的反应增加。',\n",
       " 'CYP3A4 *1/*22 is associated with decreased clearance of tacrolimus in people with Kidney Transplantation as compared to CYP3A4 *1/*1.': '与CYP3A4 * 1 / * 1相比，CYP3A4 * 1 / * 22与肾移植的人中的曲调血清的间隙降低有关。',\n",
       " \"People with CT genotype may have decreased clearance of quetiapine compared with people with genotype TT. Other genetic and clinical factors may affect a person's clearance of quetiapine.; \": '与基因型TT的人相比，CT基因型的人可能会降低喹硫氨酸的清除。其他遗传和临床因素可能会影响一个人的喹硫氨酸的清除。',\n",
       " \"Patients with the TT genotype and osteosarcoma may have an increased response to cisplatin as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to cisplatin.; Osteosarcoma\": '与CC基因型的患者相比，TT基因型和骨肉瘤的患者可能对顺铂的反应增加。其他遗传和临床因素也可能影响患者对顺铂的反应。骨肉瘤',\n",
       " 'Patients with the *1/*1 genotype may have decreased clearance of fesoterodine as compared to patients carrying at least one copy of the *3, *20 or *22 alleles. This annotation only covers the pharmacokinetic relationship between CYP3A4 genotypes and fesoterodine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also affect clearance of fesoterodine.; ': '与载有* 3，* 20或* 22等位基因的至少一种拷贝的患者相比，患有* 1 / * 1个基因型的患者可能降低了Fesoterodine的清除。该注释仅涵盖CYP3A4基因型和Fesoterodine之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响Fesoterodine的间隙。',\n",
       " 'CYP2C19 *2 is associated with increased response to tamoxifen in women with Breast Neoplasms as compared to CYP2C19 *1.': '与CYP2C19 * 1相比，CYP2C19 * 2与乳腺肿瘤的女性中的妇女的响应增加有关。',\n",
       " 'The A allele was associated with an improved systolic blood pressure response. This variant met the suggestive level of significance in the discovery meta-analysis and was successfully replicated. However, it did not reach genome-wide significance in a meta-analysis of the discovery and replication data.': '等位基因与改善的收缩压反应相关。这种变体在发现元分析中达到了暗示性的重要性，并成功复制。然而，它没有在发现和复制数据的META分析中达到基因组显着性。',\n",
       " 'Patients with the AG genotype and schizophrenia may have faster improvement in Brief Psychiatric Rating Scale (BPRS) scores when treated with aripiprazole as compared to patients with the GG genotype. Other genetic and clinical factors may also influence improvement in BPRS scores.; Schizophrenia': '与GG基因型患者相比，患有AG基因型和精神分裂症的患者可能对短暂的精神额定尺度（BPRS）分数较快改善。其他遗传和临床因素也可能影响BPRS分数的改善。精神分裂症',\n",
       " 'The CYP2C19*1 allele is assigned as a normal function allele by CPIC. Patients carrying the CYP2C19*1 allele in combination with another normal function allele may have increased metabolism of escitalopram as compared to patients with a no or decreased function allele in combination with a normal or increased function allele or with two no or decreased function alleles. Patients carrying the CYP2C19*1 allele in combination with another normal function allele may have decreased metabolism of escitalopram as compared to patients with a normal function allele in combination with an increased function allele or two increased function alleles. This annotation only covers the pharmacokinetic relationship between CYP2C19 and escitalopram and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of escitalopram.; Depressive Disorder, Major;Mental Disorders': 'CYP2C19 * 1等位基因由CPIC分配为正常功能等位基因。携带CYP2C19 * 1等位基因与另一个正常功能等位基因相结合的患者可能增加了亚太经产素的代谢，而患有NO或降低的功能等位基因与正常或增加的功能等位基因或两种没有或减少的功能等位基因组合。携带CYP2C19 * 1等位基因与另一个正常功能等位基因组合的患者可能降低了亚太经产素的代谢，与常规功能等位基因的患者相结合，与增加的功能等位基因或两种增加的功能等位基因组合。该注释仅涵盖CYP2C19和ESCITALOPRAM之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响亚太科申请的代谢。抑郁症，主要;精神障碍',\n",
       " \"Patients with hypertension and the GG genotype may have an increased response to hydrochlorothiazide, as measured by a decrease in systolic blood pressure, as compared to patients with the AA or AG genotypes. Other genetic and clinical factors may also affect a patient's response to hydrochlorothiazide.; Hypertension\": '高血压和GG基因型的患者可能对氢氯噻嗪的反应增加，与AA或AG基因型的患者相比，通过减少收缩压测量。其他遗传和临床因素也可能影响患者对氢氯噻嗪的反应。高血压',\n",
       " \"Patients with the *1/*15 diplotype may be at an increased risk of developing rifampin-induced liver injury as compared to patients who do not carry the *15 allele. Other genetic or clinical factors may also affect a patient's risk of develop rifampin-induced liver injury.; drug-induced liver injury\": '* 1 / * 15型二曲面的患者可能导致利福平诱导的肝损伤的风险增加，而与不携带* 15等位基因的患者相比。其他遗传或临床因素也可能影响患者开发利福平诱导的肝损伤的风险。药物诱导的肝损伤',\n",
       " \"Patients with the GG genotype and hypertension who are treated with verapamil may have increased risk for primary outcome as defined by first occurrence of all-cause death, nonfatal myocardial infarction, or nonfatal stroke as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to verapamil.; Hypertension\": '与AA基因型的患者相比，患有维拉帕米治疗的GG基因型和高血压的患者可能对主要发生死亡，非原因死亡，非缺乏心肌梗塞或非累乱行程的患者产生了增加的初级结果。其他遗传和临床因素也可能影响患者对维拉帕米的反应。高血压',\n",
       " 'Patients with the rs10494366 GT genotype and type 2 diabetes may have an increased risk of hypoglycemia when treated with glibenclamide as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk of hypoglycemia when treated with glibenclamide.; Diabetes Mellitus, Type 2;Hypoglycemia': '与GG基因型的患者相比，患者有10494366 GT基因型和2型糖尿病的风险增加了低血糖当用Glibenclamide处理时的风险。其他遗传和临床因素也可能在用Glibenclamide处理时影响低血糖的风险。糖尿病，2型;低血糖',\n",
       " 'Pediatric patients with the rs4149056 CC genotype and cancers may have decreased clearance of methotrexate as compared to patients with the TT genotype. However, conflicting evidence has been reported. This annotation only covers the pharmacokinetic relationship between rs4149056 and methotrexate and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence clearance of methotrexate.; Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与TT基因型的患者相比，儿科患者可能会降低甲氨蝶呤的清除。但是，已经报告了相互矛盾的证据。该注释仅涵盖RS4149056和甲氨蝶呤之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响甲氨蝶呤的许可。骨肉瘤;前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'CYP2D6 *1/*1 is associated with increased inhibition of CYP2D6 when exposed to berberine and coptisine and decreased exposure to dextromethorphan as compared to the *1/*10 or *10/*10 genotypes. Other clinical and genetic factors may also influence inhibition of CYP2D6 and exposure to dextromethorphan.; ': 'CYP2D6 * 1 / * 1与CYP2D6的抑制增加，当暴露于小檗碱和豆荚时，与* 1 / * 10或* 10 / * 10个基因型相比，在甲状腺细胞和豆荚下降并降低到右旋甲酰基。其他临床和遗传因素还可能影响CYP2D6的抑制和暴露于右旋沙仑。',\n",
       " 'Patients with the CC genotype and psoriatic arthritis may have a decreased response after 3 months of treatment with adalimumab, etanercept or infliximab as compared to patients with the TT genotype. No significant associations were seen after 6 months of treatment. Other genetic and clinical factors may also influence response to adalimumab, etanercept or infliximab.; Arthritis, Psoriatic': '与TT基因型患者相比，CC基因型和银屑病关节炎的患者可能在3个月治疗3个月后的响应减少。在治疗6个月后，没有显着的关联。其他遗传和临床因素也可能影响对AdAlimalab，依那西普或英夫利昔单抗的反应。关节炎，银屑病',\n",
       " \"Patients with the AG genotype and psychiatric disorders who are treated with olanzapine may have a decreased, but not absent, risk for more side effects as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk for side effects with olanzapine treatment.; \": '与奥氮藻治疗的AG基因型和精神病疾病的患者可能有降低，但不存在，与AA基因型患者相比，对更副作用的风险。其他遗传和临床因素也可能影响患者对奥氮平治疗的副作用的风险。',\n",
       " 'Genotype CC is associated with increased concentrations of deferasirox in people with beta-Thalassemia as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与β-地中海贫血的人的浓度增加有关。',\n",
       " 'Additive model. Those with the C allele were less likely to respond to treatment with metformin compared to AA homozygotes. Responders defined as those in whom there was a decrease in glycated hemoglobin (HbA1c) fall by >=0.5% and non-responders as those in whom fasting glucose >180mg% and HbA1c fall by <1% at the end of 12 weeks of treatment.': '添加剂模型。与AA homozygotes相比，那些具有C等位基因的可能性响应于二甲双胍的治疗。响应者定义为糖化血红蛋白（HBA1c）减少的响应者= 0.5％和非响应者，因为在12周的治疗结束时禁食葡萄糖> 180mg％和HBA1c的损失<1％。',\n",
       " 'Patients with CC genotype and breast cancer may have a decreased risk of neutropenia when treated with cyclophosphamide, doxorubicin and fluorouracil (FAC) as compared to patients with the AA genotype. Other genetic and clinical factors may also affect the risk for neutropenia in patients taking FAC chemotherapy.; Breast Neoplasms': '与AA基因型患者相比，CC基因型和乳腺癌患者可能具有下降性中性粒细胞凋亡的风险下降。其他遗传和临床因素也可能影响患有FAC化疗的患者中性粒细胞病的风险。乳房肿瘤',\n",
       " 'Patients with the CC genotype may have increased international normalized ratio variability (INR-var) when treated with warfarin as compared to patients with genotype TT or CT in European-Americans after the warfarin dose-titration phase. Other genetic and clinical factors may also influence the response to warfarin.; ': '与华法林患者在华法林剂量滴定阶段后欧洲美国人在欧洲美国人的患者相比，患有CC基因型的患者可能会增加国际标准化比变异性（INR-VAR）。其他遗传和临床因素也可能影响对华法林的反应。',\n",
       " \"Patients with two X-chromosomes, the CT genotype and psychiatric disorders who are treated with olanzapine may have a decreased, but not absent, risk of weight gain as compared to patients with the CC genotype. However, some studies find no association with weight gain. Other genetic and clinical factors may also influence a patient's risk for weight gain with antipsychotic treatment. This gene is on the X chromosome therefore some individuals may have only one allele.; Mental Disorders;Schizophrenia\": '患有两种X染色体的患者，用奥氮腺嘌呤处理的CT基因型和精神病疾病可能有降低但不存在，与CC基因型患者相比，体重增加的风险。然而，一些研究发现没有重量增益的关联。其他遗传和临床因素也可能影响患者对抗精神病的体重增加的风险。该基因位于X染色体上，因此一些人可能只有一个等位基因。精神障碍;精神分裂症',\n",
       " 'Males with basal cell carcinoma who are hemizygous for the T allele may have a poorer response to treatment with imiquimod as compared to males hemizygous for the A allele. Other genetic and clinical factors may also influence response to imiquimod treatment.; Carcinoma, Basal Cell': '与嗜来自硫蛋白的嗜血素的基础细胞癌的雄性可能具有较差的反应与咪啶的治疗相比，与亚胺嗜尼的含有等位基因。其他遗传和临床因素也可能影响对咪喹莫特治疗的反应。癌，基础细胞',\n",
       " \"Patients with the GG genotype may have decreased risk of Coronary Disease when treated with aspirin as compared to patients with the CC genotype. However, Allele G may be associated with increased risk of Coronary Disease in people not taking aspirin as compared to allele C. Other genetic and clinical factors may influence patient's response to aspirin.; Coronary Artery Disease\": '与CC基因型患者相比，患有GG基因型的患者可能会降低冠状动脉疾病的风险降低。然而，与等位基因C.相比，等位基因G可能与不服用阿司匹林的人们的风险增加。其他遗传和临床因素可能会影响患者对阿司匹林的反应。冠状动脉疾病',\n",
       " 'Patients with the rs6313 AG genotype may be at a decreased risk of experiencing side effects when treated with antidepressants as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk of side effects when treated with antidepressants.; adverse events;Bipolar Disorder;Depression;Depressive Disorder, Major': '与GG基因型患者相比，RS6313 AG基因型的患者可能是在用抗抑郁药物处理时经历副作用的风险。其他遗传和临床因素也可能在用抗抑郁药处理时影响副作用的风险。不良事件;双相情感障碍;抑郁症;抑郁症，主要',\n",
       " \"Patients with the AG genotype (Ser49Gly49) may have decreased response to metoproplol than those with the AA genotype (Ser49/Ser49). However other studies also report no association. Other genetic and clinical factors may also influence a patient's likelihood of response, in particular ADRB1 Arg389 (rs1801253).; Hypertension\": '患有Ag基因型（SER49GLY49）的患者可能对多足药蛋白的响应降低而不是AA基因型（SER49 / SER49）。然而，其他研究也没有报告任何关联。其他遗传和临床因素也可能影响患者的响应可能性，特别是ADRB1 ARG389（RS1801253）。高血压',\n",
       " \"Patients with the AC genotype and Attention Deficit Disorder with Hyperactivity may have an increased response to treatment with methylphenidate as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's response to methylphenidate.; Attention Deficit Disorder with Hyperactivity\": '与AA基因型的患者相比，患有AA基因型的AC基因型和注意力缺陷障碍的患者可能对用甲基酚的治疗增加了响应。其他遗传和临床因素也可能影响患者对甲基酚的反应。注意力缺陷症与多动症',\n",
       " \"Patients with the CC genotype and breast cancer may have a decreased chance of experiencing sensory neuropathy as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's risk for sensory neuropathy. (Note: with a C/G variant, particularly in a gene on the minus chromosomal strand, and frequencies close to 50% there can be a difficulty in interpreting the evidence for association.); Breast Neoplasms\": '与GG基因型的患者相比，患有CC基因型和乳腺癌的患者可能会降低经历感官神经病变。其他遗传和临床因素也可能影响患者对感官神经病变的风险。（注意：用C / G变体，特别是在减去染色体链的基因中，并且接近50％的频率可能难以解释关联的证据。）;乳房肿瘤',\n",
       " 'Pediatric subjects with the CC genotype may have increased concentrations of valproic acid as compared to those with TT genotype, however, this is contradicted in one study, which found no association. Other clinical and genetic factors may also influence concentrations of valproic acid in pediatric subjects with epilepsy.; Epilepsy': '与具有TT基因型的那些相比，具有CC基因型的儿科对象可以增加丙戊酸的浓度，然而，在一项研究中，这与任何一个研究相矛盾。其他临床和遗传因素还可能影响癫痫儿科受试者丙戊酸的浓度。癫痫',\n",
       " \"Patients with the DEL/DEL genotype who are treated with antipsychotics may have an increased risk for antipsychotic-induced extrapyramidal symptoms as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to treatment with antipsychotics.; \": '与AA基因型患者相比，患有抗精神病药治疗的DEL / DEL基因型的患者可能对抗精神病患者诱导的外氮瘤症状的风险增加。其他遗传和临床因素也可能影响患者对抗精神病学治疗的反应。',\n",
       " 'Genotype AC is associated with increased dose of valproic acid in people with Epilepsy as compared to genotype AA.': '与基因型AA相比，基因型AC与癫痫中的人们的丙戊酸剂量增加。',\n",
       " 'As shown by increased plasma concentrations (units = mg/L) for those with the GT genotype compared to those with the GG genotype. Fasting plasma efavirenz concentrations were measured 12 hours after the last dose, and after 12 weeks of treatment.': '如因素与GG基因型的那些相比，通过增加血浆浓度（单位= Mg / L）的血浆浓度（单位= Mg / L）所示。在最后剂量后12小时和12周治疗后测量空腹血浆EFAVIRENZ浓度。',\n",
       " 'Patients with the AA genotype and heroin addiction may require a higher dose of methadone when undergoing methadone maintenance treatment as compared to patients with the GG genotype. Other genetic and clinical factors may also influence methadone dose required for effective treatment.; Heroin Dependence;Opioid-Related Disorders': '患有AA基因型和海洛因成瘾的患者可能需要更高剂量的美沙酮，与GG基因型的患者相比，在进行美沙酮维持治疗时。其他遗传和临床因素也可能影响有效治疗所需的美沙酮剂量。海洛因依赖;阿片类药物相关的疾病',\n",
       " 'The number of G alleles present in a patient was negatively associated with PGI score. Please note that this variant is in high linkage disequilibrium with rs17382202 and rs2164660.': '存在于患者中的G等位基因与PGI评分负相关。请注意，此变体具有高键盘不平衡，RS17382202和RS2164660。',\n",
       " 'CYP2D6 poor metabolizers are associated with decreased metabolism of pridopidine in healthy individuals as compared to CYP2D6 normal metabolizers.': '与CYP2D6正常代谢剂相比，CYP2D6差的代谢剂与健康个体中普凡二宁的代谢降低有关。',\n",
       " \"Patients with the AA genotype may have a decreased response to treatment with duloxetine for major depressive disorder as compared to patients with the AT or TT genotypes. Other genetic and clinical factors may also affect a patient's response to duloxetine.; Depressive Disorder, Major\": '患有AA基因型的患者可能对患有AT或TT基因型的患者的抑郁毒素治疗的反应降低。其他遗传和临床因素也可能影响患者对Duloxetine的反应;抑郁症，主要',\n",
       " \"Patients with the AA genotype and asthma may have a decreased, but not absent, risk for aspirin-intolerant asthma as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence a patient's risk for aspirin-intolerant asthma.; Asthma\": '与AG或GG基因型的患者相比，AA基因型和哮喘患者可能有降低，但不是缺席的阿司匹林 - 不宽容性哮喘的风险。其他遗传和临床因素也可能影响患者对阿司匹林 - 不宽容性哮喘的风险。哮喘',\n",
       " 'Please note that alleles have been complemented to the positive strand. The G allele was associated with increased scores in the dizzy, drunk and nausea traits on the Subjective High Assessment Scale-Expectations (SHAS-E) questionnaire.': '请注意，等位基因已与正股线相辅相成。G等位基因与主观高评估规模 - 期望（SHA-E）问卷的主观高评估量表（SHA-E）调查问卷中的晕眩，醉酒和恶心特征增加。',\n",
       " 'There is currently no available evidence regarding an association between the TT genotype and blood alcohol concentration (BAC). Other genetic and clinical factors may also affect BAC.; ': '目前没有关于TT基因型和血液醇浓度（BAC）之间的关联的可用证据。其他遗传和临床因素也可能影响BAC;',\n",
       " \"Patients with the AG genotype may have an increased response to allopurinol as compared to patients with the GG genotype. However, another study found no association. Other genetic and clinical factors may also affect a patient's response to allopurinol.; \": '与GG基因型的患者相比，患有Ag基因型的患者可能对Allopurinol的反应增加。但是，另一名研究没有发现任何关联。其他遗传和临床因素也可能影响患者对Allopurinol的反应。',\n",
       " 'There is currently no evidence to suggest a difference in anesthesia efficacy between patients with the AG genotype and patients with the AA or GG genotypes. Other genetic and clinical factors may also affect efficacy of remifentanil in a patient.; ': '目前没有证据表明AG基因型和AA或GG基因型患者之间麻醉疗效的差异。其他遗传和临床因素也可能影响雷芬丹中的疗效。',\n",
       " 'CYP2D6 *1/*3 + *1/*4 + *1/*5 + *1/*6 + *3/*3 + *4/*4 + *4/*5 + *4/*10 + *4/*41 + *5/*41 are associated with decreased metabolism of tramadol in infants as compared to CYP2D6 *1/*1.': 'CYP2D6 * 1 / * 3 + * 1 / * 4 + * 1 / * 5 + * 1 / * 6 + * 3 / * 3 + * 4 / * 4 + * 4 / * 5 + * 4 / * 10 + *与CYP2D6 * 1 / * 1相比，4 / * 41 + * 5 / * 41与婴儿的曲马多的代谢降低有关。',\n",
       " 'Patients who carry the *2a allele and have colorectal cancer may have an increased risk for vomiting when treated with TIROX (S-1, irinotecan and oxaliplatin) as compared to patients without the *2a allele. Other genetic and clinical factors may also influence risk for vomiting on TIROX.; Colorectal Neoplasms': '携带* 2A等位基因的患者，与没有* 2A等位基因的患者相比，当用衣架（S-1，Irinotecan和Oxaliplatin）处理时，患有结直肠癌的患者可能会增加呕吐的风险。其他遗传和临床因素也可能影响扭力对衣架的风险。结直肠肿瘤',\n",
       " 'CYP2C19 *1/*2 + *2/*2 is associated with decreased response to clopidogrel in people with Acute coronary syndrome as compared to CYP2C19 *1/*1.': 'CYP2C19 * 1 / * 2 + * 2 / * 2与CYP2C19 * 1 / * 1相比，急性冠状动脉综合征的人们对氯吡格雷的响应降低有关。',\n",
       " \"Patients with the AA genotype and schizophrenia may have an increased response to risperidone as compared to patients with the GG genotype. However, another study failed to find an association between this variant and response to risperidone. Other genetic and clinical factors may also influence a patient's response to risperidone.; Schizophrenia\": '与GG基因型患者相比，患有AA基因型和精神分裂症的患者可能对Risperidone的反应增加。然而，另一项研究未能在这种变体之间找到关联和对risperidone的反应。其他遗传和临床因素也可能影响患者对Risperidone的反应。精神分裂症',\n",
       " \"Patients with the AC genotype may have an increased response to fentanyl as compared to patients with the CC genotype, but a decreased response as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's response to fentanyl.; Pain, Postoperative\": '与患有CC基因型的患者相比，患有AC基因型的患者可能对芬太尼的反应增加，但与AA基因型的患者相比，响应减少。其他遗传和临床因素也可能影响患者对芬太尼的反应。痛苦，术后',\n",
       " 'Patients with the GT genotype who are being treated with methadone for heroin addiction may require an increased dose of the drug as compared to patients with the TT genotype. Other genetic and clinical factors may also influence dose of methadone.; Heroin Dependence': '与患有TT基因型患者相比，用海洛因成瘾治疗的GT基因型的患者可能需要增加药物剂量增加。其他遗传和临床因素也可能影响美沙酮的剂量。海洛因依赖',\n",
       " 'Patients with the CC genotype and type 2 diabetes may have an increased response when treated with captopril as compared to patients with the AA genotype. Other genetic and clinical factors may also influence response to captopril.; Diabetes Mellitus, Type 2': '与AA基因型的患者相比，CC基因型和2型糖尿病患者可能具有增加的响应，与AA基因型患者相比。其他遗传和临床因素也可能影响对卡托普利的反应。糖尿病，2型',\n",
       " 'The association was found for S-mianserin. No significant relationship was found between the CYP2D6 genotype and plasma concentration of R-mianserin.': '该协会被发现为S-Mianserin。CYP2D6基因型和R-Mianserin的血浆浓度无明显的关系。',\n",
       " \"Patients with the AG genotype who have Hypercholesterolemia may have a better response to simvastatin (a greater decrease in triglyceride levels and higher increase in HDL-cholesterol levels) as compared to patients with the GG genotype, or may have a reduced response to simvastatin (a lower decrease in triglyceride levels and lower increase in HDL-cholesterol levels) as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to simvastatin treatment.; Hypercholesterolemia\": '与GG基因型的患者相比，具有高胆固醇血症的AG基因型可能对辛伐他汀（甘油三酯水平的甘油三酯水平和HDL-胆固醇水平较高）具有更好的反应，或者可能对辛伐他汀的反应减少（a与AA基因型的患者相比，甘油三酯水平降低，较低的HDL-胆固醇水平增加）。其他遗传和临床因素也可能影响患者对辛伐他汀治疗的反应。高胆固醇血症',\n",
       " \"Patients with the GG genotype and schizophrenia may have a worse response when treated with clozapine as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence a patient's response to clozapine.; Schizophrenia\": '与AA或AG基因型患者相比，用氯氮平处理时，GG基因型和精神分裂症的患者可能具有更差的响应。其他遗传和临床因素也可能影响患者对氯氮平的反应。精神分裂症',\n",
       " 'The CYP3A7 gene is on the negative strand of the chromosome. Alleles in this gene are complimented to the positive chromosomal strand in PharmGKB annotations. Tacrolimus concentration among CYP3A7 rs10211 C non-carriers is almost twofold as compared to the C carriers. (101.8 vs 59.6, P=0.0004).': 'CYP3A7基因位于染色体的阴茎上。该基因中的等位基因与PharmGKB注释中的阳性染色体链称为。与C载体相比，CYP3A7 RS10211 C的Tacrolimus浓度几乎是双重的。（101.8 Vs 59.6，p = 0.0004）。',\n",
       " 'Genotype CC is associated with increased concentrations of aripiprazole in healthy individuals as compared to genotypes AA + AC.': '与基因型AA + AC相比，基因型CC与健康个体中的aripiPrazole的浓度增加有关。',\n",
       " \"Patients with tuberculosis and the AA genotype may be at an increased risk of developing hepatotoxicity when treated with anti-tuberculosis drugs as compared to patients with the AG or GG genotypes. Other genetic and clinical factors may also affect a patient's risk of developing hepatotoxicity.; Toxic liver disease;Tuberculosis\": '与AG或GG基因型患者相比，患有结核病和AA基因型的患者可能是在用抗结核药物治疗时发育肝毒性的风险。其他遗传和临床因素也可能影响患者发育肝毒性的风险。有毒肝病;结核病',\n",
       " 'Individuals with the AA genotype may have increased area under the curve (AUC) of olanzapine as compared to individuals with the GG genotype. Other genetic and clinical factors may also influence AUC of olanzapine.; ': '与具有GG基因型的个体相比，具有AA基因型的个体可能在奥氮藻的曲线（AUC）下具有增加的面积。其他遗传和临床因素也可能影响奥兰扎丁的AUC;',\n",
       " 'Patients with the GG genotype may be less likely to experience ACE inhibitor induced cough when taking ACE inhibitors as compared to patients with the AG and AA genotype, although this is contradicted in one study. Other clinical and genetic factors may also influence likelihood of ACE inhibitor induced cough in patients who are taking ACE inhibitors.; ': '患有GG基因型的患者可能不太可能在与AG和AA基因型的患者相比，在服用ACE抑制剂时诱导咳嗽的患者诱导咳嗽，尽管在一项研究中相矛盾。其他临床和遗传因素还可能影响患有ACE抑制剂的患者患者患者诱导咳嗽的可能性。',\n",
       " \"Patients carrying at least one copy of the HLA-A*32:01:01 allele may be at an increased risk of developing vancomycin-induced DRESS as compared to patients who do not carry any copies of this allele. Other genetic and clinical factors may also affect a patient's risk of developing vancomycin-induced DRESS.; drug reaction with eosinophilia and systemic symptoms\": '患有至少一份HLA-A * 32：01：01等位基因的患者可能是在不携带这种等位基因的任何拷贝的患者的患者中发育万古霉素诱导的衣服的风险。其他遗传和临床因素也可能影响患者患有发育万古霉素诱导的连衣裙的风险。药物反应与嗜酸性粒细胞和全身症状',\n",
       " \"Lymphoma patients with the AA genotype who are treated with rituximab may be less likely to have tumor shrinkage as compared to patients with the AC or CC genotype. Other genetic and clinical factors may also influence a patient's response to rituximab.; \": '淋巴瘤患者患有利妥昔单抗治疗的AA基因型可能不太可能与AC或CC基因型的患者相比具有肿瘤收缩。其他遗传和临床因素也可能影响患者对利妥昔单抗的反应;',\n",
       " 'Response assessed as remission, defined as MADRS score =<10 at the end of treatment.': '评估作为缓解的反应，定义为Madrs得分= <10在治疗结束时。',\n",
       " 'Patients with the rs267606618 T allele (also known as the 1095T allele) may have a decreased, but not absent, risk of experiencing hearing loss when treated with kanamycin as compared to patients with the C allele. MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of hearing loss when treated with kanamycin.; Ototoxicity': 'RS267606618 T等位基因（也称为1095T等位基因）可能有降低，但不缺乏，与患有C等位基因患者相比用卡那霉素治疗时经历听力损失的风险。MT-RNR1是线粒体基因，其作为单倍体（即只有一个等位基因存在）。其他遗传和临床因素也可能影响用卡那霉素治疗时听力损失的风险。ototoxicity.',\n",
       " 'Genotypes CC + CT are associated with increased clearance of efavirenz in people with HIV Infections as compared to genotype TT.': '与基因型TT相比，基因型CC + CT与艾滋病毒感染的人们的eFaviraenz的清除程度增加。',\n",
       " 'Patients with the *1B allele in combination with another *1B allele may have decreased exposure to rosuvastatin as compared to patients with one or two copies of the *5, *15, *9 or *18 allele. Other genetic and clinical factors may also influence rosuvastatin pharmacokinetics. This annotation only covers the pharmacokinetic relationship between SLCO1B1 and rosuvastatin and does not include evidence about clinical outcomes.; ': '与另一种* 1B等位基因相结合的患者与另一个* 1B等位基因相结合，与患有* 5，* 15，* 9或* 18等位基因的一个或两份拷贝的患者相比，对罗磺酰伐他汀的暴露会降低。其他遗传和临床因素也可能影响罗苏伐他汀药代动力学。该注释仅涵盖SLCO1B1和Rosuvastatin之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " 'Genotype CC is associated with increased response to caffeine in infants with apnea of prematurity as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与对婴儿的婴儿患有呼吸暂停呼吸暂停的婴儿的响应增加有关。',\n",
       " 'Patients with the AA genotype and schizophrenia may have lower weight gain when treated with antipsychotics as compared to patients with the AG or GG genotype. Other genetic and clinical factors may also influence weight gain in patients taking antipsychotics.; Schizophrenia': '与AG或GG基因型患者相比，患有AA基因型和精神分裂症的患者可能具有较低的重量增益。其他遗传和临床因素也可能影响服用抗精神病药患者的体重增加。精神分裂症',\n",
       " 'in Han-Chinese patients with mechanical heart valve replacement.': '在汉族患者中置换机械心脏瓣膜。',\n",
       " 'Genotype TT are associated with decreased concentrations of 4-hydroxytamoxifen or endoxifen in women with Breast Neoplasms as compared to genotypes GG + GT.': '与基因型GG + GT相比，基因型TT与乳腺肿瘤的妇女中的4-羟基氧基毒素或肠毒素的浓度降低有关。',\n",
       " 'Patients with the CYP2D6*1/*1 genotype may have an increased CYP2D6 enzyme activity as compared to patients with the CYP2D6*5/*9 or *4/*38 genotype. Other genetic and clinical factors may also influence CYP2D6 enzyme activity.; ': '与CYP2D6 * 5 / * 9或* 4 / * 38基因型的患者相比，CYP2D6 * 1 / * 1基因型可能具有增加的CYP2D6酶活性。其他遗传和临床因素也可能影响CYP2D6酶活性。',\n",
       " 'Allele A is associated with decreased dose of morphine in women with Pain, Postoperative as compared to allele G.': '等位基因A与患有疼痛的女性的含量下降，与等位基因G.',\n",
       " \"Patients with the AA genotype may have increased tumor response rate and increased risk of grade 3-4 nonhematological toxicity when treated with fluorouracil, irinotecan and leucovorin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to fluorouracil, irinotecan and leucovorin.; Colorectal Neoplasms\": '与GG基因型患者相比，患有AA基因型的肿瘤反应率可能增加肿瘤反应率和3-4级非热神经毒性的风险增加。其他遗传和临床因素也可能影响患者对氟尿嘧啶，伊替康和白草素的反应。结直肠肿瘤',\n",
       " 'Healthy individuals with the AA genotype who are treated with fexofenadine may have lower plasma drug levels as compared to healthy individuals with the AG or GG genotype. Another study found no association with fexofenadine plasma concentrations. Other genetic and clinical factors may also influence plasma concentrations of fexofenadine and dose requirements.; ': '与具有FexofeNadine治疗的AA基因型的健康个体可能具有较低的血浆药物水平，与具有AG或GG基因型的健康个体相比。另一项研究发现没有与FexofenaDine血浆浓度相关的关系。其他遗传和临床因素还可能影响血浆浓度的费缩丁胺和剂量要求。',\n",
       " 'The CYP2C19*3 allele is assigned as a no function allele by CPIC. Patients carrying the CYP2C19*3 allele in combination with a no, decreased, normal, or increased function allele may have decreased metabolism of dexlansoprazole as compared to patients with two normal function alleles. This annotation only covers the pharmacokinetic relationship between CYP2C19 and dexlansoprazole and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism of dexlansoprazole.; ': 'CYP2C19 * 3等位基因由CPIC分配为NO功能等位基因。与具有两个正常功能等位基因的患者相比，携带CYP2C19 * 3等位基因携带CYP2C19 * 3等位基因的功能等位基因可能降低了DexlansoLazole的代谢。该注释仅涵盖CYP2C19和DexlansoLazole之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响DexlansoLazole的代谢。',\n",
       " \"The CYP2D6*10 allele has been assigned as a decreased function allele with an activity score of 0.25 by CPIC. Patients carrying the *10 allele in combination with another decreased function allele or a no function allele may have decreased metabolism of tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *10 allele in combination with a normal function allele or an increased function allele with an activity value of 2 may have similar metabolism of tropisetron as compared to patients with other alleles that result in a normal metabolizer phenotype. Patients carrying the *10 allele in combination with an increased function allele with an activity score of 3 or greater may have increased metabolism of tropisetron as compared to patients with alleles that result in a normal metabolizer phenotype. Be aware that the CPIC guideline for tropisetron and CYP2D6 has a 'no recommendation' for CYP2D6 intermediate and poor metabolizers. This annotation only covers the pharmacokinetic relationship between CYP2D6 and tropisetron and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence tropisetron metabolism.; \": 'CYP2D6 * 10等位基因已被分配为减少的功能等位基因，CPIC的活动分数为0.25。患者与另一种减少的功能等位基因组合携带* 10等位基因，与具有正常代谢物表型的等位基因的患者相比，对对象菌素的代谢降低，而患者与正常的患者携带* 10等位基因的患者相比，患者功能等位基因或具有活性值2的函数等位基因可能具有与患有常规代谢物表型导致的其他等位基因的患者相似的对象菌素的代谢。携带* 10等位基因的患者与具有3或更大的活动评分的增加的功能等位基因组合可能会增加对象菌素的代谢，与导致正常代谢物表型的等位基因的患者相比，对象菌素的代谢。请注意，Cyp2D6中级和代购不良的CPIC指南为Tropisetron和Cyp2D6为“没有建议”。该注释仅涵盖CYP2D6和Tropisetron之间的药代动力学关系，并且不包括关于临床结果的证据。其他遗传和临床因素也可能影响对象区代谢。',\n",
       " 'Patients with the rs6313 GG genotype and major depressive disorder may be less likely to develop sexual dysfunction when treated with sertraline as compared to patients with the AA genotype. Other genetic and clinical factors may also influence likelihood of developing sexual dysfunction when treated with sertraline.; Depressive Disorder, Major;Sexual Dysfunctions, Psychological': '与AA基因型患者相比，患有RS6313 GG基因型和重大抑郁症的患者可能不太可能在用塞拉甲酸盐处理时发生性功能障碍。其他遗传和临床因素还可能影响用塞拉司林处理时发育性功能障碍的可能性。抑郁症，主要;性功能困扰，心理',\n",
       " 'Patients with the *1/*1 diplotype may have increased metabolism as compared to patients carrying the *2 allele . Other genetic and clinical factors may also influence the metabolism of dipyrone.; ': '与携带* 2等位基因的患者相比，患有* 1 / * 1二曲面的患者可能会增加代谢。其他遗传和临床因素也可能影响二倍松的代谢。',\n",
       " 'Patients with the AG genotype may have 1) increased risk of cardiovascular events in patients undergoing percutaneous coronary intervention (PCI) when treated with aspirin and clopidogrel, 2) decreased collagen induced platelet aggregation after Aspirin or dual antiplatelet therapy (DAPT) administration as compared to patients with genotype GG. Other genetic and clinical factors may also influence the response and risk for toxicity to aspirin and clopidogrel.; ': 'AG基因型的患者可能有1）在用阿司匹林和氯吡格雷治疗后经皮冠状动脉干预（PCI）的患者中的心血管事件的风险增加，2）减少胶原蛋白诱导的血小板聚集在阿司匹林或双抗血小板治疗（DAPT）管理后基因型GG患者。其他遗传和临床因素也可能影响阿司匹林和氯吡格雷的毒性的反应和风险。',\n",
       " 'Patients with the rs9923231 CC genotype may require an increased dose of warfarin as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence warfarin dose requirement.; ': '与CT或TT基因型的患者相比，患有RS9923231 CC基因型可能需要增加的华法林剂量增加。其他遗传和临床因素也可能影响华法林剂量要求。',\n",
       " \"Patients with the CT genotype and ovarian cancer who are treated with chemotherapy involving cisplatin and cyclophosphamide may have a reduced, but not absent, risk of grade 3-4 neutropenia as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's risk of toxicity when treated with chemotherapy.; Ovarian Neoplasms\": '患有涉及顺铂和环磷酰胺的化疗治疗的CT基因型和卵巢癌的患者可能减少，但不存在，与CC基因型患者相比，3-4级中性粒细胞率的风险。其他遗传和临床因素也可能影响患者在用化疗处理时患者的毒性风险。卵巢肿瘤',\n",
       " \"Patients with the AA genotype and breast cancer may have a decreased risk of bone density loss when treated with exemestane as compared to patients with the AG and GG genotypes. Other genetic and clinical factors may also influence a patient's risk of bone mineral density loss when treated with exemestane.; Breast Neoplasms\": '与患有Ag和GG基因型的患者相比，患有AA基因型和乳腺癌的患者可能具有骨密度损失的风险降低。其他遗传和临床因素也可能影响患者在用20颗粒处理时患者的骨矿物密度损失的风险。乳房肿瘤',\n",
       " 'Genotype CC is associated with increased response to fluvoxamine, milnacipran and paroxetine in people with Depressive Disorder, Major as compared to genotypes CT + TT.': '基因型CC与抑郁症患者的人们对富氟恶胺，MilnaCipran和帕罗西汀的反应增加有关，与基因型CT + TT相比。',\n",
       " 'Patients with the rs139945292 TT genotype may have increased adverse cardiovascular risk after treatment with the beta blocking agents as compared to patients with the CC genotype. Other genetic and clinical factors may also influence the toxicity to beta-blocking agents.; ': '与β受阻剂的治疗相比，患有RS139945292 TT基因型的患者可能会增加与β受阻剂相比的CC基因型患者的不良心血管风险。其他遗传和临床因素也可能影响β-封闭剂的毒性。',\n",
       " 'Patients with GG genotype may have increased virological response to peginterferon alfa-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B as compared to patients with genotype AA or AG. Other genetic and clinical factors may also influence the response to peginterferon alfa-2b.; Hepatitis B, Chronic': '与基因型AA或AG的患者相比，GG基因型的GG基因型对Peginterferon Alfa-2b的病毒响应增加了病毒学反应，与HBeag阴性慢性乙型肝炎患者相比。其他遗传和临床因素也可能影响对Peginterferon Alfa-2b的反应。乙型肝炎，慢性',\n",
       " 'Allele G is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele A.': '与等位基因A相比，等位基因G与冠状动脉疾病的人们对氯吡格雷的响应降低有关。',\n",
       " 'Healthy individuals with the CC genotype had decreased area under the serum concentration-time curve from zero to infinity (AUCinf), decreased peak concentration (Cmax), and increased clearance (CL/F) of metformin, as compared to those with the AC genotype. Please note alleles have been complemented to the plus chromosomal strand.': '与IC基因型的血清浓度 - 时间曲线下，具有CC基因型的健康个体在血清浓度 - 时间曲线下，从零到无穷大（AUCINF），峰值浓度（cmax）和达二甲双胍的升高（Cl / f）增加，与AC基因型相比。请注意，等位基因已与加染色体股线相得益彰。',\n",
       " 'The ratio of fluoxetine/norfluoxetine increases as a result of the reduced activity of CYP2D6. However, this does not affect the sum of the plasma concentrations of the active substances (fluoxetine and norfluoxetine). There is no effect on adverse events or response.': '由于CYP2D6的活性降低，氟西汀/ NORFOXETINE的比例增加。然而，这不会影响活性物质的血浆浓度（Flyoxetine和Notfluoxetine）的总和。对不良事件或反应没有影响。',\n",
       " \"Patients with the GG genotype and Major Depressive Disorder may be more likely to respond to antidepressant treatment as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to anti-depressant treatment.; Depressive Disorder, Major\": '与AA基因型患者相比，GG基因型和主要抑郁症的患者可能更容易响应抗抑郁药物治疗。其他遗传和临床因素也可能影响患者对抗抑郁药治疗的反应。抑郁症，主要',\n",
       " 'for metabolite and as measured by desethyl hydroxychloroquine:hydroxychloroquine ratio.': '用于代谢物，并通过羟基氯喹：羟基甲基喹啉比的测量。',\n",
       " 'Genotype GG is associated with increased response to risperidone in people with as compared to genotypes AA + AG.': '与基因型AA + AG相比，基因型Gg与对人民的risperidone的反应增加有关。',\n",
       " \"Pediatric patients with epilepsy and the *1a/*8 genotype may have increased metabolism of valproic acid and may need an increased dose when treated with valproic acid when compared to patients with the *1a/*1a genotype. Other genetic and clinical factors may also influence a patient's response to therapy.; Epilepsy\": '儿科患者癫痫患者和* 1A / * 8基因型可能增加了丙戊酸的代谢，并且当与* 1A / * 1A基因型患者相比，当用丙戊酸处理时，可能需要增加剂量。其他遗传和临床因素也可能影响患者对治疗的反应。癫痫',\n",
       " 'Allele A is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype GG.': '等位基因A与Genotype Gg相比，没有疾病的人的苯妥汀的代谢降低有关。',\n",
       " 'Patients with the CT genotype and receiving methadone maintenance therapy may have increased plasma concentrations of cotinine, a metabolite of nicotine, as compared to patients with the CC genotype. Other genetic and clinical factors may also affect plasma concentrations of cotinine in patients receiving methadone maintenance therapy.; ': '与患有CC基因型患者相比，CT基因型和接受美沙酮维持治疗的患者可能增加了含有Cotinine的血浆浓度，尼古丁代谢物。其他遗传和临床因素还可能影响接受美沙酮维持治疗患者的血浆浓度。',\n",
       " 'Patients with the CC genotype have a decreased risk of post anesthesia apnea when treated with succinylcholine as compared to patients with the T genotype. Other genetic and clinical factors may also influence risk of post anesthesia apnea.; ': '与琥珀酰胆碱相比，与T基因型患者相比，患有CC基因型的患者具有降低的麻醉后呼吸暂停的风险。其他遗传和临床因素也可能影响麻醉后呼吸暂停的风险。',\n",
       " 'Patients carrying the AG genotype may have decreased pravastatin plasma AUC compared with patients carrying the GG genotype. This annotation only covers the pharmacokinetic relationship between rs4149015 and pravastatin and does not include evidence about clinical outcomes.; ': '携带AG基因型的患者可能降低了普伐他汀血浆AUC，与携带GG基因型的患者相比。该注释仅涵盖RS4149015和普伐他汀之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " \"Patients with the AA genotype were not studied, however patients with the AG genotype and Hypercholesterolemia may have a better response to fluvastatin (a higher change in triglycerides) as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to fluvastatin treatment.; Hypercholesterolemia\": '没有研究具有AA基因型的患者，然而，与GG基因型的患者相比，AG基因型和高胆固醇血症的患者可能对氟伐他汀（甘油三酯的较高变化）具有更好的反应。其他遗传和临床因素也可能影响患者对氟伐他汀治疗的反应。高胆固醇血症',\n",
       " 'Patients with the rs4680 GG genotype may have a decreased subjective response to oxycodone as compared to patients with the AA or AG genotypes. This drug-variant pair has been assigned a “no recommendation” by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect subjective response to oxycodone.; ': '与AA或AG基因型患者相比，RS4680 GG基因型的患者可能对羟考酮的主观反应降低。这种药物变异对被CPIC分配了“不建议”，因为它被确定在临床上可操作。其他遗传和临床因素也可能影响对羟考酮的主观反应。',\n",
       " 'Expected O-desmethyltramadol (active metabolite) formation': '预期O-DESMethyltramadol（活性代谢物）形成',\n",
       " \"Patients with the AG genotype may have decreased subjective positive effects from oxycodone as compared to patients with the GG genotype. Other genetic and clinical factors may also affect a patient's subjective response to oxycodone.; \": '与GG基因型的患者相比，患有Ag基因型的患者可能降低了来自羟考酮的主观正效。其他遗传和临床因素也可能影响患者对羟考酮的主观反应。',\n",
       " 'CYP2C8 *1/*3 is associated with decreased concentrations of rosiglitazone in healthy individuals as compared to CYP2C8 *1/*1.': '与CYP2C8 * 1 / * 1相比，CYP2C8 * 1 / * 3与健康个体中的罗格列酮浓度降低有关。',\n",
       " 'Patients with the TT genotype may be more likely to quit smoking by weeks 9-12 of varenicline treatment as compared to patients with the CC genotype. Other genetic or clinical factors may also affect response to varenicline.; Tobacco Use Disorder': '与CC基因型患者相比，患有TT基因型的患者可能更容易戒烟，止血率为9-12周。其他遗传或临床因素也可能影响对樟子机的反应。烟草使用障碍',\n",
       " 'Allele T is associated with decreased response to adrenergics, inhalants in children with Asthma as compared to allele C.': '等位基因T与对肾上腺素有效的反应减少，与等位基因C相比，哮喘儿童吸入剂。',\n",
       " 'Patients with opioid-related disorders and the rs2740574 TT genotype (CYP3A4*1/*1) may require a decreased dose of buprenorphine to prevent withdrawal symptoms as compared to patients with the rs2740574 CT or CC genotype (CYP3A4*1B). Other genetic and clinical factors may also influence dosage of buprenorphine in patients with opioid-related disorders.; Opioid-Related Disorders': '患有阿片类药物相关疾病的患者和RS2740574 TT基因型（CYP3A4 * 1 / * 1）可能需要降低的丁丙诺啡剂量，以防止患者与RS2740574 CT或CC基因型（CYP3A4 * 1B）相比的戒断症状。其他遗传和临床因素还可以影响与阿片类药物相关疾病患者的丁丙诺啡剂量。与阿片类药物相关的疾病',\n",
       " 'CYP2C19 *2 + *3 are associated with decreased metabolism of clopidogrel in healthy individuals as compared to CYP2C19 *1.': '与CYP2C19 * 1相比，CYP2C19 * 2 + * 3与健康个体中的氯吡格雷的代谢降低有关。',\n",
       " \"Patients with the CC genotype who are treated with antihypertensives may have a lower risk for resistant hypertension as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence a patient's risk for resistant hypertension.; Coronary Artery Disease;Hypertension\": '与患有抗高血压症治疗的CC基因型的患者可能对抗CT或TT基因型的患者相比，抗性高血压的风险较低。其他遗传和临床因素也可能影响患者的抗性高血压的风险。冠状动脉疾病;高血压',\n",
       " \"Patients with the AG genotype may be more likely to require postoperative intervention with opioids after adenotonsillectomy as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's requirement for pain management.; Pain\": '与AA基因型患者相比，患有AG基因型的AG基因型可能更有可能在腺体切除术后与阿片类药物进行术后干预。其他遗传和临床因素也可能影响患者对疼痛管理的要求。疼痛',\n",
       " 'Patients with the CT genotype and breast cancer may have shorter recurrence-free survival times when treated with tamoxifen as compared to patients with the TT genotype. Other genetic and clinical factors may also influence recurrence-free survival time.; Breast Neoplasms': '与TT基因型患者相比，CT基因型和乳腺癌的患者可能具有短暂的复发存活时间。其他遗传和临床因素也可能影响无复发的存活时间。乳房肿瘤',\n",
       " 'Identity of minor allele not specified, so minor allele of dbSNP used here. Response considered to be successful with a 50% reduction at discharge of the Hamilton Rating Scale for Depression (HRSD17). Patients measured at admission and discharge, 4-6 weeks later. Specific antidepressants not listed.': '未指定的次要等位基因的身份，如此轻微的DBSNP等位基因在此处使用。响应被认为是成功的，在抑郁症（HRSD17）的汉密尔顿评级规模的排放中减少了50％。患者在入院和排放时测量，4-6周后。未列出特异性抗抑郁药。',\n",
       " 'Patients with the rs4149056 CC genotype may have increased serum concentrations of simvastatin acid as compared to patients with the CT or TT genotypes. This annotation only covers the pharmacokinetic relationship between rs4149056 and simvastatin acid and does not include evidence about clinical outcomes. Other genetic and clinical factors may also affect serum concentrations of simvastatin acid.; ': '与CT或TT基因型患者相比，RS4149056 CC基因型的患者可能增加了血清浓度的血清浓度。该注释仅涵盖RS4149056和辛伐他汀酸之间的药代动力学关系，并不包括有关临床结果的证据。其他遗传和临床因素也可能影响血清浓度的辛伐他汀酸。',\n",
       " 'The CYP2D6*10 allele is assigned as a decreased function allele with an activity value of 0.25 by CPIC. Patients carrying the *10 allele in combination with a decreased or no function allele may have a decreased analgesic response when treated with tramadol as compared to patients with alleles that result in a normal metabolizer phenotype. Patients carrying the *10 allele in combination with a normal function allele or an increased function allele with an activity value of 2 may have a similar analgesic response when treated with tramadol as compared to patients with alleles that result in a normal metabolizer phenotype, while patients carrying the *10 allele in combination with an increased function allele with an activity value of 3 or greater may have an increased analgesic response when treated with tramadol as compared to patients with alleles that result in a normal metabolizer phenotype. Other genetic and clinical factors may also influence analgesic response when treated with tramadol.; Pain': 'CYP2D6 * 10等位基因被分配为减少的函数等位基因，CPIC的活动值为0.25。携带* 10等位基因的患者结合减少或无功能等位基因可能具有减少的镇痛反应，与曲马多的患者相比，患者与导致正常代谢物表型的等位基因的患者相比。与正常功能等位基因相结合的患者组合与具有活性值2的常规功能等位基因，当用曲马多处理时，与导致正常代谢物表型的等位基因的患者相比，当用曲马多进行处理时，可能具有相似的镇痛反应。与曲马多的患者相比，携带* 10等位基因与活性值3或更大的函数等位基因组合可能具有增加的镇痛响应，而导致正常代谢物表型的等位基因的患者。当用曲马多处理时，其他遗传和临床因素也可能影响镇痛反应。疼痛',\n",
       " 'Patients with the CC genotype had a daily dose requirement that was approximately half that of those with the TT genotype, at 1, 6 and 12 months post-transplantation. Please note that rs776746 was NOT in HWE in the overall population. The allele was in HWE within the African and Asian population subgroups, but not in the Caucasian subgroup.': '患有CC基因型的患者的每日剂量要求，其在移植后1,6和12个月下的TT基因型的大约一半。请注意，RS776746在整体人口中没有HWE。等位基因在非洲和亚洲人口亚组内的所有等位基因都在HWE，但不在高加索亚组中。',\n",
       " 'Genotype CT is associated with increased response to simvastatin as compared to genotype TT.': '与基因型TT相比，基因型CT与对辛伐他汀的响应增加相关。',\n",
       " 'Patients with the 3R/3R genotype had a decreased likelihood of response to treatment as compared to those with the 2R/2R or 2R/3R genotypes in multivariable analysis. However, note that this was only a \"nominally\" significant association: formally significant was defined as p<0.0026, and nominally significant as p<0.05. No associations with progression-free survival or overall survival were found.': '与具有2R / 2R或2R / 3R基因型的多变量分析中的2R / 2R或2R / 3R基因型相比，3R / 3R基因型的患者对治疗的响应的可能性降低。但请注意，这只是“名义上”重大关联：正式显着被定义为P <0.0026，名义上为P <0.05。没有发现没有进展生存或整体存活的关联。',\n",
       " 'Genotype CG is associated with increased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.': '与基因型CC相比，基因型CG与对癌，非小细胞肺的人们对患者的响应增加有关。',\n",
       " 'Patients with the *2/*2 diplotype may have decreased metabolism as compared to patients carrying the *1/*1 . Other genetic and clinical factors may also influence the metabolism of dipyrone.; ': '与携带* 1 / * 1的患者相比，患有* 2 / * 2二曲型的患者可能会降低代谢。其他遗传和临床因素也可能影响二倍松的代谢。',\n",
       " \"Patients with the AA genotype may have lower risk of toxicity with etoposide compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's risk for toxicity.; \": '与患有GG基因型的患者相比，AA基因型的患者可能具有较低的毒性毒性风险。其他遗传和临床因素也可能影响患者毒性的风险。',\n",
       " 'Patients with cancer and the CT genotype may have increased metabolism of gemcitabine as compared to patients with the TT genotype. However, this has been contradicted by some studies. Other genetic and clinical factors may also influence metabolism of gemcitabine.; Neoplasms': '与TT基因型的患者相比，癌症和CT基因型的患者可能增加了吉西他滨的代谢。然而，这一直受到一些研究的矛盾。其他遗传和临床因素也可能影响吉西他滨的代谢。肿瘤',\n",
       " \"Patients with the AA genotype may be at an increased risk of developing drug dependence as compared to patients with the AC or CC genotypes. Note that this association was only found in African American subjects, and not in European Americans. Other genetic or clinical factors may also affect a patient's risk of developing drug dependence.; Substance-Related Disorders\": '与AC或CC基因型患者相比，AA基因型的患者可能是发育药物依赖性的风险。请注意，此协会仅在非洲裔美国主题中发现，而不是在欧洲美国人。其他遗传或临床因素也可能影响患者发展药物依赖的风险。物质相关疾病',\n",
       " 'Patients with the CYP2D6*88 allele may have decreased clearance of dapoxetine as compared to patients with the CYP2D6*1 allele. The CYP2D6*88 allele was found to have decreased intrinsic clearance during in-vitro characterization with dapoxetine. Other genetic and clinical factors may also influence the metabolism of dapoxetine.; ': '与CYP2D6 * 1等位基因的患者相比，CYP2D6 * 88等位基因的患者可能降低了二夸甲胺的清除。发现CYP2D6 * 88等位基因在体外表征与二夸甲酰胺期间具有降低的内在间隙。其他遗传和临床因素也可能影响成兆汀的代谢。',\n",
       " 'Women with the AG genotype who are undergoing cesarean delivery may require an increased dose of phenylephrine as compared to women with the GG genotype, or a lower dose as compared to women with the AA genotype. Other genetic and clinical factors may also influence dose of phenylephrine.; ': '与患有GG基因型的女性相比，正在进行剖宫产的妇女可能需要增加的苯妥妥肾上腺素，或与AA基因型的女性相比的妇女。其他遗传和临床因素也可能影响苯妥妥的剂量。',\n",
       " 'Patients with the CC genotype and asthma may have a poorer response when treated with flunisolide as compared to patients with the TT genotype. Other genetic and clinical factors may also influence response to flunisolide.; Asthma': '与TT基因型患者相比，患有CC基因型和哮喘的患者可能具有较差的反应。其他遗传和临床因素也可能影响对氟硼化硼的反应。哮喘',\n",
       " \"Patients with the CC genotype may have an increased response to nicotine replacement therapy (NRT) and be abstinent from smoking 6 months after therapy as compared to patients with the CT or TT genotypes. Other genetic or clinical factors may also affect a patient's response to nicotine replacement therapy.; Tobacco Use Disorder\": '患有CC基因型的患者可能对尼古丁替代治疗（NRT）的反应增加，并且与CT或TT基因型的患者相比，治疗后6个月免于吸烟。其他遗传或临床因素也可能影响患者对尼古丁替代治疗的反应。烟草使用障碍',\n",
       " \"Patients with Alzheimer's disease and the CC genotype (also known as ApoE E4/E4) may have an increased response to treatment with statins, as measured by rate of cognitive decline, as compared to patients with the CT or TT genotypes. Other genetic or clinical factors may also affect a patient's response to statin treatment for Alzheimer's disease.; Alzheimer Disease\": '与CT或TT基因型的患者相比，患有阿尔茨海默病和CC基因型（也称为Apoe E4 / E4）的患者可能对用他汀类药物治疗的反应增加，与CT或TT基因型患者相比，通过认知下降率测量。其他遗传或临床因素也可能影响患者对阿尔茨海默病治疗的患者的反应。阿尔茨海默病',\n",
       " 'Patients with the AA genotype who are undergoing kidney transplantation may have an increased risk for gingival overgrowth when treated with cyclosporine as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk of gingival overgrowth.; Kidney Transplantation': '与患有GG基因型患者相比，肾移植正在进行肾移植的AA基因型可能具有增加的牙龈过度生长风险。其他遗传和临床因素也可能影响牙龈过度生长的风险。肾移植',\n",
       " \"Patients with the GG genotype may have increased reduction in total cholesterol or LDL cholesterol levels when treated with simvastatin as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence a patient's response to simvastatin.; Chronic Disease\": '与AA或AG基因型的患者相比，患有GG基因型的GG基因型的患者可能会增加总胆固醇或LDL胆固醇水平。其他遗传和临床因素也可能影响患者对辛伐他汀的反应。慢性病',\n",
       " \"Patients with the GG genotype may be at an increased risk of developing opioid dependence as compared to patients with the AA or AG genotypes. Other genetic and clinical factors may also affect a patient's risk of developing opioid dependence.; Opioid-Related Disorders\": '与AA或AG基因型的患者相比，GG基因型的患者可能是发展阿片类药物依赖性的风险。其他遗传和临床因素也可能影响患者发展阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'Patients with AA genotype may have decreased virological response to peginterferon alfa-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B as compared to patients with genotype GG. Other genetic and clinical factors may also influence the response to peginterferon alfa-2b.; Hepatitis B, Chronic': '与基因型GG患者相比，AA基因型的患者可能对Peginterferon Alfa-2b的病毒响应降低，与HBeag阴性慢性乙型肝炎患者的患者有或没有Entecavir。其他遗传和临床因素也可能影响对Peginterferon Alfa-2b的反应。乙型肝炎，慢性',\n",
       " 'Patients with the AG genotype and acute lymphoblastic leukemia (ALL) may have a decreased risk for hepatotoxicity when treated with asparaginase as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk for hepatotoxicity.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与GG基因型患者相比，患有Ag基因型和急性淋巴细胞白血病（All）的患者可能对雪芦蛋白酶处理时，肝毒性的风险降低。其他遗传和临床因素也可能影响肝毒性的风险。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Patients with the CT genotype may have increased clearance of docetaxel compared to patients with the CC genotype, or decreased clearance of docetaxel compared to patients with the TT genotype. Other genetic and clinical factors may also influence docetaxel clearance.; Carcinoma, Non-Small-Cell Lung': '与CC基因型患者相比，CT基因型的患者可增加多西紫杉醇，或与TT基因型的患者相比，多西紫杉醇的间隙降低。其他遗传和临床因素也可能影响多西紫杉醇清除。癌，非小细胞肺',\n",
       " \"Patients with the AC genotype who are treated with ondansetron may have decreased treatment response among patients carrying the SLC6A4 promoter length polymorphism long/long genotype as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to ondansetron.; Alcoholism\": '与ondansetron治疗的AC基因型的患者可能降低治疗反应，患者携带SLC6A4启动子长度多态性长/长基因型的患者，与AA基因型患者相比。其他遗传和临床因素也可能影响患者对ondansetron的反应。酗酒',\n",
       " 'Patients with the AG genotype may be at a decreased risk of developing treatment emergent suicidal ideation (TESI) when treated with tianeptine as compared to patients with the AA genotype. Other genetic and clinical factors may also affect suicidal ideation in patients.; Depressive Disorder, Major;suicidal ideation': '与AA基因型患者相比，患有AG基因型的AG基因型的患者可能处于在用天蝶的患者进行治疗时发育突出的自杀式肌瘤（TESI）的风险。其他遗传和临床因素也可能影响患者的自杀素质。抑郁症，专业;自杀意念',\n",
       " 'Reduce starting dose by 50% followed by titration of dose based on toxicity or therapeutic drug monitoring (if available). Patients with the c.[2846A>T];[2846A>T] genotype may require >50% reduction in starting dose.': '将起始剂量减少50％，然后根据毒性或治疗药物监测滴定剂量（如果有的话）。患者C. [2846A> T]; [2846A> T]基因型可能需要减少> 50％的起始剂量。',\n",
       " 'Resistance to antiepileptics was defined as poor clinical outcome and recurrent seizure events. Patients were followed up 1, 3, 6 and 12 months after treatment initiation. Please note alleles have been complemented to the plus chromosomal strand.': '抗癫痫药的抵抗被定义为临床结果和复发性癫痫发作事件。治疗开始后患者随访1,3,6和12个月。请注意，等位基因已与加染色体股线相得益彰。',\n",
       " 'Patients with the GG genotype and first episode psychosis (FEP) may have an increased risk for extrapyramidal symptoms when treated with antipsychotics as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence risk of extrapyramidal symptoms.; Psychotic Disorders': '与AA或AG基因型的患者相比，患有GG基因型和第一集心理症（FEP）的患者可能对外锥体症状的外氮瘤症状的风险增加增加。其他遗传和临床因素也可能影响蛋白化症状的风险。精神病疾病',\n",
       " 'Patients carrying the CYP2D6*89 allele may have decreased metabolism of risperidone as compared to patients with the CYP2D6*1 allele. Note that this allele has been assigned as an uncertain function allele by CPIC. This annotation only covers the pharmacokinetic relationship between CYP2D6 and risperidone and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence the metabolism of risperidone.; ': '携带CYP2D6 * 89等位基因的患者可能降低了利妥酮的代谢，与CYP2D6 * 1等位基因患者相比。请注意，此等位基因已被CPIC分配为不确定的功能等位基因。该注释仅涵盖CYP2D6和Risperidone之间的药代动力学关系，并且不包括关于临床结果的证据。其他遗传和临床因素也可能影响利培酮的代谢。',\n",
       " 'Genotype CC is associated with increased metabolism of morphine in children as compared to genotypes CT + TT.': '与基因型CT + TT相比，基因型CC与患儿中吗啡的代谢增加有关。',\n",
       " 'Patients with the TT genotype and ankylosing spondylitis may have a better response when treated with tumor necrosis factor alpha (TNF-alpha) inhibitors as compared to patients with the CC or CT genotype. Other genetic and clinical factors may also influence response to TNF-alpha inhibitors.; Spondylitis, Ankylosing': '与肿瘤坏死因子α（TNF-α）抑制剂相比，患有TT基因型和强直性脊柱炎的患者可能具有更好的反应，与CC或CT基因型患者相比，肿瘤坏死因子α（TNF-α）抑制剂。其他遗传和临床因素也可能影响对TNF-α抑制剂的反应。脊柱炎，强直性',\n",
       " 'Patients with genotype AC may have increased metabolism of digoxin as compared to patients with genotype AA. Other genetic and clinical factors may also influence the metabolism of digoxin.; ': '与基因型AA的患者相比，基因型AC的患者可能增加了高辛的代谢。其他遗传和临床因素也可能影响高辛的代谢。',\n",
       " 'Patients with the AG genotype and asthma may have a poorer response to salbutamol treatment as compared to patients with the GG genotype, or a better response as compared to patients with the AA genotype. Other genetic and clinical factors may also influence response to salbutamol.; Asthma': '与GG基因型患者相比，AG基因型和哮喘的患者可能对Salbutamol治疗的反应较差，或与AA基因型患者相比的更好的反应。其他遗传和临床因素也可能影响对Salbutamol的反应。哮喘',\n",
       " 'Patients with the CC genotype who are addicted to smoking and are trying to quit may have a reduced cravings for nicotine as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence nicotine cravings.; Tobacco Use Disorder': '与CT或TT基因型患者相比，患有吸烟的CC基因型并试图退出的患者可能对尼古丁进行降低的渴望。其他遗传和临床因素也可能影响尼古丁的渴望。烟草使用障碍',\n",
       " \"Patients with the GG genotype who are treated with statins may be less likely to reach target LDL levels as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response when treated with statins.; \": '与TT基因型患者相比，用他汀类药物治疗的GG基因型的患者可能不太可能达到目标LDL水平。其他遗传和临床因素也可能在用他汀类药物治疗时影响患者的响应。',\n",
       " \"Patients with the AG genotype may be at a decreased risk of developing opioid dependence as compared to patients with the AA genotype. Other genetic or clinical factors may also affect a patient's risk of developing opioid dependence.; Opioid-Related Disorders\": '与AA基因型的患者相比，患有AG基因型的患者可能是显影阿片类药物依赖性的风险。其他遗传或临床因素也可能影响患者发展阿片类药物依赖的风险。与阿片类药物相关的疾病',\n",
       " 'Patients with the GG genotype may have decreased plasma concentrations of methadone when undergoing methadone maintenance treatment (MMT) as compared to patients with the AA genotype. Other genetic and clinical factors may also affect plasma concentrations of methadone in patients receiving MMT.; ': '与AA基因型的患者相比，GG基因型的患者可能在接受美沙酮维持治疗（MMT）时的血浆浓度降低。其他遗传和临床因素也可能影响患者接受MMT的血浆浓度。',\n",
       " 'Patients with the GG genotype and epilepsy may have increased clearance of carbamazepine as compared to patients with the AA genotype. Other genetic and clinical factors may also influence clearance of carbamazepine.; Epilepsy': '与AA基因型的患者相比，GG基因型和癫痫的患者可能会增加卡巴马血管的间隙。其他遗传和临床因素也可能影响卡巴马啶的间隙。癫痫',\n",
       " \"Patients with the GG genotype may have an increased metabolism of nicotine as compared to patients with the TT genotype. Other genetic and clinical factors may also effect patients' response to nicotine. This annotation only covers the pharmacokinetic relationship between rs61750900 and nicotine and does not include evidence about clinical outcomes.; \": '与TT基因型的患者相比，GG基因型的患者可能对尼古丁的代谢增加。其他遗传和临床因素也可能影响患者对尼古丁的反应。该注释仅涵盖RS61750900和尼古丁之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " 'Patients with the CG genotype and breast cancer may have an increased risk for anemia when treated with paclitaxel as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk for anemia.; Breast Neoplasms': '与CC基因型患者相比，CG基因型和乳腺癌的患者可能对贫血症的风险增加增加。其他遗传和临床因素也可能影响贫血风险。乳房肿瘤',\n",
       " \"Patients with the CC genotype who are treated with pravastatin may have a reduced response (less decrease in total cholesterol) as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to pravastatin treatment.; \": '与患有GG基因型的患者相比，用普伐他汀治疗的CC基因型的患者可能具有降低的反应（总胆固醇的减少）。其他遗传和临床因素也可能影响患者对普伐他汀治疗的反应。',\n",
       " \"Patients with hypertension and the CC genotype may have an increased response to atenolol, as measured by a decrease in systolic blood pressure, as compared to patient with the AA or AC genotypes. Other genetic and clinical factors may also affect a patient's response to atenolol.; Hypertension\": '与AA或AC基因型的患者相比，高血压和CC基因型的患者可能对阿替洛尔的反应增加了响应。其他遗传和临床因素也可能影响患者对阿托尔洛尔的反应。高血压',\n",
       " 'Patients with the CT genotype and Type 2 diabetes may have a poorer response when treated with oral antidiabetes drugs (OADs) as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to OADs.; Diabetes Mellitus, Type 2': '与患有CC基因型患者相比，患有CT基因型和2型糖尿病的患者可能具有较差的反应，当用CC基因型的患者进行治疗时，患有口腔抗体药物（OAD）。其他遗传和临床因素也可能影响对OADS的反应。糖尿病，2型',\n",
       " 'The NUDT15*1 allele is assigned as a normal function allele by CPIC. Patients with the *1 allele in combination with another normal function allele may be at a decreased risk of developing leukopenia or neutropenia when treated with mercaptopurine as compared to patients with two no function alleles or a normal function allele in combination with an no function allele. Other genetic and clinical factors may also affect risk of developing mercaptopurine-induced leukopenia or neutropenia.; Leukopenia;Neutropenia': 'NUDT15 * 1等位基因被CPIC分配为正常功能等位基因。与另一种正常功能等位基因组合的患者组合可能是在用巯基嘌呤处理的患者的情况下，在没有功能等位基因或正常功能等位基因的患者的情况下，在用巯基嘌呤的患者进行治疗时，可能存在降低风险。其他遗传和临床因素也可能影响培养巯基嘌呤诱导的白细胞减少或中性粒细胞凋亡的风险。白细胞减少;中性粒细胞减少症',\n",
       " 'The A allele of this variant, when measured on plus chromosomal strand, is assigned decreased function by CPIC. Patients with the AA genotype and cancer who are treated with fluorouracil, a fluoropyrimidine-based chemotherapy, may have increased risk and increased severity of drug toxicity as compared to patients with the TT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of drug toxicity.; Neoplasms': '当在加染色体股线上测量时，该变体的等位基因被CPIC指定了降低的功能。与TT基因型患者相比，氟尿嘧啶治疗的AA基因型和癌症的患者，氟嘧啶的化学疗法可能具有增加的风险和增加的药物毒性严重程度。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响药物毒性的风险。肿瘤',\n",
       " 'Patients with the GT or TT genotype had a 1.51-fold increase in tenofovir area under the concentration-time curve (AUC) as compared to those with the GG genotype. Multivariable model controlling for age (per decade), body mass index (per 10 percent increase), African American race, ritonavir use, and whether eGFR is less than 70 ml/min per 1.73m2.': '与GG基因型的那些相比，GT或TT基因型的GT或TT基因型的患者在浓度 - 时间曲线（AUC）下具有1.51倍的胞赘面积。多变量模型控制年龄（每十年），体重指数（增加每10％），非洲裔美国人的种族，Ritonavir使用，以及EGFR是否小于70毫升/分钟/分钟/分钟/分钟。',\n",
       " 'Women with the UGT1A1*28/*28 genotype and osteoporosis may have increased hip bone mineral density when treated with raloxifene as compared to patients with the *1/*1 or *1/*28 genotype. Other genetic and clinical factors may also influence bone mineral density.; bone density': '与含有* 1 / * 1或* 1 / * 28基因型的患者相比，患有UGT1A1 * 28 / * 28基因型和骨质疏松症的基因型和骨质疏松症可能会增加髋骨骨密度增加。其他遗传和临床因素也可能影响骨密度密度。骨密度',\n",
       " 'Genotypes CC + CT are associated with increased response to adalimumab in people with Crohn Disease as compared to genotype TT.': '与基因型TT相比，基因型CC + CT与克罗恩病的人们对患有克罗恩病的患者的反应增加有关。',\n",
       " 'Healthy males with the CT genotype may have an increased response when given dobutamine as compared to healthy males with the TT genotype. Other genetic and clinical factors may also influence response to dobutamine.; ': '当与TT基因型的健康雄性相比，当给予多番胺时，具有CT基因型的健康雄性可能具有增加的反应。其他遗传和临床因素也可能影响对多巴酚胺的反应。',\n",
       " 'Patients with the CT genotype may have increased risk of statin-related myopathy or myalgia when treated with rosuvastatin as compared to patients with genotype TT. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect risk to rosuvastatin.; statin-related myopathy': '当用基因型TT的患者相比，患有CT基因型或患有鼠李蛋白相关肌病病变或肌痛的风险增加。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响罗苏伐他汀的风险。汀类药相关的肌病',\n",
       " \"Patients with the GT genotype and Attention Deficit Disorder with Hyperactivity may have an increased response to treatment with methylphenidate as compared to patients with the TT genotype. Other genetic and clinical factors may also affect a patient's response to methylphenidate.; Attention Deficit Disorder with Hyperactivity\": '患有GT基因型和注意力缺陷障碍的患者可能对具有TT基因型的患者相比，对甲基酚的治疗增加可能具有增加的反应。其他遗传和临床因素也可能影响患者对甲基酚的反应。注意力缺陷症与多动症',\n",
       " 'When allele G is in combination with rs12233719 T allele, the combination of which is defined as UGT2B7*3 by the UGT Nomenclature Committee. As compared to the A allele combined with rs12233719 G allele (wild-type, or UGT2B7*1). In other words, UGT2B7*3 is associated with decreased oral clearance (CL/F) of carvedilol as compared to UGT2B7*1.': '当等位基因G与RS12233719 T等位基因组合时，其中的组合被UGT命名委员会定义为UGT2B7 * 3。与Allele相结合的等位基因与RS12233719 G等位基因（野生型，或UGT2B7 * 1）相结合。换句话说，与UGT2B7 * 1相比，UGT2B7 * 3与Carvedilol的口头间隙（Cl / F）减小相关联。',\n",
       " 'Genotypes CC + CT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.': '与基因型TT相比，基因型CC + CT与冠状动脉疾病的人们对Perindopril的响应减少有关。',\n",
       " \"Women with the GG genotype and rheumatoid arthritis may have a worse response when treated with dalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate as compared to women with the AA genotype. Other genetic and clinical factors may also influence a patient's response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate.; Arthritis, Rheumatoid\": '与AA基因型的女性相比，当用Dalimalab，Certolizumab Pegol，葡聚糖，葡糖型，葡糖型胶质激素，英屈剂或甲氨蝶呤进行处理时，患有GG基因型和类风湿性关节炎的女性可能具有更差的反应。其他遗传和临床因素还可能影响患者对患者对患者的反应，克切尔替洛替洛，依那天葡萄球菌，糖皮质激素，英美昔单抗或甲氨蝶呤。关节炎，类风湿',\n",
       " \"The AT genotype is not associated with differences in clopi-H4 formation or antiplatelet response or increased risk of major cardiovascular events when treated with clopidogrel as compared to the TT genotype. Other genetic and clinical factors may also influence a patient's response to clopidogrel.; Cardiovascular Diseases;Myocardial Infarction\": '与TT基因型相比，基因型与Clopi-H4形成或抗血小板响应或抗血管响应的差异或主要心血管事件的风险增加无关。其他遗传和临床因素也可能影响患者对氯吡格雷的反应。心血管疾病;心肌梗死',\n",
       " \"Patients with the CT genotype and inflammatory diseases may have increased response to anti-TNFalpha treatment as compared to patients with the CC genotype. However, both conflicting and non-significant evidence exists for this association. Other genetic and clinical factors may also influence a patient's response to tumor necrosis factor alpha inhibitors.; Arthritis, Rheumatoid;Crohn Disease;Psoriasis;Spondylitis, Ankylosing\": '与CC基因型患者相比，CT基因型和炎性疾病的患者可能对抗TNFalpha治疗的反应增加。但是，这种协会存在相互冲突和非重要证据。其他遗传和临床因素也可能影响患者对肿瘤坏死因子α抑制剂的反应。关节炎，类风湿;克罗恩病;牛皮癣;脊柱炎，强直性',\n",
       " 'Patients with the rs112445441 AC genotype (G13V) and colorectal cancer may have similar response when treated with cetuximab as compared to patients with the CC genotype (reference KRAS with no mutations in codon 13). However, conflicting evidence has been reported. Note, the FDA label for cetuximab does not recommend cetuximab treatment in patients with codon 13 mutations. Other genetic and clinical factors may also influence response to cetuximab.; Colorectal Neoplasms': '与CC基因型患者相比，患者患有RS112445441和结直肠癌和结直肠癌的患者可能具有相似的响应（参考KRA在密码子13中没有突变）。但是，已经报告了相互矛盾的证据。注意，Cetuximab的FDA标签不推荐密码子13突变患者的西妥昔单抗治疗。其他遗传和临床因素也可能影响对西汀昔单抗的反应;结直肠肿瘤',\n",
       " 'The study partitioned the heterozygous extensive metabolizer group (HEM) into adults <40, adults 40-65 and elderly adults >65. Several PK parameters of venlafaxine metabolism were assessed (dose adjusted serum concentration of venlafaxine, O-desmethylvenlafaxine, N-desmethylvenlafaxine, active moiety, and the metabolic ratio of venlafaxine and its metabolites). Elderly adults >65 showed greater decreases in venlafaxine metabolism when compared with the control group of adults <40.': '该研究将杂合的广泛代谢物组（HEM）分为成人<40，成人40-65岁及老年人> 65。评估几种pk参数的venlafaxine代谢（剂量调节血清浓度Venlafaxine，O- desmethylylvenlafaxine，N- desmethylvenlafaxine，活性部分和venlafaxine的代谢比及其代谢物）。与成人对照组相比，老年人成人> 65在venlafaxine代谢中表现出更大的降低<40。',\n",
       " 'Patients with the GG genotype and acute lymphoblastic leukemia (ALL) may have an increased risk for hepatotoxicity when treated with asparaginase as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence risk for hepatotoxicity.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与AA或AG基因型的患者相比，用浅胰酶处理时，GG基因型和急性淋巴细胞白血病（All）的患者可能对肝毒性的风险增加增加。其他遗传和临床因素也可能影响肝毒性的风险。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.': '与等位基因G.',\n",
       " 'Patients with the CT genotype may have a decreased likelihood of experiencing respiratory depression as a result of fentanyl as compared to patients with the AA genotype. Other genetic and clinical factors may also affect the likelihood of a patient developing respiratory depression as a result of fentanyl.; Pain, Postoperative;Respiratory Insufficiency': '与AA基因型的患者相比，CT基因型的患者可能具有降低的经历呼吸道抑制的可能性。其他遗传和临床因素也可能影响芬太尼产生患者发育呼吸抑制的可能性。疼痛，术后;呼吸功能不全',\n",
       " 'This genotype was associated with sustained virological response (SVR). However, this genotype was associated with increased incidence of spontaneous HCV clearance when compared to patients (OR:0.32, 95%CI:[0.18-0.57], P = 6.2E10-5) with chronic hepatitis or those without an infection (OR:0.31, 95%CI:[0.17-0.56], P = 2.2E10-5).': '该基因型与持续的病毒学反应（SVR）有关。然而，与患者（或：0.32,95％CI：[0.18-0.57]，慢性肝炎或没有感染的人（或：0.31,95％CI：[0.17-0.56]，P = 2.2E10-5）。',\n",
       " 'Patients with the rs4680 GG genotype may have increased morphine dose requirements as compared to patients with the AA genotype. However, conflicting evidence has been reported. This drug-variant pair has been assigned a “no recommendation” by CPIC, as it was determined to be not clinically actionable. Other genetic and clinical factors may also affect morphine dose requirements.; Pain;Pain, Postoperative': '与AA基因型的患者相比，患有RS4680 GG基因型的患者可能会增加吗啡剂量要求。但是，已经报告了相互矛盾的证据。这种药物变异对被CPIC分配了“不建议”，因为它被确定在临床上可操作。其他遗传和临床因素也可能影响吗啡剂量要求。疼痛;疼痛，术后',\n",
       " 'Patients who are recipients of a liver transplant and have have the CYP3A5*3 allele in combination with another no function allele may require a decreased dose of tacrolimus as compared to patients with a no function allele in combination with a normal function allele or two normal function alleles, while patients who have the CYP3A5*3 allele in combination with a normal function allele may require a decreased dose of tacrolimus as compared to patients with two normal function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also affect tacrolimus dose requirements.; liver transplantation': '肝脏移植受者的患者并具有CYP3A5 * 3等位基因与另外的功能等位基因组合可能需要减少的躯干剂量，与NO功能等位基因的患者相结合，与正常功能等位基因或两种正常功能相结合等位基因，而具有CYP3A5 * 3等位基因与正常功能等位基因组合的患者可能需要减少的躯干剂量，而与具有两个正常功能等位基因的患者相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响Tacrolimus剂量要求。肝移植术',\n",
       " 'Patients with the AG genotype and colonic neoplasms may have increased area under the curve of irinotecan-based therapy as compared to patients with the AA genotype. Other genetic and clinical factors may also influence the AUC of irinotecan.; Colonic Neoplasms': '与AA基因型的患者相比，患有Ag基因型和结肠肿瘤的患者可能在伊喹霉菌的疗法曲线下具有增加的面积。其他遗传和临床因素也可能影响Irinotecan的AUC。结肠瘤',\n",
       " 'Patients with the CC genotype may have decreased clearance of pravastatin as compared to patients with the CG genotype. Other genetic and clinical factors may also influence clearance of pravastatin.; ': '与CG基因型患者相比，CC基因型的患者可能降低了普伐他汀的清除。其他遗传和临床因素也可能影响普伐他汀的许可。',\n",
       " 'Patients with the TPMT *1/*3A genotype and heart transplantation who are treated with azathioprine may have an increased risk of severe rejection as compared to patients with the TPMT *1/*1 genotype. Other genetic and clinical factors may also impact the risk for organ rejection.; Transplantation': '与TPMT * 1 / * 1基因型的患者相比，用氮杂唑治疗的TPMT * 1 / * 3A基因型和心脏移植的患者可能具有增加的严重排斥的风险。其他遗传和临床因素也可能影响器官排斥的风险。移植',\n",
       " 'Choose an alternative agent that is not dependent on CYP2C19 metabolism as primary therapy in lieu of voriconazole. Such agents include isavuconazole, liposomal amphotericin B, and posaconazolef,i. In the event that voriconazole is considered to be the most appropriate agent, based on clinical advice, for a patient with poor metabolizer genotype, voriconazole should be administered at a preferably lower than standard dosage with careful therapeutic drug monitoring.': '选择不依赖于CYP2C19代谢作为主要疗法代替伏立康唑的替代剂。这些药剂包括异戊酰唑，脂质体两性霉素B和PosaconazoLef，I。如果voriconazole被认为是基于临床建议的最合适的代理，对于弥合性良好的代谢物基因型的患者，voriconazole应优选低于标准剂量，具有仔细的治疗药物监测。',\n",
       " 'Patients with the GG genotype may have decreased risk of mortality when treated with aspirin in people with Diabetes Mellitus, Type 2 as compared to patients with genotype AA or AG. Other genetic and clinical factors may also influence the response to aspirin.; Diabetes Mellitus, Type 2': '与糖尿病患者在糖尿病患者的人群中，与基因型AA或AG的患者相比，患有GG基因型的患者可能会降低死亡率。其他遗传和临床因素也可能影响对阿司匹林的反应。糖尿病，2型',\n",
       " 'Patients with the CC genotype and non-small cell lung cancer may have decreased risk of drug toxicities when treated with platinum compound chemotherapies compared to patients with CG and GG genotypes. Other clinical and genetic factors may affect risk of toxicities with platinum compound therapies.; Carcinoma, Non-Small-Cell Lung': '与CG和GG基因型患者相比，CC基因型和非小细胞肺癌的患者可能降低了药物毒性的风险下降。其他临床和遗传因素可能影响铂复合疗法的毒性风险。癌，非小细胞肺',\n",
       " 'Genotype TT is associated with decreased response to paroxetine in people with Bipolar Disorder as compared to genotypes GG + GT.': '与基因型GG + GT相比，基因型TT与双极性疾病的人群中对帕罗西汀的响应降低有关。',\n",
       " 'Patients with the TT genotype may have an increased rate of sulfation of acetaminophen as compared to patients with the GG or GT genotypes. Other genetic and clinical factors may also affect acetaminophen sulfation in patients.; ': '与GG或GT基因型的患者相比，TT基因型的患者可能具有增加的乙酰氨基酚硫化率。其他遗传和临床因素也可能影响患者的乙酰氨基酚硫化。',\n",
       " 'Patients with the CG genotype and pancreatic cancer may have a shorter time to progression when treated with gemcitabine as compared to patients with the CC genotype. Other genetic and clinical factors may also influence time to progression in patients with pancreatic cancer.; Pancreatic Neoplasms': '与CC基因型患者相比，患有CG基因型和胰腺癌的患者可能在用吉西他滨治疗时具有较短的进展时间。其他遗传和临床因素也可能影响胰腺癌患者的进展时间。胰腺肿瘤',\n",
       " 'Patients with two copies of the *14 allele or one copy of the *14 allele in combination with one copy of the *5, *6 or *7 alleles may have decreased metabolism of isoniazid as compared to patients with any combination of the *4, *12A or *13A alleles. Other genetic and clinical factors may also affect isoniazid metabolism. This annotation only covers the pharmacokinetic relationship between NAT2 and isoniazid and does not include evidence about clinical outcomes.; Tuberculosis': '患者的* 14等位基因或一份* 14等位基因的一份副本与* 5，* 6或* 7等位基因组合的组合可能降低了异喹丽噻嗪的代谢，而* 4的任何组合相比，* 12a或* 13a等位基因。其他遗传和临床因素也可能影响异烟肼代谢。该注释仅涵盖NAT2和Isoniazid之间的药代动力学关系，并不包括有关临床结果的证据。结核',\n",
       " 'Patients with the TT genotype and colorectal cancer who are treated with folinic acid/leucovorin, fluorouracil and irinotecan (FOLFIRI) may have increased metabolism of irinotecan as compared to the CT genotype. Other clinical and genetic factors may also influence metabolism of irinotecan.; Colorectal Neoplasms': '与CT基因型相比，含有叶酸/白杨蛋白，氟尿嘧啶和氨基甲酰胺（Foldotecan（Folfiri）治疗的TT基因型和结肠直肠癌（Folfiri）可能会增加伊立替康的代谢。其他临床和遗传因素也可能影响Irinotecan的代谢。结直肠肿瘤',\n",
       " 'Patients with the AC genotype and schizophrenia may have a better response when treated with antipsychotics as compared to patients with the AA genotype. Other genetic and clinical factors may also influence response to antipsychotics.; Schizophrenia': '与AA基因型的患者相比，患有AC基因型和精神分裂症的患者可能具有更好的反应。其他遗传和临床因素也可能影响对抗精神病药的反应。精神分裂症',\n",
       " 'Patients with the rs8050894 CG genotype may require a lower dose of warfarin as compared to patients with the CC genotype. Other genetic and clinical factors may also influence warfarin dosage requirements.; ': '与患有CC基因型的患者相比，RS8050894 CG基因型可能需要较低剂量的华法林。其他遗传和临床因素也可能影响华法林剂量要求。',\n",
       " \"Patients with the CC genotype and schizophrenia who are treated with antipsychotics may have a poorer response to treatment as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to antipsychotic treatment.; Schizophrenia\": '与TT基因型患者相比，患有抗精神病药治疗的CC基因型和精神分裂症的患者可能对治疗的反应较差。其他遗传和临床因素也可能影响患者对抗精神病药治疗的反应。精神分裂症',\n",
       " 'Genotype GG is associated with decreased dose of warfarin as compared to genotype CC.': '与基因型CC相比，基因型Gg与甘氨酸剂量降低有关。',\n",
       " 'The C0/D ratio was significantly lower in CT (*1/*3) patients than CC (*3/*3) patients at 1 week (31.9±18.1 vs. 65.9±47.5, p=0.02), 2 weeks (33.1±22.1 vs. 71.1±37.8, p=0.01), 1 month (33.4±19.8 vs. 83.9±55.7, p=0.002), 3 months (40±16.5 vs. 67.9±26.8, p=0.01) and 6 months (35.4±12.9 vs. 85.2±58.9, p=0.01) post transplant. No significant results were seen for 1 year post-transplant.': 'CT（* 1 / * 3）患者的C0 / D比在1周（31.9±18.1与65.9±47.5，p = 0.02），2周（33.1）±22.1与71.1±37.8，p = 0.01），1个月（33.4±19.8与83.9±55.7，p = 0.002），3个月（40±16.5与67.9±26.8，p = 0.01）和6个月（移植后35.4±12.9 vs.85.2±58.9，p = 0.01）。移植后1年没有显着的结果。',\n",
       " 'Patients with the TT genotype and Epilepsy may have decreased metabolism of carbamazepine as compared to patients with the the CC or CT genotypes. This annotation only covers the pharmacokinetic relationship between rs1051740 and carbamazepine and does not include evidence about clinical outcomes. Other genetic and clinical factors may also influence metabolism and dose of carbamazepine.; Epilepsy': '与患有CC或CT基因型的患者相比，TT基因型和癫痫患者可能降低了卡马祖氏细胞的代谢。该注释仅涵盖了Rs1051740和卡马西平之间的药代动力学关系，并且不包括有关临床结果的证据。其他遗传和临床因素也可能影响新陈代谢和剂量的卡巴马嗪。癫痫',\n",
       " \"Patients with the TT genotype and Adrenocortical Carcinoma who are treated with mitotane may have higher mitotane plasma concentrations as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's metabolism of mitotane.; Adrenocortical Carcinoma\": '与GG基因型的患者相比，用MITOTANE治疗的TT基因型和肾上腺皮质癌的患者可能具有更高的耐胰血素浓度。其他遗传和临床因素也可能影响患者的患者的Mitotane代谢。肾上腺皮质癌',\n",
       " \"Patients with hypertension and the CC genotype may have a decreased response to atenolol, as measured by an increase in systolic blood pressure, as compared to patients with the CT or TT genotypes. Other genetic and clinical factors may also affect a patient's response to atenolol.; Hypertension\": '与CT或TT基因型的患者相比，患有高血压和CC基因型的患者可能对阿替洛尔的反应降低。其他遗传和临床因素也可能影响患者对阿托尔洛尔的反应。高血压',\n",
       " 'Patients with the CG genotype may have a better response to treatment with loop diuretics as compared to those with the GG genotype, or a poorer response to treatment as compared to those with the CC genotype. Other genetic and clinical factors may also influence response to loop diuretics.; ': '与用GG基因型的那些相比，患有CG基因型的患者可以更好地对环路利尿剂治疗，或与CC基因型的那些对治疗的反应较差。其他遗传和临床因素也可能影响对环路利尿剂的反应。',\n",
       " 'Patients with non-small cell lung cancer and the AG genotype may experience an increased severity of thrombocytopenia when treated with carboplatin and gemcitabine as compared to patients with the GG genotype. Other genetic and clinical factors may also affect severity of thrombocytopenia.; Carcinoma, Non-Small-Cell Lung;Thrombocytopenia': '与GG基因型患者相比，有非小细胞肺癌和AG基因型的患者可能会经历血小板和吉西他滨的血小板减少症的严重程度。其他遗传和临床因素也可能影响血小板减少的严重程度。癌，非小细胞肺;血小板减少症',\n",
       " \"Patients with the CG genotype may be at a decreased risk of developing methamphetamine dependence as compared to patients with the GG genotype. Other genetic and clinical factors may also affect a patient's risk of developing methamphetamine dependence.; methamphetamine dependence\": '与患有GG基因型患者相比，CG基因型的患者可能处于显影甲基苯丙胺依赖性的风险下降。其他遗传和临床因素也可能影响患者培养甲基苯丙胺依赖的风险。甲基苯丙胺依赖性',\n",
       " 'Decreased metabolism of atomoxetine and higher atomoxetine concentrations as compared to normal metabolizers. Intermediate metabolizers may be at an increased risk of discontinuation as compared to poor metabolizers.': '与正常代谢剂相比，降低氧杂志和较高的氧杂志浓度的代谢。与差的代谢剂相比，中间代谢剂可能是停止的增加风险。',\n",
       " 'Insufficient data to allow calculation of dose adjustment. Select alternative drug (e.g., quetiapine,olanzapine, clozapine) or be extra alert to ADEs and adjust dose to clinical response.': '数据不足以允许计算剂量调整。选择替代药物（例如喹喔啉，奥氮平，氯氮平）或额外警报到凹面并调节剂量至临床反应。',\n",
       " 'Meta-analysis with 4 studies, two on healthy individuals and two on individuals with invasive fungal infections or hematologic malignancies. Voriconazole concentrations were 0.57 mg/L lower in those with the *1/*17 genotype as compared to those with the *1/*1 genotype. This analysis was only provided in the supplementary material.': '荟萃分析4项研究，两个在健康个体上，两个患有侵袭性真菌感染或血液学恶性肿瘤的个体。与* 1 / * 1基因型的那些相比，voriconazole浓度为0.57mg / l，与* 1 / * 17基因型相比。该分析仅在补充材料中提供。',\n",
       " \"Female patients with the GG genotype may have increased prolactin when treated with olanzapine as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to olanzapine.; \": '与CC基因型患者相比，当用奥氮藻处理时，雌性GG基因型的女性患者可能会增加催乳素。其他遗传和临床因素也可能影响患者对奥氮平的反应。',\n",
       " 'Patients with the AA genotype and specificially localization-related epilepsy syndrome may have an increased risk for resistance to antiepileptic treatment as compared to patients with the GG genotype. However, all other studies of people with epilepsy have found no association between this variant and antiepileptic resistance. Other genetic and clinical factors may also influence resistance to antiepileptics.; Epilepsy': '与GG基因型患者相比，患有AA基因型和对大致本地化相关的癫痫综合征的患者可能对抗癫痫治疗的抵抗风险增加。然而，所有其他对癫痫的研究都没有发现这种变体与抗癫痫抗性之间的关联。其他遗传和临床因素也可能影响对抗癫痫的抗性。癫痫',\n",
       " 'Patients with the CG genotype and gastrointestinal stromal tumours may have a longer time to progression when treated with imatinib, as compared to patients with the CC genotype. Other genetic and clinical factors may also influence time to progression.; Gastrointestinal Stromal Tumors': '与CC基因型患者相比，患有CG基因型和胃肠道间质瘤的患者可能在用伊马替尼处理时具有较长的进展时间。其他遗传和临床因素也可能影响进展的时间。胃肠道间质瘤',\n",
       " 'Patients with the TT genotype who are treated with mycophenolic acid following lung transplantation may be at an increased risk of transplant rejection as compared to patients with the GG genotype. Other genetic and clinical factors may also affect response to mycophenolic acid. in lung transplant patients.; lung transplantation;transplant rejection': '与肺癌后肺癌后治疗的TT基因型患者可能处于与GG基因型的患者相比移植抑制的风险增加。其他遗传和临床因素也可能影响对霉酚酸的反应。在肺移植患者中;肺移植;移植抑制',\n",
       " \"Patients with the AG genotype and Asthma may not have an increased response to montelukast treatment, based on no change in Forced expiratory volume in one second (FEV1) response to montelukast at 6 month of treatment, compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's response to montelukast.; Asthma\": '与患有GG基因型的6个月的治疗患者，基于蒙特洛斯特治疗的Ag基因型和哮喘的患者可能没有对蒙特洛斯特治疗的反应增加，而不是GG基因型的患者。其他遗传和临床因素也可能影响患者对蒙特洛特的反应;哮喘',\n",
       " 'Patients with the CT genotype and non-small cell lung cancer may have an increased response to platinum compounds (cisplatin or carboplatin) as compared to patients with the TT genotype. Other genetic and clinical factors may also influence response to platinum compounds.; Carcinoma, Non-Small-Cell Lung': '与TT基因型患者相比，CT基因型和非小细胞肺癌的患者可能对铂化合物（顺铂或卡铂）的反应增加。其他遗传和临床因素也可能影响对铂化合物的反应。癌，非小细胞肺',\n",
       " \"Patients with the AG genotype may have an increased risk for cardiovascular events (cardiac death and recurrent myocardial infarction) when treated with aspirin and clopidogrel as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to aspirin and clopidogrel.; Myocardial Infarction\": '与AA基因型的患者相比，患有AAG和氯吡格雷的心血管事件（心脏死亡和复发性心肌梗塞）的风险增加可能具有增加的心血管事件（心脏死亡和复发性心肌梗塞）。其他遗传和临床因素也可能影响患者对阿司匹林和氯吡格雷的反应。心肌梗塞',\n",
       " 'Patients with the CYP2C19*19 allele may have decreased enzyme activity of CYP2C19 as compared to patients with the CYP2C19*1 allele. The CYP2C19*19 allele was found to have a decreased clearance of mephenytoin and decreased catalytic activity as compared to *1 during several in-vitro characterizations. Other genetic and clinical factors may also influence the metabolism of mephenytoin.; ': '与CYP2C19 * 1等位基因的患者相比，CYP2C19 * 19等位基因患者可能降低了CYP2C19的酶活性。发现CYP2C19 * 19等位基因在几种体外表征期间与* 1相比具有降低的Mephenytoin和催化活性降低。其他遗传和临床因素也可能影响Mephenytoin的代谢。',\n",
       " 'Genotype TT is associated with increased concentrations of efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.': '与基因型GG + GT相比，基因型TT与艾滋病毒感染和结核病的人们的浓度增加。',\n",
       " 'Patients with HIV and the TT genotype may have higher plasma concentrations of efavirenz as compared to patients with the CT or CC genotypes. However, other studies have failed to find this association. Other clinical and genetic factors may also influence plasma concentrations of efavirenz in patients with HIV. This annotation only covers the pharmacokinetic relationship between rs4803419 and efavirenz and does not include evidence about clinical outcomes.; HIV Infections': '与CT或CC基因型患者相比，患有艾滋病毒的患者和TT基因型可能具有更高的血浆浓度的EFAVIRENZ。但是，其他研究未能找到此协会。其他临床和遗传因素还可能影响艾滋病毒患者Efaviraz的血浆浓度。该注释仅涵盖RS4803419和efaviraz之间的药代动力学关系，并不包括有关临床结果的证据。艾滋病毒感染',\n",
       " 'The current evidence base suggests that there is no significant association between the CYP2C9*1 allele and time in therapeutic INR range in patients treated with warfarin. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence time in therapeutic INR range when treated with warfarin.; ': '目前的证据基础表明，CYP2C9 * 1等位基因与治疗型INR系列中没有显着关联，患者在Warfarin治疗的患者中。但是，已经报告了相互矛盾的证据。当用华法林处理时，其他遗传和临床因素也可能影响治疗性INR范围内的时间。',\n",
       " \"Patients with the GG genotype and Colorectal Neoplasms who are treated with fluorouracil, irinotecan and leucovorin may have a decreased, but not absent, risk for grade 3–4 severe diarrhea as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence a patient's risk for grade 3–4 severe diarrhea.; Colorectal Neoplasms\": '患有氟尿嘧啶，伊立替康和白草素治疗的GG基因型和结肠直肠肿瘤的患者可能有降低但不存在，与AA或AG基因型患者相比，3-4级严重腹泻的风险。其他遗传和临床因素也可能影响患者3-4级严重腹泻的风险。结直肠肿瘤',\n",
       " 'Patients with the CC genotype and coronary disease may have better cardiovascular outcomes when treated with rosuvastatin as compared to patients with the TT genotype. Other genetic and clinical factors may also influence cardiovascular outcomes.; Coronary Disease': '与TT基因型患者相比，患有CC基因型和冠状病的患者可能具有更好的心血管结果。其他遗传和临床因素也可能影响心血管结果。冠状病',\n",
       " 'Recipients of kidney transplants who are administered tacrolimus and who receive kidneys from donors with the CYP3A5 *1/*3 genotype may have a lower likelihood of nephrotoxicity as compared to kidneys from donors with the CYP3A5 *3/*3 genotype. Other clinical and genetic factors may also influence risk of nephrotoxicity.; Kidney Transplantation': '与CYP3A5 * 3 / * 3基因型的肾脏相比，肾脏移植的肾移植接受肾脏移植物的接受者和从供体中接受肾脏的肾脏可能具有较低的肾毒性的可能性。其他临床和遗传因素也可能影响肾毒性的风险。肾移植',\n",
       " 'The TPMT*9 allele is assigned as a no function allele by DPWG. Patients with the *9 allele, in combination with a normal function allele or a no function allele, may have an increased likelihood of toxicity when treated with mercaptopurine as compared to patients with two normal function alleles. However, conflicting evidence has been reported. Note that CPIC assigned TPMT*9 as an uncertain function allele. Other genetic and clinical factors may also influence mercaptopurine toxicity.; ': 'TPMT * 9等位基因被DPWG分配为无功能等位基因。患有* 9等位基因的患者与正常功能等位基因组合或无功能等位基因组合可能在用巯基嘌呤处理时具有增加的毒性可能性，与具有两个正常函数等位基因的患者相比。但是，已经报告了相互矛盾的证据。请注意，CPIC指定为TPMT * 9作为不确定功能等位基因。其他遗传和临床因素也可能影响巯基嘌呤毒性。',\n",
       " 'Patients with the CT genotype (CYP3A5 *1/*3) undergoing organ transplantation may have an increased risk for neurotoxicity when treated with tacrolimus as compared to patients with the CC (*3/*3) genotype. Other genetic and clinical factors may also influence risk for neurotoxicity in patients receiving tacrolimus.; Neurotoxicity Syndromes': '与CC（* 3 / * 3）基因型的患者相比，患有CT基因型的CT基因型（CYP3A5 * 1 / * 3）可能对神经毒性的风险增加可能具有增加的神经毒性风险。其他遗传和临床因素也可能影响接受他克莫司患者的神经毒性的风险。神经毒性综合征',\n",
       " 'Patients with the CT genotype and beta-thalassemia may have decreased concentrations of deferasirox as compared to patients with the TT genotype. Other genetic and clinical factors may also influence concentrations of deferasirox.; beta-Thalassemia': '与TT基因型的患者相比，CT基因型和β-地中海贫血症的患者可能降低延迟浓度。其他遗传和临床因素也可能影响脱硫血管的浓度。Beta-thalassemia',\n",
       " 'Patients with the CT genotype and major depressive disorder may have increased sexual side-effects when treated with bupropion as compared to patients with the TT genotype, or decreased sexual side-effects when treated with bupropion as compared to patients with the CC genotype. Other genetic and clinical factors may also influence sexual side-effects.; Depressive Disorder, Major': '与TT基因型患者相比，CT基因型和重大抑郁症的患者可能会增加性副作用，或者与CC基因型患者用Bupropion治疗时减少性副作用。其他遗传和临床因素也可能影响性副作用。抑郁症，主要',\n",
       " 'Patients with the TT genotype may have increased the risk of recurrent clinical events when treated with clopidogrel as compared to patients with genotype CC. Other genetic and clinical factors may also influence the response to clopidogrel.; major adverse cardiac events (mace)': '与基因型CC患者相比，患有TT基因型的患者可能增加了当用氯吡格雷处理时经复制临床事件的风险。其他遗传和临床因素也可能影响对氯吡格雷的反应。主要不利的心脏事件（MACE）',\n",
       " 'Alleles complemented to plus chromosomal strand. Significant for clearance, Cmax, and AUC.': '等位基因补充为加染色体股。对于清除，CMAX和AUC非常重要。',\n",
       " \"Patients with the TT genotype who are receiving concomitant phenytoin and isoniazid may be at an increased risk of phenytoin toxicity resulting from isoniazid-phenytoin interaction as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's risk of developing phenytoin toxicity when treated with both isoniazid and phenytoin.; Drug interaction with drug;Drug Toxicity\": '接受伴随苯妥林和异烟肼的TT基因型的患者可能是由异烟肼 - 苯妥汀相互作用而导致的苯妥辛毒性的风险增加，与CC基因型患者相比。其他遗传和临床因素也可能影响患者在用异烟肼和苯妥林治疗时发育苯毒素毒性的风险。药物与药物相互作用;药物毒性',\n",
       " 'Patients with the AA genotype and colorectal neoplasms may have decreased severity of neutropenia compared to patients with the AC and CC genotypes when taking irinotecan. Other clinical and genetic factors may affect severity of neutropenia with irinotecan treatment.; Colorectal Neoplasms;Neutropenia': '与服用Irinotecan的AC和CC基因型的患者相比，患有AA基因型和结肠直肠肿瘤的患者可能会降低中性粒细胞率的严重程度。其他临床和遗传因素可能会影响中性粒细胞率的严重程度与伊立替康治疗;结直肠肿瘤;中性粒细胞病',\n",
       " 'Patients with the AA genotype and Type 2 Diabetes may have decreased response to sitagliptin or vildagliptin compared to patients with the GG genotype. Other factors may affect response to sitagliptin and vildagliptin.; Diabetes Mellitus, Type 2': '与患有GG基因型的患者相比，AA基因型和2型糖尿病的患者可能降低对SitaTaTaLlitin或Vilyagliptin的响应。其他因素可能影响对SitaGliptin和Vildagliptin的反应;糖尿病，2型',\n",
       " 'People who smoke and have the AC genotype may have increased clearance and decreased exposure to cotinine compared to people with the CC genotype. Other clinical and genetic factors may affect metabolism and exposure of cotinine.; Tobacco Use Disorder': '与CC基因型的人相比，吸烟并具有交流基因型的人可能会增加间隙并降低对胞吨素的暴露。其他临床和遗传因素可能会影响胞苷的代谢和暴露。烟草使用障碍',\n",
       " 'Patients with osteosarcoma and the rs717620 TT genotype may have a decreased response to treatment with cisplatin, doxorubicin and methotrexate as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to treatment with cisplatin, doxorubicin and methotrexate.; Osteosarcoma': '与CC基因型患者相比，骨肉瘤和RS717620 TT基因型的患者可能具有降低对与顺铂，多柔比蛋白和甲氨蝶呤的治疗响应。其他遗传和临床因素也可能影响与顺铂，多柔比蛋白和甲氨蝶呤治疗的反应。骨肉瘤',\n",
       " 'Patients with the CC genotype may require decreased dose of acenocoumarol as compared to patients with the AA or AC genotype. Other clinical or genetic factors may also influence acenocoumarol dose.; ': '与AA或AC基因型的患者相比，CC基因型的患者可能需要减少的aceNocoumarol剂量。其他临床或遗传因素也可能影响Acenocoumarol剂量。',\n",
       " 'Log tramadol/O-desmethyltramadol ratios in both urine and plasma increased as CYP2D6 activity scores decreased. CYP2D6 genotyping was carried out for: \"The CYP2D6 2549delA variant (*3 allele), the 1846G>A SNP (*4 allele), the 1707delT variant (*6 allele), the 100C>T SNP (*10 allele), the 2988G\\x04A SNP (*41 allele), the 2613delAGA variant (*9 allele), gene deletion (*5 allele) and CYP2D6 gene duplication. Note that the authors assigned an activity score of 0.5 to the *10 allele.': '随着CYP2D6活性分数降低，尿液和血浆中的Log Tramadol / O-Desmethyltramadol比率增加。CYP2D6基因分型进行：“CYP2D6 2549Dela变体（* 3等位基因），1846g> SNP（* 4等位基因），1707个灯泡变体（* 6等位基因），100℃> T SNP（* 10等位基因），2988g SNP（* 41等位基因），2613delaga变体（* 9等位基因），基因缺失（* 5等位基因）和CYP2D6基因重复。请注意，作者将活动分数分配为0.5至* 10等位基因。',\n",
       " 'A GWAS showed that, in patients of European ancestry, the CC genotype of this SNP is associated with a twofold (95% CI 1.8-2.3) greater rate of SVR (sustained virological response) than is the TT genotype to treatment of chronic Hepatitis C genotype I infection with peginterferon-alpha-2a or -2b combined with ribavirin. In African -Americans, the response rate ratio is in the same direction, but three-fold (95% CI 1.9-4.7) . In Hispanics, the response ratio is two-fold (95% CI 1.4-3.2). The overall genome-wide association has significance p = 1.37 x 10 -28. Based upon the allele frequency in different population groups, this polymorphism appears to explain about half of the response rate difference between different populations. An association between baseline viral load and genotype was also found.': 'Gwas表明，在欧洲血症患者中，该SNP的CC基因型与双重（95％CI 1.8-2.3）相关的SVR（持续病毒学响应）的速率比治疗慢性丙型肝炎的TT基因型更高基因型I用peginterferon-α-2a或-2b与利巴韦林联合的感染。在非洲 - 美国人，响应率比在相同方向，但三倍（95％CI 1.9-4.7）。在西班牙裔人中，响应比为两倍（95％CI 1.4-3.2）。整体基因组关联具有显着性P = 1.37×10 -28。基于不同人群群中的等位基因频率，这种多态性似乎解释了不同群体之间的响应率差的一半。还发现了基线病毒载荷和基因型之间的关联。',\n",
       " \"Patients with the GG genotype may have increased risk of Nevirapine-induced rash when treated with nevirapine in people with HIV as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's response to nevirapine.; HIV Infections\": '与AA基因型的患者相比，患有GG基因型的GG基因型的患者可能具有增加的Nevirapine诱导的皮疹风险。其他遗传和临床因素也可能影响患者对Nevirapine的反应。艾滋病毒感染',\n",
       " 'Patients with the rs267606619 T allele (also known as the 1494T allele) may have a greater risk of experiencing aminoglycoside-induced hearing loss as compared to patients with the 1494C allele. However, conflicting evidence has been reported. Almost all individuals studied were homoplasmic for the T allele; it is unclear how heteroplasmy affects the severity or occurrence of aminoglycoside-induced hearing loss. MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of aminoglycoside-induced hearing loss.; Ototoxicity': '与1494C等位基因的患者相比，患有RS267606619 T等位基因（也称为1494T等位基因）的风险可能具有更大的风险。但是，已经报告了相互矛盾的证据。几乎所有学习的个体都是T等位基因的同源性;目前尚不清楚异质量如何影响氨基糖苷诱导的听力损失的严重程度或发生。MT-RNR1是线粒体基因，其作为单倍体（即只有一个等位基因存在）。其他遗传和临床因素也可能影响氨基糖苷诱导的听力损失的风险。ototoxicity.',\n",
       " 'Individuals with the TT genotype may have an increased risk of cocaine dependence as compared to those with the CC or CT genotype. Other genetic and clinical factors may also influence risk of cocaine dependence.; Cocaine-Related Disorders': '与具有CC或CT基因型的人相比，具有TT基因型的个体可能具有可卡因依赖性的风险。其他遗传和临床因素也可能影响可卡因依赖的风险。可卡因相关疾病',\n",
       " '1. reduce the dose to 50% of the standard dose and record an ECG and monitor the plasma concentration.': '1.将剂量降低至50％的标准剂量，并记录ECG并监测等离子体浓度。',\n",
       " 'Finding was significant across the total study cohort and in a subset of CYP2A6 \"decreased metabolizers\" (i.e. participants carrying at least one copy of the CYP2A6*2, *4, *7, *9 or *12 alelles) but lost significance in the subset of CYP2A6 normal metabolizers.': '在总研究队列和CYP2A6“减少的代谢者的子集中，发现是显着的（即携带CYP2A6 * 2，* 4，* 7，* 9或* 12分层的至少一个拷贝的参与者），但在此过程中丧失了重要性CYP2A6正常代谢器的子集。',\n",
       " 'After adjusted for sex, body-weight and dose of corticosteroid and mycophenolate mofetil, CYP3A5 genotype has the most profound effects on dose requirement of tacrolimus 1-5 years after transplantation.': '调整后性别，体重和皮质类固醇和霉酚酸酯的剂量后，CYP3A5基因型对移植后1-5岁的Tacrolimus的剂量要求具有最深刻的影响。',\n",
       " '4 studies evaluated the association between CC & TT and adj. serum concentration of VPA. In overall analysis of 4 studies found no association with genotype and adj. serum concentration (P = 0.35). In subgroup analysis, the TT genotype was not significantly associated with serum concentration versus CC genotype in monotherapy (P =0.71) but was associated with increased concentrations based on combination therapy data (P = 0.002). No sub-group anayses were done by age.': '4研究评估了CC＆TT和ADJ之间的关联。VPA的血清浓度。对于4项研究的总体分析，发现与基因型和adj相关联。血清浓度（p = 0.35）。在亚组分析中，TT基因型与单药治疗中的血清浓度与CC基因型显着相关（p = 0.71），但与基于联合治疗数据的增加的浓度相关（p = 0.002）。没有亚组AADESES通过年龄完成。',\n",
       " \"Patients with the CC genotype may be more likely to require postoperative intervention with opioids after adenotonsillectomy as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's requirement for pain management.; Pain\": '与TT基因型患者相比，患有CC基因型的患者可能更有可能在腺体切除术后与阿片类药物进行术后干预。其他遗传和临床因素也可能影响患者对疼痛管理的要求。疼痛',\n",
       " 'Patients with the rs71647871 CC genotype may have increased metabolism of enalapril as compared to patients with the CT genotype. This annotation only covers the pharmacokinetic relationship between rs71647871 and enalapril and does not include evidence about clinical outcomes. Other clinical and genetic factors may also influence metabolism of enalapril.; ': '与CT基因型的患者相比，患有RS71647871 CC基因型的CC基因型可能会增加烯丙胺的代谢。该注释仅涵盖了RS71647871和Enalapril之间的药代动力学关系，并且不包括有关临床结果的证据。其他临床和遗传因素也可能影响enalapril的代谢。',\n",
       " 'This association was found in carriers of the DRD3 rs6280 AA genotype (gene-gene interaction analysis).': '该关联被发现在DRD3 RS6280 AA基因型（基因基因相互作用分析）的载体中。',\n",
       " 'Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.': '与等位基因C相比，等位基因G与海洛因依赖性的人们的含量增加。',\n",
       " 'Patients carrying the UGT1A1*6 allele in combination with a normal function allele or decreased function allele may have decreased metabolism of SN-38 as compared to patients with two normal function alleles. Other genetic and clinical factors may also influence metabolism of SN-38. This annotation only covers the pharmacokinetic relationship between UGT1A1 and SN-38 and does not include evidence about clinical outcomes.; ': '携带UGT1A1 * 6等位基因与正常功能等位基因或函数等位基因组合的患者可能降低了SN-38的代谢，相比具有两个正常功能等位基因的患者。其他遗传和临床因素也可能影响SN-38的代谢。该注释仅涵盖UGT1A1和SN-38之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " 'A. If patient is oxcarbazepine-naive, do not use oxcarbazepine.B. The latency period for drug-induced SJS/TEN is short with continuous dosing and adherance to therapy (~4-28 days), and cases usually occur within 3 months of dosing; therefore, if the patient has previously used oxcarbazepine consistently for longer than 3 months without incidence of cutaneous adverse reactions, cautiously consider use of oxcarbazepine in the future.': '答：如果患者是oxcarbazepine-naive，请不要使用oxcarbazepine.b。药物诱导的SJS / Ten的潜伏期短伴随着连续给药和临证治疗（〜4-28天），并且通常在给药的3个月内发生;因此，如果患者以前使用过3个月的患者始终用皮肤不良反应的发生，如果未来，致考虑使用牛毒蛛的使用。',\n",
       " 'Patients with the GG genotype and hypertension may have a poorer blood pressure response when treated with calcium channel blockers, including amlodipine, felodipine, lacidipine, nifedipine or nitrendipine, as compared to patients with the TT genotype. Other genetic and clinical factors may also influence response to calcium channel blockers.; Hypertension': '当用TT基因型的患者相比，患有钙通道阻滞剂的GG基因型和高血压患者可能具有较差的血压响应，包括氨氯地平，Felodipine，LaCidipine，NifeDipine或NifeDipine。其他遗传和临床因素也可能影响对钙通道阻滞剂的反应。高血压',\n",
       " 'Patients with the CT genotype and acute lymphoblastic leukemia may have a greater risk of relapse when treated with doxorubicin, methotrexate, prednisolone and vincristine, as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk of relapse.; Precursor Cell Lymphoblastic Leukemia-Lymphoma': '与CC基因型患者相比，CT基因型和急性淋巴细胞白血病的患者可能具有更大的复发风险，当用CC基因型患者进行处理时，甲氨酸甲酸甲酯其他遗传和临床因素也可能影响复发风险。前体细胞淋巴细胞白血病 - 淋巴瘤',\n",
       " 'Patients with the rs9923231 CC genotype may have decreased risk of over-anticoagulation when treated with warfarin as compared with patients with genotype TT or CT. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence the toxicity to warfarin.; over-anticoagulation': '与患有基因型TT或CT的患者相比，患有RS9923231 CC基因型的患者可能会降低过度抗凝的风险。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对华法林的毒性。过度刺激',\n",
       " 'Patients with the rs4961 GG genotype may have decreased response to hydrochlorothiazide treatment as compared to patients with the TT or GT genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence response to hydrochlorothiazide.; Essential hypertension;Hypertension': '与TT或GT基因型的患者相比，RS4961 GG基因型的患者可能降低对氢氯噻嗪处理的反应。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响对氢氯噻嗪的反应。必需的高血压;高血压',\n",
       " \"Patients with the TT genotype may have decreased reduction in systolic blood pressure (SBP) when treated with hydrochlorothiazide in people with Hypertension as compared to patients with the CT or CC genotype. Other genetic and clinical factors may also influence a patient's response to hydrochlorothiazide.; Hypertension\": '当与患有CT或CC基因型患者的患者用高血压患者用高血压患者处理时，TT基因型的患者可能降低了收缩压（SBP）。其他遗传和临床因素也可能影响患者对氢氯噻嗪的反应。高血压',\n",
       " 'Good responders defined as patients whose disease activity score in 28 joints (DAS28) score improved by at least 1.2 at week 22 as compared to their DAS28 score before first infusion (EULAR criteria). Patients with the GG genotype were more likely to be good responders to infliximab treatment as compared to those with the AA or AG genotype. Additionally, those with the GG genotype had a higher mean DAS28 improvement as compared to those with the AA or AG genotype after 22 weeks.': '良好的响应者定义为28个关节（DAS28）分数在第22周的28个关节（DAS28）的疾病活动评分的患者，与第一次输注前的DAS28得分相比，在第22周之前至少1.2分。与AA或AG基因型的那些相比，患有GG基因型的患者对英夫利昔单抗治疗更可能是良好的响应者。另外，与22周后的AA或Ag基因型相比，具有GG基因型的那些具有更高的平均das28改善。',\n",
       " 'Patients with the rs1801252 GG genotype may have an increased response to carvedilol as compared to patients with the AA genotype. Other genetic and clinical factors may also influence response to carvedilol.; ': '与AA基因型的患者相比，RS1801252 GG基因型的患者可能对卡维地洛的反应增加了响应。其他遗传和临床因素也可能影响对卡维地洛的反应。',\n",
       " \"Patients with breast cancer and the TT genotype may have a decreased risk of developing neutropenia when treated with cyclophosphamide, epirubicin and fluorouracil as compared to patients with the CC or CT genotypes. Other genetic and clinical factors may also affect a patient's risk of developing neutropenia.; Breast Neoplasms;Neutropenia\": '与CC或CT基因型患者相比，乳腺癌和TT基因型的患者可能具有减少的患有环磷酰胺，同性全酶和氟尿嘧啶的中性粒细胞凋亡的风险。其他遗传和临床因素也可能影响患者的发展中性粒细胞率的风险。乳腺肿瘤;中性粒细胞病',\n",
       " 'The AUC of clopidogrel and Cmax of its active metabolite were 67% (P=0.009) and 63% (P=0.017) higher in subjects with the CES1 c.428G/A genotype than in those with the c.428G/G genotype, suggesting reduced clopidogrel hydrolysis to inactive metabolites and increased antiplatelet effects.': '氯吡格雷和C的氯吡格雷和CMAX的AUC在CES1 C.428G /基因型中的受试者中高出67％（p = 0.009）和63％（P = 0.017），而不是C.428g / g基因型的基因型，提示将氯吡格雷水解降低到活性代谢物和增加的抗血小板效应。',\n",
       " 'Patients with the CYP2B6*4 allele in combination with a normal function or an increased function allele may have increased metabolism of bupropion as compared to patients with two normal function alleles or one normal function allele in combination with a decreased function allele or two decreased function alleles. Other genetic and clinical factors may also affect bupropion metabolism. This annotation only covers the pharmacokinetic relationship between CYP2B6 and bupropion and does not include evidence about clinical outcomes.; ': '与正常功能或增加的功能等位基因组合的患者可能会增加小学的代谢，与具有两种正常功能等位基因或一个正常功能等位基因的患者相比，与函数等位基因的较低或两个降低的功能等位基因相比。其他遗传和临床因素也可能影响约伯基代谢。该注释仅涵盖CYP2B6和Bupropion之间的药代动力学关系，并不包括有关临床结果的证据。',\n",
       " \"Patients with the SLC6A4 HTTLPR long form (L allele)/HTTLPR short form (S allele) genotype who are treated with fluoxetine may have decreased, but not absent, risk for side effects as compared to the SLC6A4 HTTLPR short form (S allele)/HTTLPR short form (S allele) genotype. Other genetic and clinical factors may also influence a patient's response to fluoxetine.; Depressive Disorder, Major\": '与氟西汀处理的SLC6A4 HTTLPR长形式（L等位基因）/ HTTLPR短型（S等位基因）基因型可能降低，但与SLC6A4 HTTLPR短的形式相比，副作用的副作用风险/HTTLPR短型（S等位基因）基因型。其他遗传和临床因素也可能影响患者对氟西汀的反应。抑郁症，主要',\n",
       " 'Allele C is associated with increased response to candesartan in people with Hypertension as compared to allele T.': '与等位基因T.相比，等位基因C与高血压人民的坎莎坦的反应增加有关。',\n",
       " 'Patients with the GG genotype and and colorectal cancer who are receiving FOLFOX/XELOX regimens may have a poorer response rate as compared to patients with the GT or TT genotype. Other genetic and clinical factors may also influence response to chemotherapy regimens.; Colorectal Neoplasms': '与具有GT或TT基因型的患者相比，患有GG基因型和和结肠直肠癌的患者可能具有较差的反应率。其他遗传和临床因素也可能影响对化疗方案的反应。结直肠肿瘤',\n",
       " 'Patients with the GG genotype had a greater % decrease in the Montgomery-Asberg Depression Rating Scale (MADRS) score from baseline as compared to those with the GT genotype. Note that in the initial GWAS analysis, this variant only reached the \"suggestive\" (p<5E-5) threshold.': '与具有GT基因型的人相比，患有GG基因型的蒙哥马利 -  Asberg抑郁额度（MADRS）评分的患者减少了更大的％。注意，在初始GWAS分析中，该变体仅达到了“暗示”（P <5E-5）阈值。',\n",
       " \"Patients with the CT genotype and Rheumatoid Arthritis who are treated with methotrexate may have an increased likelihood of treatment being ineffective as compared to patients with the CC genotype or may have an increased likelihood of treatment being effective as compared to patients with the TT genotype. This association was not statistically significant after Bonferroni correction. Other genetic and clinical factors may also influence a patient's response to methotrexate treatment.; Arthritis, Rheumatoid\": '与甲氨蝶呤治疗的CT基因型和类风湿性关节炎的患者可能导致治疗的可能性随比患有CC基因型的患者，或者可能具有与TT基因型患者有效的治疗的可能性增加。Bonferroni校正后，这种关联在统计学上没有统计学意义。其他遗传和临床因素也可能影响患者对甲氨蝶呤治疗的反应。关节炎，类风湿',\n",
       " \"Patients with the GG genotype and Hypercholesterolemia may have an increased risk of statin-related myalgia as compared to patients with the AA or AG genotype. Other genetic and clinical factors may also influence a patient's risk for myalgia.; Myalgia unspecified\": '与AA或AG基因型的患者相比，GG基因型和高胆固醇血症的患者可能产生肠毒素相关的肌痛的风险增加。其他遗传和临床因素也可能影响患者对肌痛的风险。Myalgia未指明',\n",
       " \"Cancer patients with the GG genotype who are treated with doxorubcin or idarubicin may have a decreased, but not absent, risk for cardiotoxicity as compared to patients with the AA genotype. Other genetic and clinical factors may also influence a patient's risk for cardiotoxicity.; Neoplasms\": '与AA基因型的患者相比，癌症患者患有多柔吩或近毒素或近毒素的GG基因型可能具有减少，但不存在的风险，毒性患者。其他遗传和临床因素也可能影响患者心脏毒性的风险。肿瘤',\n",
       " 'Patients with the TT genotype may have an increased risk for developing prostate cancer when treated with aspirin as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk of developing prostate cancer in patients taking aspirin.; Prostatic Neoplasms': '与患有GG基因型患者相比，患有TT基因型的患者可能对发育阿司匹林进行治疗时的风险增加。其他遗传和临床因素也可能影响服用阿司匹林患者培养前列腺癌的风险。前列腺肿瘤',\n",
       " 'Note that the association of *17/*17 alone with trough concentrations was significant in univariate (p=0.0077) but not multivariate analysis.': '注意，单独具有槽浓度的* 17 / * 17的关联在单变量中具有显着性（P = 0.0077）但不具有多变量分析。',\n",
       " \"Patients with the CC genotype and Attention Deficit Disorder with Hyperactivity may have a decreased response to treatment with methylphenidate as compared to patients with the CT or TT genotypes. Other genetic and clinical factors may also affect a patient's response to methylphenidate; Attention Deficit Disorder with Hyperactivity\": '患有CC基因型和注意力缺陷障碍的患者可能对CT或TT基因型的患者相比，对甲基酚的治疗可能会降低。其他遗传和临床因素也可能影响患者对甲基酚的反应;注意力缺陷症与多动症',\n",
       " 'The C allele of rs75017182 when measured on plus chromosomal strand is a marker for the Hap3B allele and is assigned decreased function by CPIC. Patients with the CC genotype and cancer who are treated with fluorouracil, a fluoropyrimidine-based chemotherapy, may have an increased risk of drug toxicity as compared to patients with the GG genotype. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence risk of drug toxicity.; Neoplasms': '在加染色体链上测量时RS75017182的C等位基因是HAP3B等位基因的标志物，并通过CPIC分配降低的功能。与氟嘧啶的化学疗法治疗的CC基因型和癌症的患者可能具有增加的药物毒性的风险增加，与GG基因型患者相比。但是，已经报告了相互矛盾的证据。其他遗传和临床因素也可能影响药物毒性的风险。肿瘤',\n",
       " 'SLC6A4 HTTLPR short form (S allele)/HTTLPR short form (S allele) is associated with increased response to fluoxetine or sertraline in people with Depressive Disorder, Major as compared to SLC6A4 HTTLPR long form (L allele).': 'SLC6A4 HTTLPR短型（S等位基因）/ HTTLPR短型（S等位基因）与抑郁症的人对氟西汀或肉甲胺的响应增加有关，与SLC6A4 HTTLPR长形式（L等位基因）相比。',\n",
       " 'Patients with osteosarcoma and the rs17222723 TT genotype may have an increased risk of developing leukopenia when treated with methotrexate as compared to patients with the AA genotype. Other genetic and clinical factors may also influence risk of developing leukopenia when treated with methotrexate.; Leukopenia;Osteosarcoma': '与AA基因型患者相比，患有骨肉瘤和17222723 TT基因型的TT基因型可能具有增加的风险，当用AA基因型患者用甲氨蝶呤处理时，在用甲氨蝶呤处理时。其他遗传和临床因素还可能影响用甲氨蝶呤处理时显影白细胞减少症的风险。白细胞减少症;骨肉瘤',\n",
       " 'Patients with the CC genotype may have decreased blood concentrations of acetaldehyde, a metabolite of ethanol, as compared to patients with the CT genotype. Note that this association was not seen at all timepoints studied. Other genetic and clinical factors may also affect blood concentrations of acetaldehyde.; ': '与CT基因型的患者相比，CC基因型的患者可能降低乙醛，乙醇代谢物的血液浓度。请注意，在研究的所有时间点都没有看到此关联。其他遗传和临床因素也可能影响丙醛的血液浓度;',\n",
       " 'Patients with the CT genotype and inflammatory bowel disease may have decreased response to adalimumab compared to patients with the TT genotypes. Other factors may affect response to adalimumab.; Inflammatory Bowel Diseases': '与TT基因型的患者相比，患有CT基因型和炎性肠病疾病的患者可能会降低对Adalimalab的反应。其他因素可能会影响对Adalimumab的反应;炎症性肠病疾病',\n",
       " 'Patients with the AA genotype may have an increased risk for alcoholism as compared to patients with the GG genotype. Other genetic and clinical factors may also influence risk of alcoholism.; Alcoholism': '与GG基因型患者相比，AA基因型的患者可能对酗酒的风险增加。其他遗传和临床因素也可能影响酗酒的风险。酗酒',\n",
       " \"Patients with hypertension and the CT genotype may have an increased response to metoprolol, as measured by a decrease in systolic blood pressure, as compared to patients with the CC genotype. Other genetic and clinical factors may also affect a patient's response to metoprolol.; Hypertension\": '与CC基因型的患者相比，高血压和CT基因型的患者可能对富含托洛尔的响应增加，如通过收缩压的降低。其他遗传和临床因素也可能影响患者对美托洛尔的反应。高血压',\n",
       " 'Patients with the TT genotype and sickle-cell anemia may have increased levels of glucuronidation of morphine as compared to patients with the CC or CT genotypes and sickle cell anemia. Other genetic and clinical factors may also affect morphine glucuronidation in patients with sickle cell anemia.; Anemia, Sickle Cell': '与CC或CT基因型和镰状细胞贫血患者相比，TT基因型和镰状细胞贫血患者可能增加了吗啡的葡萄糖水平。其他遗传和临床因素也可能影响镰状细胞贫血患者的吗啡葡糖醛糖。贫血，镰状细胞',\n",
       " 'Patients with the CC genotype who underwent kidney transplantation may have increased trough concentrations of sirolimus as compared to patients with the CT or TT genotype. Other genetic and clinical factors may also influence sirolimus trough concentrations.; Kidney Transplantation': '与CT或TT基因型患者相比，接受肾移植的CC基因型的患者可能具有增加的超毒素浓度。其他遗传和临床因素也可能影响西罗莫司槽浓度。肾移植',\n",
       " 'Patients with the CT genotype and breast cancer may have an increased risk for nausea when treated with cyclophosphamide, doxorubicin and fluorouracil (FAC) as compared to patients with the CC genotype. Other genetic and clinical factors may also influence risk for nausea in patients taking FAC chemotherapy.; Breast Neoplasms': '与CC基因型患者相比，患有CT基因型和乳腺癌的患者可能对恶心的风险增加了恶心的风险。其他遗传和临床因素也可能影响患有FAC化疗的患者恶心的风险。乳房肿瘤',\n",
       " \"Patients with the AA genotype and open-angle glaucoma who are treated with timolol may have an increased risk for bradycardia as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's risk for bradycardia.; Bradycardia\": '与蒂洛尔治疗的AA基因型和开口角度胶囊患者可能对Bradycardia的风险增加，与GG基因型的患者相比。其他遗传和临床因素也可能影响患者对Bradycardia的风险。Bradycardia',\n",
       " \"Patients with schizophrenia and the CG genotype may have a decreased response to lurasidone as compared to patients with the CC genotype. Note that this association was only found in patients of European ancestry. Other genetic and clinical factors may also affect a patient's response to lurasidone.; Schizophrenia\": '与CC基因型的患者相比，有精神分裂症和CG基因型的患者可能对LuraAnidone的反应降低。请注意，此协会仅在欧洲祖先患者中找到。其他遗传和临床因素也可能影响患者对LURASIDONE的反应。精神分裂症',\n",
       " 'Patients with genotype AA may have increased likelihood of cardiotoxicity when exposed to anthracyclines and related substances in children with Neoplasms as compared to patients with genotype CC or AC, although this is contradicted in one study. Other genetic and clinical factors may also influence the toxicity to anthracyclines.; ': '患有基因型AA的患者可能会增加心脏毒性时的可能性在暴露于肿瘤儿童中的蒽霉素和相关物质中，而与基因型CC或AC的患者相比，虽然这在一项研究中相矛盾。其他遗传和临床因素也可能影响对蒽氟胺的毒性。',\n",
       " 'Patients with the TT genotype who are undergoing methadone maintenance treatment may have decreased severity of opiate withdrawal symptoms as compared to patients with the CC genotype. Other genetic and clinical factors may also influence opiate withdrawal symptoms in patients receiving methadone.; Opioid-Related Disorders': '与CC基因型患者相比，患有甲基维持治疗的TT基因型的TT基因型可能降低了印刷症状的严重程度。其他遗传和临床因素也可能影响接受美沙酮患者的印章戒断症状。与阿片类药物相关的疾病',\n",
       " 'Patients with HIV and the CT genotype may experience a decreased severity of nephrotoxicity when treated with tenofovir disoproxil fumarate as compared to patients with the TT genotype. Other genetic and clinical factors may also affect severity of nephrotoxicity.; HIV Infections;nephrotoxicity': '与TT基因型的患者相比，患有HIV和CT基因型的患者可能会经历肾致毒性富马特的肾毒性的严重程度。其他遗传和临床因素也会影响肾毒性的严重程度。艾滋病毒感染;肾毒性',\n",
       " 'Patients with the TT genotype and rheumatoid arthritis may have an increased likelihood of achieving remission when treated with sulfasalazine as compared to patients with the GG genotype. Other genetic and clinical factors may also influence response to sulfasalazine.; Arthritis, Rheumatoid': '与磺基碱处理相比，患有TT基因型和类风湿性关节炎的患者可能会增加在用GG基因型的患者用磺基碱处理时达到缓解的可能性。其他遗传和临床因素也可能影响对苏氟碱的反应。关节炎，类风湿',\n",
       " 'Post-menopausal women with the TT genotype and breast cancer, who are taking letrozole may have increased plasma concentrations of triglycerides and decreased hdl cholsterol as compared to women with the CC or CT genotypes. Other clinical and genetic factors may also influence triglyceride levels in postmenopausal women with breast cancer who are taking letrozole.; Breast Neoplasms;Menopause': '患有TT基因型和乳腺癌的绝经后妇女，他服用Letrozole可能会增加甘油三酯的血浆浓度，与患有CC或CT基因型的女性相比的HDL Cholsterol降低。其他临床和遗传因素还可能影响患有乳腺癌的绝经后妇女甘油三酯水平，患有Letrozole。乳腺肿瘤;更年期',\n",
       " 'Patients with the GG genotype and breast cancer may have a better response when treated with cyclophosphamide, epirubicin and fluorouracil as compared to patients with the CC genotype. Other genetic and clinical factors may also influence response to treatment with cyclophosphamide, epirubicin and fluorouracil. (Note: with a C/G variant, particularly in a gene on the minus chromosomal strand, and frequencies close to 50% there can be a difficulty in interpreting the evidence for association.); Breast Neoplasms': '与CC基因型患者相比，当用环磷酰胺，同源素和氟尿嘧啶处理时，GG基因型和乳腺癌的患者可能具有更好的反应。其他遗传和临床因素也可能影响与环磷酰胺，同质素和氟尿嘧啶治疗的反应。（注意：用C / G变体，特别是在减去染色体链的基因中，并且接近50％的频率可能难以解释关联的证据。）;乳房肿瘤',\n",
       " \"Patients with the GG genotype may have increased opioid dose requirements as compared to patients with the AA genotype. Other genetic and clinical factors may also affect a patient's opioid dose requirements.; Pain\": '与AA基因型患者相比，GG基因型的患者可能会增加阿片样物剂量要求。其他遗传和临床因素也可能影响患者的阿片类药物需求。疼痛',\n",
       " \"Patients with the CC genotype and asthma who are treated with corticosteroids may have increased change in forced expiratory volume in 1 s (FEV1) as compared to patients with the CG or GG genotype. Other genetic and clinical factors may also influence a patient's response to corticosteroids.; Asthma\": '与CG或GG基因型患者相比，用皮质类固醇治疗的CC基因型和哮喘的患者可能在1S（FEV1）中的迫使呼气量增加。其他遗传和临床因素也可能影响患者对皮质类固醇的反应。哮喘',\n",
       " ...}"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dict(zip(list(df_translate[\"en_str\"].values),\n",
    "         list(df_translate[\"cn_str\"].values)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "029ccae6",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
